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1.1. Cancer - The Need for Effective Diagnosis and Therapy 
i 
1.1.1. Cancer 
At t h e b e g i n n i n g o f t h i s c e n t u r y t h e I m p e r i a l Cancer Research Fund 
(ICRF) was founde d i n London, an i n d i c a t i o n a t t h e t i m e o f t h e g r o w i n g 
c o n c e r n f o r t h e m y s t i c a l d i s e a s e , c a n c e r . Cancer has been known s i n c e 
t h e t i m e o f t h e a n c i e n t E g y p t i a n s , b u t i t i s o n l y r e l a t i v e l y r e c e n t l y , 
as l i f e e x p e c t a n c y has i n c r e a s e d , t h a t c ancer has become a major cause 
o f d e a t h . Today, i n t h e developed w o r l d , cancer accounts f o r one d e a t h 
i n e v e r y f i v e , and one person i n t h r e e i s l i k e l y t o c o n t r a c t t h e 
d i s e a s e . 
1.1.2. Carcinogenesis 
C a r c i n o g e n e s i s i s a m u l t i s t a g e p r o c e s s . Exposure t o a c a r c i n o g e n 
l e a d s t o an " i n i t i a t i o n " p r o c e s s , w h i c h i s w i d e l y b e l i e v e d t o i n v o l v e a 
d i s r u p t i o n o f c e r t a i n genes i n DNA. " I n i t i a t e d " c e l l s may e x i s t f o r a 
l o n g p e r i o d o f t i m e w i t h o u t t r a n s f o r m i n g t o tumour c e l l s . Only when 
a c t e d upon by a " p r o m o t i n g a g e n t " do t h e subsequent s t a g e s o f 
c a r c i n o g e n e s i s o c c u r , r e s u l t i n g i n tumour g r o w t h . Much i s y e t t o be 
l e a r n t about t h e g r o w t h c o n t r o l p r o c e s s e s o f c e l l s , b u t i t i s u n d e r s t o o d 
t h a t i n normal c i r c u m s t a n c e s t h e r e a r e f i n e l y b a l a n c e d s t i m u l a t i n g and 
i n h i b i t i n g f a c t o r s . Tumour c e l l s may be d e f i n e d as b e i n g d i f f e r e n t f r o m 
normal c e l l s i n t h a t t h e y a r e no l o n g e r r e s p o n s i v e t o nor m a l g r o w t h 
c o n t r o l l i n g f a c t o r s , o r a t l e a s t n o t a l l o f them, so t h e b a l a n c e i s 
l o s t . 
1.1.3. Cancer Research - the goals 
The p r i m a r y g o a l o f cancer r e s e a r c h i s t o g a i n a f u l l u n d e r s t a n d i n g 
o f t h e d i s e a s e and u l t i m a t e l y t o d e v e l o p t h e t e c h n o l o g y t o p r e v e n t i t . 
I n t h e meantime t h e o b j e c t i v e o f much can c e r r e s e a r c h work i s t h e 
a b i l i t y t o a t l e a s t c o n t r o l cancer. T h i s i n v o l v e s d e v i s i n g a r e l i a b l e 
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method f o r t h e d e t e c t i o n o f tumours a t an e a r l y s t a g e f o l l o w e d by 
a d m i n i s t r a t i o n o f an e f f e c t i v e t h e r a p y t r e a t m e n t . 
1.1.4. Existing Chemotherapy 
Many c h e m o t h e r a p e u t i c agents have been used i n t h e t r e a t m e n t o f 
c a n c e r s and many more a r e b e i n g i n v e s t i g a t e d f o r a n t i t u m o u r a c t i v i t y . 
I t i s p o s s i b l e f o r chemotherapy t o c u r e some can c e r s e.g. c e r t a i n t y p e s 
o f l e u k e m i a , s o f t t i s s u e sarcomas and lymphomas. The drugs c i s p l a t i n 
( c i s - ( P t C l 2 ( N H 3 ) 2 ) ) and c a r b o p l a t i n ( C 3 H 6 - C ( C 0 2 ) 2 - P t ( N H 3 ) 2 ) w h i c h a r e 
2-4 
known t o c r o s s l i n k between a d j a c e n t g u a n i n e r e s i d u e s i n DNA, c a u s i n g 
d i s t o r t i o n o f t h e do u b l e h e l i x s t r u c t u r e , have been used s u c c e s s f u l l y i n 
t h e t r e a t m e n t o f some c a n c e r s . For example, g r e a t e r t h a n 807. r e m i s s i o n 
has been a c h i e v e d f o r t e s t i c u l a r and c e r t a i n t y p e s o f o v a r i a n c a n c e r . 
However, t h i s c o n s t i t u t e s o n l y a s m a l l p e r c e n t a g e o f t h e c a n c e r s i n t h e 
w o r l d . Some o f t h e most common can c e r s ( e . g . l u n g , c o l o n / r e c t u m and 
p r o s t a t e ) a r e among t h e l e a s t t r e a t a b l e by c h e m o t h e r a p e u t i c d r u g s and 
have t h e l o w e s t s u r v i v a l r a t e s [ F i g . 1 . 1 ] . One o f t h e main 
d i s a d v a n t a g e s o f c h e m o t h e r a p e u t i c a g e n t s i s t h e i r l a c k o f s p e c i f i c i t y o f 
a c t i o n upon tumour c e l l s o v e r normal c e l l s . For t h i s r e a s o n h i g h doses 
have t o be a d m i n i s t e r e d i n o r d e r t o have any e f f e c t upon t h e tumour 
c e l l s , b u t t h i s o f t e n has h a r m f u l e f f e c t s on normal t i s s u e and v i t a l 
o r g a n s . 
1.1.5. The aims of this research project 
An o b v i o u s s o l u t i o n t o t h e p r o b l e m o f dosage i s t o use a t a r g e t i n g 
d e v i c e i n o r d e r t o d i r e c t t h e c y t o t o x i c agent s p e c i f i c a l l y t o t h e 
tumour, such t h a t a l e t h a l dose can be d e l i v e r e d t o t h e tumour c e l l s 
w i t h o u t h a r m i n g normal c e l l s . T h i s p r o j e c t i s d e d i c a t e d t o a method o f 
tumour t a r g e t i n g u s i n g monoclonal a n t i b o d i e s ( s e c t i o n 1.2.3.) t h a t have 
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1.2.2.). I t i s proposed t h a t by l a b e l l i n g t h e a n t i b o d y w i t h s e l e c t e d 
r a d i o i s o t o p e s i t w i l l be p o s s i b l e t o d e t e c t and d e s t r o y tumour c e l l s , 
w i t h m i n i m a l e f f e c t t o normal c e l l s . T h i s method i s hoped t o be 
p a r t i c u l a r l y u s e f u l i n t h e d e t e c t i o n and d e s t r u c t i o n o f s m a l l secondary 
tumours o r metastases w h i c h a r e a t p r e s e n t v e r y d i f f i c u l t t o d e t e c t and 
t r e a t ( l a r g e r p r i m a r y tumours can o f t e n be removed s u r g i c a l l y ) . 
The work d e s c r i b e d i n t h i s p r o j e c t i s concerned w i t h t h e c h e m i s t r y 
o f b i n d i n g t h e r a d i o n u c l i d e and a t t a c h i n g i t t o t h e mo n o c l o n a l a n t i b o d y . 
1.2. Antibodies for Tumour Targeting 1 , 5' 1 2 
1.2.1. Antibodies 
A n t i b o d i e s a r e p r o t e i n s ( i m m u n o g l o b u l i n s ) made by h i g h e r a n i m a l s 
when i n f e c t e d w i t h b a c t e r i a , v i r u s e s o r o t h e r f o r e i g n s u b s t a n c e s . They 
a r e produced by B-Lymphocyte c e l l s ( p r e s e n t i n t h e lymph nodes and t h e 
s p l e e n ) as p a r t o f a complex immune response a g a i n s t t h e f o r e i g n 
s u b s t a n c e . 
I n t h e i r s i m p l e s t f o r m a n t i b o d i e s a r e made o f two p a i r s o f heavy 
and l i g h t p o l y p e p t i d e c h a i n s l i n k e d by d i s u l p h i d e bonds ( F i g . 1 . 2 ) . The 
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r e g i o n s . The l i g h t c h a i n s c o n s i s t o f one v a r i a b l e r e g i o n and o n l y one 
c o n s t a n t r e g i o n . One l i g h t c h a i n f o l d s o v e r t h e f i r s t h a l f o f one heavy 
c h a i n f o r m i n g a " F ( a b ) n arm w i t h a complex 3-D s t r u c t u r e w h i c h 
c o n s t i t u t e s t h e a n t i g e n b i n d i n g s i t e . The c o m p l e t e a n t i b o d y c o n s i s t s o f 
two F ( a b ) arms a t t a c h e d t h r o u g h d i s u l p h i d e b r i d g e s . The r e m a i n i n g 
c o n s t a n t r e g i o n s o f t h e heavy c h a i n , t h e "Fc" p o r t i o n , m e d i a t e s t h e 
e f f e c t o r f u n c t i o n s o f t h e a n t i b o d y (complement b i n d i n g , a t t a c h m e n t t o 
and t r a n s p o r t a c r o s s membranes) a c c o r d i n g t o t h e i m m u n o g l o b u l i n c l a s s t o 
w h i c h i t b e l o n g s . 
1.2.2. Antigens 
A n t i g e n s a r e t h e f o r e i g n s u b s t a n c e s w h i c h i n v o k e a r e s p o n s e f r o m 
t h e immune system. Tumour c e l l s u s u a l l y e x p r e s s a n t i g e n s w h i c h a r e n o t 
produced by n o r m a l c e l l s ( e . g . a l t e r e d p r o t e i n s o r c a r b o h y d r a t e s ) . 
These a n t i g e n s may be s p e c i f i c t o t h e tumour c e l l , o r a t l e a s t h i g h l y 
s e l e c t i v e t o them. 
A n t i b o d i e s w h i c h r e c o g n i s e a p a r t i c u l a r a n t i g e n may be r a i s e d by 
i n j e c t i n g t h a t a n t i g e n i n t o a mouse and c o l l e c t i n g t h e a n t i b o d y 
p r o d u c i n g B-Lymphocyte c e l l s f r o m t h e s p l e e n . I n t h i s way a n t i b o d i e s 
may be r a i s e d a g a i n s t s p e c i f i c tumour a s s o c i a t e d a n t i g e n s . However, 
t h i s n o r m a l a n t i b o d y response i n t h e mouse produces a g r e a t d i v e r s i t y o f 
a n t i b o d i e s , a l l o f w h i c h r e c o g n i s e t h e tumour a s s o c i a t e d a n t i g e n . These 
a r e known as ' p o l y c l o n a l ' a n t i b o d i e s . The use o f r a d i o l a b e l e d 
p o l y c l o n a l a n t i b o d i e s f o r radioimmunoimaging and r a d i o i m m u n o t h e r a p y has 
i n t h e p a s t been shown t o be v e r y l i m i t e d . T h i s i s because t h e 
p o l y c l o n a l a n t i b o d i e s a r e n o t s p e c i f i c enough i n t a r g e t i n g t h e tumour 
c e l l s . 
1.2.3. Monoclonal antibodies 
I n 1975 K o h l e r and M i l s t e i n d e v e l o p e d t h e so c a l l e d "Hybridoma" 
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t e c h n i q u e f o r c l o n i n g i n d i v i d u a l a n t i b o d y f o r m i n g c e l l s such t h a t a 
s i n g l e t y p e o f a n t i b o d y ('monoclonal') h a v i n g a s p e c i f i c a n t i g e n b i n d i n g 
s i t e , c o u l d be produced. T h i s was a s i g n i f i c a n t b r e a k t h r o u g h i n t h e 
f i e l d o f a n t i b o d y t e c h n o l o g y and meant t h a t a n t i b o d i e s w i t h s u f f i c i e n t l y 
h i g h s p e c i f i c i t y f o r tumour t a r g e t i n g c o u l d be produced. T h i s l e d t o a 
r e v i v a l o f i n t e r e s t i n t h e "magic b u l l e t " approach o f t a r g e t i n g 
c y t o t o x i c agents t o tumour c e l l s . 
The "hybridoma" t e c h n i q u e ( F i g . 1.3) i n v o l v e s t h e f u s i n g o f t h e 
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F i g . 1.3. The "hybridoma" t e c h n i q u e f o r t h e p r o d u c t i o n o f 
monoclonal a n t i b o d i e s . 
B-Lymphocyte c e l l s f r o m t h e s p l e e n o f t h e immunised mouse, w i t h mouse 
myeloma c e l l s , p r o d u c i n g a h y b r i d c e l l ( H y b r i d o m a ) . The h y b r i d c e l l 
i n h e r i t s t h e c a p a c i t y o f t h e myeloma c e l l f o r c o n t i n u o u s p r o l i f e r a t i o n 
as w e l l as t h e B-Lymphocyte c e l l f o r p r o d u c i n g t h e s p e c i f i c a n t i b o d y . 
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The h y b r i d c e l l s a r e t h e n s e p a r a t e d f r o m u n f u s e d myeloma c e l l s by 
g r o w i n g t h e m i x t u r e i n a c u l t u r e w h i c h encourages h y b r i d o m a g r o w t h b u t 
n o t myelomal g r o w t h . The m i x t u r e i s t h e n d i l u t e d and p l a c e d i n 
m i c r o t i t r e w e l l s such t h a t each w e l l c o n t a i n s , on average, l e s s t h a n one 
c e l l . The c l o n e s a r e a l l o w e d t o grow and t h e c o n t e n t s o f each w e l l 
assayed f o r t h e r e q u i r e d m o n o c l o n a l a n t i b o d y . The a n t i b o d y used i n t h e 
13 
s t u d i e s d i s c u s s e d h e r e i n i s B72.3 whic h b i n d s s e l e c t i v e l y t o tumour 
a s s o c i a t e d g l y c o p r o t e i n (TAG-72) f o u n d p a r t i c u l a r l y i n human c o l o r e c t a l 
and b r e a s t c a n c e r s . 
1.2.4. Antibody fragments and chimaeric a n t i b o d i e s ^ 
A major p r o b l e m w i t h t h e use o f mouse mo n o c l o n a l a n t i b o d i e s f o r 
tumour t a r g e t i n g i s t h a t t h e y a r e t h e m s e l v e s immunogenic i n man. Human 
a n t i b o d i e s w ould be l e s s immunogenic because, a l t h o u g h t h e h y p e r v a r i a b l e 
r e g i o n c o n s t i t u t i n g t h e a n t i g e n b i n d i n g s i t e w o u l d i n h e r e n t l y be 
f o r e i g n , t h e r e m a i n i n g c o n s t a n t r e g i o n s would be c o n s i s t e n t w i t h o t h e r 
human i m m u n o g l o b u l i n s . However, s e v e r a l problems a r e e n c o u n t e r e d when 
u s i n g t h e h y b r i d o m a t e c h n i q u e w i t h human B-Lymphocyte c e l l s and i t has 
p r o v e d d i f f i c u l t t o produce human 'monoclonals' w i t h a p p r o p r i a t e 
s p e c i f i c i t y i n s u f f i c i e n t q u a n t i t i e s . A t p r e s e n t o t h e r ways o f 
i m m o r t a l i s i n g human a n t i b o d y f o r m i n g c e l l s a r e b e i n g s o u g h t . 
I n an a t t e m p t t o redu c e t h e i m m u n o g e n i c i t y t h e use o f a n t i b o d y 
' f r a g m e n t s ' has been i n v e s t i g a t e d , where o n l y t h e a n t i g e n b i n d i n g 
p o r t i o n o f t h e a n t i b o d y i s used. The c o n s t a n t "Fc" r e g i o n i s n e c e s s a r y 
f o r t h e normal immune response o f a n t i b o d i e s , b u t i s n o t r e q u i r e d f o r 
tumour t a r g e t i n g . The i n t a c t m o l e c u l e may be c l e a v e d u s i n g t h e 
p r o t e o l y t i c enzymes p e p s i n o r p a p a i n t o g i v e F f a b ' ^ o r Fab f r a g m e n t s 
r e s p e c t i v e l y ( F i g . 1.4). 
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F i g . 1.4. P r o t e o l y t i c c l e a v a g e o f t h e a n t i b o d y t o Fab and F ^ b ' ^ 
f r a g m e n t s . 
p r o t e i n m o l e c u l e s t r a v e l more e a s i l y t h r o u g h narrow c a p i l l a r i e s and so 
l o c a l i s e more q u i c k l y a t t h e s i t e o f a tumour, w i t h a g r e a t e r chance o f 
p e n e t r a t i n g t h e more h i n d e r e d s i t e s . The f r a g m e n t a n t i b o d i e s a r e a l s o 
c l e a r e d more r a p i d l y f r o m g e n e r a l c i r c u l a t i o n , i m p r o v i n g t h e tumour t o 
background r a t i o when r a d i o l a b e l e d . One d i s a d v a n t a g e i s t h e h i g h 
k i d n e y background l e v e l o b s e r v e d as a r e s u l t o f t h e f a s t e r and more 
d i r e c t c l e a r a n c e . 
An a l t e r n a t i v e a pproach t o t h e p r o b l e m o f i m m u n o g e n i c i t y o f mouse 
mo n o c l o n a l s has been i n v e s t i g a t e d . U s i n g r e c o m b i n a n t DNA t e c h n o l o g y t h e 
i m m u n o l o g i s t s have d e v i s e d a way o f making a n t i b o d i e s c a l l e d " C h i m a e r i c " 
a n t i b o d i e s w h i c h a r e p a r t human and p a r t mouse. T h i s i s done by 
co m b i n i n g p o r t i o n s o f one a n t i b o d y gene w i t h segments o f a n o t h e r . 
C h i m a e r i c a n t i b o d i e s have been c o n s t r u c t e d i n w h i c h t h e v a r i a b l e r e g i o n s 
o f t h e heavy and l i g h t c h a i n s are encoded by genes o f t h e mouse a n t i b o d y 
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s e c r e t i n g c e l l s and t h e c o n s t a n t r e g i o n s a r e encoded by human genes. 
Hence t h e a n t i b o d y has t h e a n t i g e n r e c o g n i s a b l e v a r i a b l e r e g i o n s o f t h e 
mouse a n t i b o d y and t h e c o n s t a n t "Fc" r e g i o n o f t h e human a n t i b o d y , w h i c h 
i s much l e s s l i k e l y t o produc e an immune response i n humans. 
1.3. Radionuclides For Tumour Imaging 1 4 
1.3.1. Imaging methods*4 
I n v i v o i m a g i n g r e l i e s upon a f o r m o f e l e c t r o m a g n e t i c r a d i a t i o n 
w hich has m i n i m a l i n t e r a c t i o n w i t h t h e b i o l o g i c a l t i s s u e s o f t h e body, 
b u t w h i c h can i n t e r a c t e f f i c i e n t l y w i t h a d e t e c t o r t o produc e a s i g n a l . 
B i o l o g i c a l t i s s u e s absorb r a d i a t i o n i n t h e mid range ( 1 0 ^ - 1 0 ^ Hz) 
l e a v i n g t h e h i g h energy and low energy ends o f t h e sp e c t r u m f o r use i n 
i m a g i n g . M R ( r a d i o f r e q u e n c y ) and u l t r a s o u n d a r e examples o f low energy 
r a d i a t i o n s w h i c h may be used f o r i m a g i n g . The use o f r a d i o n u c l i d e s , 
e m i t t i n g h i g h energy r a d i a t i o n , i s t h e most common f o r m o f i m a g i n g t o 
d a t e . 
The r a d i o n u c l i d e s most s u i t a b l e f o r i m a g i n g a r e gamma (7) e m i t t e r s . 
There a r e two d i f f e r e n t t y p e s o f 7 e m i t t e r s : s i n g l e p h o t o n e m i t t e r s , 
where t h e 7 e m i s s i o n o c c u r s as a d i r e c t r e s u l t o f s i m p l e n u c l e a r decay; 
and p o s i t r o n e m i t t e r s where t h e i s o t o p e e m i t s a p o s i t r o n and l e a d s t o 
t h e c r e a t i o n o f two o p p o s i n g 511 keV 7-rays, by e l e c t r o n p o s i t r o n 
a n n i h i l a t i o n . Two d i f f e r e n t methods o f d e t e c t i o n a r e used f o r t h e two 
t y p e s o f gamma e m i s s i o n . 
Gamma Rav S c i n t i g r a p h y - s i n g l e p h o t o n e m i t t e r s 
The s i n g l e p h o t o n emitting i s o t o p e s require a s t a t i c Anger camera 
(Fig. 1.5). A c o l l i m a t o r i s required due t o t h e random n a t u r e o f t h e 
gamma e m i s s i o n . The gamma rays then s t r i k e t h e N a l ( T l ) c r y s t a l , 












F i g . 1.5. The Anger Camera. 
g i v e an e l e c t r i c a l s i g n a l and t h e e l e c t r i c a l p u l s e s a r e t h e r e a f t e r 
c o u n t e d . As t h e r e i s a l i m i t e d number o f p h o t o m u l t i p l i e r t u b e s , t h e 
p o s i t i o n o f t h e y r a y i n t e r a c t i o n w i t h t h e c r y s t a l i s i d e n t i f i e d by t h e 
l i g h t i n t e n s i t y d e t e c t e d by each t u b e . The r e s o l u t i o n o b t a i n a b l e f r o m 
t h i s system i s modest a t 1-2 cm. 
I n o r d e r t o o b t a i n a more t h r e e d i m e n s i o n a l image o f t h e tumour 
(Tomography) t h e Anger camera may be r o t a t e d around t h e p a t i e n t , 
r e c o r d i n g t h e s i g n a l s a t d i f f e r e n t a n g l e s and r e c o n s t r u c t i n g t h e 
a c t i v i t y d i s t r i b u t i o n t h r o u g h a back p r o j e c t i o n p r o c e s s . The p r o c e d u r e 
i s c o m p u t e r i s e d and known as S i n g l e Photon E m i s s i o n Computerised 
Tomography (SPECT). 
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P o s i t r o n E m i s s i o n Tomography 
I f a r a d i o n u c l i d e e m i t s a p o s i t r o n (/?+) whi c h a n n i h i l a t e s w i t h an 
e l e c t r o n f r o m t h e s u r r o u n d i n g t i s s u e , two p h o t o n s (511 keV) a r e p r o d u c e d 
w h i c h t r a v e l a t 180° t o each o t h e r . As a r e s u l t o f t h e d i r e c t i o n a l 
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n a t u r e o f t h e s e e m i s s i o n s , t o m o g r a p h i c a l i n f o r m a t i o n may be o b t a i n e d by 
d e t e c t i n g t h e two gamma's i n c o i n c i d e n c e . A l i n e may be drawn between 
t h e two p o i n t s o f d e t e c t i o n , on whic h t h e i s o t o p e must l i e . The e x a c t 
p o s i t i o n o f t h e source may be d e t e r m i n e d by t h e d i f f e r e n c e i n t h e 'time 
o f f l i g h t ' measurements, a f t e r c o r r e c t i n g f o r an absorbance f a c t o r 
a s s o c i a t e d w i t h t h e body t i s s u e s . The e a r l y PET scanners c o n s i s t e d o f 
two d e t e c t o r s o p p o s i t e each o t h e r which were r o t a t e d around t h e p a t i e n t , 
whereas t o d a y t h e d e s i g n s u s u a l l y c o n s i s t o f a c o n t i n u o u s r i n g o f 
d e t e c t o r s i n whic h t h e p a t i e n t i s p o s i t i o n e d i n t h e c e n t r e . I n o r d e r t o 
make a more a c c u r a t e d e t e r m i n a t i o n o f t h e t i m e o f f l i g h t , f a s t e r 
s c i n t i l l a t o r s such as CsF o r BaF2 ( r a t h e r t h a n N a l ) a r e used i n t h e 
modern i n s t r u m e n t s . T h i s i s i m p o r t a n t f o r a c h i e v i n g b e t t e r r e s o l u t i o n 
w h i c h a t 3-4 mm i s much b e t t e r t h a n w i t h s i n g l e photon e m i t t e r s and t h e 
Anger camera. The main d i s a d v a n t a g e w i t h PET scanners i s t h e c o s t o f 
t h e cameras r e q u i r e d . At around one m i l l i o n pounds t h e y a r e 
a p p r o x i m a t e l y t e n t i m e s more e x p e n s i v e t h a n t h e Anger cameras. For t h i s 
r e ason i t i s e x p e c t e d t h a t t h e l a t t e r r a t h e r t h a n t h e f o r m e r w i l l 
c o n t i n u e t o be used most commonly. 
1.3.2. Selection of radionuclides f o r tumour imaging 
I n a d d i t i o n t o s e l e c t i n g t h e t y p e o f r a d i a t i o n r e q u i r e d f o r tumour 
i m a g i n g , t h e r e a r e s e v e r a l more n u c l e a r p r o p e r t i e s t o c o n s i d e r b e f o r e 
s e l e c t i n g t h e most s u i t a b l e r a d i o n u c l i d e s : 
H a l f l i f e 
The h a l f l i f e o f t h e r a d i o n u c l i d e needs t o be l o n g enough t o a l l o w 
t r a n s p o r t a t i o n t o t h e tumour s i t e and a l l o w c o m p l e t e d i a g n o s i s , b u t 
s h o r t enough t o l i m i t t h e r a d i a t i o n dose r e q u i r e d . One must c o n s i d e r 
t h e t i m e r e q u i r e d f o r r a d i o l a b e l l i n g t h e a n t i b o d y , o r a n t i b o d y c o n j u g a t e 
(see s e c t i o n 1 . 5 . ) , t h e t i m e i t t a k e s f o r o p t i m a l target t o n o n - t a r g e t 
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r a t i o t o be a c h i e v e d a f t e r i n j e c t i o n and t h e t i m e i t t a k e s t o r e c o r d an 
image. The b i o d i s t r i b u t i o n c h a r a c t e r i s t i c s a r e p a r t i c u l a r l y i m p o r t a n t . 
B e f o r e b i n d i n g a t t h e t a r g e t a n t i g e n can o c c u r , t h e r a d i o l a b e l e d 
a n t i b o d y must p r o c e e d f r o m t h e b l o o d s t r e a m t o t h e e x t r a c e l l u l a r f l u i d 
o f t h e tumour s i t e . T h i s i s t h e r a t e l i m i t i n g s t e p , as t r a n s p o r t o f 
l a r g e l i p i d - i n s o l u b l e a n t i b o d y m o l e c u l e s ( m o l e c u l a r w e i g h t o f an IgG i s 
t y p i c a l l y 150,000) t h r o u g h t h e e n d o t h e l i a l p o r e s i n t o t h e e x t r a c e l l u l a r 
f l u i d i s r e l a t i v e l y slow ( e . g . 18-24 h o u r s ) . Once t h e r e , t h e b i n d i n g t o 
t h e s u r f a c e a n t i g e n s i s e x p e c t e d t o be r e l a t i v e l y f a s t . T a k i n g t h e s e 
f a c t o r s i n t o a c c o u n t a s u i t a b l e range o f h a l f l i f e i s c o n s i d e r e d t o be; 
6 h o u r s < t | < 8 days. 
Gamma energy 
The gamma e n e r g i e s o f t h e s i n g l e p h o t o n e m i t t e r s must be such t h a t 
t h e Anger camera ( N a l s c i n t i l l a t i o n ) can d e t e c t them and such t h a t 
b i o l o g i c a l t i s s u e s a r e r e l a t i v e l y t r a n s p a r e n t t o them. S u i t a b l e p h o t o n 
e n e r g i e s a r e ; 
80 keV < E pho t o n < 240 keV. 
Gamma abundance 
To m i n i m i s e t h e dose r e q u i r e d i t i s d e s i r a b l e t o have a h i g h 
abundance o f t h e s i n g l e energy gamma r a d i a t i o n used f o r t h e d e t e c t i o n . 
A l s o d e s i r a b l e , i s a z e r o o r low abundance o f p a r t i c u l a t e e m i s s i o n s 
( b e t a o r a l p h a p a r t i c l e s ) w h i c h may damage s u r r o u n d i n g t i s s u e . 
R a d i o c h e m i c a l p r o p e r t i e s 
The method o f p r o d u c t i o n o f t h e r a d i o i s o t o p e needs t o be r e l a t i v e l y 
s t r a i g h t f o r w a r d , such t h a t i t may be made a v a i l a b l e t o t h e c l i n i c i a n a t 
a r e a s o n a b l e c o s t . I t i s n e c e s s a r y t o be a b l e t o p u r i f y t h e r e q u i r e d 
i s o t o p e f r o m t h e p a r e n t t o a v o i d l a b e l l i n g w i t h ' c o l d ' i s o t o p e . A l s o i t 
i s i m p o r t a n t t h a t t h e s e l e c t e d i s o t o p e does n o t have hazardous d a u g h t e r 
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p r o d u c t s ( A l p h a o r Beta e m i t t e r s ) . 
Chemical p r o p e r t i e s 
The r a d i o n u c l i d e must be s u i t a b l e f o r a t t a c h m e n t t o t h e a n t i b o d y 
e i t h e r d i r e c t l y o r , more u s e f u l l y , by b i f u n c t i o n a l c o m p l e x i n g a g e n t s 
( s e c t . 1 . 5 . ) . 
1.3.3. Candidates f o r imaging 
A l i s t o f c a n d i d a t e s which s a t i s f y some o r a l l o f t h e c r i t e r i a 
d i s c u s s e d i n s e c t i o n 1.3.2. a r e l i s t e d i n T a b l e 1.1. 
Of t h e s e , I o d i n e - 1 3 1 , Technetium-99m and I n d i u m - I l l a r e t h e 
i s o t o p e s which have been most e x t e n s i v e l y i n v e s t i g a t e d t o d a t e . 
T a b l e 1.1 
L i s t o f c a n d i d a t e s f o r tumour i m a g i n g 
R a d i o n u c l i d e t ^ E ph o t o n (7c) 
1 2 3 I 13.2 h r 159(83) 
1 2 5 I 60.0 d 27(138) 
3 5 ( 7 ) 
1 3 1 I * 8.05 d 364(82) 
1 1 3 m I n 1.68 h r 391(66) 
n l I n 2.83 d 171(88) 
247(94) 
9 9 m T c 6.02 h r 141(89) 
6 7 G a 3.25 d 184(24) 
8 2 R b (PET) 1.4 h r 511 
6 4 C u * (PET) 12.8 h r 511(120) 
6 8 G a (PET) 1.20 h r 511(178) 
* 131 
I has an accompanying /? e m i s s i o n E 0.188 MeV max 
T Cu has an accompanying f e m i s s i o n E 0.57 MeV 
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I o d i n e - 1 2 3 has i d e a l p r o p e r t i e s , b u t i s v e r y e x p e n s i v e t o produce 
i n a c a r r i e r f r e e f o r m ( g e n e r a t e d u s i n g a c y c l o t r o n ) . I o d i n e - 1 3 1 was 
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used most e x t e n s i v e l y i n t h e e a r l y a t t e m p t s a t i m a g i n g , b u t t h e gamma 
energy i s t o o h i g h f o r e f f i c i e n t d e t e c t i o n w i t h an Anger camera and t h e 
h a l f l i f e i s r a t h e r l o n g . F u r t h e r m o r e , I o d i n e - 1 3 1 has a c y t o t o x i c b e t a 
e m i s s i o n and t h e r a d i o l a b e l e d a n t i b o d y t e n d s t o d e i o d i n a t e i n v i v o . 
T h i s l e a d s t o i n c o r p o r a t i o n o f m e t a b o l i s e d I o d i n e - 1 3 1 i n t h e t h y r o i d and 
t h e e x c r e t i o n o f I o d i n e by t h e stomach and u r i n a r y t r a c t s , i m p a i r i n g 
s p e c i f i c tumour i m a g i n g . 
Technetium-99m has been f a v o u r e d f o r i m a g i n g purposes by v i r t u e o f 
i t s i d e a l gamma energy (141 keV) o f h i g h abundance and i t s r e a d y 
a v a i l a b i l i t y a t a r e a s o n a b l e c o s t f r o m a Molybdenum-99 g e n e r a t o r 
( o b t a i n a b l e c a r r i e r f r e e v i a A ^ O g / S i t ^ column c h r o m a t o g r a p h y ) . The 
major l i m i t i n g f e a t u r e however, i s t h e s h o r t h a l f l i f e (6.02 h ) . By t h e 
t i m e a h i g h t a r g e t t o n o n - t a r g e t r a t i o has been o b t a i n e d ( e . g . 2 days -
see s e c t . 1.3.2.) most o f t h e gamma a c t i v i t y w i l l have been l o s t . 
I n d i u m - 1 1 1 has r e c e i v e d most a t t e n t i o n i n r e c e n t y e a r s as a 
s u i t a b l e i m a g i n g c a n d i d a t e . I t has two h i g h abundance gamma e m i s s i o n s 
(173 and 247 keV) w i t h no a s s o c i a t e d p a r t i c u l a t e r a d i a t i o n and an i d e a l 
h a l f l i f e o f 2.83 days. The main d i s a d v a n t a g e i s t h a t i t i s o b t a i n e d 
f r o m a r e a c t o r w h i c h i s more i n c o n v e n i e n t and e x p e n s i v e t h a n a 
g e n e r a t o r . 
G a l l i u m - 6 7 i s b e g i n n i n g t o r e c e i v e some a t t e n t i o n as a p o t e n t i a l 
i m a g i n g i s o t o p e , t h o u g h t h e gamma i n t e n s i t y i s s i g n i f i c a n t l y l o w e r t h a n 
t h a t o f i n d i u m - 1 1 1 . 
Of t h e p o s i t r o n e m i t t e r s l i s t e d , o n l y Copper-64 has a s u i t a b l e h a l f 
l i f e (12.8 h ) . However, t h e c o s t o f p r o d u c t i o n i s t e n t i m e s t h a t o f 
i n d i u m - I l l , so a g a i n t h e h i g h c o s t d i s f a v o u r s t h e use o f PET. 
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1.4. Radionuclides For Tumour Therapy 
1.4.1. Introduction 
The use o f r a d i o n u c l i d e s f o r tumour t h e r a p y i s based upon t h e i r 
d e s t r u c t i v e power i . e . t h e a b i l i t y o f p a r t i c u l a t e r a d i a t i o n t o 
i r r e v e r s i b l y c l e a v e bonds i n t h e DNA o f tumour c e l l s and so d e s t r o y 
them. The advantage o f u s i n g r a d i o n u c l i d e s , r a t h e r t h a n a n t i - c a n c e r 
d r u g s t h a t a r e c o v a l e n t l y l i n k e d t o monoclonal a n t i b o d i e s , i s t h a t t h e 
f o r m e r need n o t e n t e r t h e c e l l t o d e s t r o y i t . A n t i - c a n c e r d r u g s l o s e 
t h e i r a b i l i t y t o pass r e a d i l y t h r o u g h c e l l membranes when a t t a c h e d t o 
l a r g e a n t i b o d y m o l e c u l e s and c o n s e q u e n t l y l o s e most o f t h e i r a c t i v i t y . 
I t s h o u l d be n o t e d t h a t r a d i o i m m u n o t h e r a p y i s a much more 
' c r i t i c a l 1 process t h a n r a d i o i m m u n o s c i n t i g r a p h y . The l a t t e r can 
t o l e r a t e a c e r t a i n l e v e l o f background r a d i a t i o n w i t h l i t t l e i l l - e f f e c t . 
The f o r m e r depends much more h e a v i l y on t h e achievement o f a h i g h t a r g e t 
t o n o n - t a r g e t r a t i o , e s p e c i a l l y w i t h r e s p e c t t o t h e r a d i o s e n s i t i v e 
o r g a n s such as bone marrow, i n t e s t i n a l mucosa, l i v e r and k i d n e y s . 
1.4.2. Choice of radiation 
A l p h a e m i t t e r s 
A l p h a e m i t t e r s on f i r s t c o n s i d e r a t i o n s appear t o be i d e a l 
c a n d i d a t e s f o r t h e r a p y . They have a s h o r t range (50-90 fim) and have a 
h i g h " l i n e a r energy t r a n s f e r " (LET) i . e . t h e y d e l i v e r a r e l a t i v e l y l a r g e 
amount o f energy w i t h i n a s h o r t d i s t a n c e (~ 80 keV/^m). A p p r o x i m a t e l y 
f o u r hundred t i m e s as many b e t a p a r t i c l e s would be r e q u i r e d t o o b t a i n a 
similar s o r t o f energy d e p o s i t i o n when t r a v e r s i n g a c e l l n u c l e u s 
( a p p r o x . 10 fim). P o t e n t i a l a l p h a s o u r c e s a r e Bismuth-212 and 
Astatine-211. I n g e n e r a l , the problem w i t h a l p h a s o u r c e s i s t h a t t h e 
very l a r g e a l p h a r e c o i l energy ( t y p i c a l l y several hun d r e d keV) i s l i k e l y 
t o r u p t u r e t h e a n t i b o d y r a d i o n u c l i d e bond, l e a v i n g t h e d a u g h t e r p r o d u c t 
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t o d i f f u s e away f r o m t h e tumour. As a l p h a e m i t t e r s a r e u s u a l l y t h e 
h e a v i e r e l e m e n t s ( a t o m i c number > 82) w h i c h decay t o u n s t a b l e d a u g h t e r 
p r o d u c t s , t h i s i s a major l i m i t a t i o n t o t h e i r use i n t h e r a p y . There a r e 
26 212 c e r t a i n w o r k e r s who c o n t i n u e t o p r o m u l g a t e t h e case f o r B i d e s p i t e 
i t s o b v i o u s l i m i t a t i o n s . 
B e t a e m i t t e r s 
The m a j o r i t y o f r a d i o n u c l i d e s c o n s i d e r e d f o r t h e r a p y a r e b e t a 
e m i t t e r s . D e s p i t e h a v i n g a l o w e r LET t h a n a l p h a p a r t i c l e s , b e t a 
p a r t i c l e s have t h e advantage o f h a v i n g a much g r e a t e r v a r i a t i o n i n 
range. The r a d i o n u c l i d e can be s e l e c t e d a c c o r d i n g t o t h e range r e q u i r e d 
i . e . t a i l o r e d t o t h e r e q u i r e m e n t s o f a p a r t i c u l a r t y p e and s i z e o f 
tumour. For example, Gold-199 has a range o f 100 m^ w h i c h i s s u i t a b l e 
f o r t h e t r e a t m e n t o f c e r t a i n t y p e s o f Leukemia, s m a l l m e t a s t a s e s and 
s m a l l tumours g e n e r a l l y . Y t t r i u m - 9 0 , on t h e o t h e r hand, has a mean 
range o f 3.9 mm and i s s u i t a b l e f o r t h e t r e a t m e n t o f l a r g e r tumours. I n 
many tumours t h e r e a r e " c o l d r e g i o n s " where t h e r e a r e low l e v e l s o f t h e 
t a r g e t a n t i g e n , so an i m p o r t a n t f a c t o r i s t h e " c r o s s f i r e " e f f e c t 
a s s o c i a t e d w i t h l o n g range e m i t t e r s i . e . t h e b e t a r a d i a t i o n t r a v e r s e s 
many c e l l d i a m e t e r s , p e n e t r a t i n g t h e c o l d r e g i o n s and a d m i n i s t e r i n g a 
l e t h a l dose o f r a d i a t i o n . 
1.4.3. General c r i t e r i a f o r the s e l e c t i o n of r a d i o n u c l i d e s f o r t h e r a p y 
H a l f l i f e 
The h a l f l i f e r e q u i r e d f o r t h e r a p y i s g e n e r a l l y a l i t t l e l o n g e r 
t h a n t h a t f o r i m a g i n g . The same p r i n c i p l e s a p p l y f o r a l l o w i n g t h e 
r e q u i r e d b i o d i s t r i b u t i o n t o t a k e p l a c e ( s e c t . 1.3.2.), but w i t h t h e r a p y 
a c o n t i n u e d p r e s e n c e o f t h e r a d i o n u c l i d e i s r e q u i r e d . This i s t o e n a b l e 
a s t e r i l i s i n g dose o f r a d i a t i o n ( e . g . 6000 r a d ) t o be a d m i n i s t e r e d t o 
t h e tumour c e l l s , perhaps o v e r a p e r i o d o f days. However, e x p e r i m e n t s 
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have shown t h a t a r a d i a t i o n dose d e l i v e r e d o v e r a l o n g p e r i o d o f t i m e i s 
l e s s e f f e c t i v e t h a n t h e same dose d e l i v e r e d more r a p i d l y by a s h o r t e r 
l i v e d i s o t o p e . F u r t h e r m o r e , t h e r a d i a t i o n dose must be d e l i v e r e d b e f o r e 
t h e r a d i o l a b e l e d a n t i b o d y i s i t s e l f c a t a b o l i s e d . A s u i t a b l e range o f 
h a l f l i f e i s c o n s i d e r e d t o be; 
6 h r < t£ < 4 weeks. 
More s p e c i f i c a l l y , t h e i d e a l h a l f l i f e has been suggested t o be between 
t h r e e and s i x days. 
Other c r i t e r i a 
The b e t a e m i t t e r s h o u l d have no gamma e m i s s i o n s ( w h i c h make 
v i r t u a l l y no c o n t r i b u t i o n t o t h e s t e r i l i s i n g dose) a l t h o u g h a l i m i t e d 
l e v e l c o u l d be t o l e r a t e d and i n f a c t used, f o r s i m u l t a n e o u s i m a g i n g 
p u r p o s e s . 
The r a d i o n u c l i d e must be o b t a i n e d " c a r r i e r f r e e " as d i s c u s s e d i n 
s e c t i o n 1.3.2. T h i s i s p a r t i c u l a r l y i m p o r t a n t f o r t h e r a p y , due t o t h e 
d i f f i c u l t i e s a s s o c i a t e d w i t h r a d i o l a b e l l i n g t h e a n t i b o d y w i t h enough 
a c t i v i t y t o r e s u l t i n a s t e r i l i s i n g dose o f r a d i a t i o n b e i n g d e l i v e r e d t o 
t h e tumour. The problem i s m e r e l y i n c r e a s e d i f t h e a n t i b o d y i s l a b e l l e d 
w i t h any " c o l d " i s o t o p e . 
A g a i n , t h e r a d i o n u c l i d e must have no hazardous d a u g h t e r p r o d u c t s 
and i t s c h e m i s t r y s h o u l d be amenable t o p e r m i t s t a b l e a t t a c h m e n t t o t h e 
a n t i b o d y . 
1.4.4. Candidates f o r therapy 
The i s o t o p e s which have been s e r i o u s l y c o n s i d e r e d f o r use i n 
t h e r a p y a r e l i s t e d i n T a b l e 1.2. 
A l t h o u g h I o d i n e - 1 3 1 i s t h e o n l y i s o t o p e t o have been used so f a r i n 
t h e t r e a t m e n t o f human c a n c e r , i t s p r o p e r t i e s a r e f a r f r o m i d e a l . I t 
has a r e l a t i v e l y h i g h i n t e n s i t y gamma component and t h e i o d i n a t e d 
- 18 -
Tabl e 1.2 
Ca n d i d a t e s f o r t h e r a p y 
I s o t o p e H a l f l i f e ( h r ) 0 Q (MeV 7.) Mean Gamma (keV 7.) 
Range (mm) 
6 7 C u 62 0.40 (45) 0.2 93 ( 17) 
0.48 (35) 184 (47) 
0.58 (20) 
64 2.25 (100) 3.9 — 
"'AS 179 1.04 (93) 1.1 342 ( 6 ) 
0.69 ( 6 ) 
1 3 1 j 193 0.61 (90) 0.4 364 ( 79) 
1 6 1 T b 166 0.45 0.3 75 
0.57 57 ( 21) 
0.58 
1 8 8 R e 17 1.96 3.3 155 
2.12 
1 9 9 A „ 75 0.25 (22) 0.1 158 (76) 
0.30 (72) 
a n t i b o d y does n o t have t h e r e q u i r e d i n v i v o s t a b i l i t y f o r e f f e c t i v e 
tumour t h e r a p y . The r e m a i n i n g i s o t o p e s a r e a t t a c h e d t o t h e a n t i b o d y by 
t h e use o f b i f u n c t i o n a l c o m p l e x i n g a g e n t s ( s e c t i o n 1 . 5 . ) . 
Terbium-161 has good n u c l e a r p r o p e r t i e s as a medium range b e t a 
e m i t t e r b u t i s v e r y d i f f i c u l t t o o b t a i n i n c a r r i e r f r e e f o r m . 
Rhenium-188 and Gold-199 have p o t e n t i a l l y u s e f u l c h a r a c t e r i s t i c s , as 
l o n g r a n g e and s h o r t range e m i t t e r s r e s p e c t i v e l y . However, b o t h have 
somewhat complex aqueous c o o r d i n a t i o n c h e m i s t r i e s t h a t do n o t l e n d 
t h e m s e l v e s t o r a p i d (< 2 h r . ) f o r m a t i o n o f k i n e t i c a l l y i n e r t complexes, 
- 19 -
27 though some p r o g r e s s has been made r e c e n t l y w i t h rhenium. The t h r e e 
most p r o m i s i n g c a n d i d a t e s a r e Y t t r i u m - 9 0 , S i l v e r - I l l and Copper-67. *^Y 
has r e c e i v e d t h e most a t t e n t i o n as a t h e r a p y c a n d i d a t e . I t i s a p u r e 
b e t a e m i t t e r ( l o n g range) w i t h a u s e f u l h a l f l i f e (64 h o u r s ) and i s 
a v a i l a b l e " c a r r i e r f r e e " f r o m a S t r o n t i u m - 9 0 g e n e r a t o r a t a r e l a t i v e l y 
low c o s t . The decay p r o d u c t Z i r c o n i u m - 9 0 i s s t a b l e . 
* ^ A g has a h i g h abundance o f a medium range b e t a e m i s s i o n and a 
s u i t a b l e h a l f l i f e (7.4 d a y s ) . I t decays t o a s t a b l e p r o d u c t , 
C a d m i u m - I l l and i s o b t a i n a b l e f r o m P a l l a d i u m - l l l m by a ( n , ? ) r e a c t i o n 
( r e a c t o r ) , t h o u g h i t i s r e l a t i v e l y e x p e n s i v e . 
Cu has a h i g h abundance o f b e t a p a r t i c l e s (E : 0.40, 0.48, 
0.58 MeV) and a moderate abundance o f gamma r a y s which can be used f o r 
s i m u l t a n e o u s i m a g i n g . I t has a s i m i l a r h a l f l i f e t o and decays t o 
s t a b l e Z i n c - 6 7 . However, i t s p r o d u c t i o n f r o m Z i n c - 6 8 (p,2p) u s i n g a 
l i n e a r a c c e l e r a t o r makes i t e x p e n s i v e . 
1.5. Bifunctional Complexing Agents 
1.5.1. Introduction 
For some t i m e i t has been r e c o g n i s e d t h a t t h e way f o r w a r d i n 
r a d i o l a b e l l i n g a n t i b o d i e s i n v o l v e s t h e i m p l e m e n t a t i o n o f b i f u n c t i o n a l 
28 
c o m p l e x i n g a g e n t s . T h i s i s because c e r t a i n l i g a n d s can b i n d m e t a l l i c 
r a d i o i s o t o p e s much more e f f e c t i v e l y t h a n an a n t i b o d y can i t s e l f . A 
b i f u n c t i o n a l l i g a n d i s one which has t h e c a p a c i t y t o b i n d a m e t a l i o n by 
v i r t u e o f i t s donor atoms and a l s o has a f u n c t i o n a l i t y t h a t may be used 
t o a t t a c h t h e complex t o t h e a n t i b o d y . I t has been d e m o n s t r a t e d t h a t 
r a d i o a c t i v e m e t a l complexes may be c o v a l e n t l y a t t a c h e d t o t h e a n t i b o d y 
( t h r o u g h t h e NHg o f t h e l y s i n e r e s i d u e o f t h e a n t i b o d y ) w i t h o u t 
29 30 
compromising a n t i g e n b i n d i n g . ' 
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1.5.2. Acyclic chelating agents 
C o n v e n t i o n a l l y t h e a c y c l i c c h e l a t o r s e t h y l e n e d i a m i n e t e t r a a c e t i c 
a c i d (EDTA) and d i e t h y l e n e t r i a m i n e p e n t a a c e t i c a c i d (DTPA) have been used 
28-31 
t o b i n d t h e m e t a l r a d i o n u c l i d e . J i EDTA i s a h e x a d e n t a t e c h e l a t e w i t h 
two n i t r o g e n and f o u r oxygen donor atoms whereas DTPA i s o c t a d e n t a t e 
w i t h t h r e e n i t r o g e n and f i v e oxygen donor atoms. 
These l i g a n d s were chosen i n i t i a l l y as a r e s u l t o f t h e i r r e m a r k a b l e 
v e r s a t i l i t y i n b i n d i n g m e t a l i o n s . For example EDTA and i t s a n a l o gues 
a r e known t o f o r m s t a b l e complexes w i t h about h a l f t h e known e l e m e n t s . 
Examples o f b i f u n c t i o n a l EDTA and DTPA l i g a n d s p r e p a r e d by Gansow 
CO2H 
H Q J O 
C Q J H 
E D T A D T P A 
32 
e t a l . a r e g i v e n i n F i g . 1.6. L i n k a g e t o t h e a n t i b o d y i s a c h i e v e d 
t h r o u g h t h e C - l p o s i t i o n o r w i t h t h e DTPA d i a n h y d r i d e system, t h r o u g h 
one o f t h e N-carboxymethyl s u b s t i t u e n t s . B i f u n c t i o n a l DTPA systems have 
33-37 
been used t o a t t a c h Indium-111 and Y t t r i u m - 9 0 t o a n t i b o d i e s . These 
i s o t o p e s a r e t h e p r e f e r r e d c a n d i d a t e s f o r r a d i o i m m u n o i m a g i n g and 
ra d i o i m m u n o t h e r a p y r e s p e c t i v e l y . 
1.5.3. Thermodynamic vs. k i n e t i c s t a b i l i t y 
The 1:1 EDTA and DTPA complexes o f i n d i u m ( I I I ) and y t t r i u m ( I I I ) 

























F i g . 1.6. B i f u n c t i o n a l EDTA and DTPA systems. 
and l o g K = 22.1 f o r Y-DTPA). However, when t h e g o a l i s an a p p l i c a t i o n 
t o a l i v i n g s y s t e m , t h e s t a b i l i t y c o n s t a n t m e r e l y s e r v e s as a u s e f u l 
g u i d e t o t h e s u i t a b i l i t y o f t h e complex. The more i m p o r t a n t f a c t o r i s 
t h e k i n e t i c s t a b i l i t y o f t h e complex i n v i v o . The c o n c e n t r a t i o n o f t h e 
complex i n t h e b l o o d i s v e r y low and i t i s s u b j e c t t o c o m p e t i t i o n f r o m 
m e t a l b i n d i n g p r o t e i n s such as t r a n s f e r r i n and a l b u m i n . F u r t h e r m o r e , 
2+ -8 
t h e r e i s c o m p e t i t i o n f o r t h e l i g a n d f r o m m e t a l i o n s such as Zn (10 2+ -3 39 M) and Ca (10 M) p r e s e n t i n human serum. ( S t u d i e s have shown t h a t 
2+ 2+ 
Ni and Cu promote m e t a l i o n l o s s f r o m EDTA and DTPA complexes.) 
Moreover, l i g a n d s such as EDTA and DTPA a r e v e r y s u s c e p t i b l e t o 
p r o t o n a t i o n and t h e s t a b i l i t i e s o f t h e i r complexes a r e v e r y much pH 





Fig . 1.7. Logarithmic p lo t of the "condi t ional" (or apparent) 
s t a b i l i t y constant of the I n f i l l ) EDTA complex as a 
func t ion of pH. 
The complex used f o r radioimmunotargeting must remain k i n e t i c a l l y 
i ne r t over the f u l l physiological pH range. The important f ac to r is the 
rate of protonation of the ligand-complex. Idea l ly the ra te constants 
k k k 
ML MLH = ^ MLH2 MLH 3 . . . .etc. 
Ka^ Ka^ 
k p k 2 . . . etc. should be small and the pK& values (protonation 
constants) low, so that protonation of the complex occurs only at low 
pH. DTPA forms an anionic complex wi th indium [In-DTPA] and so 
a t t r ac t s protons or other metal ions which encourages d i ssoc ia t ion . 
Radioimmunoimaging studies using DTPA bound indium have had some 
success. However, tumours smaller than 1.5 cm i n diameter have proved 
d i f f i c u l t to detect. I n a l l cases the invest igators have struggled 
against r e l a t i v e l y high background levels of r ad i a t i on , especial ly in 
38 
the v i t a l organs e.g. l i v e r , kidney and bone marrow. This indicates 
that the loss of indium from the chelate i s s t i l l a problem. For 
23 -
radioimmunotherapy the background leve l is more c r i t i c a l and high 
r ad ia t ion levels in these organs cannot be to le ra t ed . 
For the fu tu re success of the radioimmunotherapy and imaging, 
complexes which are less susceptible to acid promoted d issoc ia t ion and 
which have greater i n vivo s t a b i l i t y are required. I t i s proposed that 
the use of macrocyclic l igands, which have been ' t a i l o r e d ' to the 
binding requirements of ind iv idua l radionuclides, w i l l s i g n i f i c a n t l y 
enhance the i n vivo propert ies of the antibody conjugate. 
1.6. Macrocyclic Complexiag Agents 
1.6.1. Introduction 
Since Pedersen^ reported the synthesis and propert ies of crown 
ethers e.g. (1) 18-Crown-6 and (2) tribenzo-18-Crown-6, a vast amount of 
work has been directed towards the synthesis and complexation propert ies 
of macrocyclic l igands. 
Pedersen's cyc l i c polyethers were observed to form stable 1:1 
complexes wi th a l k a l i and a lkal ine earth metal cat ions. The macrocyclic 
r ings were seen to form molecular cav i t i e s , l ined wi th oxygen donor 
atoms, which were able to bind metal ions through ion-dipole 
R 
(1) 18-Crown-6 (2) Tribenzo-18-Crown-6 
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in terac t ions , forming 'host-guest ' complexes. High s t a b i l i t y constants 
were observed when there was a good cor re la t ion between the size of the 
macrocyclic cavi ty and the size of the ca t ion . 
Soon a f t e r , the synthesis of macrocyclic diamines was reported^* 
and since then a great var ie ty of macrocycles of d i f f e r e n t sizes wi th 
d i f f e r e n t donor atoms (usually 0, N or S) have been reported. 
1.6.2. Factors a f f e c t i n g the binding properties of macrocycles^ 
The fac tors which e f f e c t the binding properties of macrocycles 
include; 
1) The type of binding s i t e ( s ) in the r i n g 
2) The number of binding s i tes in the r i n g 
3) The physical placement of the binding s i tes 
4) The r e l a t i ve sizes of the ion and the macrocyclic cavi ty 
5) Steric hindrance i n the r i n g 
6) The solvent and the extent of solvat ion of the ion and of the 
ligand 
7) The e l e c t r i c a l charge of the ion . 
With so many variables there i s considerable scope to design 
macrocycles which match the requirements of ind iv idua l metal ions. 
The polycycl ic ethers show l i t t l e tendency to bind t r a n s i t i o n metal 
ions. However, when the oxygen atoms are replaced by so f t e r ni trogen or 
sulphur donor atoms then more stable macrocyclic complexes are observed. 
The "sof ter" t r a n s i t i o n metal cations (with larger and more polar isable 
valence shells) prefer to interact with "sof te r" donor atoms forming 
metal donor bonds which are more covalent i n nature than the purely 
e lec t ros ta t i c in te rac t ion of group I and I I metal cations wi th "hard" 
oxygen donor atoms. 
By analogy wi th known natural p roducts^ (e .g. the i ron and 
- 25 -
magnesium porphyrins of haemoglobin and ch lorophyl l ) most of the early 
macrocycles designed to bind f i r s t row t r a n s i t i o n metals were 
tetradentate ni trogen donor ligands such as (3) and (4 ) . 
n 
; 2 
(3) (4) 14N4 "Cyclam" 
For a macrocycle of t h i s type to bind a f i r s t row t r a n s i t i o n metal i t 
most o f ten consists of a t h i r t e e n to sixteen membered r i n g ^ ' ^ * wi th 
spacing between the atoms such that f i v e , s ix or seven membered chelate 
r ings are formed with the metal ion ( f i v e and s ix membered r ings are 
most common) [F ig . 1 .8] . 
< M 
Five membered chelate r i n g Six membered chelate r i n g 
F ig . 1.8. 
A l i s t of the common tetraaza macrocyclic ligands that have been 











(8) 14N4' (9) 15N4 (10) 16N4 
Square planar coordination geometries are most o f t en observed, wi th the 
cat ion s i t t i n g i n the plane of the four nitrogen atoms e.g. 
Cu(II)-cyclam [F ig . 1 .9] . The highest s t a b i l i t y constants are generally 
observed f o r those t r a n s i t i o n metal complexes where there i s good 
co r re l a t ion between the size of the cat ion and the cavi ty of the l igand, 
a l lowing optimum metal-nitrogen bond lengths. For example, the 
s t a b i l i t y constant of the copper(II) complex of 14N4 ("cyclam") i s at a 
maximum and f a l l s o f f r ap id ly wi th smaller or larger r i n g sizes. 
02A 
Fig . 1.9. Crystal s tructure of [Cu(cyclam)].2C10^ 
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1.6.3. The macrocyclic effect 
Macrocyclic metal ion complexes are almost always found to be 
considerably more thermodynamically and k i n e t i c a l l y stable wi th respect 
to dissocia t ion of the ca t ion, than t h e i r acycl ic counterparts. That 
i s , there is an addi t iona l enhancement in s t a b i l i t y beyond that expected 
from the gain i n t r ans l a t iona l entropy when chelates replace coordinated 
solvent from the metal ions ("chelate e f f e c t " ) . This feature i s known 
as the "macrocyclic e f f e c t " . 
Much ca lor imetr ic and spectroscopic work has been done to 
invest igate the thermodynamic parameters involved in the macrocyclic 
e f f e c t . Cabbiness and Margerum^ reported that the red copper( I I ) 
complex of 5,7,7,12,14,14-hexamethyl-1,4,8,11-tetraazacyclotetradecane 
["tet-a"] (11) was 10,000 times more stable than the copper(II) complex 




H 2 H 2 
(11) "tet-a 1 ii (12) "2 ,3 ,2- te t I I 
Table 1.3 
Complex log_K* 
C u ( 2 , 3 , 2 - t e t ) 2 + 
C u ( t e t - a ) 2 + - red 28 
23.9 
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S i m i l a r l y , there i s a 10 f o l d increase i n the s t a b i l i t y of the 
n i c k e l ( I I ) complex of cyclam (4) compared to the n i c k e l ( I I ) complex of 
"2,3,2-tet" ( 1 2 ) ^ (both complexes square p lanar ) . Calor imetr ic studies 
by Margerum suggested that the e f f e c t was enthalpic in o r i g i n , Table 
1.4. Such a large e f f e c t could not be a t t r i b u t e d to stronger n i c k e l -
Table 1.4 
-1 1 - 1 Complex log K5 AH/kcal mol AS cal K mol 
N i ( 2 , 3 , 2 - t e t ) 2 + 15.8 -13.0±0.6 7.4 
Ni(cyc lam) 2 + 22.2 -19.4±0.1 -2 
nitrogen bonds in the macrocyclic complex as both formed s imi l a r square 
planar coordination geometries. Marge rum^ '^ postulated that the f r e e 
macrocycle was less solvated i n solut ion than the acycl ic counterpart 
due to greater s t e r i c hindrance, hence fewer hydrogen bonds (OH N) 
were needed to be broken to form the complex. A small unfavourable 
entropy e f f e c t was suggested as a consequence of less molecules of 
solvat ion being released upon complexation, f o r the macrocycle. 
50 51 
However, two d i f f e r e n t sets of authors, Fabr i zz i , P a o l e t t i ' and 
52 
Kimura found that there was a large entropic con t r ibu t ion to the 
macrocyclic e f f e c t f o r t r a n s i t i o n metal complexes of polyamines. 
53 
Kimura, f o r example, reported that the e f f e c t f o r Cu(II)-cyclam arose 
from both enthalpic (ca. 607.) and entropic (ca. 407o) cont r ibut ions 
[Table 1.5]. 
Table 1.5 
Complex log K, -AH/kcal mol" 1 AS/cal K" 1 mol" 1 
Cu(cyclam) 2 + 27.2 30.4 22.4 
Cu (2 ,3 ,2 - t e t ) 2 + 23.9 27.7 16.5 
- 29 -
54 55 
Fabr izz i and Pao le t t i ' reported a s imi la r r a t i o of enthalpic 
and entropic contr ibut ions f o r n i cke l ( I I ) - cyc l am, Table 1.6. 
Table 1.6 
Complex log_K, -AH/kcal mol" 1 AS/cal K" 1 mol" 1 
N 1 ( cyc l am) 2 + 22.2 20.3 33.6 
N 1 ( 2 , 3 , 2 - t e t ) 2 + 15.8 18.6 10.4 
Here, i t was suggested that the most s i g n i f i c a n t f a c t o r was the 
preorganisation of the macrocyclic l igand in the required conformation 
f o r complexation, unl ike the acyclic l igand which has to undergo major 
conformational changes. 
Invest igat ions of d i f f e r e n t types of macrocyclic systems have given 
56 
equally var iable r e su l t s ; Sokol et a l . studying copper( I I ) complexes 
of 12-16 membered te t ra th iaethers reported that entropic contr ibut ions 
57 
were dominant; I z a t t et a l . inves t igat ing 18-Crown-6 systems wi th 
+ + 2+ 
Na , K and Ba reported favourable entropic contr ibut ions and 
58 
Schwing-Weill et a l . wi th copper(II) mixed 0, N, S donor macrocycles, 
reported both enthalpic and entropic contr ibut ions . 
More recently a study of the thermodynamic data f o r a series of 
59 
polyamine N i ( I I ) complexes has shown that the weighting of enthalpic 
and entropic contr ibut ions changes through the ser ies . 
The only conclusion to draw is that the nature of the macrocyclic 
e f f e c t i . e . the r e l a t i v e importance of the entropy and enthalpy of 
complexation, varies according to the type of cat ion and l igand 
involved. For example, the highly solvated 'hard' a l k a l i metal ions 
e.g. L i + tend to have have dominant entropic contr ibut ions associated 
wi th the loss of solvat ion molecules upon complexation, whereas, larger 
- 30 -
so f t e r cations tend to have dominant enthalpic cont r ibut ions associated 
with metal donor atom bond energies. 
Another feature associated with the macrocyclic e f f e c t i s the 
k i n e t i c inertness of macrocyclic complexes towards metal ion 
d issoc ia t ion . Possibly the most extreme example i s provided by the 
GO 
square planar N i c k e l ( I I ) cyclam complex which under acid condit ions 
(1.0 Molar HCIO^, 25°C) was claimed to have an estimated ha l f l i f e of 
approximately t h i r t y years. 
The k ine t ics of the acid catalysed dissocia t ion of the copper( I I ) 
complex of 15N5 (13) has been invest igated. ' The rate of 
dissociat ion was found to be f i r s t order in l igand and second order i n 
ac id , suggesting the involvement of two protons i n the t r a n s i t i o n state 
s t ruc ture . A proposed scheme f o r the d issocia t ion i s given i n F i g . 
1.10. The stepwise d issocia t ion of the l igand from the coordinat ion 
sphere of the metal requires d i s t o r t i o n of the l igand, in order to 
minimise e lec t ros ta t i c repulsion between the protonated s i t e and the 
cation and to allow room f o r the incoming solvent molecule. The 
conformational r e s t r i c t i o n s of the macrocycle can make t h i s 
energet ical ly unfavourable, r e su l t ing i n an energy ba r r i e r t o 
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Fig . 1.10. Stepwise dissocia t ion of (CuL) i n ac id . 
change t h e i r conformation as the donor atoms dissociate from the metal 
ion . I t fol lows that the more r i g i d the macrocycle the greater i s the 
energy bar r ie r f o r d issocia t ion and hence the greater the k i n e t i c 
s t a b i l i t y . 
Similar pr inc ip les apply to the rate of associat ion, i n that 
conformational changes are required i n order f o r complexation to occur, 
but the e f f ec t is less marked. 
1.6.4. Cavity size correlations 
In previous sections, examples where there has been reasonable 
co r re l a t ion between the cav i ty /ca t ion size and the observed s t a b i l i t y 
constant of the complex have been described. However, t h i s i s not 
always the case. Macrocyclic l igands, especially the larger r ings can 
be f l e x i b l e and can adapt t h e i r conformations to accommodate cations of 
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d i f f e r e n t s ize. 
As discussed e a r l i e r , the copper(II) complexes of the tetramine 
series (5)-(10) show good cavi ty size cor re la t ion and a maximum 
s t a b i l i t y is achieved wi th 14N4 (cyclam). However, studies by Hancock 
2+ 2+ 
have shown that the large cations Ca and Pb ac tua l ly form more 
thermodynamically stable complexes wi th the smaller 12N4 r i n g . This is 
a t t r i bu t ed to the f a c t that the macrocycles can adopt d i f f e r e n t 
conformations, F ig . 1.11. 
\ / 
3 N H N M 
N H N \ / \ H 
trans - I I I 
H \ M N N 











Fig . 1.11. Conformers of the 12N4 macrocycle. 
The trans I I I isomer allows the metal to s i t inside the r i n g wi th 
square planar coordination geometry. The ' trans I ' isomer allows a 
s l i g h t l y larger cat ion to s i t above the plane of the r i n g and the ' c i s 
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V isomer allows yet larger cations to coordinate f a c i a l l y (e .g . Cd 
2+ 
and Pb ) . I n t h i s case the overa l l s t a b i l i t y i s determined by the 
r e l a t i v e s t a b i l i t i e s of 5 and 6 membered chelate rings formed with the 
metal. For large cations the 5 membered chelate i s p r e f e r r e d , ^ so 12N4 
gives the highest s t a b i l i t y complex. 
Smaller r ings e.g. 1,4,7-triazacyclononane (14) and 1,4,7- t r iaza-
cyclodecane (15) have more r i g i d structures and the lone pairs are o f ten 
exposed on one face of the cycle . Consequently, many complexes are 
observed where the metal ion s i t s on top of the macrocycle e.g. 
2+ 
Cu-[9]N 9 S^ T [F ig . 1.12] or even sandwiched between two macrocycles e.g. N i - ( [ 1 0 ] N 3 ) 2 + [F ig . 1.13]. 
H H 















F i g . 1.12. Crystal s tructure of 
(Cu- [9 ]N 2 S)(Br 2 ) . 
F ig . 1.13. Crystal s t ructure of 
N i ( [ 1 0 ] N 3 ) 2 + . 
- 34 -
For nine membered macrocycles the most commonly observed 
conformation i s refer red to as the [3.3.3] conformer, according to a 
scheme devised by Dale. ' The numbers in the bracket r e f e r to the 
number of bonds between "bends" or "corners" i n the r i n g , s t a r t i n g wi th 
the smallest and moving in the d i r ec t ion around the r i n g so as to 
minimise the next number. A corner may be defined by p a r t i c u l a r 
combinations of to r s iona l angles around the r i n g [F ig . 1.14]. Positions 




F ig . 1.14. Torsion Angles. 
-60 (gauche [ - ] ) and 180 ( an t i ) respect ively. More generally a gauche 
bond may be defined as having a to rs ion angle 6 < 9 0 ° . ^ A corner 
occurs at the junc t ion of two gauche bonds ( [+] or [ - ] ) or at the 
junc t ion of an isolated gauche bond wi th the adjacent bond of smaller 
to r s ion angle. 
Most complexes of the cyclononane macrocycles exis t i n a [3 .3 .3] 
2+ 
conformation e.g. N i ^ j N g S ) though some do exis t i n a [2 .3 .4] 
conformation e.g. Cu( [9 ]N 2 S) 2 + [F ig . 1.15]. 
Molecular mechanics c a l c u l a t i o n s ^ have shown that f o r a l l sulphur 
and nitrogen mixed donor cyclononane macrocycles in the f r e e form the 
[2 .3 .4] conformation was more strained than the [3 .3 .3] conformation. 
Hence [2.3.4] conformations are usually associated wi th metal ions which 
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F ig . 1.15. a) [3 .3 .3] conformation of N i ( [9 ]N 2 Sr and b) the [2 .3 .4] 
conformation of C u f f Q j ^ S ) 
cannot accept symmetrical f a c i a l coordinat ion, such as the Jahn-Teller 
d i s to r ted Cu(II ) complex [Fig . 1.15]. 
1.6.5. Cryptands and spherands 
I n 1968 Lehn ' reported the synthesis of a macrobicyclic l igand 
(16) which consisted of a 1,10-diaza-18-crown-6 r i n g bridged between the 
two nitrogens wi th another polyether chain, forming a 3-dimensional 
a) [2.1.1]m=0,n=1 f ~ \ r ~ \ 
\ / l m \ b) [2.2.1)m=1,n-0 
d) [3.2.2] m=1,n=2 
-o 0 _ V \ _ o a _ V e ) [3"3-21 m = 2 ' n = 1 
\ / \ / T n f) [3.3.3] m=2,n=2 
(16) (17) 
cav i ty . A series of ligands with the general s t ructure (17) were 
synthesised and t h e i r complexation propert ies invest igated. They 
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were found to form inc lus ion complexes wi th a substrate (usual ly a 
cation) s i t t i n g inside the cage l i k e cavi ty (or ' c r y p t ' ) [ F i g . 1.16] 
r e l a t i v e l y shielded from the outside environment. Lehn named such 
l igands, 'cryptands' and t h e i r inclusion complexes ' c ryp t a t e s ' . 
Analogous to the "macrocyclic e f f e c t " there i s a "cryptate e f f e c t " 
f o r metal ion complexes of cryptands. The b i c y c l i c ligands are more 
conformationally r e s t r i c t e d than t h e i r monocyclic counterparts and hence 
F i g . 1.16. Formation equi l ibr ium of a cryptate inc lus ion complex 
between cryptand [2.2 .2] and a metal ion. 
show a more pronounced thermodynamic and k i n e t i c s t a b i l i t y . Thus the K + 
complex of [2 .2 .2] i s 10 times more stable than the corresponding 
monocyclic analogue (diaza-18-crown-6). As a consequence, the s t a b i l i t y 
and s e l e c t i v i t y charac te r i s t ics are usually consistent wi th the simple 
cav i ty /ca t ion 'best f i t ' idea. The polyether cryptands (17) form stable 
complexes wi th a l k a l i and a lka l ine earth metal ions. L i + , Na + and K + 
are complexed p r e f e r e n t i a l l y by cryptands [2 .1 .1] (17a), [2 .2 .1] (7b) 
and [2 .2 .2] (17c) respect ively . 
o N N N <3 
n + 
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Replacing the oxygen atoms by sulphur or ni trogen donor atoms 
favours the binding of t r a n s i t i o n metal ions, as wi th monocyclic 
l i g a n d s 7 3 (sect. 1.6.1). 
M\ AAA* AAA-
CMj CMj C H j CM 3 CH 3 C H 3 
(18) (19) (20) 
For example the aza analogue of [2 .2 .1] (18) forms stable complexes 
2+ 2+ 2+ 
wi th Co , Ni and Zn and the aza analogues of [2.2.2] form stable 
2+ 2+ 9+ 
complexes wi th the larger cations Cd , Hg and Pb" . 
2+ 2+ 9+ Cryptate (19) shows very high s e l e c t i v i t i e s f o r Cd , Hg and Pb 
over the smaller cation Z n 2 + (10^, l O 1 ^ and 10^ respect ively) 
h i g h l i g h t i n g the s ignif icance of cavi ty size f o r the cryptates. 
A p o t e n t i a l l y l i m i t i n g f ac to r to the use of cryptands f o r l a b e l l i n g 
antibodies wi th radionuclides, i s the r e l a t i v e l y slow ra te of metal ion 
complexation. This can be a t t r i bu ted to the r e s t r i c t e d access f o r the 
cat ion and the l imi t ed f l e x i b i l i t y of the l igand. Spherands such as 
( 2 1 ) 7 4 exh ib i t an even greater degree of preorganisation i n the l igand. 
In t h i s example, the s ix oxygen donor atoms are locked in to an 
octahedral arrangement by the r i g i d i t y of the benzene r i n g backbone (the 
cav i t i e s of the cryptands i n the unbound state are p a r t i a l l y f i l l e d by 
the methylene groups turned inwards). This resul ts in enhanced 
s e l e c t i v i t y and s t a b i l i t y f o r metal ion complexes of the r i g h t s ize . 
For example spherand (21) binds Na+ and L i + ( log K: 14 and 16 
r e s p e c t i v e l y ) 7 5 but does not bind K + , R b 2 + , Cs 2 + , Mg 2 + or C a 2 + . 
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C H 3 
C H 
C H 
C H , C H 5 
CH 
C H 3 
C H S 
(21) 
However t h e r a t e s o f complex f o r m a t i o n are c h a r a c t e r i s t i c a l l y slow. 
1.6.6. Conclusion 
I t i s t h e combined c a t i o n complexation c h a r a c t e r i s t i c s o f 
macrocycles, t h e h i g h thermodynamic and k i n e t i c s t a b i l i t i e s as w e l l as 
th e acceptable r a t e s of a s s o c i a t i o n , t h a t make them t h e f i r s t c h o i c e f o r 
b i n d i n g r a d i o n u c l i d e s f o r tumour t a r g e t i n g . 
The s p e c i f i c c o o r d i n a t i o n c h e m i s t r i e s of i n d i u m ( I I I ) and s i l v e r ( I ) 
are discussed a t t h e beg i n n i n g of Chapter 2 and Chapter 4 r e s p e c t i v e l y . 
[ * * * I n a candidate f o r tumour imaging and ***Ag a ca n d i d a t e f o r tumour 
t h e r a p y . ] 
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CHAPTER TVfl 
MACROCYCLES TO BIND TNDHMflll) AND GALLIUMfim 
- 43 -
2.1. Indium Coordination Chemistry 
2.1.1. Introduction 
Indium i s t h e f o u r t h member of group I I I i n t h e p e r i o d i c t a b l e , 
10 2 
w i t h an e l e c t r o n i c c o n f i g u r a t i o n of [ K r ] 4 d 5s 5p. I n d i u m ( I I I ) i s t h e 
most common o x i d a t i o n s t a t e , b ut i n d i u m ( I ) and i n d i u m ( I I ) complexes are 
1 2 
al s o known. ' 
I n d i u m ( I I I ) forms n e u t r a l , c a t i o n i c and a n i o n i c complexes e.g. 
I n C l g ( p y ) g , [ I n ( e n ) g ] [ 3 C 1 ] and [NH^][InFg] r e s p e c t i v e l y . The m a j o r i t y 
2 
of i n d i u m ( I I I ) complexes are o c t a h e d r a l and many examples a r e known o f 
n e u t r a l complexes w i t h monodentate amine donors o f s t o i c h i o m e t r y InX^L^ 
(e.g. L = p y r i d i n e , o - p i c o l i n e , a n i l i n e and X = C I , Br, I ) . 
As mentioned i n Chapter 1 , the m o d i f i e d c h e l a t e s EDTA and DTPA have 
been used t o b i n d i n d i u m ( I I I ) f o r use i n r a d i o i m m u n o s c i n t i g r a p h y . The 
n i t r o g e n donor atoms and the n e g a t i v e l y charged oxygen donor groups o f 
these l i g a n d s are w e l l s u i t e d t o the b i n d i n g o f i n d i u m ( I I I ) as th e y form 
r e l a t i v e l y s t r o n g c o v a l e n t In-N and In-0 bonds. However, EDTA w i t h an 
4- 5-
donor set and DTPA w i t h an NgOg donor set produce a n i o n i c 
complexes when bound t o i n d i u m ( I I I ) ([In-EDTA]" and [ I n - D T P A ] 2 " ) . These 
complexes are s t a b l e a t pH 7 but they p r o t o n a t e a t lower pH (e.g. l i v e r , 
stomach f o r i n v i v o a p p l i c a t i o n ) . These p r o t o n a t e d complexes may be 
more s u s c e p t i b l e t o d i s s o c i a t i o n ( e i t h e r a c i d or metal c a t a l y s e d ) 
compared t o a n e u t r a l complex. The X-ray c r y s t a l s t r u c t u r e o f 
Na 2In(DTPA).7H 20 has r e c e n t l y ( J u l y 1989) been r e p o r t e d . 3 The indium 
i o n i s bound by t h e t h r e e amino groups and a l l f i v e o f t h e deprot o n a t e d 
c a r b o x y l a t e groups i n a complex which adopts a s l i g h t l y d i s t o r t e d 
Archimedian a n t i p r i s m a t i c c o n f i g u r a t i o n [ F i g . 2 . 1]. 
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F i g . 2.1. ORTEP view o f Na 2In(DTPA).7H 20. 
2.1.2. Indimn(III) macrocyclic complexes 
L i t t l e work has been r e p o r t e d on t h e complexation of i n d i u m ( I I I ) 
w i t h m a c r o c y c l i c l i g a n d s , a l t h o u g h i n d i u m ( I I I ) p o r p h y r i n complexes of 
t h e t y p e InX-L (L = p o r p h y r i n X = C I " , OAc" or PhO ) _ have been known 
f o r some t i m e . I n 1981 Tuck r e p o r t e d t h e f o r m a t i o n o f i n d i u m ( I I I ) 
h a l i d e complexes o f dibenzo-18C6 (22) and cyclam (4) d u r i n g t h e course 
o f s t u d i e s d i r e c t e d towards t h e use o f macrocycles t o s t a b i l i s e t h e 
Q n 
(22) Dibenzo-18C6 (4) "Cyclam 
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i n d i u m ( I ) o x i d a t i o n s t a t e . 
o 
Wieghardt has r e p o r t e d t h a t t h e t r i d e n t a t e macrocycles 
1,4,7-triazacyclononane (14) and N , N ' , N " - t r i m e t h y l - l , 4 , 7 - t r i a z a c y c l o -
nonane (23) form 1:1 complexes w i t h i n d i u m ( I I I ) , o f the t y p e LlnX- (X = 
C I , Br, I ) , w i t h f a c i a l c o o r d i n a t i o n of t h e nine-membered r i n g . A l s o , 
l i g a n d (14) forms the o c t a h e d r a l b i s - m a c r o c y c l i c complex w i t h 
i n d i u m ( I I I ) . These t r i a z a macrocycles show a s t r o n g " m a c r o c y c l i c 
e f f e c t " w i t h t r a n s i t i o n metal ions (e.g. C u ( I I ) , Z n ( I I ) and N i ( I I ) ^ ) but 
no thermodynamic or k i n e t i c data has been r e p o r t e d f o r t h e i n d i u m ( I I I ) 
complexes. 
X-ray c r y s t a l s t r u c t u r e s have been r e p o r t e d f o r t h e r e l a t e d oxo and 
hydroxo b r i d g e d i n d i u m ( I I I ) complexes of l i g a n d ( 1 4 ) . I n t h e hydroxy 












F i g . 2.2. The s t r u c t u r e of [ L 4 I n 4 U - ( f f l ) 6 ] ( S 2 0 6 ) 3 . 4 H 2 0 . 
- 46 -
binds t o t h r e e b r i d g i n g hydroxy groups f o r m i n g a [ I n ^ ( / ^ - 0 H ) g ] ^ + c o r e , 
w i t h an adamantane-like s t r u c t u r e . I n a d d i t i o n , each indium c a t i o n i s 
bound f a c i a l l y by t h e t r i a z a macrocycle, r e s u l t i n g i n a s l i g h t l y 
d i s t o r t e d o c t a h e d r a l c o o r d i n a t i o n sphere w i t h an N^Og donor s e t . 
S i m i l a r l y , i n t h e b i n u c l e a r oxo b r i d g e d s t r u c t u r e 
[ I ^ I i ^ C H g C f ^ ^ / J - O ) ] ( F i g . 2.3) the indium i s bound f a c i a l l y by t h e 
macrocycle and i s a l s o bound by t h r e e n e g a t i v e l y charged oxygen donor 
atoms (two a c e t a t e ions and one b r i d g i n g oxygen) f o r m i n g a n e u t r a l 
complex. The 1:1 complexes LlnX^ (L = ( 1 4 ) , (23) X = C I , Br) are u s e f u l 
s t a r t i n g m a t e r i a l s f o r t h e s y n t h e s i s o f indium hydroxy and oxy b r i d g e d 




F i g . 2.3. The s t r u c t u r e o f [ L 2 I n 2 ( C H 3 C 0 2 ) 4 ( / i - 0 ) ] .2NaC104. 
w i t h aqueous a l k a l i n e s o l u t i o n : hence no p r e c i p i t a t i o n o f I n ( 0 H ) g i s 
observed. 
2.1.3. The selection of new macrocycles to bind indium(IH) 
I n o r d e r t o b i n d i n d i u m ( I I I ) e f f e c t i v e l y f o r use i n 
radi o i m m u n o s c i n t i g r a p h y , a h e x a c o o r d i n a t i n g l i g a n d which c o u l d adopt 
o c t a h e d r a l geometry was r e q u i r e d . I n a d d i t i o n , a l i g a n d w i t h t h r e e 
i o n i s a b l e groups was sought, i n order t o reduce the e f f e c t i v e n u c l e a r 
I n 
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charge a t t h e metal c e n t r e . The o v e r a l l complex would t h e n be 
e l e c t r i c a l l y n e u t r a l and the r e b y much l e s s s e n s i t i v e t o a c i d c a t a l y s e d 
d i s s o c i a t i o n . 
The t r i a z a macrocycle (14) has been shown t o form s t a b l e complexes 
w i t h i n d i u m ( I I I ) as discussed i n the p r e v i o u s s e c t i o n . When t h e 
macrocycle i s N - f u n c t i o n a l i s e d w i t h t h r e e carboxymethyl groups t h e donor 
se t i s expanded from t h r e e (Ng) t o s i x (N^Og). Furthermore, w i t h t h e 
n e g a t i v e l y charged oxygen donor groups t h e o v e r a l l complex i s n e u t r a l . 
The f o u r N - f u n c t i o n a l i s e d t r i a z a macrocycles (24) t o ( 2 7 ) , w i t h r i n g 
s i z e s v a r y i n g from nine t o t w e l v e , were s e l e c t e d f o r s y n t h e s i s and 
i n v e s t i g a t i o n of t h e i r i n d i u m ( I I I ) complexation c h e m i s t r y . 
CQ>H CQ>H C02H CQ>H 
N N ^ N N N N NCT 
\ - N - V \ - N - ^ 0/ N0 
( ( ( < 
^COfcH XC02H N C X ^ H C ° 2 H 
( 2 4 ) ( 2 5 ) ( 2 6 ) ( 2 7 ) 
(24) 9 N 3 - t r i a c e t a t e (TCTA) (25) 1 0 N 3 - t r i a c e t a t e (26) H N 3 - t r i a c e t a t e 
(27) 1 2 N 3 - t r i a c e t a t e 
10 
The s y n t h e s i s of th e l i g a n d (24) was f i r s t r e p o r t e d i n 1973 and 
t h e f o r m a t i o n o f n e u t r a l F e ( I I I ) , C r ( I I I ) and C o ( I I I ) complexes o f 
11 
l i g a n d s (24) and (25) r e p o r t e d i n 1977. Hancock prepared t h e 
n i c k e l ( I I ) complex of l i g a n d (24) HgO[Ni(TCTA)] 1 2 and found t h a t on st a n d i n g i n a c i d s o l u t i o n i t converted t o the n e u t r a l n i c k e l ( I I I ) 
complex N i ( T C T A ) 1 3 [ F i g . 2 . 4 ] . W i e g h a r d t 1 4 has r e p o r t e d t h e syntheses 
and s p e c t r a l p r o p e r t i e s ( U V - v i s i b l e , I n f r a - r e d ) o f s e v e r a l t r a n s i t i o n 
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metal complexes of TCTA and has r e p o r t e d t h e p r e p a r a t i o n o f t h e group 
I I I metal complex A1-TCTA. 
F i g . 2.4. X-ray c r y s t a l s t r u c t u r e of Ni(TCTA) 
I n r e c e n t years t h e sy n t h e s i s of s e v e r a l o t h e r N - f u n c t i o n a l i s e d 
d e r i v a t i v e s o f t r i a z a macrocycles have been r e p o r t e d , o f which some 
Q 1 ^  99 
examples are l i s t e d i n Table 2.1. ' A p o t e n t i a l l y u s e f u l 
Table 2.1 
N - f u n c t i o n a l i s e d d e r i v a t i v e s o f TACN (14) 
R A b b r e v i a t i o n 
-CH 2C0 2(C 2H 5) TCTAE 




-CH 2P(0)(Ph) 2 TPA 
-CH2CH2NH2 TAETACN 
-CB 2-(2)pyr TPTCN 
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a l t e r n a t i v e t o t h e c a r b o x y l a t e f u n c t i o n a l i t y o f t h e pendant arm i s t h e 
ph o s p h i n i c a c i d group (-CH^P^f^H, R = H, a l k y l ) which a l s o p r o v i d e s a 
s i n g l y charged oxygen donor atom f o r b i n d i n g t o t h e metal i o n . I n 
t h e o r y , t h e lower pK of the phosphinic a c i d group would reduce t h e 
s u s c e p t i b i l i t y o f t h e metal complex t o p r o t o n a t i o n and hence a c i d 
c a t a l y s e d d i s s o c i a t i o n . For s i m i l a r reasons t h e s u l p h o n i c a c i d group 
(R-SOgH) would appear t o be a f a v o u r a b l e candidate f o r pendant arm 
f u n c t i o n a l i t y . However, i n aqueous s o l u t i o n t h e amino(methylsulphonato) 
23 
f u n c t i o n a l i t y undergoes h y d r o l y s i s ; 
The species e x i s t s i n e q u i l i b r i u m w i t h t h e f r e e secondary amine w i t h K 
( e q u i l i b r i u m c o n s t a n t ) = 1.2 x 10"^. 
The c a r b o x y l a t e f u n c t i o n a l i t y was chosen i n t h e f i r s t i n s t a n c e f o r 
t h e r e l a t i v e ease o f s y n t h e s i s . The s y n t h e s i s o f t r i a z a macrocycles 
b e a r i n g pendant arms w i t h phosphinic a c i d f u n c t i o n a l i t y i s c u r r e n t l y 
underway i n our l a b o r a t o r i e s a t Durham. 
24 
I n mid-1989, Kaden r e p o r t e d t h e syntheses and X-ray c r y s t a l 
s t r u c t u r e s of t h e i n d i u m ( I I I ) complexes of two N,N',N"-triscarboxymethyl 










c o o r d i n a t e , b i n d i n g t o f o u r n i t r o g e n s and t h r e e c a r b o x y l a t e s and b o t h 
complexes adopt a capped t r i g o n a l p r i s m a t i c geometry [ F i g . 2 . 5 ] . 
The s m a l l e r l i g a n d (28) i s seen t o f u l f i l t h e g e o m e t r i c a l requirements 
of I n + b e t t e r than (29) w i t h more un i f o r m bond l e n g t h s and angles 
r e s u l t i n g i n a more compact and symmetrical s t r u c t u r e . 
2.1.4. Synthesis of four tribasic hexacoordinating macrocyclic ligands 
With t h e e x c e p t i o n of t h e nine-membered r i n g , 1 , 4 , 7 - t r i a z a -
cyclononane (14) which i s a v a i l a b l e from A l d r i c h , t h e t r i a z a macrocycles 
(33) t o (35) [Table 2.2] were synthesised a c c o r d i n g t o t h e method 
o u t l i n e d i n Scheme 2.1. The a c y c l i c t o s y l a t e s and t o s y l a m i d e s were 
prepared from t h e parent amines and a l c o h o l s a c c o r d i n g t o l i t e r a t u r e 
25-27 
procedures, u s i n g p - t o l u e n s u l p h o n y l c h l o r i d e and p y r i d i n e . 
C y c l i s a t i o n r e a c t i o n s t o form small t r i a m i n e r i n g systems have been 
28-30 
r e p o r t e d p r e v i o u s l y . The method used here was a m o d i f i c a t i o n o f 
29 
t h e d i t o s y l a m i d e method of Richman and A t k i n s , u s i n g caesium carbonate 
31 









F i g . 2.5. a) X-ray c r y s t a l s t r u c t u r e b) X-ray c r y s t a l s t r u c t u r e o f 
t h e I n ( I I I ) complex o f 
l i g a n d (29 
of t h e I n ( I I I ) complex 
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Scheme 2.1. The s y n t h e s i s o f N , N ' , N " - t r i a c e t a t e - t r i a z a macrocycles. 
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s l o w l y t o a w e l l s t i r r e d suspension o f caesium carbonate i n a s o l u t i o n 
o f t h e d i t o s y l a m i d e i n DMF, under anhydrous c o n d i t i o n s . The t r i t o s y l -
amide c y c l e s were obtained i n good y i e l d (60-80%) a f t e r p u r i f i c a t i o n by 
r e c r y s t a l l i s a t i o n (EtOH-CH^C^) f o r (30) and s i l i c a g e l chromatography, 
e l u t i n g w i t h dichloromethane-methanol, f o r (31) and ( 3 2 ) . 
D e t o s y l a t i o n was e f f e c t e d u s i n g concentrated s u l p h u r i c a c i d a t 120°C 
f o l l o w e d by b a s i f i c a t i o n w i t h sodium h y d r o x i d e s o l u t i o n and e x t r a c t i o n 
32 
i n t o c h l o r o f o r m . The n i n e , t e n and eleven membered c y c l e s were N-
a l k y l a t e d w i t h c h l o r o a c e t i c a c i d i n aqueous s o l u t i o n at pH 10 (LiOH) 
33 
a c c o r d i n g t o t h e method of Takamoto. The N,N',N"-triacetates were 
p u r i f i e d by r e c r y s t a l l i s a t i o n from an a c i d i c aqueous (HC1)-ethanol 
system w i t h slow d i f f u s i o n of t h e e t h a n o l i n t o t h e aqueous l a y e r , 
y i e l d i n g c o l o u r l e s s c r y s t a l s . M i c r o a n a l y s i s r e v e a l e d t h a t t h e n i n e -
membered N - a l k y l a t e d c y c l e was i s o l a t e d as t h e d i h y d r o c h l o r i d e s a l t 
whereas t h e t e n and eleven-membered analogues were o b t a i n e d as t h e f r e e 
amines. I n o r d e r t o o b t a i n t h e former c h l o r i d e f r e e , t h e a l k y l a t i o n 
r e a c t i o n was repeated u s i n g bromoacetic a c i d and a c i d i f i c a t i o n was 
e f f e c t e d w i t h n i t r i c a c i d , r a t h e r than h y d r o c h l o r i c a c i d , i n t h e work 
up. R e c r y s t a l l i s a t i o n from t h e aqueous-ethanol system proved t o be more 
d i f f i c u l t , but d i d i n f a c t y i e l d the c h l o r i d e f r e e product as a f i n e 
w h i t e s o l i d . 
The twelve-membered t r i a z a r i n g (prepared by Dr. I.M. Helps) was 
N - a l k y l a t e d u s i n g ethylbromoacetate w i t h caesium carbonate i n e t h a n o l . 
The t r i e s t e r was p u r i f i e d by alumina chromatography e l u t i n g w i t h 
dichloromethane-methanol and then hydrolysed t o t h e t r i a c i d w i t h 
h y d r o c h l o r i c a c i d . 
2.1.5. Indium complexation at low concentration 
An i m p o r t a n t f e a t u r e of any complexing agent f o r a p p l i c a t i o n i n 
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radioimmunotargeting is the a b i l i t y to bind the radioisotope r ap id ly at 
low concentration and moderate temperature and pH. Once the macrocycle 
has been l inked to the antibody i t is necessarily present i n low 
concentration ( t y p i c a l l y 10-40 /M) i n aqueous so lu t ion . The temperature 
and pH must not exceed that of normal physiological conditions (pH 4-9; 
T < 37°C) i n order not to denature the immunoglobin. This method of 
r ad io l abe l l i ng the antibody-macrocycle conjugate is known as 
"pos t - l abe l l ing" . The a l t e rna t ive procedure of "p re - l abe l l i ng" involves 
r ad io l abe l l i ng the macrocycle p r i o r to antibody l inkage, and allows 
greater freedom in the complexation step. However, t h i s method i s 
severely l i m i t e d by the time required to covalently l i n k the 
r a d i o l a b e l e d macrocycle to the antibody and p u r i f y the conjugate. I n 
addi t ion to the p rac t i ca l problems of the chemistry using a ' ho t 1 
radioisotope, much of the a c t i v i t y would be los t before the 
r a d i o l a b e l e d antibody was in jected in to the pa t ien t . 
Hence, the fou r t r i a z a - t r i a c i d macrocycles (24)-(27) were screened 
f o r t h e i r a b i l i t y to bind i n d i u m - I I I r ap id ly (< 1 hr) under mild 
conditions (20°C, pH 5) at low concentration, yet s t i l l form a 
k i n e t i c a l l y ine r t complex i n v ivo . The ligands were investigated at 
concentrations of 1 0 - 1 0 0 //Molar in aqueous so lu t ion buffered at pH 5 
with 0.1M NaOAc, at 20°C. The forward rate of association wi th ^ I n 
was monitored by HPLC (reverse phase-polymer, 150 x 4.6 mm) wi th 
radiometric detect ion. Elu t ion times f o r the indium complexes, e l u t i n g 
wi th H20 (897.), 1.0M NH40Ac (107.) and MeCN ( 1 7 . ) wi th f low ra te 1.0 
ml /min . , were between 2.5 and 4.0 minutes. The resul t s are summarised 
i n Table 2 . 3 . 3 4 
At 100 (M ( l igand concentration) the extent of indium uptake a f t e r 
30 minutes was; 




Relative rates of In association of ligands (24) to (27) 
at low concentration (not optimised) 
111 
Ligand Concentration time/min. 7. In uptake 
(24) 1 mM 10 72 
100 /xM 20 75 
10 fM 30 74 
(25) 1 mM 
100 (M 
10 fM 
























At 10 fM, only the nine-membered t r i a c i d showed e f f e c t i v e radio-
l a b e l l i n g , wi th a y i e l d of 747. a f t e r 30 minutes. In subsequent studies 
an improved r ad io l abe l l i ng y i e l d of 967. was determined (30 min . , pH 5, 
20°C). When the * ^ I n complex of (24) was in jec ted in to normal mice, 
a l l r a d i o a c t i v i t y was cleared from the t issue i n a few hours. This 
indicated that the isotope was staying bound to the macrocycle i n v i v o , 
which, as a fo re ign body, is excreted by the mouse. 
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Hence the nine-membered t r i a z a - t r i a c i d was selected f o r f u r t h e r 
i nves t iga t ion . 
2 .1 .6 . Synthesis and characterisat ion of i n d i u m ( I I I ) complexes 
The complexation of I n ( I I I ) by ligand (24) was observed by *H nmr 
in D 2 O . An equimolar quant i ty of indium t r i c h l o r i d e was added to the 
l igand (25 mMolar) i n D 2 O , buffered at pD 5 wi th deuteroacetate/ 
deuteroacetic acid ( I = 0 . 1 , pD = 5 .0) . The diastereotopic r i n g protons 
of the complex resonated as an AA'BB' system wi th mu l t ip l e t s centred at 
3.28 and 3.12 ppm and the methylene 'CH^CO' protons gave a single 
resonance at 3.75 ppm (Fig . 2 .6 ) . In the f r e e l igand the r i n g protons 
30 40 30 PPM PPM 
a) Ligand b) I n ( I I I ) complex 
F ig . 2.6. 1 H nmr of a) the ligand (24) and b) i t s i n d i u m ( I I I ) 
complex i n DgO. 
resonated as a s ing le t at 3.42 ppm and the methylene protons 'CH^CO' 
gave a s ing le t at 3.96 ppm. 
Two forms of the indium complex of (24) were isolated as 
c r y s t a l l i n e so l ids , the simple 1:1 complex In -L (36) and the hydrated 
chloroindium complex [ ( I n - L ) . H C 1 . 0 ] (37). The former was prepared by 
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react ing equimolar quant i t ies of indium n i t r a t e and ligand (24) 
(prepared chlor ide f r ee - section 2 .1 .4 . ) i n aqueous n i t r i c acid (0.04M) 
at room temperature f o r several hours (acidic conditions s t a b i l i s e s the 
In(N0g)g wi th respect to hydrolysis to the insoluble hydroxide In(OH)g). 
The complex was prec ip i ta ted by the addi t ion of acetone and 
r ec rys t a l l i s ed from water-acetone (1 :4 ) . Microanalysis and DCI mass 
spectrometry (m/e: 416 [M + +l ] ) resul ts were consistent wi th the 
formation of a neutral 1:1 hexacoordinate complex. The hydrated 
chloroindium complex (37) was prepared by react ing equimolar quant i t ies 
of indium t r i c h l o r i d e wi th the ligand [dihydrochloride] in hydrochloric 
acid ( i n i t i a l l y 0.04 Molar) . Slow evaporation of solvent over several 
days yielded colourless crys ta ls of the [(InL)HCl.h^O] complex. The two 
complexes gave the same proton nmr i n (at s imi la r pD) i nd i ca t i ng 
that the so lu t ion state structures were the same. 
Crystals sui table f o r X-ray d i f f r a c t i o n were obtained by the slow 
evaporation method f o r the hydrated chloroindium complex. The 
so l id-s ta te s t ructure (F ig . 2.7) was determined independently at two 
centres. 
The molecule comprises an ind ium( I I I ) ion i n a pentagonal 
bipyramidal coordination environment in which the ax ia l s i tes are 
occupied by a chloro l igand and one t e r t i a r y amine (In-N(3) 2.288(5)8) 
of the t r i a z a macrocycle. The two remaining nitrogens occupy posi t ions 
in the equatorial plane ( I n - N ( l ) 2.332(5), In-N(2) 2.331(5) and 
N( l ) - In -N(2) 7 5 . 3 ° ) . The remaining three equatorial s i tes are f i l l e d by 
an oxygen atom from each of the three carboxymethyl groups, one of which 
i s protonated (In-0 2.284, 2.424, 2 . 1 1 6 8 ) . These and other selected 
bond lengths and angles are given in Table 2.4. 




<—> InCI-LH , L 






















f o r ( In-L) 
2.4 
and bond angles 
.HC1.H20 
(deg) 
In-Cl 2.399(2) In -O( l ) 2.284(4) 
In-0(3) 2.424(4) In-0(5) 2.116(5) 
I n - N ( l ) 2.332(5) In-N(2) 2.331(5) 
In-N(3) 2.288(5) 
C l - I n - O ( l ) 83.1(1) Cl- In-0(3; 83.0(1) 
0 ( l ) - I n - 0 ( 3 ) 143.2(1) Cl- In-0(5; 112.0(1) 
0 ( l ) - I n - 0 ( 5 ) 80.3(1) 0(3) - In-0 (5) 73.8(1) 
C l - I n - N ( l ) 99.6(1) 0(1)-In-N (1) 71.3(2) 
0 ( 3 ) - I n - N ( l ) 144.8(2) 0(5)-In-N (1) 134.2(2) 
Cl-In-N(2) 91.0(1) 0(1)- In-N (2) 144.5(2) 
0(3)-In-N(2) 69.5(2) 0(5)-In-N (2) 133.5(2) 
N( l ) - In -N(2 ) 75.3(2) Cl-In-N(3, 168.3(2) 
0(1)-In-N(3) 104.8(2) 0(3)-In-N (3) 94.9(1) 
0(5)-In-N(3) 78.1(2) N ( l ) - I n - N (3) 75.4(2) 
N(2)-In-N(3) 77.6(2) 
favourably wi th those reported f o r other indium complexes, wi th the 
exception of the one long In-0 bond. For example, the hydroxy bridged 
indium tetrameric cat ion of the tr iamine (14) [F ig . 2.2, section 2 .1 .2 . ] 
has In-N bonds ranging from 2.29-2.358 and the oxo bridged binuclear 
tetraaceto species of the same ligand [F ig . 2.3] gives In-N bonds 
2.27-2.328 and In-0 (aceto) bonds of 2.14 and 2.878. Hepta-coordination 
i n indium complexes i s unusual, as 5 or 6-coordinate complexes are 
usually observed. However, Kaden has recently r e p o r t e d ^ two more 
heptacoordinate indium complexes of the tetraaza-tr icarboxymethyl 
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macrocyles (28) and (29) [Fig . 2.5, section 2 .1 .2 . ] as mentioned 
e a r l i e r . In these complexes, the In-N bonds are general ly longer than 
f o r the smaller macrocyclic ligand reported here, wi th In-N bonds 
ranging from 2.31-2.398 f o r (28) and 2.26-2.47^ f o r (29) . In-0 bonds 
are reported as 2.16-2.32$. Furthermore, the indium complex reported 
here has shorter In-N bond lengths than observed in the In-DTPA complex 
[ In -N , 2.388(8) to 2.414(8)S] 3 . 
The indium complex of the ten-membered t r i a z a - t r i a c i d (25) [ In -L] 
was prepared in a s imi la r manner to that used f o r the nine-membered 
analogue (Indium t r i n i t r a t e method). Microanalysis and mass 
spectrometry confirmed that a 1:1 neutral complex had formed, wi th no 
i 
chloride or water of hydration. The H nmr in was very complex, 
consistent wi th the lower symmetry of the complex. The indium complexes 
of the eleven and twelve-membered analogues, (26) and (27) , were not 
isolated as c r y s t a l l i n e so l ids , but t h e i r complexation was observed by 
nmr (again rather complex nmr spectra were observed). 
2.2. Dissociat ion Kinet ics of I n - [ 9 ] - N g t r i a c i d 
2 . 2 . 1 . In t roduc t ion 
Of primary importance f o r radiopharmaceutical app l i ca t ion is the 
k i n e t i c s t a b i l i t y of the indium-macrocycle complex i n v i v o . In 
p a r t i c u l a r , the k i n e t i c s t a b i l i t y at low pH is of in te res t since 
d issocia t ion is acid catalysed. In some parts of the human body acidic 
conditions as low as pH 2 may be encountered (e .g . l i v e r and stomach). 
Therefore, i dea l ly no appreciable dissociat ion of the macrocycle indium 
complex should occur at that pH. 
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2.2.2. 1 J C nmr studies 
The k ine t i c s of d i s soc ia t ion , under acidic condi t ions, were 
investigated f o r the indium complex of the [9]-Ng t r i a c i d (24) , using 
1 9 1 9 
C nmr. The C aceto carbonyl enriched ligand (39) was synthesised 
13 
[Scheme 2.2] using C aceto carbonyl enriched bromoacetic acid 
[A ld r i ch , 99%], using the same procedure as f o r the non-labelled 
analogue. The indium complex In-L was prepared using indium t r i n i t r a t e 
* = i 0 C enriched 
Scheme 2.2. Synthesis of 1 3 C label led [ 9 ] - N g - t r i a c i d (39) . 
i n n i t r i c acid (0.04 Molar) to give the neutral complex [ I n - L ] . 
13 
The C nmr ^ 0 , pD 2-3) of the complex gave a sharp s ing le t at 
175.4 ppm. A separate sharp s inglet was observed at 172.1 ppm f o r the 
f r ee l igand, hence the dissocia t ion of the indium complex of the [9]-N^ 
13 13 
t r i a c i d could be monitored by C nmr. The C nmr spectra were 
recorded at 60.896 MHz on a Bruker AC 250 spectrometer. Typ ica l ly 
75-100 scans wi th a re laxa t ion delay of 1 second were required to obtain 
spectra i n which the signals could be integrated to give the r e l a t i v e 
r a t i o of complexed to dissociated l igand. Longer re laxa t ion delays of 2 
and 3 seconds resulted i n no change in the signal i n t e n s i t i e s . 
Representative spectra are shown in F ig . 2.8. 
CO?H 
¥°^\ r\ J 
N N 
LiOH/H 20 H H 
+ BrCH 2 C0 2 H <_.J <-._> pH 10 H 
(14 ) CQ>H 
(39) 
- 61 -
190 180 170 160 
PPM 
190 180 170 160 
PPM 
190 180 170 160 
PPM 
A) 1007. In -L (B) 807. In-L 
207. LH 3 
C) 187. In-L 
82/. LHg 
F ig . 2.8. C nmr spectra showing the dissocia t ion of the In -L 
complex in 
Dissociat ion of the indium complex (0.01 mol dm , D 2 O ) was 
monitored at pD 1, pD 0, pD -0.4 and pD -0.6 ( a c i d i f i e d wi th 
concentrated n i t r i c acid) at 23°C. I n an early experiment i t was 
discovered that the sample was being heated i n the nmr probe, hence an 
early run was observed at 39°C. This was a t t r i bu ted to the loca l 
heating of the sample caused by the proton decoupler, which was running 
continuously. In a second experiment the temperature of the sample was 
reduced to 31.5°C by blowing a i r over the probe. The problem was solved 
by using a gated-decoupling technique, combined with maintaining a 
constant stream of a i r over the probe, which resulted i n no heating of 
the D 2 O so lu t ion . Thereafter, a l l f u r t h e r experiments were conducted at 
a constant 23°C. 
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At pD 2 the complex was observed to be stable i n D 2 O . Addi t ion of 
indium t r i n i t r a t e to a so lu t ion of the f r ee l igand (equimolar 
quant i t ies ) revealed that complex formation occurred at t h i s pD and was 
seen to be complete w i th in 25 minutes. At pD 1 the d issoc ia t ion of the 
complex was seen to reach an equi l ibr ium. Approximately 207. 
d issocia t ion was observed over a period of several hours, but no f u r t h e r 
d issocia t ion was observed over several weeks. When indium t r i n i t r a t e 
was added to a so lu t ion of the ligand in more s t rongly ac id ic conditions 
(pD = 0) no complex formation was observed over a period of 200 hours 
i . e . association was too slow to observe at t h i s pD. Hence the 
d issocia t ion of the preformed complex at pD < 0 i s essen t ia l ly 
i r r e v e r s i b l e . The dissocia t ion of the complex at pD 0 occurred over 3-4 
hours. The resul ts of t h i s run and experiments conducted at pD = -0.4 
and pD = -0.6 are presented as plots of - l o g [ C ] , / [ C ] vs. time (sec) 
[F ig . 2.9] where [ C ] t = concentration of the complex at time ' t ' and 
[C] = i n i t i a l concentration of the complex. 
These p lo ts gave s t ra ight l ines ind ica t ing that the d i ssoc ia t ion 
react ion was pseudo-f i rs t order [ i n f ac t the k ine t i c s of the 
d issocia t ion was second order; f i r s t order dependence on complex 
concentration and f i r s t order acid dependence]. The rate expression i s ; 
Rate = k [ C ] [ H + ] n k = rate constant 
When the acid i s i n large excess, as i n the experiments described 
here, we can make the approximation that i t s concentration does not 
a l t e r s i g n i f i c a n t l y during the reaction. Hence, the concentration of 
the acid can be incorporated into a new rate constant " k ^ g " , the 
pseudo-f i rs t order rate constant; 




pD = -0-6 © 
p D = - 0 U 
A PD = 0 
I 
2 0 10 6 0 8 0 100 
T (x10 J) seconds 
Fig . 2.9. Plot of - l o g [ C ] t / [ C ] 0 vs. t/sec f o r the d issocia t ion of 
I n - [ 9 ] N 3 - t r i a c i d at pD = 0, -0.4 and -0.6 (23°C). 
and; 
-d[C] 
- a r - = k o b s ^ 
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integrates; 
, ^ t , 
W o 
By measuring the "k ^ " values (determined from the slopes of the p l o t s , 
F ig . 2.9, where lnX = 2.3026 log X) at d i f f e r e n t acid concentrations, we 
were able to deduce that the dissocia t ion process was f i r s t order in 
acid concentration: 
kobs = k I» + ] 
The rate constants are l i s t e d in Table 2.5. 
Table 2.5 
Results of the k i n e t i c experiments on I n - [ 9 ] N ^ - t r i a c i d complex 
Run Temp/°C [D + ] (pD) k o b s ( x l 0 " 4 ) s ^ k ( x l 0 " 4 ) / m o l " 1 d m 3 s ' 1 
(1) 39 0 0.98 (0) 9.34 ± 0 24 9 53 ± 0.24 
(2) 31 5 0.98 (0) 4.04 ± 0 32 4 12 ± 0.33 
(3) 23 0 0.98 (0) 1.81 ± 0 06 1 85 ± 0.06 
(4) 23 0 2.36 (-0.4) 4.81 ± 0 20 2 04 ± 0.09 
(5) 23 0 4.08 (-0.6) 6.56 ± 0 21 1 61 ± 0.05 
a) errors are reported as the estimated deviat ion of the slope from the 
l i n e of best f i t . 
Hence i t was concluded that the d issocia t ion of the indium complex 
[ In -L] was ove ra l l second order; 
Rate = k[C] [H + ] 
and the value of the second order rate constant was; 
k = 1.8 * 0.3 (x lO" 4 ) morWs" 1 
The " k ^ g " values obtained f o r the dissociat ions observed at the three 
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d i f f e r e n t temperatures (23.0, 31.5 and 39.0°C) at the same pD (0) gave 
reasonable agreement wi th the Arrhenius re la t ionship ; 
k = A e " E a / R T 
Ink = lnA- E a /RT 
i . e . a p lo t of Ink vs. */T gave a s t ra igh t l i ne (as f a r as could be 
determined wi th jus t three points) wi th a slope = 9.40 x 10 s. Using 
the Arrhenius p lo t to estimate the errors associated wi th temperature 
f l u c t u a t i o n , i t was found that a deviat ion of ± 1.0°C in the temperature 
led to a deviat ion of ±0.23 x 10 ^s~* in the value of the rate constant. 
This i s s imi la r to the error ac tual ly observed in the experiments 
described. I t i s most l i k e l y , therefore , that temperature f l uc tua t i ons 
were the major source of error in these experiments. 
The resul t s reported here do not lead to a precise value of the 
second order rate constant ' k ' and require more experiments to be 
performed to enable a sa t i s fac to ry assessment of the errors involved. 
However, our immediate goals were achieved in that we were able to 
determine an approximate value of the rate constant and deduce that the 
d issocia t ion was f i r s t order with respect to the acid concentration at 
low pH (< 0 ) . 
Further information with respect to the acid catalysed dissocia t ion 
13 
pathway was available from the r e l a t i v e C nmr s h i f t s of the indium 
13 
complex at d i f f e r e n t pD (Table 2 .6) . The C nmr s h i f t of the complex 
remained unchanged between pD 4.5 and 1.0, but was s h i f t e d by +0.78 ppm 
at pD 0. This suggests that at pD < 1.0 the complex may have protonated 
13 
and thus the C nmr signal observed at pD < 0 (176.17) was i n f a c t that 
of the monoprotonated species In-LH. Furthermore, the l i n e broadening 
observed at pD 1 suggests that the pK f t j value f o r the complex may be 
close to one. By comparison, a s h i f t of 0.68 ppm was observed f o r the 
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Table 2.6 
C nmr s h i f t s (-C0 9 -) and l inewidths 'w, ' of the indium 
complex of (24) at d i f f e r e n t pD 
pD i 0 C nmr sh i f t /ppnT wA/Hz 
2 
4.5 175.40 19 
2.0 175.39 21 
1.0 175.41 59 
< 0 176.17 24 
a 1 3 C s h i f t s t y p i c a l l y ±0.02 ppm. 
k l inewidths t y p i c a l l y ±2.0 Hz. 
f r ee ligand between pD 3.5 (172.78 ppm) and pD 2.0 (172.14 ppm) and a 
f u r t h e r s h i f t of 0.98 ppm between pD 2.0 and pD 1.0 (171.16). This i s 
35 
consistent w i th the reported pK f t values f o r the l igand ( p K ^ = 3.163 
f o r LHg and p K ^ =1.955 f o r LH^). I f the indium complex observed at pD 
< 1 was in f a c t the monoprotonated species In-LH, then a second 
protonation would then resu l t i n rapid d issocia t ion of the complex. The 
acid catalysed dissocia t ion pathway may then be represented as; 
A + H + J ^ L B + H + C — ^ 
where A = I n - L , B = In-LH, C = InLH2 and K ^ , are the acid 
dissociat ion constants where; 
[ H + ] [ A ] [ H + ] [ B ] 
K . = and K Q 0 = 
al j - B j &z j - c - | 
The rate of d issocia t ion i s ; 
k [ H + ] [B] 
Rate = k[C] = — ^ 
a2 
2 where [B] i s related to the t o t a l substrate concentration [S] - 10 mol 
-3 13 
dm" i n the C nmr experiments - where [A] + [B] = [ S ] , so; 
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K a l [ B ] [S] [H + ] 
[S] = [B] + hence [B] = r 
[H + ] ( [ H ] + K a l ) 
Therefore 
[S] [ H + ] 2 
Rate = k . j j — 
la2 ( [ H + ] + K a l ) 
I n the l i m i t i n g cases of a) low acid concentration ( K a l > [ H + ] ) 
then the rate expression approximates t o ; 
R a t e = [" ] 
hence d issoc ia t ion of the complex i s second order with respect to [H ] 
whereas b) high acid concentration ( [ H + ] > K ^ ) then the rate expression 
approximates t o ; 
k[S] . 
Rate = g [H ] 
hence d issoc ia t ion is f i r s t order with respect to acid concentrat ion. 
I t i s proposed that t h i s may have been the case f o r the d i ssoc ia t ion of 
the indium complex at pD < 0, i . e . ; 
^ = 4 t H + 1 
2.2 .3 . Conclusions 
Both s o l i d state studies (X-ray d i f f r a c t i o n ) and so lu t ion studies 
1 13 
( H and C nmr) have shown that I n ( I I I ) i s bound e f f e c t i v e l y by the 
13 
[ 9 ] - N g - t r i a c i d l igand (24). Furthermore, the C nmr studies have 
provided a usefu l ind ica t ion of the k i n e t i c s t a b i l i t y of the indium 
complex towards acid catalysed d i ssoc ia t ion . A desirable extension of 
t h i s work would be to perform s imi la r studies on the In-DTPA complex, 
which, we bel ieve, would dissociate more r ead i ly at considerably higher 
pH values. The s t a b i l i t y of In-DTPA (or other indium complexes f o r use 
i n radioimmunoimaging) at low pH has not been reported. T r a d i t i o n a l l y 
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the k i n e t i c s t a b i l i t y of relevant indium complexes has been determined 
24 36 
in serum i n the presence of t r a n s f e r r i n , ' in an attempt to reproduce 
i n vivo condi t ions . However, at pH 7.4, these studies are un l i ke ly to 
provide an accurate measure of the k i n e t i c s t a b i l i t i e s of the complexes 
i n v ivo . 
Perturbed angular cor re la t ion (PAC) spectroscopic measurements f o r 
111 
the I n - [ 9 ] - N ^ - t r i a c e t a t e complex revealed a quadrupole frequency 
(78K), Wq of 60 MHz. This compares favourably wi th the values f o r 
1 U I n - t r a n s f e r r i n (14 MHz) and m i n - D T P A (9.8 MHz) and i s consistent 
37 
wi th a high complex s t a b i l i t y in so lu t ion . 
2.3. G a l l i m n ( I I I ) Coordination Chemistry 
2 . 3 . 1 . In t roduc t ion 
Gallium (67) has a t t r a c t i ve features as a 7-emit t ing isotope f o r 
use i n radioimmunoscintigraphy. I t has a ha l f l i f e of 78.1 hours, a 
single energy 7-emission (184 keV) and the isotope i s obtainable 
' c a r r i e r - f r e e ' from Zn (p ,n ) . A second isotope, gal l ium (68) also has 
considerable radiopharmaceutical appl ica t ion as a posi t ron emit ter f o r 
use i n posi t ron emission tomography (PET). Although the h a l f l i f e i s 
rather short (68 min.) f o r monoclonal antibody re la ted tumour imaging, 
38 39 
i t does have po ten t i a l use i n brain/renal scanning ' and evaluation 
of myocardial blood f l o w . ^ A major advantage of gal l ium (68) over 
other posi t ron emi t t ing isotopes is that i t i s avai lable r e l a t i v e l y 
easi ly and cheaply from a germanium (68) generator. 
The coordinat ion requirements of both types of gal l ium 
radiopharmaceutical are the same. The metal ion must be bound by a 
l igand such tha t i t i s rendered k i n e t i c a l l y i ne r t towards ( i ) exchange 
wi th the plasma p ro t e in , t r a n s f e r r i n (Ga-Transferrin log K = 2 0 . 3 ^ ) , 
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( i i ) metal or acid catalysed d issocia t ion and ( i i i ) hydrolysis to the 
insoluble Ga(0H)g. Hence i t was considered sui table to assess the 
complexation properties of g a l l i u m ( I I I ) with the [9 ]Ng- t r i ac id (24). As 
f o r i t s neighbouring group ( I I I ) element, indium, the N^Og donor set of 
t h i s l igand provides a p o t e n t i a l l y octahedral coordination of the 
gal l ium ion , forming an ove ra l l neutral complex. This may be 
p a r t i c u l a r l y useful f o r the use of Ga in brain scanning, as the 
increased l i p o p h i l i c i t y of a neutral complex enhances i t s a b i l i t y to 
cross the blood-brain b a r r i e r . More hydrophi l ic complexes such as the 
anionic EDTA complex ([Ga-EDTA]") are known to be unable to cross the 
blood-brain b a r r i e r . ^ 
In order to form neutra l more l i p o p h i l i c complexes of g a l l i u m ( I I I ) 
(and i n d i u m ( I I I ) ) new acyc l ic ligands such as HBED (40) and PLED (41) 
have been synthesised r e c e n t l y . H o w e v e r , as wi th the analogous 
CO2H HOgC 
H HO O H HO 
X J 
N ^ C H 3 H g C ^ N ^ 
(40) HBED (41) PLED 
EDTA ligand they possess an ^ 0 ^ ' donor set and t h e i r gal l ium or indium 
complexes are un l i ke ly to have any greater s t a b i l i t y towards acid 
catalysed d issoc ia t ion . Although the non-protonated complexes Ga-L and 
In-L (L = (40) and (41)) have high thermodynamic s t a b i l i t y constants 
(e .g . log K f o r Ga-HBED = 39.57 and f o r In-HBED = 39.66) these are not 
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the major species i n aqueous solu t ion at pH < 7 (the complexes exis t as 
equi l ib r ium mixtures of various protonated species). 
13 2 The C nmr of the [Ga-DTPA] complex in has been reported 
o 
recent ly and reveals that two of the carboxylate groups do not bind the 
metal ion , h i g h l i g h t i n g the u n s u i t a b i l i t y of t h i s complex f o r i n vivo 
radiopharmaceutical app l i ca t ion . 
2 .3.2. Macrocyclic complexes of g a l l i m n ( I I I ) 
Very l i t t l e work has been reported on the macrocyclic coordination 
chemistry of ga l l ium. Wieghardt^ '^ has investigated the complexation 
of gal l ium t r i h a l i d e s wi th 1,4,7-triazacyclonane (14) and reported the 
formation of complexes of the type LGaX^ (X = C I , Br, I ) , as wi th indium 
t r i h a l i d e s . Also /i-hydroxy bridged gall ium complexes of t h i s l igand 
have been prepared ,^ f o r example, the binuclear species 
[L 2 Ga 2 ( / i -0H) 2 ( / i -CH 3 C0 2 ) ] I 3 .H 2 0 (F ig . 2.10). 
o r 
® 0 
F ig . 2.10. Crystal s t ructure of the [L 2 Ga 2 (/*-0H) 2 (/*-CH 3 C0 2 )]Ig.I^O 
complex. 
The complex adopts an approximately octahedral geometry wi th three 
nitrogens from the macrocycle coordinating f a c i a l l y and three oxygen 
donor atoms (two hydroxy and one aceto). 
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45 
In recent months (1989) Moore has reported the synthesis and 
g a l l i u m ( I I I ) coraplexation of a new [9]-Ng N-funct ional ised 
hexacoordinate l igand (42). The X-ray s t ructure is reported f o r the 1:1 
H . C 
OH 
H . C 




CH H . C 
(42) TX-TACN 
complex i n a monoprotonated form, wi th one molecule of so lvat ion (MeOH) 
[Ga(TX-TACN)H]+[C104]".CH30H (Fig . 2 .11) . The in te rac t ion of the 
methanol wi th the complex (hydrogen bonds wi th the 0 donor atoms) 
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F i g . 2 .11 . ORTEP drawing of [Ga(TX-TACN)]H+. 
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2.3 .3 . Synthesis of g a l l i u m ( I I I ) complexes 
The 1:1 g a l l i u m ( I I I ) complexes of the nine and ten-membered t r i a z a -
t r i a c i d s (24) and (25) were prepared. The neut ra l complexes were 
isolated as colourless c r y s t a l l i n e sol ids using a method s imi l a r to that 
f o r the preparation of the i nd ium( I I I ) complexes. Equimolar amounts of 
gal l ium t r i n i t r a t e and ligand were reacted i n n i t r i c acid (0.04 mol 
dm ) at room temperature f o r 12 hours. The complexes were prec ip i ta ted 
by the addi t ion of acetone and r ec rys t a l l i s ed from water. 
The proton nmr of the [9]-N^ t r i a c i d gal l ium complex i n [F ig . 
2.12] gave a s imi l a r spectrum to the indium complex. The methylene 
protons (CH2CO) resonated as a s inglet at 3.88 ppm and the 





F i g . 2.12. nmr of the G a ( I I I ) complex of (24) . 
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The gall ium complex of the [10]-N^ t r i a c i d (25) gave a wel l defined 
proton nmr [F ig . 2.13] in contrast to the indium complex. The "CHgCO" 
protons resonated as one s ingle t (2H) at 3.81 ppm and an AB doublet of 
J-0 PPM * • 
- i — 
Fig . 2.13. *H nmr of the [10]-Ng t r i a c i d - g a l l i u m ( I I I ) complex. 
doublets centred at 3.73 ppm. This i s seen more c l ea r ly i n the proton 
decoupled (3.16 ppm) spectrum (Fig . 2.14) and i s consistent wi th a plane 
of symmetry i n the complex. The diastereotopic r i n g protons resonate as 
two AA'BB' systems with mul t ip le t s centred at 3 .56, 3.16 ppm (12H, CHrjN) 
and 2 .37, 1.88 ppm (2H, C H 2 - C ) . Slow r e c r y s t a l l i s a t i o n of the 
ga l l i um- [9 ]Ng- t r i ac id complex from D20 gave crys ta ls of su i tab le q u a l i t y 
f o r X-ray d i f f r a c t i o n . The X-ray c rys t a l s t ructure i s i l l u s t r a t e d i n 
F i g . 2.15 and selected bond lengths and angles, wi th estimated standard 
devia t ions , are given in Table 2.6. The coordination of the ga l l ium 






Fig . 2.14. H nmr, decoupled (3.16 ppm), of [ 1 0 ] - N , - t r i a c i d - G a ( I I I ) 
of the macrocycle occupying a f a c i a l set of s i tes and the pendant 
carboxylates occupying the opposite face. A l l three trans N-Ga-0 angles 
are approximately 167° corresponding to the l i m i t e d 5- r ing chelate 
"b i t e" of the pendant arms. This has resulted i n a r e l a t i v e t w i s t of 
the Og and planes of donor atoms by 13° away from a symmetrically 
staggered conformation ( i . e . perfect octahedron). The Og atoms are 
' tw i s t ed ' clockwise r e l a t i ve to the atoms (when viewed from above, on 
the side of the 0 atoms) and so const i tu te a "type I " s t ruc tu re , 
12 13 
according to the c l a s s i f i c a t i o n of Boeyens and Hancock. ' "Type I " 
structures were observed f o r N i ( I I ) , N i ( I I I ) and C r ( I I I ) complexes^' 
of TCTA (24), whereas "type I I " structures (anticlockwise t w i s t ) were 
observed f o r the Cu( I I ) and F e ( I I ) complexes. Twist angles are l i s t e d 
i n Table 2.7. The gallium-TCTA structure most closely resembles those 
of the N i ( I I ) and C r ( I I I ) complexes. 
complex. 
75 
C 0 2 
^ — N — ' 
Ga-L 
< C 0 2 
C6 C7 










F i g . 2.15. X-ray c rys ta l s t ructure of the Ga ( I I I ) complex of (24). 
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Table 2.6 
Selected bond lengths (8) and bond angles (deg) f o r the G a ( I I I ) 
complex of (24) 
Ga-O(l) 1.948(5) Ga-0(3) 1.933(6) 
Ga-0(5) 1.940(5) Ga-N(l) 2.104(6) 
Ga-N(2) 2.102(6) Ga-N(3) 2.110(6) 
0(1)-Ga- 0(3) 95.6(2) 0(l)-Ga-0(5) 94.2(2) 
0(3)-Ga- 0(5) 95.0(2) 0(1)-Ga-N(l) 167.1(2) 
0(3)-Ga- N(l ) 97.2(2) 0(5)-Ga-N(l) 83.6(2) 
0(1)-Ga- N(2) 83.5(2) 0(3)-Ga-N(2) 167.7(2) 
0(5)-Ga- N(2) 97.3(2) N(l)-Ga-N(2) 84.2(2) 
0(1)-Ga- N(3) 98.8(2) 0(3)-Ga-N(3) 83.8(2) 
0(5)-Ga-•N(3) 167.0(2) N(l)-Ga-N(3) 83.7(2) 
N(2)-Ga-•N(3) 84.3(2) 
Table 2.7 
Twist angles and structure type f o r M-TCTA complexes 
Complex Twist angle ' f l ' Type 
Ni[TCTA] 6.9 I 
Ni[TCTA]" 12.0 I 
Cr[TCTA] 11.0 I 
Ga[TCTA] 13.0 I 
Fe[TCTA] 35.0 I I 
Cu[TCTA]~ 33.4 I I 
a) 6 = 0 (octahedral) and 6 = 60 ( t r i g o n a l p r i s m a t i c ) . 
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The two symmetrically occupied faces are p a r a l l e l (0.6 ) but the Og 
set i s enlarged, hence the O-Ga-0 angles average 95° whereas the N-Ga-N 
angles average 84° . The whole molecule has approximate, but not 
c rys t a l log raph ica l ly imposed, Cg symmetry. There is l i t t l e va r i a t i on in 
the ind iv idua l Ga-N and Ga-0 bond lengths and the average bond lengths 
[Ga-N 2.1058 and Ga-0 1.9408] are jus t marginally shorter than those 
reported f o r the complex [Ga(TX-TACN)H]+ 4 2 [Ga-N 2.1098 and Ga-0 
1.9448, see section 2 .3 .2 . ] . Similar Ga-N (2.1078) and Ga-0 (1.94l8) 
bond lengths were reported f o r the Cg symmetric complex of the 
hexadentate l igand (43). 
2.4. Gallium NMR Studies 
2 . 4 . 1 . I n t r o d u c t i o n 4 7 , 4 8 
Gallium occurs na tu ra l ly as a mixture of two isotopes, Ga (60.47.) 
71 3 and Ga (39.67.) both possessing spin, I = / 2 . The nuclear 
character is t ics are summarised in Table 2.8. 
71 
The Ga isotope i s preferred f o r nmr work, despite having the 
lower abundance, as i t has a higher r ecep t iv i t y and a s l i g h t l y less 
e f f i c i e n t quadrupolar re laxat ion and hence narrower l i n e widths. I t may 
71 
be noted that 99.87. enriched Ga i s available from Oakridge (U.S.A.) at 
a cost of £1.50 per mg. 
71 
The use of Ga nmr f o r i n vivo imaging has so f a r proved to be 
impossible, as the resonances of a l l the complexes invest igated e.g. 
HO 






Nuclear properties of u y Ga and ' 'Ga 
^Ga IlGa 
Spin 3 / 2 3 / 2 
Nat. Abundance 60.4 39.6 
R e c e p t i v i t y / 1 3 C 237 319 
Gyromagnetic r a t i o 6.420 8.158 
Quad, moment 0.178 0.112 
c i t r a t e , lac ta te and EDTA have proved to be too broad to observe. 
Gallium s h i f t s are quoted r e l a t i ve to the G a ^ O ) ^ s ignal which i s 
reported to have a minimum l i n e width of 140 Hz [ L i t : 200 H z ^ ] . 
Although the gal l ium signals tend to be r e l a t i v e l y broad, t h i s i s 
compensated by the large chemical s h i f t range of approximately 1400 ppm 
[Fig . 2 .16] . 
C H E M I C A L S H I F T S ; reference G a ( H 2 0 ) 6 3 + 
I G a 2 X 2 
:Ga: 
_ G a _ 
I 
ppm 
+ 4 0 0 0 - 400 
Fig . 2.16. 7 1 Ga s h i f t s . 
The major i ty of ga l l ium s h i f t s reported are f o r the ga l l ium 
te t rahalo species, which generally give r e l a t i v e l y sharp signals in 
aqueous or non aqueous solvent, with s h i f t s ranging from -500 ppm 
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(Gal^/MeCN) to +250 ppm (GaCl^/MeCN). Octahedral species which have 
been observed by gal l ium nmr include the cat ions, Ga(DMF)g+, Ga(MeCN)3+ 
and Ga(T.M.P.)g + [T.M.P. = trimethylphosphate] wi th s h i f t s between 0 and 
-100 ppm. 
2 .4 .2 . 7 1 Ga NMR of Ga- [9] -Ng-t r iac id 
71 
The Ga nmr of the gal l ium complex of [ 9 ] - N ^ - t r i a c i d (24) was 
recorded in D20 (0.03 mol dm" 3 ) . Referenced to Ga(D 20)g + (6a(N0g) 3 , 0.1 
mol dm i n D2O) at 0 ppm the complex gave a sharp signal = 210 Hz) 
at +170.2 ppm. A second reference peak f o r Ga(OD)^ was observed at 
222.6 ppm (<4 220 Hz) in D20 (pD 12). The resonance of the ga l l ium 
complex i s shown r e l a t i v e to the two reference signals in F i g . 2.17. No 
s h i f t of the signal was observed in the pD range 0 to 12. 
71 
The narrow l i n e width of the Ga-[9]Ng-t r iac id signal i s 
consistent wi th the formation of a complex of r e l a t i v e l y high symmetry 
in which the metal ion i s t i g h t l y bound. I n t r i n s i c l i n e broadening in 
the spectra of quadrupolar nucle i is caused by the in te rac t ion of the 
nuclear quadrupole moment with the e l e c t r i c f i e l d gradient (efg) at the 
nucleus. Since quadrupolar t r ans i t i ons change the electromagnetic 
environment, the magnetic dipole and e l e c t r i c dipole are s t rongly 
coupled, hence re laxat ion of the nuclear e l e c t r i c quadrupole wi th 
changes i n the loca l efg (due to molecular motions, i n the l i q u i d phase) 
also relaxes the nuclear spin ("Quadrupolar r e l axa t ion" ) . For an 
octahedral complex wi th a pa i r of f a c i a l Ng and Og donors the meridional 
gradient ( i . e . i n the ' x - y 1 plane) tends to zero and the resul tan t f i e l d 
gradient at the nucleus i s highly anisotropic ( i . e . only i n the ' z 1 
a x i s ) . This resul t s in a minimal degree of l i n e broadening. The 
gal l ium complex of the [10]-Ng t r i a c i d (25) gave a very broad signal at 
132.5 ppm (10$ = 2000 Hz) which was only j u s t discernable against a 
- 80 
L = N n rrr 
y \ / V ' b U 2 
co; 
Ga(OD)~ 
U ) V = 220Hz 
GaL 
U)v = 210 Hz 
7 
Ga(D 20) 6 3 + 
w 1 ; = 140 Hz 
7 
400 300 200 100 0 -100 -200 
n g . 2.17 " G a NMR(298K,D 2o) 
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non-linear baseline. No ^Ga resonance was observed f o r the [11]-Ng 
t r i a c i d complex. The enhanced l i ne broadening i s consistent wi th the 
lower symmetry of these complexes, wi th strong in te rac t ion between the 
enhanced e l e c t r i c f i e l d gradient and the quadrupole moment. 
The k i n e t i c s t a b i l i t y of the G a ( I I I ) - [ 9 ] N g - t r i a c i d complex was 
71 
investigated at low pH, using Ga nmr. The complex was found to be 
remarkably stable with respect to acid catalysed d i s soc ia t ion , wi th the 
signal at 170.2 ppm being observed wi th the sample in 6 molar n i t r i c 
acid . No sign of dissociat ion of the complex to give f r e e g a l l i u m ( I I I ) 
( i . e . Ga(H 20)£ at 0 ppm) was observed at t h i s pH, over a period of 
several weeks. The complex was also stable towards d issoc ia t ion in 
basic media up to pH 13.5, at least . 
71 
2.4.3. I n vivo Ga nmr imaging 
Recent studies at the Medical Research Council Radiobiology Unit 
have shown encouraging resul ts with respect to the use of the 
71 
Ga-[9]Ng-t r iac id complex in NMR imaging. A sample of the complex 
o 
(0.012 mol dm in H^O, phosphate b u f f e r ) was in jec ted intravenously 
71 
in to a mouse and the Ga-[9]Ng-tr iacid signal observed 20 minutes 
l a t e r , i n the l i v e r , using an external 3 cm surface c o i l as a probe. 
The spectrum obtained i s presented along wi th that observed f o r the 
gal l ium complex in aqueous solut ion using the same probe [ F i g . 2 .18] . 
71 
Further work i s in progress to evaluate the u t i l i t y of Ga nmr j j i 
v ivo . 
2 .4 .4 . Conclusion 
The very high k ine t i c and thermodynamic s t a b i l i t y of the 
ga l l i um- [9 ]Ng- t r i a c id complex in aqueous solut ion at both low and high 




8000 6000 COO 2000 „ -2000 -6000 Hz 
Fig . 2.18. Ga nmr spectra of the Ga- [9]N^- t r iac id complex observed 
i n a) the l i v e r region of the mouse (20 min.) and 
b) i n aqueous so lu t ion . 
app l i ca t ion . In addi t ion to the po ten t i a l use in radioimmuno-
scintigraphy ( 6 7 Ga) and PET ( 6 8 G a ) , i s the p o s s i b i l i t y of i t s use i n i n 
71 
vivo NMR imaging by d i rec t observation of the Ga nucleus. 
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CHAPTER THREE 
SYNTHESIS OF FUNCTIONALISED MACROCYCLES TO BIND INDIUMmn 
AND CALLIUMQII) 
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3 . 1 . In t roduct ion 
Having selected the [ 9 ] - N ^ - t r i a c i d (24) as the prefer red macrocycle 
f o r binding indium and ga l l ium, the synthesis of a func t iona l i sed 
analogue permi t t ing attachment of the ligand to the antibody was 
required. 
A number of d i f f e r e n t methods f o r ligand-antibody conjugation have 
been reported. The major i ty of these involve the react ion of an 
e l e c t r o p h i l i c group on a side chain of the l igand wi th the lys ine 
e-amino group of the antibody. 
DTPA has been conjugated to antibodies using a route based on the 
cyc l i c dianhydride (CA-DTPA) 1" 3 [F ig . 3 . 1 ] . The anhydride reacts wi th a 
lys ine e-amino group forming an amide l i n k with the antibody. However, 
i n the case of the indium complex i t is known that the loss of one of 
COO coo 




Fig . 3 . 1 . Conjugation of DTPA dianhydride (CA-DTPA) to the 
lys ine Pffl^ group of the antiboay. 
the carboxylate binding s i tes reduces the k i n e t i c s t a b i l i t y of the 
complex i n v ivo . 
3-5 
A series of reagents derived from aromatic amines [Fig- 3.2] 
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have been used f o r the linkage of EDTA, DTPA and the macrocyclic l igand 
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Fig . 3.2. Synthesis of func t iona l i sed EDTA der ivat ives 
('BABE', 'CITC1 and 'azobenzyl- 1 ) . 
found to react wi th several d i f f e r e n t amino acid residues of the 
antibody (e.g. tyros ine (OH) and h i s t i d ine (NH) ) . The p - i so th io -
cyanatobenzyl-EDTA ( 'CITC 1 ) and p-(a-bromoacetamidobenzyl)-EDTA ('BABE') 
systems were found to react more s p e c i f i c a l l y wi th the lys ine e-amino 
group. The ft-bromoacetamido reagents also react wi th f r e e t h i o l groups 
as shown f o r the 'TETA' system in F ig . 3.3. I n t h i s case the antibody 
was treated wi th 2-iminothiolane ("Trauts reagent") which reacts wi th 
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F i g . 3.3. Antibody conjugates of tog: azobenzyl-EDTA, middle: 
'CITC and bottom: a-bromoacetamidobenzyl-TETA 
(v ia 2-iminothiolane spacer). 
generating a f r ee t h i o l . Meares reported that the l a b e l l i n g of the 
TETA-antibody conjugate wi th Cu, was only e f f e c t i v e when the side 
chain had f i r s t been extended in t h i s way. 
For the [9 ]Ng- t r i ac id system, the synthesis of a C-funct ional ised 
der iva t ive with a simple a l i p h a t i c primary amine side arm (52) i s 
reported. 
The linkage of the macrocycle, with a nucleophil ic amino group, to 
a nucleophi l ic residue on the antibody, requires the use of a hetero-
b i f u n c t i o n a l cross l i nke r molecule. The l inker molecule must contain 
two d i s t i n c t groups, one of which w i l l react s p e c i f i c a l l y towards the 
- 89 -




( 5 2 
amine of the macrocycle and the other towards the antibody residue ( i . e . 
a t h i o l group - when treated wi th "Trauts" reagent). Two such 
heterobi funct ional l i nke r molecules, (a 2 - v i n y l pyr id ine ester system 
and a maleimide ester system) are discussed l a t e r (sect. 3 . 4 . ) . 
8 9 Arano et a l . and Meares et a l . have reported that the 
r ad io l abe l l i ng of antibody-ligand conjugates i s a f fec ted by the length 
and l i p o p h i l i c i t y of the chain separating the two. I f the chain was too 
short or too l i p o p h i l i c then the ligand was "buried" w i t h i n the antibody 
and unavailable f o r r ad io l abe l l i ng . I t was postulated tha t the use of 
"Trauted" antibodies and cross l inker molecules would minimise any 
r ad io l abe l l i ng problems associated wi th the r e s t r i c t e d access to the 
l igand, in the conjugate. 
3.2. Synthesis of the C-Functionalised [ 9 ]-N^-triacid 
The C-funct ional ised macrocycle (52) has been synthesised by two 
routes, s t a r t i n g from the commercially avai lable (2S)- lysine 
monohydrochloride. 
3 . 2 . 1 . Route A 
The f i r s t route i s out l ined in Scheme 3 . 1 . The (2S)- lysine was 
converted to the methyl ester (43) by b o i l i n g under r e f l u x i n methanol 






v C0 2 Me 
(43) 
H 2N "0 
BH 3 .DMS/THF 
NHCOPh 
. T s C l / E t 3 N 
NHCOPh 
i) C u 2 ' 
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TsN / D M F / C s 2 C 0 3 
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c 
(49) 
C 0 3 H 
NHCOPh 
H0 2 C 
(52) 
c . H 2 S 0 4 




B r C H 2 C 0 2 H / L i O H / H 2 0 
.CO,H 
H0 2 C 
NHCOPh 
(51) 
Scheme 3 . 1 . Synthesis of a C-functionalised [9 ]Ng- t r i ac id (Route A) 
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with l i q u i d ammonia at -77°C resulted i n only p a r t i a l conversion to the 
amide (44) . I t was found that by treatment wi th l i q u i d ammonia alone at 
-77°C f o r several hours, a l l of the ester was consumed to give a mixture 
of the required product and one minor impur i ty . Mass spectrometry data 
13 
and C nmr revealed that t h i s was the lactam (45), the product from a 




achieved by tak ing up the mixture in methanol and removing the insoluble 
white s o l i d by f i l t r a t i o n . The product was s u f f i c i e n t l y pure (approx. 
907.) to continue wi th the next steps of the synthesis, wi th p u r i f i c a t i o n 
at the tosylamide stage. However, i n subsequent syntheses the 
commercially ava i l ab le , but expensive, (2S)-lysine amide dihydrochloride 
was used. The amide (44) proved to be very insoluble in THF, r e su l t i ng 
in a very slow reduct ion, using a large excess of borane.DMS in THF, 
wi th heating under r e f l u x (2 weeks). (Both LiAlH^ i n THF and 
NaAlH 2(0CH 2CH 20CH 3) 2 [REDAL] in toluene (3.4M) f a i l e d to reduce the 
amide.) The crude tr iamine (46) was obtained i n quan t i t a t ive y i e l d by 
ext rac t ion in to chloroform from basic aqueous so lu t ion and used without 
f u r t h e r p u r i f i c a t i o n . I n order to tosyla te the amines i n the 1- and 
2-posi t ions , i t was necessary to protect the primary amine at the 
6-pos i t ion . The ethylenediamine sub-unit of (46) was protected by 
complexation wi th copper(I I ) (using CuC0 3.Cu(0H) 2) in aqueous so lu t i on , 
- 9 2 -
thereby permi t t ing select ive acylat ion of the remote primary amine 
group, wi th benzoyl chloride ( 0 ° C , pH > 9 ) . Treatment wi th hydrogen 
sulphide afforded the benzamide ( 4 7 ) in 497o y i e l d a f t e r exhaustive 
ex t rac t ion in to chloroform from basic aqueous so lu t ion . The 
ditosylamide ( 4 8 ) was prepared by reaction of the benzamide ( 4 7 ) wi th 
t o s y l chloride in dichloromethane in the presence of t r i e thy lamine . 
P u r i f i c a t i o n was effected by ' f l a s h 1 s i l i c a gel chromatography wi th a 
low p o l a r i t y gradient e lu t ion (MeOH-Cf^C^) • Two 'column' p u r i f i c a t i o n s 
were required i n order to obtain an a n a l y t i c a l l y pure sample ( 4 3 7 c ) . 
Condensation of ( 4 8 ) with the relevant 1 , 5 - d i t o s y l a t e , using caesium 
carbonate in DMF ( 1 8 h r . ) ^ afforded the cyc l i c t r i tosy lamide ( 4 9 ) . As 
wi th the acycl ic ditosylamide ( 4 8 ) , p u r i f i c a t i o n required ca r e fu l 
' f l a s h ' s i l i c a column chromatography wi th slow movement of the product 
down the column, to give a n a l y t i c a l l y pure material ( 3 5 7 . ) - Detosylation 
was e f fec ted by heating ( 4 9 ) i n concentrated sulphuric acid ( 1 1 5 ° C , 1 8 
h r . ) , leaving the benzoyl group i n t a c t . The tr iamine ( 5 0 ) was obtained 
i n 4 1 7 . y i e l d a f t e r extract ion in to dichloromethane from basic aqueous 
so lu t i on . The product gave a single peak by cat ion exchange HPLC [F ig . 
3 . 4 ] . The t r i ace ta te ( 5 1 ) was prepared by treatment of the t r iamine 
J 
00 5-0 10-0 15-0 20-0 
T/Min 
Fig. 3 . 4 . HPLC trace of ( 5 0 ) . 
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(50) wi th a large excess of bromoacetic acid i n water (65°C) wi th 
addi t ion of LiOH to maintain the solut ion at pH 10. The react ion was 
monitored by reverse phase HPLC ("Spherisorb" S50DS) . A f t e r the 
addi t ion of several portions of bromoacetic acid over a period of 46 
hours, no f u r t h e r change was observed in the HPLC trace and a major peak 
had emerged at 12.0 minutes (see Ch. 6 f o r HPLC cond i t ions ) . The 
t r i ace ta t e was p u r i f i e d by ion exchange chromatography (sepharose, 
DEAE-cation exchange: gradient e lu t ion wi th NH^OAC) fol lowed by reverse 
phase column chromatography, to remove excess NH^OAc. For the ion 
exchange chromatography, the s t a r t i ng mixture had to be d i l u t e d (500 ml, 
H2O) in order to reduce i t s ionic strength to that of the s t a r t i n g 
1 
eluant. The H nmr ^ O ) and the anion exchange HPLC trace of the 
product, which was obtained i n 797. y i e l d , are given i n F ig . 3.5. I n the 
*H nmr charac te r i s t i c resonances were observed f o r the benzoyl group 
(7.5-7.8 ppm) and the a l k y l chain (6H, 1.4-1.7 ppm). The methylene 
' ^ C O ' groups resonated between 3.5 and 4.1 ppm and the remaining 
'CHgN' protons gave a complex set of mu l t ip l e t s between 2.9 and 3.5 ppm. 
The benzoyl group was readi ly cleaved by r e f l u x i n hydrochloric 
acid (6M, 12 h r . ) to y i e l d the amino-functionalised t r i a c i d (52) i n 
quant i ta t ive y i e l d . 
3.2.2. Route B 
The second route to the synthesis of the amino-functional ised 
[9 ]Ng- t r i ac id [Scheme 3.2] was s imi lar i n strategy to that of the f i r s t . 
The major d i f fe rence was that 'route B' involved the synthesis of a 
t r i tosy lamide acycl ic precursor for condensation wi th a 1 ,3-d i tosy la te , 
to form the nine-membered r i n g . Al ternat ive methods f o r detosyla t ion 
and N-a lky la t ion are also described. Reaction of the methyl ester of 
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F ig . 3.5. H nmr and cation exchange HPLC trace of (51). 
the amide (53) i n 967. y i e l d (excess ethylenediamine was removed by 
d i s t i l l a t i o n under reduced pressure). Reduction of the amide (53) was 
e f fec ted using borane.THF in THF, heating under r e f l u x f o r 21 hours. 
The tetraamine (54) was obtained i n 757. y i e l d a f t e r exhaustive 
ex t rac t ion from basic aqueous so lu t ion . A l t e rna t ive ly the product could 
be obtained, f o r use i n the next step, as the hydrochloride s a l t . The 
diethylenetr iamine sub-unit was protected by forming the copper( I I ) 
complex i n aqueous so lu t ion , al lowing acyla t ion of the remote primary 
amine wi th benzoyl chloride (as i n 1 route A 1 ) . The copper was removed 
by treatment wi th HgS followed by exhaustive ext rac t ion wi th 
- 9 5 -
dichloromethane from basic aqueous so lu t ion , to y i e l d the benzamide ( 5 5 ) 
in 587o y i e l d . (Further ex t rac t ion in to chloroform gave a mixture of 
benzoylated and non-benzoylated products.) The t r i tosy lamide ( 5 6 ) was 
H,N 
, r-NH 2 
*-
ii) BH 3 -THF 
H 2N, 
C0 2 Me 
(43) 
NHCOPh 
i) C u 2 * 
ii) PhCOCI/OH" 
iii) H 2 S 
E t 0 2 C 
NHCOPh 
i) L i / N H 3 / E t O H 
ii) BrCH 2 C0 2 Et C 0 2 E 1 ^ J 
K 2 C0 3 /MeCN 
i) H 3 0 
H,N 
i) T s C I / E t 3 N K I 5 6 ) ) 
•OTs 
-OTs 




Ts ! 0 
(49) 
Scheme 3.2. Synthesis of C-funct ional ised [ 9 ] - N o - t r i a c i d : 'Route B ' . 
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prepared by the reaction of (55) wi th tosy lch lo r ide i n dichloromethane 
in the presence of t r ie thylamine . The product was found to p rec ip i t a t e 
from dichloromethane and was obtained i n 687. y i e l d . Co-condensation of 
(56) wi th ethyleneglycol d i tosy la te (Cs 2C0 3/DMF/65°C/18 h . ) af forded the 
cyc l i c t r i tosy lamide (49) i n 717. y i e l d . An a l t e rna t ive method of 
detosylat ion was attempted using Li/NHg/MeOH/THF. The *H nmr of the 
crude product revealed that the cycle had f u l l y detosylated, but also 
some cleavage of the benzoyl group had occurred (ca. 307.). Furthermore, 
the appearance of a benzylic signal at 3.75 ppm indicated that some 
reduction of the benzamide to the benzylamine had also occurred. 
12 
Previous studies had shown that the benzylamine f u n c t i o n a l i t y was 
unsuitable as a protect ing group, as a l l standard methods f a i l e d to 
cleave the benzyl-amine bond. 
The t r i e s t e r (57) was prepared by the react ion of (50) wi th 
ethylbromoacetate and caesium carbonate i n ethanol (70°C, 16 h r . ) 
fol lowed by p u r i f i c a t i o n by alumina column chromatography (777.). 
Treatment of (57) wi th hydrochloric acid (6M, 18 hr . r e f l u x ) e f fec ted 
hydrolysis of the ester groups and benzamide group to give the amino 
func t iona l i sed t r i a c i d i n quant i ta t ive y i e l d . 
3.2.3. Conclusion 
The most e f f i c i e n t synthesis of the amino func t iona l i sed 
[9 ]Ng- t r i ac id i s achieved wi th a combination of the two synthetic 
routes. Route 'B ' i s preferred up to the synthesis of the c y c l i c 
t r i tosy lamide (49) as a resul t of the higher y ie lds (197. ove ra l l from 
the amide c j [ . 67. f o r route 'A') and more s t ra ight forward p u r i f i c a t i o n 
procedures. Concentrated sulphuric acid i s the preferred reagent f o r 
detosyla t ion, g iv ing a clean product, leaving the benzamide group 
i n t a c t . The N-alkylated product can be prepared equally we l l wi th 
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e i ther bromoacetic acid or ethylbromoacetate. 
20 
The op t i ca l ro t a t ion resul ts of the intermediate products 
(49) to (51) [Table 3.1] are consistent with a lack of racemisation. 
20 
Although the [a]p values are not conclusive evidence of 1007. 
enantiomeric p u r i t y , i t i s most probable that racemisation has not 
occurred, as the c h i r a l centre is not involved d i r e c t l y ( i . e . as a 
react ion centre) in any of the conversions. 
Table 3.1 
[a]jj° values f o r (49) , (50) and (51) 
Product [a ]p° (c 1.0 g/100 ml) 
(49) +9.2 (CH2C12) 
(50) +4.1 (CH2C12) 
(51) +7.5 (H 20) 
3 .2.4. Synthesis of C-functionalised DTPA 
I n order to run a d i rec t comparison of the ind ium-[9]N^- t r i ac id 
system with an analogous indium-DTPA system ( i n animal b i o d i s t r i b u t i o n 
studies) the ligand (60) was prepared. 
I-UN 
C0 2 H 
C 0 2 H 
c 
(60) 
This l igand contains the same lysine-derived aminoalkyl 
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f u n c t i o n a l i t y , at the C-l pos i t i on , as the [9 ]Ng- t r i ac id system 
described i n the las t sect ion. As a su i tab le precursor had already been 
prepared (Intermediate (55) - Scheme 3 .2 ) , the synthesis of the DTPA 
analogue ( requ i r ing N-a lky la t ion of (55)) appeared to be r e l a t i v e l y 
s t ra igh t fo rward . However, several attempts at the synthesis of the DTPA 
analogue f a i l e d ; 
( i ) (BrCH2C02H/LiOH/H20/80°C) - react ion gave a mixture of products 
(no major component) which could not be separated by column 
chromatography, or 'semi-preparative' HPLC. 
( i i ) ClCH 2C0 2H/LiOH/H 20/80°C) - no react ion observed. 
( i i i ) (BrCH2C02Me/K2C03/DMF/9O°C) - no react ion observed. 
( i v ) (BrCH 2 C0 2 Et)/Cs 2 C0 3 /EtOH/70°C) - a mixture of several products 
by alumina t . l . c . 
The DTPA analogue was eventually prepared using a method reported 
by Gansow et a l . [Scheme 3 . 3 ] . The t r iamine (55) was t reated wi th a 
NHCOPh 
NHCOPh 
HjN—< BrCH2C0 2 H/Toluene/K0H/H 2 0 H 0 2 C - ^ \ # 
- (60) 
HN^ ^ J . C 0 , H 
HjN-J 
155) |59) 
H 0 2 C 
Scheme 3.3. Synthesis of C-funct ional ised DTPA. 
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so lu t ion of bromoacetic acid i n toluene and aqueous KOH s o l u t i o n , at 
0°C, wi th vigorous s t i r r i n g . Af t e r 24 hours a mixture of products was 
observed by anion exchange HPLC, so f u r t h e r quant i t i es of reagent 
(BrCR^Cl^H/KOH, 3 eq.) were added. A f t e r a f u r t h e r 24 hours a major 
component had emerged, wi th a r e l a t i v e l y long re ten t ion time by anion 
exchange HPLC (R^ = 18 min. - consistent wi th a doubly or t r i p l y 
negatively charged species). The crude mixture was a c i d i f i e d and passed 
down a cat ion exchange column, e lu t ing i n i t i a l l y wi th water, to remove 
sa l ts and hydrolysis products and la te r with aqueous ammonia so lu t ion , 
to br ing o f f the product. The *H nmr of (59) [F ig . 3 .6(a)] was s imi l a r 
a) 
A 1 V W~~ 80 ft M~ W ~ 30 20 W 0 
b 
J 
0-0 5? XM) l?0 2O0 
T/Min 
F i g . 3.6. a) *H nmr and b) anion exchange HPLC trace of (59). 
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t o t h a t observed f o r t h e analogous [ 9 ] - N ^ system and t h e anion exchange 
HPLC t r a c e [ F i g . 3 . 6 ( b ) ] of t h e p u r i f i e d product gave a s i n g l e peak a t 
18 min. H y d r o l y s i s t o t h e amine (60) was e f f e c t e d by h e a t i n g under 
r e f l u x i n h y d r o c h l o r i c a c i d (6M, 12 h r . ) . 
3.3. Synthesis of N-Functionalised [9]Ng-triacids 
The p r e p a r a t i o n of an N - f u n c t i o n a l i s e d d e r i v a t i v e o f t h e 
[ 9 ] N g - t r i a c i d was sought, i n order t o i n v e s t i g a t e t h e e f f e c t t h a t t h e 
p o s i t i o n of f u n c t i o n a l i t y had on the i n v i v o s t a b i l i t y o f t h e indium 
complex. A s h o r t e r s y n t h e t i c r o u t e t o a f u n c t i o n a l i s e d system was a l s o 
sought. Furthermore, t h e s y n t h e t i c s t r a t e g y proposed f o r 
N - f u n c t i o n a l i s a t i o n enabled t h e s y n t h e s i s of a l i g a n d w i t h two 
am i n o a l k y l s i d e arms t o be prepared. This was considered t o be o f 
p o t e n t i a l use w i t h respect t o new methods o f l i n k a g e t o t h e a n t i b o d y , as 
being i n v e s t i g a t e d by our i n d u s t r i a l c o l l a b o r a t o r s a t C e l l t e c h L t d . (see 
s e c t i o n 3.4.). 
2-Bromo-N-benzoyl-6-aminohexylethanoate (63) was s y n t h e s i s e d i n two 
steps from t h e commercially a v a i l a b l e N-benzoyl-6-aminohexanoic a c i d 
13 
(61) [Scheme 3.4]. Treatment of (61) w i t h red phospherous and bromine 
NHCOPh NHCOPh NHCOPh 
HOjC 









(61) (62) (63) 
Scheme 3.4. 
acc o r d i n g t o t h e method o f Eck et a l . gave t h e o-bromoacid ( 6 2 ) . T h i s 
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was converted t o t h e o-bromoester (63) by b o i l i n g under r e f l u x i n 
eth a n o l and 57. a c e t y l c h l o r i d e , w i t h p u r i f i c a t i o n by ' f l a s h ' s i l i c a g e l 
chromatography. 
The o-bromo e s t e r (63) can be considered as an et h y l b r o m o a c e t a t e 
d e r i v a t i v e , w i t h a p r o t e c t e d a l k y l a m i n e f u n c t i o n a l i t y a t t h e 2 - p o s i t i o n . 
The i n i t i a l s t r a t e g y was t o prepare t h e N,N ' - b i s ( e t h o x y c a r b o n y l -
1 5 
methyl) d e r i v a t i v e of [9]Ng, as r e p o r t e d by Wieghardt (BrCfl^Cl^Et/ 
NaOEt/EtOH), f o l l o w e d by a l k y l a t i o n w i t h t h e a-bromo e s t e r (63) t o g i v e 
t h e N - f u n c t i o n a l i s e d product (67) (Scheme 3.5). 
EtOjjCk 
N N 
E t O g C ^ N ] 
BrCHgCOpH 63 ( 9 ) N 3 HN KgCCtyDMF NaOEt 
N 




However, t h e d i e s t e r (64) f a i l e d t o r e a c t w i t h t h e a-bromoester (63) 
under s e v e r a l d i f f e r e n t r e a c t i o n c o n d i t i o n s ( ( i ) I^COg/DMF ( i i ) 
K2C03/CH3CN ( i i i ) Cs 2C0 3/EtOH o r ( i v ) NaOEt/EtOH). I t was p o s t u l a t e d 
t h a t t h e s t e r i c hindrance t o t h e l a s t secondary n i t r o g e n may have been a 
s i g n i f i c a n t f a c t o r w i t h t h e r e l a t i v e l y b u l k y a-bromoester. I n p r e v i o u s 
r e a c t i o n s where t h e N - a l k y l a t i o n was monitored by HPLC, i t was noted 
t h a t t h e f i n a l a l k y l a t i o n took s i g n i f i c a n t l y l o n g e r than t h e f i r s t two. 
Hence t h e o r d e r of t h e s y n t h e s i s was re v e r s e d , such t h a t a l k y l a t i o n of 
the t h i r d amine would be w i t h t h e l e s s s t e r i c a l l y hindered ethylbromo-
a c e t a t e (Scheme 3.6). 
Reaction of equimolar q u a n t i t i e s o f 1,4,7-triazacyclononane w i t h 
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the o-bromoester (63) and potassium carbonate i n DMF (60°C) gave a 
mi x t u r e o f t h e "mono" and " d i - " a l k y l a t e d p r o d u c t s (65) and (66) i n a 
1:2 r a t i o ( u n r eacted [ 9 ] N ^ must have been pre s e n t i n t h e crude product 
a l s o ) . These were separated on a r e l a t i v e l y s m a l l s c a l e (< 100 mg) by 
1 s e m i - p r e p a r a t i v e ' c a t i o n exchange HPLC (monitored a t X - 282 nm). The 
( 9 ) N 3 
( 1 3 ) 
( 6 5 ) 
( 6 6 ) 
EtOoC NHCOPh HCOPh 
> r r N N (63)/K 2 C0 3 /DMF HN HN 
N 
EtO? 
65) ( 6 6 ) 
H O A EO2CX N H 2 NHCOPh 
r r N N 
E t O g C ^ N J 
H3Cf BrCH 2 C0 2 Et / 
CS2C0 3/DMF 
COoH COpEt 
( 6 8 ) 67 
H 2 HCOPh 
r N N 
H O a C K ^ N J 
H aO + 
E t O g C ^ N J kV BrCH 2 C0 2 Et / CsoCCWDMF 
nose/ 
HCOPh Ho 
( 69 ) ( 70 ) 
Scheme 3.6. Synthesis o f "mono-" and " d i - " N - f u n c t i o n a l i s e d 
[9]-No t r i a c i d . 
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r a t i o of t h e products (65) and (66) were reversed (3:1) by i n c r e a s i n g 
t h e r a t i o o f t h e t r i a m i n e t o o-bromoester, t o 2:1, w i t h slow dropwise 
a d d i t i o n o f t h e l a t t e r . The crude product was used w i t h o u t p u r i f i c a t i o n 
i n t h e next step. Treatment w i t h ethylbromoacetate and caesium 
carbonate i n DMF (60°C, 20 hours) y i e l d e d a m i x t u r e , w i t h two major 
components, (67) and ( 6 9 ) . I n i t i a l l y , i n v e s t i g a t i o n o f t h e crude 
product proved t o be c o n f u s i n g , as both products had t h e same Rp by 
alumina t . l . c . and t h e same r e t e n t i o n t i m e on c a t i o n exchange HPLC. 
However, very c a r e f u l g r a v i t y alumina column chromatography d i d a f f o r d 
t h e s e p a r a t i o n of q u a n t i t i e s o f each component (though many middle 
f r a c t i o n s contained a m i x t u r e ) . A l t e r n a t i v e l y , t h e s y n t h e s i s o f t h e 
"mono-" and " d i - " f u n c t i o n a l i s e d systems were e f f e c t e d s e p a r a t e l y on a 
smal l s c a l e , u s i n g t h e m a t e r i a l p u r i f i e d by HPLC i n t h e p r e v i o u s s t e p . 
These products (67) and (69) were a l s o p u r i f i e d by c a t i o n exchange HPLC. 
H y d r o l y s i s of (67) and (69) w i t h h y d r o c h l o r i c a c i d (6M, 6 h r . ) a f f o r d e d 
t h e "mono-" and " d i - " N - a m i n o f u n c t i o n a l i s e d t r i a c i d s (68) and ( 7 0 ) . 
3.4. Bifunctional Linker Molecules 
3.4.1. Vinylpyridine l i n k e r molecules 
A b i f u n c t i o n a l l i n k e r molecule was sought which c o u l d be a t t a c h e d 
s e l e c t i v e l y t o t h e e x o c y c l i c primary amino group o f t h e macrocycle, a t 
one t e r m i n a l p o s i t i o n and which was r e a c t i v e s e l e c t i v e l y towards an 
ant i b o d y t h i o l r e s i d u e a t t h e oth e r t e r m i n a l p o s i t i o n . 
In an attempt t o improve t h e t h i o l s p e c i f i c i t y and r e a c t i v i t y o f 
known b i f u n c t i o n a l l i n k e r systems (e.g. maleimides) ' t h e 
p - n i t r o p h e n y l e s t e r o f 2 - v i n y l - 6 - ( 4 1 - c a r b o x y - 3 ' - o x a b u t y l ) p y r i d i n e (71) 
was synthesised (Durham/Celltech c o l l a b o r a t i v e work). I t has been 





e t h y l ) - L - c y s t e i n e , i s 300 times more r e a c t i v e towards 4 - v i n y l p y r i d i n e 
than i t s amino g r o u p . T h e t h i o l r e a c t s a t t h e e l e c t r o p h i l i c 
t e r m i n a l s i t e of t h e v i n y l p y r i d i n e group [ F i g . 3 . 7 ] . The 4 - v i n y l -
p y r i d i n e system i s more r e a c t i v e towards t h i o l s t han t h e 2 - v i n y l p y r i d i n e 
S-R N N R H 
H 
N N R S-R H 
F i g . 3.7. Reaction of a t h i o l w i t h 2 - v i n y l p y r i d i n e . 
(though both are s p e c i f i c t o t h i o l s over p r i m a r y amines) due t o t h e 
g r e a t e r degree of c o n j u g a t i o n w i t h t h e e l e c t r o n d e f i c i e n t p y r i d i n e r i n g , 
w i t h t h e former, l e a d i n g t o a more e l e c t r o p h i l i c t e r m i n a l s i t e . 
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However, f o r t h e ease of s y n t h e s i s from commercially a v a i l a b l e s t a r t i n g 
m a t e r i a l s , t h e 2 - v i n y l - p y r i d i n e e s t e r (71) was p r e f e r r e d i n i t i a l l y . 
The e x o c y c l i c p r i m a r y amino group o f the macrocycle i s thus 
u n r e a c t i v e towards t h e v i n y l p y r i d i n e group and r e a c t s s e l e c t i v e l y w i t h 
t h e e s t e r group, f o r m i n g an amide l i n k . 
3.4.2. Synthesis of macrocycle-vinylpyridine conjugates 
Condensation o f t h e m a c r o c y c l i c primary amine w i t h t h e 
p - n i t r o p h e n o l e s t e r (71) t o a f f o r d t h e m a c r o c y c l e - l i n k e r c o n j u g a t e (72) 
was e f f e c t e d i n two d i f f e r e n t ways [Scheme 3 . 7 ] . 
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Scheme 3.7. Synthesis of t h e C - f u n c t i o n a l i s e d - v i n y l p y r i d i n e c o n j u g a t e 
of t h e [9]-Ng t r i a c i d . 
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The conjugate was synthesised by t h e a d d i t i o n of a s o l u t i o n o f t h e 
e s t e r (1.5 eq) i n dioxane t o an equal volume of an aqueous s o l u t i o n o f 
the amine, b u f f e r e d a t pH 6.8-7.0 w i t h "pipes" b u f f e r (0.5M). Reaction 
proceeded t o completion over a p e r i o d of 12 hours a t 40°C. 
A l t e r n a t i v e l y , t h e r e a c t i o n was c a r r i e d out a t room temperature, i n DMF, 
by m i x i n g t h e same reagents i n the presence of d i i s o p r o p y l e t h y l a m i n e . 
The m a j o r i t y of s t a r t i n g m a t e r i a l was consumed a f t e r 3-4 hours, a l t h o u g h 
t h e r e a c t i o n was u s u a l l y l e f t f o r 12 hours t o ensure c o m p l e t i o n . I n 
both cases t h e r e a c t i o n was monitored by reverse phase HPLC and t h e 
product (72) was separated from s t a r t i n g m a t e r i a l s and h y d r o l y s i s 
products by t h e same tec h n i q u e . The macrocycle v i n y l p y r i d i n e c o n j u g a t e 
had a r e t e n t i o n t i m e o f 12 minutes [ F i g . 3 . 8 ( a ) ] when run w i t h a 
g r a d i e n t e l u t i o n of MeCN(0.l7. TFA)-H 20(0.l7, TFA) [5:95] t o [95:5] over 
20 minutes. The s m a l l e r peak observed a t 10 minutes was d i s c o v e r e d t o 
be t h e c o p p e r ( I I ) complex o f ( 7 2 ) , due t o metal i o n c o n t a m i n a t i o n i n t h e 
HPLC guard column. The *H nmr of the product [ F i g . 3 . 8 ( b ) ] r e v e a l e d t h e 
c h a r a c t e r i s t i c resonances o f t h e v i n y l p y r i d i n e group (5.8 t o 8.3 ppm) 
and two d i a g n o s t i c methylene (C^O) resonances a t 4.15 and 4.88 ppm. 
Attempts t o s y n t h e s i s e t h e analogous v i n y l p y r i d i n e c o n j u g a t e o f t h e 
DTPA C - f u n c t i o n a l i s e d l i g a n d (60) were i n i t i a l l y u n s u c c e s s f u l u s i n g b o t h 
methods o u t l i n e d p r e v i o u s l y . Only a f t e r f u r t h e r p u r i f i c a t i o n o f t h e 
s t a r t i n g m a t e r i a l (66) by reverse phase HPLC d i d t h e r e a c t i o n proceed i n 
DMF i n t h e presence o f DIPEA. 
3.4.3. Maleimide l i n k e r molecules 
The use of N-maleimidobenzoyl-N-hydroxysuccinimide e s t e r (MBS) (73) 
as a c o u p l i n g reagent f o r p r o t e i n s was f i r s t r e p o r t e d by Kitagawa i n 
1976. Primary amines r e a c t r e a d i l y w i t h t h e e s t e r group t o form an 
amide l i n k , l e a v i n g t h e maleimide group a t t h e o t h e r t e r m i n a l p o s i t i o n , 
a) 
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1 0 Min 20 
b) 
PyCHjO 
M 80 7-0 M 5-0 40 30 
PPM 
20 >0 
F i g . 3.8. a) Reverse phase HPLC t r a c e and b) t h e 1H nmr o f (72) 
which i s r e a c t i v e s e l e c t i v e l y towards t h i o l s . Maleimides t e n d t o 
h y d r o l y s e r e a d i l y i n aqueous s o l u t i o n , a t h i g h pH (> 7.5) t o malearaic 
a c i d [ F i g . 3 . 9 ] . More r e c e n t l y , new maleimide cross l i n k e r reagents 
which are l e s s s u s c e p t i b l e t o h y d r o l y s i s than t h e o r i g i n a l MBS system, 
have become commercially a v a i l a b l e . One such maleimide e s t e r , 
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F i g . 3.9. H y d r o l y s i s of maleimides. 
N - s u c c i n i m i d y l - 3 - m a l e i m i d o p r o p i o n a t e (74) [Sigma] was s e l e c t e d f o r use 
i n t h e s t u d i e s d e s c r i b e d h e r e i n . 
3.4.4. Synthesis of macrocycle-maleimide l i n k e r conjugates 
The s y n t h e s i s o f t h e maleimide cross l i n k e r conjugates i s r e p o r t e d 
here f o r t h e "mono" and " d i - " N - f u n c t i o n a l i s e d macrocycles (68) and 
( 7 0 ) . However, t h e methods descri b e d l e n d themselves e q u a l l y as w e l l t o 
t h e C - f u n c t i o n a l i s e d systems. 
Two d i f f e r e n t methods were attempted f o r t h e s y n t h e s i s of (75) and 
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(76) [Scheme 3 . 8 ] . The r e a c t i o n was attempted u s i n g a water-dioxane 
system b u f f e r e d a t pH 6.8-7.0 ("pipes" b u f f e r ) as d e s c r i b e d f o r t h e 
v i n y l p y r i d i n e c o n j u g a t e s y n t h e s i s . However, t h i s method f a i l e d t o y i e l d 
an a p p r e c i a b l e amount o f product ( t h e main r e a c t i o n component a f t e r 24 
hours was t h e e s t e r h y d r o l y s i s product ( 7 7 ) ) . A more s u c c e s s f u l 
(77) 
( 6 8 ) 
( 7 4 ) / D M F / V I N \ " 
- - HCfccy^N J 
0 O 
•COt>H 
( 7 5 ) 
( 7 . , ™'dmf/ & . H c o - r N ) 
Scheme 3.8. Syn t h e s i s o f "mono" and " d i " N - f u n c t i o n a l i s e d 
macrocycle-maleimide conjugates. 
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s y n t h e s i s was e f f e c t e d u s i n g DMF as t h e s o l v e n t . The maleimide e s t e r 
(1.2 eq) i n DMF was added t o t h e d e p r o t e c t e d amine (68) f o l l o w e d by t h e 
a d d i t i o n of N-methylmorpholine (5 e q ) . Immediate p r e c i p i t a t i o n o f t h e 
deprotonated macrocycle r e s u l t e d , hence a minimum amount o f water (8-107c 
v o l ) was added i n o r d e r t o r e d i s s o l v e t h e m a t e r i a l . The m a j o r i t y o f t h e 
s t a r t i n g m a t e r i a l had been consumed a f t e r 5 hours, though t h e r e a c t i o n 
was stopped a f t e r 12 hours t o ensure completion o f r e a c t i o n . S i m i l a r 
r e a c t i o n c o n d i t i o n s were employed f o r t h e " d i " f u n c t i o n a l i s e d system 
( 7 0 ) , except t h a t 7 e q u i v a l e n t s of base were r e q u i r e d i n o r d e r t o 
deprotonate t h e amine and a i d n u c l e o p h i l i c a t t a c k a t t h e e s t e r s i t e . I n 
both cases r e a c t i o n was f o l l o w e d by re v e r s e phase HPLC ( a t X = 282 nm) 
e l u t i n g w i t h H 20 (0.17. TFA)/MeCN (0.17. TFA) from 95:5 t o 5:95 over 20 
minutes. R e t e n t i o n t i m e s i n c l u d e d ; 10.5 min. f o r t h e " d i " N - l i n k e d 
maleimide conjugate ( 7 6 ) ; 9.3 min. f o r t h e maleimide e s t e r s t a r t i n g 
m a t e r i a l ( 7 3 ) ; 8.7 min. f o r t h e "mono" N-linked maleimide c o n j u g a t e 
(75) and 6.6 min. f o r t h e maleimide e s t e r h y d r o l y s i s p r o d u c t ( 7 7 ) . 
P u r i f i c a t i o n was t h u s achieved by re v e r s e phase HPLC. I n subsequent 
r e a c t i o n s i t was found t h a t mixtures o f "mono" and " d i " f u n c t i o n a l i s e d 
s t a r t i n g m a t e r i a l c o u l d be condensed w i t h t h e maleimide e s t e r i n t h e 
same r e a c t i o n m i x t u r e , r e q u i r i n g p u r i f i c a t i o n at t h e f i n a l stage i . e . as 
the maleimide macrocycle conjugates. T h i s p r o v i d e d a r e l a t i v e l y q u i c k 
and convenient r o u t e t o t h e r e q u i r e d products (75) and ( 7 6 ) . I n t h e *H 
nmr s p e c t r a of t h e maleimide macrocycle conjugates, two t r i p l e t s c e n t r e d 
a t 2.49 and 3.79 ppm, a t t r i b u t a b l e t o t h e 'N-CI^CHgCO' group and t h e 
s i n g l e o l e f i n i c resonance a t 6.9 ppm, were p a r t i c u l a r l y d i a g n o s t i c . 
T y p i c a l *H nmr s p e c t r a and HPLC t r a c e s are presented i n F i g . 3.10. The 
HPLC t r a c e o f t h e " d i - " maleimide product (76) revealed t h e presence o f 
a sma l l amount (ca. 107.) o f t h e maleimide e s t e r h y d r o l y s i s product ( 7 7 ) . 
I l l 
HOD 
u J 
8-0 70 60 5-0 4-0 3-0 20 10 
PPM 
( 7 5 ) ( 7 6 ) 
JL 
00 5-0 100 15-0 0-0 5-0 
T/Min 
F i g . 3.10. h nmr o f (75) and HPLC t r a c e s o f (75) and ( 7 6 ) . 
10-0 15-0 
T/Min 
F u r t h e r p u r i f i c a t i o n was considered unnecessary (as t h i s would have 
r e s u l t e d i n t h e loss of v a l u a b l e m i l l i g r a m s of p r o d u c t ) s i n c e i t was 
recognised t h a t the i m p u r i t y c o u l d be removed i n t h e p u r i f i c a t i o n step 
( g e l f i l t r a t i o n ) of t h e a n t i b o d y c o n j u g a t i o n r e a c t i o n ( s e c t i o n 3.5.). 
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The product (76) appears as a doublet i n t h e HPLC t r a c e , p o s s i b l y 
a t t r i b u t a b l e t o t h e e x i s t e n c e of a m i x t u r e of RS and RR/SS 
diastereomers. I n c o n t r a s t t o the C - f u n c t i o n a l i s e d systems, t h e 
s y n t h e t i c r o u t e t o t h e N - f u n c t i o n a l i s e d systems i n v o l v e d a l k y l a t i o n w i t h 
a racemic a-bromoester ( 6 3 ) , so t h a t racemates were produced. 
The maleimide conjugates of C - f u n c t i o n a l i s e d [ 9 ] N g - t r i a c i d and 
C - f u n c t i o n a l i s e d DTPA ( F i g . 3.11) have been prepared u s i n g s i m i l a r 
methods. 
OH 
o o o HO N 













F i g . 3.11. C - f u n c t i o n a l i s e d , [ 9 ] N 3 - t r i a c i d and DTPA, 
maleimide conjugates. 
3.5. Antibody Conjugation 
3.5.1. The use of "Trants reagent" 
The monoclonal a n t i b o d y used i n th e work discussed here i s "B72.3" 
which binds t o a tumour a s s o c i a t e d g l y c o p r o t e i n found i n human br e a s t 
and c o l o r e c t a l cancers. B72.3 p r o d u c t i o n and s y n t h e s i s o f 
antibody-macrocycle conjugates was c a r r i e d out a t C e l l t e c h L t d . 
The g e n e r a t i o n o f f r e e t h i o l s on the a n t i b o d y was r e q u i r e d f o r 
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t h e i r r e a c t i o n w i t h e i t h e r maleimide groups or v i n y l p y r i d i n e groups. 
Reaction o f t h e antibody (Lysine r e s i d u e ) w i t h 2 - i m i n o t h i o l a n e [ F i g . 
3.12] was c a r r i e d out i n b u f f e r e d s o l u t i o n (phosphate b u f f e r , pH 7.4) a t 
MAb-Lys-NH 2 • ( " _ V V ^ ^ k ^ N ^ - S H VJ \ \ H 
MAb 
F i g . 3.12. Reaction of 2 - i m i n o t h i o l a n e w i t h an a n t i b o d y l y s i n e 
r e s i d u e . 
4°C. The product was p u r i f i e d by g e l f i l t r a t i o n through Sephadex G-50. 
I n c u b a t i o n of t h e m o d i f i e d antibody (ca. 2-3 t h i o l s per a n t i b o d y ) w i t h 
t h e f u n c t i o n a l i s e d macrocycle (pH = 7, 4°C) y i e l d e d t h e a n t i b o d y -
macrocycle conjugate, which was p u r i f i e d by e i t h e r g e l f i l t r a t i o n o r 
HPLC. Reaction o f t h e 2 - v i n y l p y r i d i n e conjugates w i t h t h e t h i o l 
r e s i d u e s on th e a n t i b o d y was found t o be r a t h e r slow, hence t h e 
maleimide conjugates were s e l e c t e d as th e p r e f e r r e d reagents f o r 
a n t i b o d y c o n j u g a t i o n . 
3.5.2. A l t e r n a t i v e methods f o r macrocycle-antibody c o n j u g a t i o n 
S i t e S p e c i f i c Attachment 
Using t h e method o u t l i n e d above, t h e t h i o l groups and hence t h e 
macrocycles are i n t r o d u c e d w i t h a comp l e t e l y random d i s t r i b u t i o n a l o n g 
t h e a n t i b o d y s t r u c t u r e . A p r e f e r a b l e s t r a t e g y would be t o generate 
t h i o l groups s p e c i f i c a l l y o u t s i d e t h e immunologically i m p o r t a n t v a r i a b l e 
r e g i o n o f t h e a n t i b o d y . The number o f macrocycles l i n k e d t o t h e 
a n t i b o d y c o u l d then be increased w i t h o u t i m p a i r i n g a n t i g e n r e c o g n i t i o n . 
The use of g e n e t i c a l l y engineered a n t i b o d i e s w i t h t h i o l groups generated 
a t t h e hinge r e g i o n ( i . e . between t h e 'Fab' and 'Fc' p o r t i o n s o f t h e 
a n t i b o d y - see s e c t i o n 1.2.1.) e n a b l i n g " s i t e s p e c i f i c " attachment o f 
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macro-cycles, i s c u r r e n t l y being i n v e s t i g a t e d . 
"DFM" Method 
An a l t e r n a t i v e approach t o macrocycle a n t i b o d y c o n j u g a t i o n 
c u r r e n t l y b e ing developed a t C e l l t e c h L t d . , i s r e f e r r e d t o as t h e 
"Di-Fab-Maleimide" (DFM) method. The d i s u l p h i d e bonds t h a t l i n k t h e two 
halves of t h e a n t i b o d y are cleaved t o g i v e t h e F(ab) fragments (see 
s e c t i o n 1.2.4.). A m a c r o c y c l e - l i n k e r conjugate which possesses two 
maleimide groups may be i n s e r t e d between the two fragments, by r e a c t i o n 
w i t h t h e f r e e t h i o l s , when the two halves are recombined [ F i g . 3.13]. 
SH + HS 
O O 
i N I 
s s 
o 
F i g . 3.13. "DFM" approach t o macrocycle-antibody c o n j u g a t i o n . 
The major advantage i s t h a t antibody-macrocycle c o n j u g a t i o n i s 
r e s t r i c t e d t o t h e constant domain of t h e 'long c h a i n ' and i s u n l i k e l y t o 
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a f f e c t t h e v a r i a b l e r e g i o n of t h e a n t i b o d y . T h i s i s l i k e l y t o minimise 
any adverse e f f e c t s t h a t macrocycle l i n k a g e may have on a n t i g e n 
r e c o g n i t i o n and immunogenic response of t h e a n t i b o d y conjugate. 
I n o r d e r t o a t t a c h t h e C - f u n c t i o n a l i s e d [ 9 ] N g - t r i a c i d macrocycle 
(52) t o t h e a n t i b o d y , u s i n g t h i s approach, i t was necessary t o 
sy n t h e s i s e a m o d i f i e d maleimide-macrocycle conjugate ( 7 9 ) . Reaction o f 
'Bis-Z-lys-osu' (78) [Sigma, Z = CgHgCH^OCO-] w i t h t h e p r i m a r y amine o f 
t h e C - f u n c t i o n a l i s e d macrocycle ( 5 2 ) , f o l l o w e d by removal o f t h e 
benzoxycarbonyl ('Z') groups (TMSil) generated two pr i m a r y e x o c y c l i c 
amino groups, which were condensed w i t h N-succinimidyl-3-maleimido-
p r o p i o n a t e ( 2 .1 eq) t o g i v e t h e b i s maleimide ( 7 9 ) . 
A l t e r n a t i v e l y t h e " d i - " N - f u n c t i o n a l i s e d [ 9 ] N g - t r i a c i d (70) 
r e q u i r e s no m o d i f i c a t i o n f o r a n t i b o d y l i n k a g e u s i n g t h e 'DFM1 approach, 
by v i r t u e o f t h e two maleimide groups a l r e a d y a t t a c h e d t o t h e 
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21 3.6. Tnmonr Imaging - B i o d i s t r i b n t i o n Studies 
I n i t i a l b i o d i s t r i b u t i o n studies in tumour bearing mice have been 
111 
carried out on the In labelled C-functionalised [9]Ng-triacid-B72.3 
conjugate. The antibody macrocycle conjugate was r a d i o l a b e l e d using 
111 
InClg i n 0.1M sodium acetate buffer at pH 5 (> 807, eff i c i e n c y at ~ 30 
fM i n macrocycle). 
Athymic mice bearing the LS-174T human colon carcinoma Xenograft 
111 
(implant) were injected intraveneous l y with the l x l I n labelled 
macrocycle-B72.3 conjugate. B i o d i s t r i b u t i o n data recorded at 24 and 96 
hours ( p o s t i n j e c t i o n ) , expressed as percentage of injected dose per gram 
of tissue (7. lD/g) are presented in Table 3.1. 
Table 3.1 
Bi o d i s t r i b u t i o n data f o r m i n labelled B72.3-[9]N 3-triacid 
conjugate expressed as 7. lD/g (24 hr. and 96 hr.) 
% ID/g 
24 hr. 96 hr. 
Tissue Mean ±SD Mean ±SD 
Blood 8.17 1.32 4.02 0.84 
Liver 4.67 1.00 4.55 0.47 
Kidney 5.92 1.53 3.83 0.80 
Lung 3.65 0.56 2.42 0.65 
Spleen 3.39 0.65 3.31 0.70 
Colon 1.55 0.16 1.29 0.53 
Muscle 1.17 0.38 0.77 0.32 
Tumour 8.00 1.54 9.54 0.82 
Bone 1.65 0.32 1.32 0.37 
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Localisation of the ra d i o l a b e l e d antibody at the tumour is 
apparent, with superior tumour to background r a t i o s observed at 96 
hours. However, these and subsequent studies have shown that 
s i g n i f i c a n t background levels of radiation are observed i n the l i v e r and 
kidneys. A s i g n i f i c a n t amount of a c t i v i t y i n the majority of tissues i s 
accounted f o r by the blood associated a c t i v i t y i n these tissues. Hence, 
a useful form i n which to express the results i s as blood-to-tissue 
r a t i o s , thereby minimising the effect of "blood pool" differences. 
Blood-to-tissue r a t i o s in the l i v e r , kidney and tumour are presented in 
Table 3.2 and are compared to the values obtained i n analogous 
experiments using a DTPA-B72.3 conjugate ('CA-DTPA' - see section 3.1). 
At 24 and 96 hours the tumour-to-blood r a t i o f o r the macrocyclic 
conjugate i s superior to that of the DTPA conjugate. The macrocyclic 
conjugate also shows lower accumulation of r a d i o a c t i v i t y i n the kidneys, 
although accumulation in the l i v e r i s greater than f o r the DTPA 
conjugate. 
Table 3.2 
Blood-to-tissue r a t i o s f o r B72.3-[9]N 3 and B72.3-DTPA 
conjugates at 24 and 96 hours 
Conjugate Time/hr. Blood/tumour Blood/kidney Blood/liver 
B72.3-[9]N 3 24 1.02 1.38 1.75 
96 0.42 1.05 0.88 
B72.7-DTPA 24 1.28 1.42 2.28 
96 0.62 0.77 1.20 
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Similar b i o d i s t r i b u t i o n studies were carried out using conjugates 
with chimaeric ("humanised") B72.3 antibody (see section 1.2.4.). The 
b i o d i s t r i b u t i o n data f o r the * ^ I n labelled conjugate of [9]N^ in mice 
bearing the LS-174T Xenograft at 24 and 72 hours are presented in Table 
3.3. 
Table 3.3 
Bi o d i s t r i b u t i o n of 1 1 A I n labelled ch imaeric B72.3- [9]N 
conjugate expressed as 7. lD/g a f t e r 24 and 72 hr. 
I ID/g 
Tissue 24 hr 72 hr. 
Mean ± SD Mean ± SD 
Blood 13.33 1. ,24 9, .72 1.20 
Liver 4.40 0. .73 4, .09 1.23 
Kidney 13.90 1. .60 16, .47 1.88 
Lung 5.96 0. ,37 4, .70 0.30 
Spleen 3.30 0. ,35 3, .37 0.43 
Colon 1.63 0. 29 1. .22 0.12 
Muscle 1.49 0. 26 1. .20 0.53 
Bone 1.61 0. 11 1. ,39 0.22 
Tumour 14.48 0. 55 19. ,74 0.31 
The very high levels of ra d i o a c t i v i t y found i n the kidneys i n these 
studies were not observed with the analogous murine B72.3 studies and 
are most l i k e l y t o be a feature of the modified antibody. A s i g n i f i c a n t 
proportion of the conjugate did not remain intact a f t e r i n j e c t i o n into 
the mice, r e s u l t i n g in r e l a t i v e l y rapid excretion v i a the kidneys. This 
is possibly a consequence of the mouse p a r t i a l l y r e j e c t i n g the 
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"humanised" antibody in a si m i l a r response to that observed with murine 
antibodies i n human patients. However, observation of the 
blood-to-liver and blood-to-tumour r a t i o s determined between 24 and 144 
hr. f o r both [9]N g and DTPA chimaeric B72.3 conjugates (Table 3.4) show 
an improvement over the previous set of res u l t s . The [9]N^ conjugate 
shows s i g n i f i c a n t l y reduced accumulation in the l i v e r compared to the 
DTPA conjugate, although only a s l i g h t l y superior blood-to-tumour r a t i o 
was observed f o r the macrocyclic conjugate. 
Table 3.4 
Blood-to-tissue r a t i o s f o r m l n labelled [9]Ng and CA-DTPA 
chimaeric B72.3 conjugates between 24 and 144 hrs. 
Conjugate Time/hr. Blood/tumour Blood/liver 
[9]-N 3 24 0.92 3.03 
48 0.56 3.27 
72 0.49 2.38 
144 0.27 1.22 
DTPA 24 0.87 1.88 
48 0.65 1.45 
72 0.53 1.24 
144 0.35 0.51 
Clearly more studies are required i n order to draw any furt h e r 
conclusions. Studies are i n progress using conventional and 'DFM' 
antibody-macrocycle conjugates, which are to be compared with the 
C-functionalised DTPA ligand (60), the preparation of which was reported 
in section 3.2.4. 
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CHAPTER FOUR 
MACRQCYCLIC COORDINATION CHEMISTRY OF SILVER 
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4.1. Factors Affecting the Macrocyclic Coordination of S i l v e r ( I ) 
4.1.1. Introduction 
The most common oxidation state f o r s i l v e r i s unipositive. The Ag + 
ion i n water probably exists as Ag^O^*, but the water i s very l a b i l e 
and no hydrated salts are known. The s i l v e r ( I ) cation i s a r e l a t i v e l y 
large, polarisable d ^ cation with an ionic radius of 1.158. As a d ^ 
cation, i t has no preference f o r any p a r t i c u l a r coordination geometry 
from ligand f i e l d considerations. I n practice, s i l v e r ( I ) exhibits a 
preference f o r linear two coordination and tetrahedral four 
coordination. With polydentate macrocyclic ligands, f i v e and six 
coordinate complexes are quite common, but six, seven and eight 
coordinate complexes have also been reported.^ 
4.1.2. Donor atoms 
Being a " s o f t " cation (according t o the c l a s s i f i c a t i o n of Pearson ) 
s i l v e r ( I ) has a strong preference f o r the " s o f t " sulphur and nitrogen 
donor atoms over the hard oxygen donor atom.^'^ The interaction of 
s i l v e r ( I ) with nitrogen and sulphur donor atoms i s more covalent i n 
nature than the el e c t r o s t a t i c ion-dipole i n t e r a c t i o n that occurs with 
oxygen donor atoms. 
This preference is i l l u s t r a t e d by the s t a b i l i t y constants of the 
s i l v e r ( I ) complexes of the 1,10-diaza and 1,10-dithia derivatives of 
18-crown-6, (81) and (82), compared to that f o r 18-crown-6 (1) i t s e l f 
(Table 4.1). ' By replacing j u s t two of the six oxygen donor atoms 
5 
with nitrogen or sulphur donor atoms, there i s a greater than 10 f o l d 
increase i n complex s t a b i l i t y . The estimated bond enthalpies f o r the 
three d i f f e r e n t donor atoms with s i l v e r ( I ) have been reported and are 
shown in Table 4.2. 
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Abbrev-
(1) X=0 [18-C-6] 
(81) X=N [2.2] 
(82) X=S [DT18C6] 
Table 4.1 
Ligand log K a -AH/kJ mol" 1 TAS/kJ mol" 1 
[18C6] 4.58 39.1 -13 
[2.2] 10.02 44.9 12 
[DT18C6] 10.33 64 -5.3 








Thus, from purely enthalpic considerations, the order of preference 
f o r s i l v e r ( I ) i s 
S > N » 0. 
For ligand (81) i t should be noted that the observed enthalpy of 
complexation i s lower than that expected from the r e l a t i v e bond 
- 123 -
energies, given in Table 4.2. This can be a t t r i b u t e d to a 
conformational change of the diamine during complexation. I t is known 
that b i c y c l i c diamines (with bridgehead nitrogens) can exist i n 
d i f f e r e n t conformational forms (exo-exo, endo-exo and endo-endo) and i t 
is l i k e l y that monocyclic aza-crowns can do the same, Fig. (4.1).' 
In a polar medium (e.g. H^ O, MeOH) the lone pairs are usually 
directed outside the cavity (exo-exo) but during complexation the ligand 
must change to the endo-endo conformation. The difference i n observed 
and calculated enthalpy of complexation f o r ligand (81) with s i l v e r ( I ) 
i s s i m i l a r to the energy of inversion of b i c y c l i c diamines. 
The s o l i d state structure of the s i l v e r ( I ) complex of the mono-thia 
o 
derivative of 18-crown-6 (83) [Fig. 4.2] provides a good example of the 
a f f i n i t y of the s i l v e r ( I ) cation f o r sulphur over oxygen. 
C°~°^ 
N N: H N N v y v 3 C 3 V s R 
exo-exo exo-endo endo-endo 
Fig. 4.1. Different conformations of diaza crowns. 
c (83) 
Two similar conformations exist, one being the near mirror image of 
the other. The s i l v e r binds to two sulphurs, one intramolecular 
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S U L P H U R 
Fig. 4.2. X-ray structure of the s i l v e r ( I ) complex of (83). 
interaction (Ag-S 2.58 and 2.608) and one intermolecular interaction 
(Ag-S 2.61 and 2.67$) with a sulphur from an adjacent ligand. Only one 
of the f i v e oxygen donor atoms forms a moderately strong bond (Ag-0 
2.48$) the remaining Ag-0 distances (2.66-2.928) indicating j u s t weak 
cation-dipole interaction. 
4.1.3. Cavity size 
A simple way to determine the most suitable macrocyclic cavity size 
f o r s i l v e r ( I ) i s to look at the s t a b i l i t y constants f o r a series of 






3 c 1) 85) 
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Table 4.3 
S t a b i l i t y constants f o r the s i l v e r ( I ) complexes of 15C5, 18C6 and 21C7 
Ligand log K a Cavity size^/8 
15C5 3.65 0.9 
18C6 4.58 1.4 
21C7 2.46 1.9 
a log K measured i n MeOH at 25°C. 
b r e f . 5. 
The s t a b i l i t y constants indicate that the 18C6 ligand (1) has the 
optimal cavity size. This i s i n good agreement with the calculated 
cavity size** of 1.408 and the ionic radius of Ag + (1.158). In fur t h e r 
agreement with t h i s are the s t a b i l i t y constants f o r the Ag + complexes of 
the d i t h i a and diaza analogues of 15C5 and 18C6, (Table 4.4). 
abbrev-$ \ X=NH: 
(86) n=0 [2.1] 
(81) n=l [2.2] 
X=S: 
(87) n=0 [DT15C5] 
(82) n=l [DT18C6] 
The smaller 15C5 analogues show reduced s t a b i l i t y constants. 
Lindoy, McPartlin and Tasker^"^ have carried out extensive 
studies on dibenzo and tribenzo mixed donor macrocyclic ligands, of the 
type (88), (89) and (90), with systematic v a r i a t i o n of r i n g size and 
donor atom sequence. 
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Table 4.4 
S t a b i l i t y constants f o r the Ag+ complexes of ligands (86), (81), 











a measured i n MeOH, 25°C. 
The aromatic substituents reduce the f l e x i b i l i t y of these ligands 
compared to t h e i r crown ether analogues. This may have an unfavourable 
e f f e c t , i n r e s t r i c t i n g any conformational changes necessary 
Y X Y X 
a) 0 0 f ) s NH 
b 0 s g) NH 0 
c) 0 NH h) NH s 
d) S 0 i ) NH NH 
e) s s 
(89) X,Y = NH, 0 or S 





NH, 0 or S 
( C H 2 ) n 
2, 3 or 4 
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fo r complexation, but, as with other more r i g i d systems (e.g. 
'cryptates 1), i t leads to a greater dependence on matching cavity size 
with cation size. 
1 f{ 
Lindoy has reported t h a t , within t h i s series, the most stable 
complex with s i l v e r ( I ) i s formed with the 17 membered mixed sulphur and 
nitrogen donor ligand 88(e) [log K = 12.4 in MeOH, 25°C]. 
The highest s t a b i l i t y constant known f o r a Ag(I) complex, i n 
methanol, i s with the cryptand [2.2.1] (17b). For the s l i g h t l y smaller 
and s l i g h t l y larger cryptates, [2.1.1] (17a) and [2.2.2] (17c) 
respectively, the s t a b i l i t y constants are s i g n i f i c a n t l y lower, (Table 




(88e) Dibenzo[17]-N 2S 3 
4.5). 
Table 4.5 
and [2.2.2] (298K, MeOH) 





4.1.4. Macrocyclic effe c t 
35 
Schwing-Veill reported on the macrocyclic effect f o r a series of 
t r a n s i t i o n metal ions, with the mixed donor macrocycle (91) and i t s 
acyclic analogue (92). 
Only a moderate macrocyclic effect was observed f o r s i l v e r ( I ) 
compared to larger effects f o r copper(II) and n i c k e l ( I I ) , but also an 
absence of an effect f o r l e a d ( I I ) . The s t a b i l i t y constants are given 
•NH 2 H 2N 
( 9 1 ) 
i n Table 4.6. 
(92) (93) 
Table 4.6 
+ 2+ 2+ 2+ The s t a b i l i t y constants f o r the Ag , Cu , Ni and Pb complexes 
of ligands (91) and (92) 
Cation log K (91) log K (92) A log K 
Ag-L+ 9.91±0.02 7.32±0.05 2.59 
Cu-L 2 + 13.26±0.08 9.15±0.04 4.11 
N i - L 2 + 8.06±0.02 4.78±0.04 3.28 
Pb-L 2 + 6.78*0.02 7.49±0.04 -0.71 
The nature of the cation clearly has a marked influence upon the 
macrocyclic e f f e c t , as does the nature of the ligand. The s t r u c t u r a l l y 
isomeric ligand (93) forms a somewhat weaker s i l v e r ( I ) complex than 
ligand (91) [log K = 8.95]. 
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The absence of a macrocyclic effect f o r the s i l v e r ( I ) complex of 
the diaza crown [2.2] (81) or, a cryptate e f f e c t f o r the b i c y c l i c 
17 
diamine [2.2.2] (17c) has been reported and can be a t t r i b u t e d to the 
conformational changes of the ligand during complexation (as discussed 
in section 4.1.2). In these examples, the unfavourable enthalpic 
contributions are p a r t i a l l y compensated f o r by a favourable entropic 
contribution. This i s a result of the l i b e r a t i o n of solvent molecules 
from the ligand in i t s uncomplexed form (exo-exo) during the t r a n s i t i o n 
to the endo-endo conformation. 
The macrocyclic effe c t has not been assessed f o r the mixed sulphur 
and nitrogen 18-crown-6 systems. 
4.1.5. Structure and conformations of thioether crowns 
From considerations of bond enthalpy alone, sulphur donor atoms are 
preferred over nitrogen donor atoms. However, recent work has 
highlighted the tendency of sulphur atoms i n macrocycles to adopt 
18 19 
exodentate conformations, ' with the lone pairs directed away from 
the macrocyclic cavity. The thioether crowns 12-S-4 and 15-S-5 have 
only exodentate sulphurs and 18-S-6 has four exodentate and two 
19 
endodentate sulphurs. Cooper has reported that a l l three of these 
ligands adopt s o l i d state structures which are composed of r i g h t angle 
"bracket" units (Fig. 4.3), with a sulphur atom at the corner; 12-S-4 S-CH„-CH„-S k k 
Fig. 4.3. "bracket" u n i t of thioether crowns. 
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contains two of these units fused at the terminal sulphurs; 15-S-5 
consists of two units fused at one end by the terminal sulphurs and 
linked at the other by an ethylene bridge and 18S6 consists of two 
bracket units linked at both ends by ethylene bridges. This 
conformational preference, which is not observed f o r oxygen or nitrogen 
crowns, can be rationalised according t o the preferred t o r s i o n a l angles 
of the C-S and C-C bonds. Sulphur atoms show a strong tendency f o r the 
gauche conformation [gauche = ±60° and a n t i = ±180°] (Fig. 4.4) whereas 







C E SIDE 
GAUCHE ANT I 
Fig. 4.4. Gauche and an t i placements at C-C-E-C bonds. 
oxygen prefers the a n t i arrangement. Two types of 1,4 int e r a c t i o n are 
proposed to account f o r t h i s . A gauche C-C-O-C linkage (Fig. 4.5) 
suffers an unfavourable s t e r i c interaction between the two terminal 
hydrogens, whereas the equivalent sulphur linkage avoids t h i s by v i r t u e 
of the longer C-S bond. However, gauche placements at O-C-C-0 linkages 
(Fig. 4.6) are favoured f o r oxygen crowns due to favourable 0...0 
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2. 4 A H > 
1.8 A " " ^ Q 
F i g . 4.5. 1,4 I n t e r a c t i o n s a t gauche C-C-E-C l i n k a g e s . 
•0 0 — 
\ / STABILIZING 
C C - 3-DESTABILIZING 
C C 
F i g . 4.6. 1,4 I n t e r a c t i o n s a t gauche E-C-C-E l i n k a g e s . 
i n t e r a c t i o n s ( d i s p e r s i o n f o r c e s ) , whereas t h e e q u i v a l e n t s u l p h u r 
l i n k a g e s are d i s f a v o u r e d due t o s t e r i c r e p u l s i o n between t h e l a r g e 
s u l p h u r atoms. 
The un f a v o u r a b l e c o n f o r m a t i o n a s s o c i a t e d w i t h t h i o e t h e r l i n k a g e s 
r e s u l t s i n an unfavourable c o n t r i b u t i o n t o t h e entropy o f complexation. 
T h i s i s i l l u s t r a t e d by t h e thermodynamic parameters f o r t h e s i l v e r 
complexes o f l i g a n d s [2.2] ( 8 1 ) , [2s2o] and [2s2s] which have i n c r e a s i n g 
numbers of S atoms, Table 4.7. 
Y Y w 
abbrev 
X=S Y=0 [2s2o] 
X=S Y=S [2s2s] 
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Table 4.7 
Thermodynamic parameters f o r A g ( l ) complexes of [2.2] ( 8 1 ) , 
[2s2o] and [2s2s] 
Ligand l o g K a -AH/kJ m o l " 1 TAS/kJ m o l " 1 
[2.2] 10.02 51.4 5.7 
[2s2o] 11.5 67.7 -2.0 
[2s2s] 13.7 83.2 -5.0 
a l o g K i n MeOH (25°C). 
Of i n t e r e s t are t h e e n t r o p i e s of co m p l e x a t i o n , which s t a r t a t a 
f a v o u r a b l e +5.7 f o r l i g a n d [2.2] and become more un f a v o u r a b l e f o r t h e 
d i t h i a and t e t r a t h i a macrocycles [2s2o] and [ 2 s 2 s ] . 
This p o i n t i s discussed again w i t h some o f our own thermodynamic 
r e s u l t s i n Chapter 5. 
4.2. Coordination Geometry 
Thi s s e c t i o n c o n t a i n s a b r i e f review o f some of t h e s i l v e r ( I ) 
m a c r o c y c l i c s t r u c t u r e s r e p o r t e d t o d a t e , h i g h l i g h t i n g t h e d i f f e r e n t 
c o o r d i n a t i o n geometries observed. 
The X-ray s t r u c t u r e s o f t h e Ag + complexes o f t h e two 15-membered 
N2S2O macrocycles (91) and (93) were determined as t h e i r t h i o c y a n a t e 
20 21 
s a l t s [ F i g . 4.7 and F i g . 4 . 8 ] . ' Both complexes e x h i b i t d i s t o r t e d 
square pyr a m i d a l c o o r d i n a t i o n w i t h t h e s i l v e r i o n s i t t i n g i n s i d e t h e 
c a v i t y o f t h e macrocycle, b i n d i n g t o t h e two s u l p h u r s and two n i t r o g e n s 
The t h i o c y a n a t e anion occupies t h e a p i c a l s i t e , b i n d i n g t h r o u g h t h e 
sulp h u r . With l i g a n d (93) t h e r e i s a weak s i l v e r - o x y g e n i n t e r a c t i o n 
(Ag-0 2.98), but not w i t h l i g a n d (91) (Ag-0 3.728). 
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F i g . 4.7. X-ray s t r u c t u r e o f 
t h e A g ( l ) (SCN) complex 
o f (91) [15-N 2S 20] 
F i g . 4.8. X-ray s t r u c t u r e o f 
t h e A g ( l ) (SCN) complex 
o f (93) [15-S 2N 20] 
The s i l v e r ( I ) a c e t a t e complex o f t h e 16-membered Nr,S2 macrocycle 
22 
( 9 4 ) , has an approximately square pyr a m i d a l c o o r d i n a t i o n ( F i g . 4.9) 
d i s t o r t e d towards t r i g o n a l b i p y r a m i d a l , w i t h a x i a l n i t r o g e n donors 
[N-Ag-N 179.3°, Ag-N 2.48 and 2.438] and e q u a t o r i a l aceto oxygen [Ag-0 
2.698] and s u l p h u r donors [Ag-S both 2.598]. A l l f o u r o f t h e s i x 
membered c h e l a t e s form t w i s t - b o a t conformations. 
The 17-membered NgS 2 macrocycle (95) p r o v i d e s an example o f t h e 
s i l v e r c o o r d i n a t i n g t o f i v e m a crocyclic donor atoms, i n a d i s t o r t e d 
23 
t r i g o n a l b i p y r a m i d a l arrangement, w i t h t h e two s u l p h u r s and t h e 
p y r i d i n e n i t r o g e n e q u a t o r i a l [ F i g . 4.10]. The major d e v i a t i o n f r o m 
i d e a l i s e d geometry i s due t o t h e g e o m e t r i c a l r e s t r i c t i o n s imposed by t h e 
p y r i d i n e - N 2 u n i t [N-Ag-N ca. 72°]. 
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S2 
N N > C N 
AG I 
( 9 4 ) 
S i 
F i g . 4.9. X-ray c r y s t a l s t r u c t u r e o f t h e A g ( I ) (OCOMe) complex 
of (94) [16-N 2S 2] 
C(17) 
S(16) 
C(18) A en a S5^ C M S(2) C(3) N 7 H H C(13) N N CM N(6) N(12) 
a n w N9) C(10) 
C(20) C(24) 
( 9 5 
CB3J CI21) 
C(22) 
F i g . 4.10. X-ray c r y s t a l s t r u c t u r e of t h e A g ( I ) complex o f (95) 
[17-N3S2]• 
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A s i x c o o r d i n a t e m a c r o c y c l i c complex has been observed w i t h t h e 
24 
t r i t h i a d i i m i n o p y r i d i n e l i g a n d (96) [ F i g . 4.11]. The c o o r d i n a t i o n i s 
i r r e g u l a r and s t r a i n e d , as a consequence of t h e g e o m e t r i c a l r e s t r i c t i o n s 




( 9 6 ) N12 
S 1 5 
F i g . 4.11. X-ray c r y s t a l s t r u c t u r e of t h e A g ( I ) complex o f 
(96) [ 1 8 - N 3 S 3 ] . 
imposed by t h e p l a n a r d i i m i n o p y r i d i n e u n i t . The t h r e e s u l p h u r atoms 
d e v i a t e from t h e plane by 0.52, 2.32 and -1.058 w i t h bond l e n g t h s 2.95, 
2.67 and 2.658 r e s p e c t i v e l y and the S-Ag-N angles vary from 87.1° t o 
122.0°. 
More r e c e n t l y , a novel s i x c o o r d i n a t e s t r u c t u r e has been r e p o r t e d 
25 
w i t h two n i n e membered Sg r i n g s (97) c o o r d i n a t i n g f a c i a l l y t o a s i l v e r 
c a t i o n sandwiched between t h e two ( F i g . 4.12). 
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r 7 c s 
( 9 7 ) 
( 9 8 ) 
5(7) S(4) S( l ) 
Ag 
F i g . 4.12. X-ray c r y s t a l s t r u c t u r e o f t h e b i s [ 9 ] - S g - A g ( I ) complex. 
T r i g o n a l e l o n g a t i o n r e s u l t s i n a d i s t o r t i o n o f t h e p o t e n t i a l l y 
o c t a h e d r a l c o o r d i n a t i o n o f t h e s i l v e r c a t i o n . S i l v e r - s u l p h u r bond 
l e n g t h s vary from 2.696 t o 2.7538. The e l o n g a t i o n i s i l l u s t r a t e d by t h e 
s i l v e r - s u l p h u r bond angles which are on average 80.0° f o r S ( l ) - A g - S ( l ) 
and 100° f o r S ( l ) - A g - S ( 2 ) . 
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9fi 
Weighardt has r e p o r t e d a s i m i l a r 2:1 s i l v e r complex o f [9]Sg. He 
a l s o i s o l a t e d a c r y s t a l l i n e s o l i d which was found t o be made up o f two 
c a t i o n s ; t h e monomeric kglt [as shown i n F i g . 4.12] and a t r i m e r i c 
S5 
S3 
* 0 ? * 9 ? 
s r 
F i g . 4.13. X-ray c r y s t a l s t r u c t u r e o f [Ag^L^] 
[ A g g L g ] ^ + [ F i g . 4.13]. I n t h i s case t h e s i l v e r adopts t e t r a h e d r a l 
c o o r d i n a t i o n w i t h t h e a p i c a l s i t e being occupied by a s u l p h u r from an 
adja c e n t l i g a n d . The s i x membered Ag^Sg r i n g i s almost p l a n a r . 
For t h e h e x a t h i a 18-crown-6 l i g a n d (99) a simple 1:1 s t r u c t u r e has 
not been observed, though r e c e n t l y a d i s i l v e r p i c r a t e complex 
[ A g 2 ( 1 8 S 6 ) ( p i c ) ] ( p i c ) 2 7 has been r e p o r t e d , F i g . 4.14. 
Two d i s t i n c t c o o r d i n a t i o n geometries are observed f o r A g ( l ) and 
Ag(2). The former has a d i s t o r t e d t r i g o n a l b i p y r a m i d a l c o o r d i n a t i o n , 
b i n d i n g w i t h t h r e e s u l p h u r s from the l i g a n d , one s u l p h u r f r o m an 
adjacent l i g a n d and t h e p i c r a t e i o n . Ag(2) has a d i s t o r t e d t e t r a h e d r a l 
c o o r d i n a t i o n w i t h t h r e e s ulphurs from t h e l i g a n d (one of which i s shared 
w i t h an A g ( l ) of an adj a c e n t l i g a n d ) and one sulphur from an a d j a c e n t 
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F i g . 4.14. X-ray c r y s t a l s t r u c t u r e o f [ A g 2 ( 1 8 S 6 ) ( p i c ) ] ( p i c ) 
18S6 l i g a n d i s o b v i o u s l y not w e l l s u i t e d t o t h e f o r m a t i o n o f a r e g u l a r 
h exacoordinate complex w i t h s i l v e r ( I ) . The c o n f o r m a t i o n a l e f f e c t s o f 
r e p l a c i n g oxygen donor atoms w i t h s u l p h u r donor atoms i n crown e t h e r s i s 
discussed i n s e c t i o n 4.1.5. 
A b i s 'sandwich' m a c r o c y c l i c complex o f s i l v e r ( I ) has been r e p o r t e d 
28 
p r e v i o u s l y w i t h t h e crown e t h e r 12-Crown-4, p r o v i d i n g an example o f an 
e i g h t c o o r d i n a t e d s i l v e r complex [ F i g . 4.15]. 
I n summary, a v a r i e t y of c o o r d i n a t i o n geometries have been r e p o r t e d 
f o r s i l v e r ( I ) m acrocyclic complexes, b u t th e y are o f t e n i r r e g u l a r . For 
example, a r e g u l a r o c t a h e d r a l c o o r d i n a t i o n geometry has not been 
observed, the c l o s e s t being i n t h e b i s 9 [ S ] ^ s t r u c t u r e [ F i g . 4.12]. 
4.3. Design of New Macrocycles to Bind Silver ( I ) 
I n d e s i g n i n g new mac r o c y c l i c l i g a n d s t o b i n d s i l v e r ( I ) our 
o b j e c t i v e s were t o o b t a i n complexes o f g r e a t e r k i n e t i c and thermodynamic 
s t a b i l i t y . As t h e r a t e o f complexation i s an importa n t f e a t u r e w i t h 
r e s p e c t t o a p p l i c a t i o n s f o r radioimmunotherapy, we i n i t i a l l y c o n s i d e r e d 
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F i g . 4.15. X-ray s t r u c t u r e of t h e A g ( I ) complex o f 12-Crown-4 
The main f a c t o r s t o cons i d e r were c a v i t y s i z e , t h e number and t y p e 
o f donor atoms and t h e l i k e l y c o o r d i n a t i o n geometry t h a t would r e s u l t . 
Each o f these f a c t o r s have been discussed i n p r e v i o u s s e c t i o n s and lead 
t o t h e f o l l o w i n g c o n c l u s i o n s ; 
(1) The 18-crown-6 c a v i t y s i z e i s optimum f o r A g ( I ) . 
(2) S i x s y m m e t r i c a l l y placed donor atoms p r o v i d e t h e best chance o f 
29 30 
o b t a i n i n g a r e g u l a r o c t a h e d r a l l y c o o r d i n a t e d complex. ' 
(3) Sulphur and n i t r o g e n donor atoms are much p r e f e r r e d t o oxygen donor 
atoms and mixed sulp h u r and n i t r o g e n systems form t h e most s t a b l e 
complexes. T e r t i a r y n i t r o g e n s are p r e f e r r e d over secondary 
n i t r o g e n s i n terms o f bond e n t h a l p i e s i . e . NR > NH but i n t r a a n n u l a r 
s t e r i c i n t e r a c t i o n s may a l s o be imp o r t a n t . 
(4) I n mixed sulp h u r and n i t r o g e n 18-crown-6 systems a m a j o r i t y of 
sulphur atoms i s more l i k e l y t o lead t o an u n f a v o u r a b l e 
c o n f o r m a t i o n o f t h e f r e e l i g a n d than a m a j o r i t y of n i t r o g e n atoms. 
The t a r g e t molecules chosen f o r s y n t h e s i s were t h e 18 membered N 4S 9 
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macrocycle 1,10-dithia-4,7,13,16-tetraazacyclooctadecane (100) and i t s 
N-methylated d e r i v a t i v e , N ,N',N",N , M-tetramethyl-l,10-dithia-4,7,13,16-
t e t r a a z a c y c l o o c t a d e c a n e (101). 
A t h i r d t a r g e t molecule chosen f o r s y n t h e s i s was t h e N,N 1-ethylene 
br i d g e d b i s - ( 1 , 4 - d i t h i a - 7 - a z a c y c l o n o n a n e ) l i g a n d (102). 
This l i g a n d was designed as a means of p r o v i d i n g an donor s e t , 
i n a p o t e n t i a l l y o c t a h e d r a l c o o r d i n a t i o n , w i t h o u t e n c o u n t e r i n g t h e 
u n f a v o u r a b l e c o n f o r m a t i o n e f f e c t s t h a t may be a s s o c i a t e d w i t h t h e s i n g l e 
r i n g analogue. The more r i g i d nine-membered r i n g s are i d e a l l y s e t up 
f o r f a c i a l c o o r d i n a t i o n t o a metal c e n t r e . I n a d d i t i o n , i t was 
hypothesised t h a t t h e f l e x i b i l i t y about the N-N1 l i n k a g e would 
f a c i l i t a t e r a p i d complexation. S i m i l a r N,N' br i d g e d b i s - m a c r o c y c l i c 






l i g a n d s have been r e p o r t e d , f o r example, t h e b i s - [ 9 ] - N g l i g a n d 
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SYNTHESIS AND PROPERTIES OF S I L V E R m MACROCYCLIC COMPLEXES 
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5.1. Synthesis of Macrocycles to Bind Silver(I) 
5.1.1. 1.10-dithia-4.7.13.16-tetraazacvclooctadecane (100) 
Several a t t e m p t s t o synthesise t h e [ 1 8 ] m a c r o c y c l e (100) were 
made b e f o r e a s u c c e s s f u l r o u t e was developed. I n i t i a l l y , a s h o r t 
s y n t h e t i c r o u t e t o t h e bas i c c y c l e (R = H, (100)) was sought, such t h a t 
t h e s i l v e r ( I ) complexation chemistry o f t h e l i g a n d c o u l d be 
i n v e s t i g a t e d . However, a stepwise s y n t h e s i s of t h e l i g a n d which would 
enable t h e C - f u n c t i o n a l i s a t i o n of t h e l i g a n d (e.g. R = (CH 2) nNH 2 or 
p - C H r j C g H ^ C H ^ N H r , ) a t a l a t e r stage was a l s o r e q u i r e d . 
Many mixed polyoxapolyaza and p o l y t h i a p o l y a z a macrocycles have been 
s y n t h e s i s e d by t h e s o - c a l l e d "high d i l u t i o n " t e c h n i q u e ( h i g h d i l u t i o n 
encourages i n t r a m o l e c u l a r r e a c t i o n over i n t e r m o l e c u l a r r e a c t i o n ) . I n 
p a r t i c u l a r , t h e " h i g h d i l u t i o n " condensation of a c i d d i c h l o r i d e s w i t h 
diamines t o y i e l d m a c r o c y c l i c and m a c r o b i c y c l i c l i g a n d s has been used 
1-8 
e x t e n s i v e l y by Lehn and co-workers. For example, t h e 12-membered 
N2S2 macrocycle and t h e 15-membered N2S2O and N 2Sg macrocycles were 
s y n t h e s i s e d by t h i s method [ F i g . 5.1]. The m a c r o c y c l i c amides thus 
produced were reduced t o t h e corresponding amines u s i n g BH^.THF. The 
18-membered macrocycle (107) was a l s o s y n t h e s i s e d by t h i s method, 
though a p r e v i o u s p r e p a r a t i o n of t h e l i g a n d , r e p o r t e d by Black and 
McClean,^ i n v o l v e d t h e hi g h d i l u t i o n r e a c t i o n o f e t h a n e - 1 , 2 - d i o l and 
di( 2 - b r o m o e t h y l ) a m i n e (87. y i e l d ) [ F i g . 5.2]. 
I n i t i a l l y , t h e s y n t h e s i s of the [18]-N4S« macrocycle (100) was 
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F i g . 5.1. Synthesis o f macrocyclic l i g a n d s u s i n g t h e " h i g h - d i l u t i o n " 
r e a c t i o n o f a c i d - d i c h l o r i d e s and diamines. 
H N 
Br 
SH C EtOH HN SH 
Br N H 
F i g . 5.2. Synthesis of [ 1 8 ] - N 2 S 4 (107). 
attempted u s i n g two ' s h o r t ' r o u t e s , i n v o l v i n g 'one-pot' c o - c y c l i s a t i o n 
r e a c t i o n s ( i n which two molecules of each s t a r t i n g reagent were r e q u i r e d 
t o form t h e [ 1 8 ] - r i n g ) . The f i r s t o f these i n v o l v e d t h e r e a c t i o n o f t h e 
d i e t h y l e s t e r o f t h i o d i g l y c o l l i c a c i d (108) w i t h e t h y l e n e d i a m i n e , under 
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h i g h d i l u t i o n c o n d i t i o n s , i n e t h a n o l [Scheme 5.1] 
OEt 




The d i e s t e r ( 1 0 8 ) , s y n t h e s i s e d f r o m t h i o d i g l y c o l l i c a c i d 
(EtOH/h^SO^/reflux 3 h r . ) , was used as an a l t e r n a t i v e r e a g e n t t o t h e 
h i g h l y t o x i c m ustard gas d e r i v a t i v e , S^B^COCl^. The r e a c t i o n f a i l e d 
t o a f f o r d an a p p r e c i a b l e y i e l d o f t h e c y c l i c t e t r a a m i d e ( 1 0 9 ) , g i v i n g 
p r e d o m i n a n t l y a m i x t u r e o f o l i g o m e r i c p r o d u c t s . 
An a l t e r n a t i v e "one-pot" r e a c t i o n was a t t e m p t e d u s i n g t h e 
11 
t o s y l a m i d e r i n g c l o s u r e method o f Richman and A t k i n s [Scheme 5 . 2 ] . 
E t h y l e n e d i a m i n e d i t o s y l a m i d e (110) and t h i o d i e t h a n o l d i t o s y l a t e (111) 
were p r e p a r e d u s i n g s t a n d a r d t o s y l a t i o n t e c h n i q u e s (pyridine/TsCl/0°C). 
Tr e a t m e n t o f (110) w i t h sodium i n e t h a n o l gave t h e d i s o d i u m s a l t ( 1 1 2 ) , 
TsO 
Ts Ts Ts Ts N N N" Na NH 3 c c DMF NaOEt/EtOH N N' Na NH Ts Ts Ts Ts 
TsO 
(110) (112) (111) (113) 
Scheme 5.2 
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w h i c h was r e a c t e d w i t h an e q u i m o l a r q u a n t i t y o f t h e 1 , 5 - d i t o s y l a t e (111) 
(110°C, 24 h r . ) . A g a i n a m i x t u r e o f o l i g o m e r s was o b t a i n e d , w i t h no 
e v i d e n c e (^H nmr, mass s p e c t r o m e t r y ) o f any c y c l i s e d p r o d u c t ( e i t h e r 
[ 1 8 ] - o r [9]-membered r i n g s ) . 
The [ 1 8 ] m a c r o c y c l e (100) was e v e n t u a l l y p r e p a r e d by a seven 
s t e p s y n t h e t i c r o u t e , Scheme 5.3. T h i o d i g l y c o l l i c a n h y d r i d e (114) was 
p r e p a r e d by t r e a t m e n t o f t h i o d i g l y c o l l i c a c i d w i t h a c e t y l c h l o r i d e 
( h e a t e d u n d e r r e f l u x f o r 18 h o u r s ) and p u r i f i e d by r e c r y s t a l l i s a t i o n 
f r o m c h l o r o f o r m . The d i - c a r b o x y l i c a c i d (115) was p r e p a r e d by d r o p w i s e 
a d d i t i o n o f e t h y l e n e d i a m i n e t o a s o l u t i o n o f t h e a n h y d r i d e (114) (2 
e q u i v a l e n t s ) i n d i c h l o r o m e t h a n e . The e x o t h e r m i c r e a c t i o n r e s u l t e d i n 
t h e i m m e d i a t e p r e c i p i t a t i o n o f a r e s i n o u s w h i t e s o l i d . The c r u d e d i a c i d 
(115) was c o l l e c t e d by f i l t r a t i o n and washed w i t h d i c h l o r o m e t h a n e . 
C o n v e r s i o n t o t h e d i e s t e r (116) was e f f e c t e d by h e a t i n g under r e f l u x i n 
e t h a n o l w i t h 17. s u l p h u r i c a c i d . A l a r g e volume o f s o l v e n t was r e q u i r e d , 
w i t h h e a t i n g under r e f l u x f o r 48-60 h o u r s , i n o r d e r t o consume t h e 
i n s o l u b l e s t a r t i n g m a t e r i a l . The c o o l e d r e a c t i o n m i x t u r e y i e l d e d t h e 
d i e t h y l e s t e r o f t h i o d i g l y c o l l i c a c i d ( t h e p r o d u c t o f a c o m p e t i t i v e 
amide c l e a v a g e r e a c t i o n ) as a w h i t e c r y s t a l l i n e s o l i d ( c a . 507. y i e l d ) . 
The r e q u i r e d d i e s t e r (116) was o b t a i n e d i n o v e r a l l 277. y i e l d (2 s t e p s ) 
a f t e r e x t r a c t i o n i n t o c h l o r o f o r m f r o m b a s i c aqueous s o l u t i o n , f o l l o w e d 
by r e c r y s t a l l i s a t i o n f r o m t o l u e n e . A l t h o u g h t h e y i e l d o f (116) was 
r a t h e r p o o r due t o t h e c o m p e t i t i v e amide c l e a v a g e , s u f f i c i e n t q u a n t i t i e s 
(20 g ) o f t h e r e q u i r e d p r o d u c t were o b t a i n e d t o c o n t i n u e w i t h t h e 
s y n t h e t i c r o u t e . 
R e a c t i o n o f t h e d i e s t e r (116) w i t h e t h y l e n e d i a m i n e i n e t h a n o l , 
h e a t e d u n d e r r e f l u x (120 h r . ) f a i l e d t o g i v e t h e c y c l i c t e t r a a m i d e 
( 1 0 9 ) . The m a j o r component, by t h i n l a y e r c h r o m a t o g r a p h y , was t h e 
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H OH N C CH2CI9 OH NH, 
(114) 0 (115) 
EtOH / H 









Ts H Ts H N N N N c HBr/PhOH/CH3C02H N N N Ts Ts U J k / (100 121 
Scheme 5.3. S y n t h e s i s o f [18]-N 4S« ( 1 0 0 ) . 
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u n r e a c t e d s t a r t i n g m a t e r i a l ( 1 1 6 ) . 
The d i e s t e r was c o n v e r t e d t o t h e c o r r e s p o n d i n g t e t r a a m i d e ( 1 1 7 ) by 
t r e a t m e n t w i t h e t h a n o l , s a t u r a t e d w i t h ammonia ( 6 0 h r . ) , i n a t i g h t l y 
s t o p p e r e d v e s s e l . The p r o d u c t was c o l l e c t e d by f i l t r a t i o n as a w h i t e 
s o l i d (757c). R e d u c t i o n o f t h e t e t r a a m i d e t o t h e t e t r a a m i n e ( 1 1 8 ) was 
e f f e c t e d u s i n g an excess ( 4 eq. per amide g r o u p ) o f borane.THF complex 
(1.0M) i n THF, w i t h h e a t i n g under r e f l u x f o r 60 h o u r s . T r e a t m e n t o f t h e 
r e s u l t i n g amino-borane compound w i t h h y d r o c h l o r i c a c i d ( 6 M o l a r / 1 1 0 ° C / 3 
h r . ) f o l l o w e d by e x t r a c t i o n i n t o c h l o r o f o r m f r o m b a s i c aqueous s o l u t i o n , 
gave t h e t e t r a a m i n e as a c l e a r o i l ( 7 1 7 . ) . T h i n f i l m I R r e v e a l e d t h a t 
1 13 
a l l f o u r amide groups had been reduced and H and C nmr ( F i g . 5.3) 
c o n f i r m e d t h a t t h e p r o d u c t d i d n o t r e q u i r e f u r t h e r p u r i f i c a t i o n . The 
s y n t h e s i s o f t h e [19]-membered N 4S« m a c r o c y c l e ( 1 1 9 ) (Scheme 5.4) was 
a t t e m p t e d by r e a c t i o n o f t h e t e t r a a m i n e ( 1 1 8 ) w i t h d i e t h y l m a l o n a t e i n 
e t h a n o l ( 1 2 0 h r . ) , a c c o r d i n g t o t h e method r e p o r t e d by T a b u s h i e t a l . 
f o r t h e s y n t h e s i s o f cyclam ( t h e use o f s u b s t i t u t e d d i e t h y l m a l o n a t e s 
J 
1 i 
*> ppM 20 *> 80 60 4 0 PPM 
F i g . 5.3. 1H and 1 3C nmr o f t h e t e t r a a m i n e ( 1 1 8 ) . 
20 o 
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EtOH 
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( 1 1 8 ) (119 ) 
Scheme 5.4 
p r o v i d e d a c o n v e n i e n t s y n t h e s i s o f C - f u n c t i o n a l i s e d c y c l a m s ) . The 
f a i l u r e t o o b t a i n any o f t h e r e q u i r e d p r o d u c t i n t h i s r e a c t i o n was a 
f u r t h e r i n d i c a t i o n o f t h e r e l u c t a n c e o f t h e system t o undergo 
i n t r a m o l e c u l a r c y c l i s a t i o n . 
The t e t r a a m i n e (118) was c o n v e r t e d t o t h e t e t r a t o s y l a m i d e (120) by 
r e a c t i o n w i t h t o s y l c h l o r i d e i n p y r i d i n e , a t 0°C, under anhydrous 
c o n d i t i o n s . The p r o d u c t was p u r i f i e d by r e c r y s t a l l i s a t i o n f r o m 
MeOH-CHClg t o g i v e a p a l e brown s o l i d (567.). C y c l i s a t i o n was a f f e c t e d 
by t h e r e a c t i o n o f t h e t e t r a t o s y l a m i d e (120) w i t h e t h y l e n e g l y c o l 
d i t o s y l a t e i n DMF i n t h e presence o f caesium c a r b o n a t e . The use o f 
caesium c a r b o n a t e as t h e p r e f e r r e d base f o r t h e p r o m o t i o n o f r i n g 
c l o s u r e r e a c t i o n s , i n p a r t i c u l a r f o r l o n g c h a i n d i t o s y l a m i d e s , has been 
r e p o r t e d by K e l l o g g e t a l . 1 3 ' 1 4 The c y c l i c t e t r a t o s y l a m i d e (121) was 
i s o l a t e d as a f i n e cream c o l o u r e d s o l i d f r o m h o t t o l u e n e (627.). 
D e t o s y l a t i o n was e f f e c t e d by two d i f f e r e n t methods. T r e a t m e n t o f 
t h e t e t r a t o s y l a m i d e w i t h H B r / P h e n o l / a c e t i c a c i d (80°C, 10 da y s ) gave t h e 
[ 1 8 ] - N ^ m a c r o c y c l e i n 327. y i e l d . The p r o d u c t was i s o l a t e d f r o m t h e 
c o o l e d r e a c t i o n m i x t u r e as t h e HBr s a l t , and o b t a i n e d as t h e f r e e amine 
a f t e r b a s i f i c a t i o n i n aqueous s o l u t i o n (NaOH) f o l l o w e d by e x t r a c t i o n 
1 5 1 
i n t o t h e c h l o r o f o r m . The p r o d u c t was r e c r y s t a l l i s e d f r o m t o l u e n e t o 
g i v e a w h i t e s o l i d . D e t o s y l a t i o n o f ( 1 2 1 ) u s i n g Li/NH^/THF/EtOH l e d t o 
an improved y i e l d o f t h e amine (647o) a f t e r r e c r y s t a l l i s a t i o n f r o m 
t o l u e n e . I n t h e nmr (CDClg) o f t h e m a c r o c y c l i c t e t r a a m i n e ( 1 0 0 ) 
[ F i g . 5.4] t h e N-Ch^Ch^-N p r o t o n s gave a s i n g l e t a t 2.76 ppm and t h e 
r e m a i n i n g Ch^S and Ch^N p r o t o n s r e s o n a t e d as an A2B2M system c e n t r e d a t 
2.81 ppm. [ I n t h e Ch^S and Ch^N p r o t o n s r e s o n a t e d as t r i p l e t s a t 
3.01 and 2.84 ppm w i t h t h e N-CH 9CfL-N s i n g l e t a t 2.91 ppm.] 
r 
1 L 
S So 34 ~ 24 i * 0 
F i g . 5.4. !H nmr (CDCl-) o f t h e ma c r o c y c l e ( 1 0 0 ) . 
5 . 1.2. N.N1.N".N"'-tetramethvl-1.10-dithia-4.7.13.16-tetraazacvcloocta-
decane (101) 
The [ 1 8 ] - N 4 S 2 m a c r o c y c l e was c o n v e r t e d t o i t s t e t r a m e t h y l 
d e r i v a t i v e ( 1 2 2 ) [Scheme 5.5] u s i n g t h e E s c h w e i l e r - C l a r k e m e t h y l a t i o n 
p r o c e d u r e . The t e t r a a m i n e ( 1 0 0 ) was t r e a t e d w i t h an e q u i m o l a r r a t i o o f 
f o r m a l d e h y d e (377.) and f o r m i c a c i d (95°C, 20 h r . ) . R e c r y s t a l l i s a t i o n 
f r o m hexane gave t h e m a c r o c y c l e ( 1 0 1 ) as a w h i t e s o l i d ( 5 5 7 . ) . The ^ 
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H N N' H Me N N Me 
HCC^I-yHCHO 
N 
H Me' N N Me 
( 1 0 0 ) ( 1 0 1 ) 
Scheme 5.5. S y n t h e s i s o f [ 1 8 ] - N 4 S 2 M e 4 (101) 
13, and C nmr were s i m p l e ( F i g . 5 . 5 ) , c o n s i s t e n t w i t h t i m e a v e r a g e d 
symmetry o f t h e l i g a n d . I n c o n t r a s t t o t h e n o n - m e t h y l a t e d c y c l e ( 1 0 0 ) , 
t h e c o n s t i t u t i o n a l l y h e t e r o t o p i c 'N-Cf^Ch^-S1 p r o t o n s were a c c i d e n t a l l y 
i s o c h r o n o u s g i v i n g a s i n g l e t a t 2.64 ppm i n t h e H nmr sp e c t r u m (CDCl^). 
CDCI 
TMS 
30 PPM 2-0 1-0 M 60 PPM t0 20 
F i g . 5.5. h and 1 3C nmr (CDClg) o f ( 1 0 1 ) . 
5.1.3. 1.2-Bis(l-aza-4.7-dithia-l-cvclononvl)ethane (102) 
The N,N'-ethylene b r i d g e d [IJj-NSg l i g a n d (102) was s y n t h e s i s e d by a 
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f i v e s t e p s y n t h e t i c r o u t e s t a r t i n g f r o m d i e t h a n o l a m i n e [Scheme 5 . 6 ] . 
The s y n t h e s i s o f t h e [ 9 ] - N S 2 m a c r o c y c l e (126) ( p r e c u r s o r t o t h e N,N' 
l i n k e d system) has n o t p r e v i o u s l y been r e p o r t e d and c o m p l e t e s t h e [ 9 ] - X 
s e r i e s (X = 0, N, S ) . 1 5 
T r e a t m e n t o f d i e t h a n o l a m i n e w i t h t o s y l c h l o r i d e (pyridine/0°C) 
a f f o r d e d t h e t o s y l a t e d p r o d u c t (123) w h i c h was p u r i f i e d by 
r e c r y s t a l l i s a t i o n f r o m e t h a n o l - t o l u e n e ( y i e l d , 847.). The d i t h i o l (124) 
was p r e p a r e d u s i n g a method s i m i l a r t o t h a t r e p o r t e d by Rosen and 
1 f\ 
Busch f o r t h e s y n t h e s i s o f 1 , 1 0 - d i t h i o l s , as p r e c u r s o r s t o t e t r a t h i a 
m a c r o c y c l e s . The d i t o s y l a t e (123) was t r e a t e d w i t h t h i o u r e a i n e t h a n o l 
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Scheme 5.6. S y n t h e s i s o f N,N'-bridged [ 9 ] - N S 2 ( 1 0 2 ) . 
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under r e f l u x i n s a t u r a t e d NaHCOg s o l u t i o n . E x t r a c t i o n f r o m n e u t r a l 
aqueous s o l u t i o n gave a c l e a r o i l which was f o u n d t o be a m i x t u r e o f t h e 
r e q u i r e d d i t h i o l (124) and some m o n o t h i o l a t e d p r o d u c t ( c a . 107. by *H 
nm r ) . The d i t h i o l was o b t a i n e d as a w h i t e s o l i d (837.) a f t e r 
p u r i f i c a t i o n by " f l a s h " s i l i c a chromatography. R i n g c l o s u r e t o g i v e t h e 
c y c l i c d i t o s y l a m i d e (125) was e f f e c t e d by t h e slow d r o p w i s e a d d i t i o n (12 
ho u r s ) o f s o l u t i o n s o f t h e d i t h i o l (124) and 1,2-dibromoethane i n DMF t o 
a w e l l s t i r r e d s u s p e n s i o n o f caesium c a r b o n a t e i n DMF a t 55°C. The 
p r e p a r a t i o n o f c y c l i c t h i o e t h e r s by r e a c t i o n o f d i t h i o l s w i t h d i b r o m i d e s 
16 17 18 
has been w e l l documented. ' K e l l o g g r e p o r t e d t h a t t h e r e a c t i o n was 
p a r t i c u l a r l y e f f i c i e n t w i t h t h e use o f caesium c a r b o n a t e i n DMF. He 
o r i g i n a l l y p o s t u l a t e d t h a t t h e poor s o l v a t i o n o f t h e l a r g e C s + i o n l e d 
t o t h e f o r m a t i o n o f t i g h t i o n p a i r s (RS Cs +) whi c h encouraged 
i n t r a m o l e c u l a r S*T2 r e a c t i o n ( F i g . 5 . 6 ) . However, l a t e r s t u d i e s , ^ u s i n g 
X " C s + 
(chain) (chain) 
C s + Y' 
F i g . 5.6. I n t r a m o l e c u l a r S^2 c y c l i s a t i o n r e a c t i o n . 
133 
Cs nmr, r e v e a l e d t h a t t h e caesium s a l t s ( e . g . t h i o l a t e s , c a r b o x y l a t e s 
and amides) d i d n o t e x i s t as t i g h t i o n p a i r s i n DMF and i n f a c t t h e i r 
g r e a t e r s o l u b i l i t y compared t o o t h e r g r o u p I s a l t s (Cs > Rb > K > Na) 
was c o n t r i b u t i n g t o w a r d s t h e enhancement o f t h e i n t r a m o l e c u l a r S^2 
r e a c t i o n . 
The r e a c t i o n o f t h e d i t h i o l (124) w i t h 1,2-dibromoethane was f o u n d 
t o y i e l d b o t h t h e nine-membered r i n g (437.) and t h e eighteeen-membered 
155 -
r i n g (128) (107.) [Scheme 5 . 7 ] . The two p r o d u c t s were i s o l a t e d as w h i t e 
c r y s t a l l i n e s o l i d s by f r a c t i o n a l c r y s t a l l i s a t i o n f r o m t o l u e n e - h e x a n e , 
t h e l a r g e r r i n g b e i n g t h e l e a s t s o l u b l e . T r e a t m e n t o f (125) w i t h 
HBr/PhOH/CH 3C0 2H (80°C, 48 h r . ) gave t h e d e t o s y l a t e d p r o d u c t , 
1 , 4 - d i t h i a - 7 - a z a c y c l o n o n a n e (126) i n good y i e l d (737.) a f t e r 
r e c r y s t a l l i s a t i o n f r o m t o l u e n e - h e x a n e . D e t o s y l a t i o n o f t h e 18-membered 
d i t o s y l a m i d e (128) was e f f e c t e d i n a s i m i l a r manner, t o g i v e t h e 
[18] -N9S4 m a c r o c y c l e (107) i n 307. y i e l d , a f t e r r e c r y s t a l l i s a t i o n f r o m 
Ts r N HS 




Scheme 5.7. S y n t h e s i s o f t h e 18-membered r i n g ( 1 2 8 ) . 
c h l o r o f o r m - h e x a n e . T h i s p r o v i d e s a u s e f u l a l t e r n a t i v e s y n t h e s i s o f t h e 
[ 1 8 ] - ^ 2 ^ 4 m a c r o c y c l e w h i c h a v o i d s t h e use o f t h e h i g h l y t o x i c 
a c i d - d i c h l o r i d e s , as r e p o r t e d by Lehn e t a l . The N,N'-bridged b i s 
[9]-NS2 l i g a n d (102) was p r e p a r e d by t h e r e a c t i o n o f 2 e q u i v a l e n t s o f 
t h e m a c r o c y c l i c amine (126) w i t h e t h y l e n e g l y c o l d i t o s y l a t e (Na2COg/MeCN) 
f o l l o w e d by r e c r y s t a l l i s a t i o n f r o m t o l u e n e ( y i e l d , 537.). I n t h e *H nmr 
o f t h e l i g a n d (102) t h e N-CH2CH2-N and S-CH2CH2-S p r o t o n s r e s o n a t e d as 
s i n g l e t s (2.62 and 3.09 ppm r e s p e c t i v e l y ) and t h e r e m a i n i n g m e t h y l e n e 
r i n g p r o t o n s r e s o n a t e d as a second o r d e r m u l t i p l e t c e n t r e d a t 2.80 ppm. 
Two 'CH2N' s i g n a l s (58.7 and 55.6 ppm) and two 'CH2S' s i g n a l s ( 3 4 . 8 , 
13 
33.1) were observed i n t h e C nmr ( F i g . 5.7) c o n s i s t e n t w i t h t h e t i m e 
averaged C 9-symmetry o f t h e l i g a n d . 
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F i g . 5.7. 13, C nmr o f l i g a n d ( 1 2 7 ) . 
5.1.4. l,10-dioxa-4,7..13«16-tetraazacyclooctadecane (131) and i t s 
tetramethyl derivative (132) 
I n o r d e r t o c o m p l e t e thermodynamic s t u d i e s on t h e s i l v e r ( I ) 
complexes o f mixed donor eighteen-membered m a c r o c y c l i c l i g a n d s , t h e 
19 
[ 1 8 ] m a c r o c y c l e (131) and i t s t e t r a m e t h y l d e r i v a t i v e (132) were 
s y n t h e s i s e d [Scheme 5 . 8 ] . R e a c t i o n o f e t h y l e n e d i a m i n e d i t o s y l a m i d e w i t h 
3 - o x a - l , 5 - b i s ( p - t o l u e n s u l p h o n a t o ) p e n t a n e (Cs2C0g/DMF) gave a m i x t u r e o f 
t h e n i n e and eighteen-membered r i n g p r o d u c t s (417. and 207. r e s p e c t i v e l y ) . 
E a r l i e r e x p e r i m e n t s , w h i c h had been c a r r i e d o u t a t h i g h e r d i l u t i o n , 
f a v o u r e d t h e f o r m a t i o n o f t h e nine-membered r i n g ( 1 3 0 ) . D e t o s y l a t i o n 
was e f f e c t e d u s i n g HBr/PhOH/CHgCC^H f o l l o w e d by r e c r y s t a l l i s a t i o n f r o m 
c h l o r o f o r m - h e x a n e , t o g i v e t h e [ 1 8 ] - N ^ c y c l e as a c o l o u r l e s s 
c r y s t a l l i n e s o l i d ( y i e l d , 257.). The t e t r a m e t h y l d e r i v a t i v e (132) was 
pr e p a r e d u s i n g t h e E s c h w e i l e r - C l a r k e p r o c e s s , as f o r t h e [ 1 8 ] - N 4 S 2 
l i g a n d . 
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Scheme 5.8. S y n t h e s i s o f t h e 18-membered l i g a n d s ( 131) and ( 1 3 2 ) . 
5.2. Silver(I) Complexes 
5.2.1. Silverd;) complex of [18]-N 4S 2 (100) 
The 1:1 s i l v e r ( I ) complex o f l i g a n d (100) was p r e p a r e d by t h e 
a d d i t i o n o f one e q u i v a l e n t o f s i l v e r n i t r a t e , i n a c e t o n i t r i l e , t o a 
s o l u t i o n o f t h e l i g a n d i n d i c h l o r o m e t h a n e , a t room t e m p e r a t u r e . 
A t t e m p t s t o i s o l a t e a c r y s t a l l i n e p r o d u c t f r o m t h i s r e a c t i o n m i x t u r e 
were n o t s u c c e s s f u l . A s o l u t i o n o f t h e c r u d e complex i n methanol was 
t r e a t e d w i t h a s o l u t i o n o f ammonium h e x a f l u o r o p h o s p h a t e ( 1 eq.) i n 
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m e t h a n o l , i n o r d e r t o exchange t h e n i t r a t e a n i o n f o r t h e 
h e x a f l u o r o p h o s p h a t e c o u n t e r i o n . C o l o u r l e s s c r y s t a l s o f [ A g - L ] [ P F g ] 
(134) were o b t a i n e d a f t e r t h e s o l u t i o n was l e f t t o s t a n d i n t h e d a r k , a t 
-20°C, f o r 36 h o u r s . The complex was i n i t i a l l y c h a r a c t e r i s e d by F a s t 
Atom Bombardment (FAB) mass s p e c t r o m e t r y and *H nmr. M o l e c u l a r i o n s 
(M +) o f a p p r o x i m a t e l y e q u a l i n t e n s i t y were o b s e r v e d a t m/e 399 and 4 0 1 , 
c o n s i s t e n t w i t h complexes o f t h e two i s o t o p e s o f s i l v e r ( Ag +-L and 
^ A g + - L ) . M o l e c u l a r i o n s c o r r e s p o n d i n g t o s i l v e r - l i g a n d complexes o f 
o t h e r s t o i c h i o m e t r y (1:2 o r 2:1) were n o t ob s e r v e d . The *H nmr (CD^OD) 
gave a s i m p l e spectrum c o n s i s t e n t w i t h l o c a l C 2 symmetry f o r t h e 
complex, w i t h a l l 6 donor atoms b i n d i n g t h e s i l v e r . The N-CH2CH2-N 
p r o t o n s gave a sha r p s i n g l e t a t 2.79 ppm and t h e a d j a c e n t Ch^S and CI^N 
p r o t o n s were a c c i d e n t a l l y i s o c h r o n o u s , g i v i n g a s i n g l e t a t 2.99 ppm. A 
s i m i l a r s p e c t r u m was observed i n D2O. 
By slow r e c r y s t a l l i s a t i o n o f t h e complex ( o v e r 72 h r . ) i n m e t h a n o l , 
i n t h e d a r k ( d u s t f r e e c o n d i t i o n s ) c r y s t a l s s u i t a b l e f o r X-ray 
d i f f r a c t i o n s t u d i e s were o b t a i n e d . The m o l e c u l a r s t r u c t u r e i s 
i l l u s t r a t e d i n F i g . 5.8 w i t h s a l i e n t bond l e n g t h s and bond a n g l e s g i v e n 
i n T a b l e 5.1. The c a t i o n i c s i l v e r complex (and t h e PF^ a n i o n ) possess 
Table 5.1. 
S e l e c t e d bond l e n g t h s (8) and bond a n g l e s (deg) 
f o r [ A g - L ] [ P F 6 ] , L = [18 ] - N 4 § 2 
A g ( l ) - S ( l ) 2.658(5) A g ( l ) - N ( l ) 2.589(10) 
A g ( l ) - N ( 2 ) 2.553(11) 
S ( l ) - A g ( l ) - N ( l ) 75.9(3) S ( l ) - A g ( l ) - N ( 2 ) 113.2(3) 
N ( l ) - A g ( l ) -N(2) 70.6(4) S ( l ) - A g ( l ) - S ( l ' ) 1 24.5(2) 
S ( l ) - A g ( l ) - N ( l ' ) 144.7 N ( l ) - A g ( l ) - N ( l ' ) 104.3(4) 
S ( l ) - A g ( l ) -N(2*) 74.6 N ( l ) - A g ( l ) - N ( 2 ' ) 9 9 . 5 ( 4 ) 
N ( 2 ) - A g ( l ) -N(2') 164.3 
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F i g . 5.8. X-ray c r y s t a l s t r u c t u r e o f t h e s i l v e r ( I ) complex o f 
[ 1 8 ] - N 4 S 2 ( 1 0 0 ) . 
c r y s t a l l o g r a p h i c a l l y imposed C2-symmetry. Only t h e c e n t r a l atom 
a c t u a l l y l i e s on t h e symmetry a x i s . The s i l v e r ( I ) i o n i s s i x 
c o o r d i n a t e d by t h e f u l l S2N4 donor s e t o f t h e m a c r o c y c l e . However, t h e 
geometry i s f a r f r o m o c t a h e d r a l w i t h t h e most n e a r l y ' t r a n s ' p a i r o f 
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l i g a n d s b e i n g t h e s y m m e t r y - r e l a t e d secondary amine n i t r o g e n atoms, N(2) 
and N(2') ( N ( 2 ) - A g - N ( 2 ' ) , 164.3°). I f t h e s e donor atoms a r e c o n s i d e r e d 
as o c c u p y i n g t h e a x i a l s i t e s , S ( l ) and N ( l ' ) a r e d i s p l a c e d below t h e 
e q u a t o r i a l p l a n e by 0.684 and 0.8238 r e s p e c t i v e l y , w i t h t h e i r C 2 
symmetry r e l a t e d c o u n t e r p a r t s e q u a l l y d i s p l a c e d above t h e p l a n e . 
A l t e r n a t i v e l y , t h e m a c r o c y c l e can be vi e w e d as p r o v i d i n g two 
m e r i d i o n a l , t r i d e n t a t e f r a g m e n t s c o m p r i s i n g N ( l ) , N(2) and S ( l ' ) ( r . m . s . 
d e v i a t i o n o f AgSN 2 p l a n e , 0.0608) which i s i n c l i n e d a t 70° t o i t s 
symmetry r e l a t e d e q u i v a l e n t , c o m p r i s i n g atoms N ( l ' ) , N(2') and S ( l ) . 
The s i l v e r - s u l p h u r bond l e n g t h [2.658(5)8] compares f a v o u r a b l y t o t h o s e 
f o u n d f o r o t h e r s i l v e r ( I ) - m a c r o c y c l e complexes. For example, bond 
l e n g t h s range f r o m ; 2.70-2.758 i n t h e b i s - 9 S g - A g ( l ) complex r e p o r t e d by 
Cooper e t a l ; 2 0 f r o m 2.67-3.008 i n t h e [ 1 5 ] N 2 S 2 0 - A g ( l ) and 
[ 1 5 ] S 2 N 2 0 - A g ( l ) c o m p l e x e s 2 * and f r o m 2.65-2.958 i n t h e i r r e g u l a r 
22 
[ 1 8 ] - P y N 2 S g - A g ( l ) complex [see s e c t i o n 4.2. f o r d e s c r i p t i o n s o f t h e s e 
s t r u c t u r e s ] . 
Both independent Ag-N d i s t a n c e s a r e s i m i l a r ( 2 . 5 5 3 ( 1 1 ) and 
2. 5 8 9 ( 1 0 ) , t h o s e f o r t h e ' t r a n s ' p a i r a r e j u s t 0.038 s h o r t e r ) and a r e 
w i t h i n t h e range o b s e r v e d f o r t h e mixed s u l p h u r n i t r o g e n donor 
m a c r o c y c l i c complexes j u s t mentioned [2.40-2.6l8]. S u r p r i s i n g l y none o f 
t h e secondary amines p a r t i c i p a t e i n any hydrogen b o n d i n g . A l t h o u g h t h e 
complex does n o t possess an o c t a h e d r a l c o o r d i n a t i o n geometry as 
o r i g i n a l l y h y p o t h e s i s e d , t h e s i l v e r i o n i s w e l l e n c a p s u l a t e d w i t h i n t h e 
m a c r o c y c l i c c a v i t y f o r m i n g r e l a t i v e l y s t r o n g i n t e r a c t i o n s w i t h a l l s i x 
donor atoms, g i v i n g a complex w i t h o v e r a l l C 2 symmetry. 
The r a t e o f c o m p l e x a t i o n o f t h e [ 1 8 ] - N 4 S 2 m a c r o c y c l e w i t h s i l v e r ( I ) 
was m o n i t o r e d by nmr i n D 20 b u f f e r e d a t pD = 5 (CDgC0 2Na +/CDgC0 2D) a t 
23°C. One e q u i v a l e n t o f s i l v e r n i t r a t e was added t o t h e s o l u t i o n o f t h e 
9 
l i g a n d [10 m o l a r ] and t h e p r o t o n nmr r e c o r d e d i m m e d i a t e l y . The 
c h a r a c t e r i s t i c spectrum o f t h e 1:1 s i l v e r complex (two s i n g l e t s 2.79 and 
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2.99 ppm) was o b s e r v e d , w i t h no s i g n o f any f r e e l i g a n d . I t was 
c o n c l u d e d t h a t c o m p l e x a t i o n was comp l e t e (> 957«) w i t h i n t h e t h r e e 
m i n u t e s r e q u i r e d t o o b t a i n t h e nmr spe c t r u m . 
5.2.2. Silver(I) complex of [18]-N4S2Me4 (101) 
The s i l v e r ( I ) complex o f t h e l i g a n d (101) was p r e p a r e d , as t h e 
h e x a f l u o r o p h o s p h a t e s a l t [ A g - L ] [ P F g ] ( 1 3 5 ) , as d e s c r i b e d f o r t h e p a r e n t 
[ 1 8 ] - N 4 S 2 l i g a n d . 
I n i t i a l l y , brown c o l o u r e d c r y s t a l s were o b t a i n e d b u t subsequent 
r e c r y s t a l l i s a t i o n s f r o m methanol y i e l d e d c o l o u r l e s s c r y s t a l s . However, 
c r y s t a l s s u i t a b l e f o r X-ray d i f f r a c t i o n s t u d i e s were n o t o b t a i n e d . The 
1 1 complex was c h a r a c t e r i s e d by H nmr (CD^OD) [ F i g . 5.9 - H nmr o f t h e 
s i l v e r complex i s compared t o t h a t o f t h e f r e e l i g a n d ] and FAB mass 
s p e c t r o m e t r y ( m o l e c u l a r i o n s (M +) a t m/e 455 and 4 5 7 ) . The *H nmr 
sp e c t r u m r e v e a l e d t h a t t h e 1CH 2S' p r o t o n s , w h i c h r e s o n a t e d as a s i n g l e t 
(2.76 ppm) i n t h e f r e e l i g a n d (CH 2N and CH2S a c c i d e n t a l l y i s o c h r o n o u s ) 
L (101) 
AJ 
X> PPM 2-0 
Ag-L (13/») 
to >0 PPM 2-0 1-0 
F i g . 5.9. H nmr s p e c t r a (CDgOD) o f l i g a n d (101) and i t s 
s i l v e r ( I ) complex ( 1 3 4 ) . 
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were s h i f t e d to higher frequency (3.05 ppm, t r i p l e t ) i n the complex. 
i 
The r a t e of complexation was observed by H nmr i n a t pD 5.5 
(CD 3C0 2D/CD 3C0 2Na) a t 23°C (10" 2M i n l i g a n d ) . As noted f o r the 
[18]-N^S2 l i g a n d , complexation was observed t o be complete (> 957.) 
w i t h i n t h r e e minutes. 
5.2.3. Silver(I) complex of bis N,N'-bridged [9]-NS2 (102) 
Reaction of equimolar q u a n t i t i e s of s i l v e r n i t r a t e and l i g a n d (102) 
i n d i c h l o r o m e t h a n e - a c e t o n i t r i l e (1:1) l e d to the formation of the s i l v e r 
complex, which was i s o l a t e d as the hexafluorophosphate s a l t [Ag-L][PFg] 
(136). The H nmr of the complex gave a broad m u l t i p l e t between 2.6 and 
2.9 ppm i n both CD^OD and D 20. Molecular ions (M +) a t m/e 461 and 459 
( ^ A g - L and ^ A g - L r e s p e c t i v e l y ) were observed i n the FAB mass 
spectrum. Slow r e c r y s t a l l i s a t i o n of the complex from 
m e t h a n o l - a c e t o n i t r i l e (10:1) i n the dark, i n a dust f r e e v e s s e l , y i e l d e d 
small c r y s t a l s (0.1-0.2 mm diameter) s u i t a b l e f o r X-ray d i f f r a c t i o n 
s t u d i e s . The c r y s t a l s t r u c t u r e of the [ A g - L ] + ion i s presented i n F i g . 
5.10 and s e l e c t e d bond lengths and angles given i n Table 5.2. The 
s i l v e r ion i s bound by a l l s i x nitrogen and sulphur donor atoms, i n a 
d i s t o r t e d o c t a h e d r a l c o o r d i n a t i o n . Both the c a t i o n [Ag-I/T (and the PF" 
anion) have 2 - f o l d c r y s t a l l o g r a p h i c symmetry. The nine-membered r i n g s 
adopt the expected [3.3.3] conformation a l l o w i n g f a c i a l c o o r d i n a t i o n t o 
the s i l v e r , with one s h o r t s i l v e r sulphur bond (Ag-S(7) = 2.611(2)8), 
one long s i l v e r - s u l p h u r bond (Ag-S(4) = 2.802(2)8) and a r e l a t i v e l y 
s h o r t s i l v e r - n i t r o g e n bond (Ag-N(l) = 2.586(3)8). The planes through 
the S ( 4 ) , S(7) and N ( l ) atoms i n the two r i n g s a r e not p a r a l l e l , but a r e 
i n c l i n e d at an angle of 17°, i n d i c a t i n g t h a t the b r i d g i n g e t h y l e n e group 
i s a l i t t l e too sh o r t t o allow the r i n g s to adopt the optimum binding 
p o s i t i o n . The r e s u l t a n t coordination of s i l v e r i s d i s t o r t e d o c t a h e d r a l , 
i n which the t r i g o n a l donor s e t s N ( l ) , S(4) and S(7) and N ( l ' ) , S ( 4 ' ) 
163 
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F i g . 5.10. X-ray c r y s t a l s t r u c t u r e of the s i l v e r ( I ) complex of (102) 
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Table 5.2 
S e l e c t e d bond lengths (ft) and bond an g l e s (deg) f o r [Ag-L][PFg] 
L = B i s [9]-NS 2 (101) 
Ag-S(4) 2.802(2) Ag-N(l) 2.586(5) 
Ag-S(7) 2.611(2) 
S(4)-Ag- S(4') 156.83(7) N(l)-Ag-N(l') 73.7(1) 
S(4)-Ag- S(7) 80.90(7) S(7)-Ag-S(7') 149.62(6) 
S(4)-Ag- S(7') 93.04(6) S(7)-Ag-N(l) 77.0(6) 
S(4)-Ag-•N(l) 74.0(1) S(7)-Ag-N(l') 130.1(1) 





F i g . 5.11. R e l a t i v e d i s p o s i t i o n of the two NS 2 donor s e t s i n the 
[ A g - L ] + complex ( 1 3 5 ) . 
and S(7') are t w i s t e d by 15° r e l a t i v e to one another [ F i g . 5.11]. The 
1 2 r a t e of complexation was observed by H nmr i n (10 M i n l i g a n d , 
23°C). The pD was reduced to 4 ( C D g C O ^ / C D g C O ^ b u f f e r ) i n order to 
completely d i s s o l v e the l i g a n d . As with the eighteen-membered 
macrocycles, complexation was complete (> 957.) w i t h i n t h r e e minutes. 
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5.2.4. Silver(I) complex of [9]-NS2(126) 
I n order to s y n t h e s i s e a b i s [9]-NS2 s i l v e r complex, analogous to 
20 
the [9]-Sg system reported by Cooper e t a l . , the l i g a n d (126) was 
re a c t e d with s i l v e r n i t r a t e (0.5 eq.) i n d i c h l o r o m e t h a n e - a c e t o n i t r i l e 
( 1 : 1 ) . A small amount of complex was i s o l a t e d as the PFg s a l t from 
methanol s o l u t i o n , as a c o l o u r l e s s c r y s t a l l i n e s o l i d . The *H nmr [ F i g . 




7-0 6-0 5-0 20 1-0 U-0 ppM 3-0 
F i g . 5.12. *H nmr of the s i l v e r complex of [9]NS2-
gave a s i n g l e t a t 2.93 ppm, while the remaining methylene r i n g protons 
(CHgN and CE^S) resonated as an A2B2 system centred a t 2.89 ppm [ c f . two 
s i n g l e t s 2.85 and 2.81 ppm f o r the f r e e l i g a n d i n CD3OD]. FAB mass 
spectrometry r e v e a l e d molecular ions (M +) a t m/e 433 and 435 c o n s i s t e n t 
with the b i s - [ 9 ] - N S 2 c a t i o n s [ 1 0 7 A g - L 2 ] + and [ 1 0 9 A - L 2 ] ~ . Unf o r t u n a t e l y , 
due to l o s s of sample and f a i l u r e to obtain the complex as a c r y s t a l l i n e 
s o l i d i n subsequent syntheses, the molecular composition was not 
confirmed by elemental a n a l y s i s or by X-ray d i f f r a c t i o n s t u d i e s . 
5.2.5. Other silver(I) complexes 
Attempts were made to prepare the 1:1 s i l v e r complexes of the 
ma c r o c y c l i c l i g a n d s (137)-(140) using the same ge n e r a l procedure as 
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d e s c r i b e d p r e v i o u s l y . FAB mass spectrometry r e v e a l e d molecular ions 
c o n s i s t e n t with the formation of 1:1 complexes f o r a l l f o u r l i g a n d s , but 
only l i g a n d (140) y i e l d e d c r y s t a l s [Ag-L] [PFg] of s u f f i c i e n t q u a l i t y f o r 
X-ray d i f f r a c t i o n s t u d i e s . The c r y s t a l s t r u c t u r e r e v e a l e d t h a t the 
s s V 
(137) 
(139) 
complex was dimeric [Ag-L]2[PFg]2 i n the s o l i d s t a t e , with two f i v e 
c o o rdinate s i l v e r ions adopting approximately square pyramidal geometry, 
but i n two d i s t i n c t l y d i f f e r e n t c o o r d i n a t i o n environments [ F i g . 5.13]. 
One s i l v e r ion i s coordinated by an NSO^ donor s e t with s t r o n g Ag-N 
[2.370(6)8] and Ag-S [2.502(3)8] bonds and t h r e e Ag-0 bonds [ 2 . 3 9 8 ( 6 ) , 
2.461(5) and 2.605(8)8] f rom the same macrocycle. The second s i l v e r 
ion, which i s coordinated by an NS^O donor s e t , i s bound by the p y r i d i n e 
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F i g . 5.14. The ORTEP diagram showing the l i n k between the two s i l v e r monomeric u n i t s . 
Table 5.3 
S e l e c t e d bond lengths (8) and bond angles (deg) f o r [ A g - L ] 2 [ P F 6 ] 2 , L = (137? 
Ag(l) -N(1A) 2.370(6) Ag(2)-N(1B) 2.529(8) 
A g ( l ) -S(8A) 2.502(3) Ag(2)-S(8B) 2.611(3) 
A g ( l ) -0(11H) 2.605(8) Ag(2)-S(20B) 2.609(3) 
A g ( l ) -0(14A) 2.461(5) Ag(2)-S(20A) 2.545(2) 
Ag(l) -0(17A) 2.398(6) Ag(2)-0(17B) 2.879(7) 
N(1A) -Ag(l)-S(8A) 81.3(2) S(20A)-Ag(2)-N(1B) 123.3(2) 
N(1A) -Ag(l)-0(11A) 83.4(3) S(20A)-Ag(2)-S(8B) 100.57(8) 
N(1A) -Ag(l)-0(14A) 129.7(2) S(20A)-Ag(2)-S(20B) 115.66(8) 
N(1A) -Ag(l)-0(17A) 104.3(2) N(1B)-Ag(2)-S(8B) 74.7(2) 
S(8A) -Ag(l)-0(11A) 77.4(2) N(1B)-Ag(2)-S(20B) 75.5(2) 
S(8A) -Ag(l)-0(17A) 158.5(2) S(8B)-Ag(2)-S(20B) 141.80(9) 
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by both sulphur atoms of the second macrocycle [ 2 . 6 1 1 ( 3 ) , 2.609(3)8] and 
by one sulphur from the f i r s t macrocycle [Ag(2)-S(20A) = 2.545(2)8], 
thereby c o n s t i t u t i n g the bridge i n the di m e r i c s t r u c t u r e [ F i g . 5.14]. A 
weak c a t i o n - d i p o l e i n t e r a c t i o n with one oxygen [Ag(2)-0(17B) = 
2.879(7)8] completes the approximately square pyramidal geometry around 
the s i l v e r ion. 
The s t r u c t u r e r e v e a l s t h a t the 2,6-di ( t h i o m e t h y l ) p y r i d i n e sub-unit 
i s not i d e a l l y s u i t e d to binding the s i l v e r ion, as evidenced by the 
r a t h e r obtuse S(8B)-Ag(2)-S(20B) bond angle of 141.80(9)° [ c f . 169.8° 
and 165.1° i n the f i v e coordinate rhodium c a r b o n y l ^ and c o p p e r ( I I ) 
24 
c h l o r i d e complexes of l i g a n d (137)] and the long Ag(2)-N(1B) bond 
len g t h . A l s o , t o r s i o n a l s t r a i n i n the p o l y e t h e r chain of the macrocycle 
i n t h i s conformation i s evidenced by the d e v i a t i o n of the t o r s i o n a l 
a ngles from the i d e a l i s e d s t r a i n f r e e v a l u e s of 180° ( t r a n s ) f o r C-O-C-C 
and ±60° (gauche) f o r O-C-C-0 2 5 [e.g. C(10B)-0(11B)-C(12B)-C(13B) = 
-78.3°]. 
I n the *H nmr spectrum of the complex ( ( C D ^ C O ) , the b e n z y l i c 
methylene protons resonated as a s i n g l e t which broadened (wk 60 Hz, 
2 
203K) a t lower temperature as did the eight methylene protons of the 
13 
p o l y e t h e r c h a i n (OCH2CH2OCH2CH2O). The C nmr spectrum a l s o i n d i c a t e d 
t h a t the complex had the same symmetry (on the nmr time s c a l e ) as the 
f r e e l i g a n d . T h i s behaviour suggests t h a t e i t h e r the p y r i d i n e n i t r o g e n 
and both sulphurs do not bind the s i l v e r s i multaneously i n the s o l u t i o n 
s t a t e s t r u c t u r e , or t h a t the polyet h e r c h a i n i s s u f f i c i e n t l y mobile to 
permit r a p i d i n v e r s i o n of the sulphur c e n t r e s (thereby r e n d e r i n g the 
geminal methylene b e n z y l i c protons i s o c h r o n o u s ) . 
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5.3. Some Thermodynamic Aspects of Silver(I) Macrocycle Complexation 
5.3.1. Potentiometric titrations 
The s t a b i l i t y c o n stants ( l o g K , MeOH) f o r the s i l v e r ( I ) complexes 
of l i g a n d s [ 1 8 ] - N 4 S 2 ( 1 0 0 ) , [18]-N 4S 2Me 4 ( 1 0 1 ) , [ 1 8 ] - N 4 0 2 (131) and 
[18]-N 40 2Me 4 (132) were determined by potentiometry with a s i l v e r ion 
s e l e c t i v e e l e c t r o d e , " us i n g a technique o r i g i n a l l y developed by 
30 
F r e n s d o r f f . T h i s work was c a r r i e d out by H-J. Buschmann 
( U n i v e r s i t a t - G H Siegen, FRG) and H. Schneider ( M a x - P l a n c k - I n s t i t u t f i i r 
B i o p h y s i k a l i s c h e Chemie, FRG). 
A s o l u t i o n of s i l v e r n i t r a t e (1.0 mM, 20 ml) i n methanol was 
t i t r a t e d with a s o l u t i o n of the l i g a n d i n methanol (0.02M). The i o n i c 
s t r e n g t h was kept constant a t I = 0.05M by a d d i t i o n of t e t r a m e t h y l -
ammonium p e r c h l o r a t e . The co n c e n t r a t i o n of f r e e s i l v e r ion was measured 
u s i n g a s i l v e r ion s e l e c t i v e e l e c t r o d e (Metrohm EA 282) with a second 
s i l v e r e l e c t r o d e as a r e f e r e n c e e l e c t r o d e . The emf observed could be 
used d i r e c t l y to determine the f r e e s i l v e r ion c o n c e n t r a t i o n , a c c o r d i n g 
to the Nernst equation, which s i m p l i f i e s t o ; 
E = E Q + A l n [ A g + ] 
where [Ag +] i s the c o n c e n t r a t i o n of f r e e s i l v e r ion and 'A' i s a 
constant which may be determined u s i n g a p p r o p r i a t e c a l i b r a t i o n 
s o l u t i o n s . 
The s t a b i l i t y constant K which r e f e r s to the r e a c t i o n ; 
Ag + + L i = » AgL + 
i s d e f i n e d a s ; 
[AgL +] 
S " [Ag +] [L] 
K g i s the conc e n t r a t i o n s t a b i l i t y constant, assuming t h a t the a c t i v i t y 
c o e f f i c i e n t s of the th r e e s p e c i e s are equal to u n i t y . 
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Using the assumption t h a t only 1:1 complex formation was o c c u r r i n g 
i t was noted t h a t ; 
C j g = [Ag +] + [AgL +] 
and C£ = [L] + [AgL +] 
where was the i n i t i a l c o n c e n t r a t i o n of s i l v e r ion and was the 
o v e r a l l c o n c e n t r a t i o n of l i g a n d i n s o l u t i o n ( f r e e or complexed) thus; 
s [Ag +] (C°-[AgL +]) [Ag +](C°-C° g +[Ag +]) 
Varying the i n i t i a l s i l v e r ion c o n c e n t r a t i o n from 5 x 1 0 " % up to 
5x10 M did not e f f e c t the c a l c u l a t e d K g v a l u e s . The e n t h a l p i e s of 
complexation (AH) were measured by c a l o r i m e t r i c methods thereby 
p e r m i t t i n g the c a l c u l a t i o n of the e n t r o p i e s of complexation. The 
thermodynamic parameters ( s t a b i l i t y constant, enthalpy and entropy of 
complexation) a r e l i s t e d i n Table 5.4 along with those r e p o r t e d f o r 
Table 5.4 
log K , AH and TAS va l u e s f o r the s i l v e r ( I ) complexes of 
18-membered m a c r o c y c l i c l i g a n d s 
Macrocycle lo g K g ( m o r 1 ) a -AH (kJ mol" 1) TAS (kJ mol 
N 4S 2 14.1 77.0 +3.3 
N 4S 2Me 4 14.6 102.1 -18.7 
N4°2 11.2 - -
N 40 2Me 4 13.4 84.3 -7.84 
N 2 ° 4 b 10.0 51.4 +5.7 
S 2 ° 4 b 10.3 64.0 -5.3 
N 2 S 4 b 13.7 83.2 -5.0 
0 c 4.6 38.3 -12.1 
a) e r r o r s i n log K a r e t y p i c a l l y ±0.1 or l e s s and f o r AH ± 0.3 kJ 
mol~* or l e s s . b) r e f . 31. c) r e f . 32. 
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comparable eighteen-membered m a c r o c y c l i c l i g a n d s . I t may be noted t h a t 
the s i l v e r binding constant f o r the [ l S j - N ^ M e ^ l i g a n d (102) ( l o g K g = 
14.6) i s the h i g h e s t recorded f o r a monocyclic l i g a n d . C e r t a i n t r e n d s 
are apparent from the parameters l i s t e d i n Table 5.4. The r e a c t i o n 
e n t h a l p i e s (AH) i n d i c a t e t h a t the sulphur atoms bind the s i l v e r ion 
s l i g h t l y more s t r o n g l y than secondary amine atoms (e.g. AH = 83.2, 
AH = 77.0 k J mol ) . However, more sulphur atoms i n the macrocycle 
r e s u l t s i n a l e s s f a vourable entropy of complexation. Hence the 
macrocycle has a s l i g h t l y higher log K g v a l u e than the macrocycle. 
T h i s i s c o n s i s t e n t with the o b s e r v a t i o n t h a t sulphur atoms i n the 
macrocycles tend to adopt exodentate conformations, with the lone p a i r s 
d i r e c t e d away from the m a c r o c y c l i c c a v i t y , hence an unfavourable 
conformation change i s a s s o c i a t e d with complexation, (see s e c t i o n 
4.1.5.). The high e n t h a l p i e s of complexation f o r the N-methylated 
l i g a n d s i n d i c a t e t h a t a t e r t i a r y amine i s a b e t t e r donor atom f o r s i l v e r 
than e i t h e r sulphur or secondary amines. However, t h i s i s not r e f l e c t e d 
i n the metal binding c o n s t a n t s , as l a r g e n e g a t i v e e n t r o p i e s of 
complexation a r e observed i n complexes of these l i g a n d s . I n p a r t i c u l a r , 
the entropy change (TAS = -18.7 k J mol"*) f o r the N^Me^ s i l v e r ( I ) 
complexation i s unusually l a r g e and c o n t r a s t s to the f a v o u r a b l e entropy 
change observed f o r the parent macrocycle (TAS = +3.3 k J mol"*). 
T h i s i s l i k e l y to be due t o unfavourable s t e r i c i n t e r a c t i o n s a s s o c i a t e d 
with the N-Me groups i n the complexed form of the macrocycle, which 
r e s u l t i n an unfavourable conformation change a s s o c i a t e d w i t h 
complexation. T h i s view i s supported by the s o l i d s t a t e s t r u c t u r e of 
the s i l v e r ( I ) complex of (100) [ s e c t i o n 5.2.1]. T h i s r e v e a l s t h a t the 
macrocycle i s 'wrapped' around the metal ion i n a conformation t h a t may 
be envisaged to cause a c o n s i d e r a b l e degree of s t e r i c crowding, i f the 
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N-H groups were r e p l a c e d by N-Me groups. 
T h i s i s not wholly unexpected, as c o n s i d e r a b l e evidence e x i s t s to 
suggest t h a t N-methylation of m a c r o c y c l i c polyamines has a s i g n i f i c a n t 
e f f e c t upon t h e i r complexation p r o p e r t i e s . For example, Lehn has 
33 
reported t h a t the d i n u c l e a r rhodium carbonyl complex of a 24-membered 
Ng0 2 macrocycle formed a c r y p t a t e - l i k e s t r u c t u r e , with a t r i p l y bridged 
2+ 
[Rh(C0)gRh] u n i t held i n s i d e the m a c r o c y c l i c c a v i t y . However, the 
permethyl d e r i v a t i v e of the l i g a n d formed a d i n u c l e a r complex which 
contained only t e r m i n a l l y bound ca r b o n y l s , i n d i c a t i n g t h a t methyl 
s u b s t i t u t i o n of the l i g a n d had introduced s u f f i c i e n t t r a n s a n n u l a r s t e r i c 
e f f e c t s to hinder b r i d g i n g . Also, the r e l a t i v e i n s t a b i l i t y ( i n both 
s o l u t i o n and s o l i d s t a t e ) of the ruthenium(VI) dioxo complex of the 
te t r a m e t h y l d e r i v a t i v e of cyclam compared to t h a t of cyclam i t s e l f , has 
been a t t r i b u t e d t o the d e s t a b i l i s i n g i n t e r a c t i o n between the N-Me groups 
OA o r 
and the oxygen lone p a i r s . ' Furthermore, the C u ( I I ) complex of 
[18]-N 2S 4Me 2 has been reported ' to have a s i g n i f i c a n t l y d i f f e r e n t 
redox p o t e n t i a l ( C u ( I I ) | C u ( I ) , MeCN) to t h a t of the C u ( I I ) - N 2 S 4 complex. 
I t was suggested t h a t a s u b s t a n t i a l s t e r e o c h e m i c a l change a t the C u ( I I ) 
c e n t r e had r e s u l t e d on going from the N 2 S 4 complex to the dimethylated 
complex. 
5.3.2. pH-Hetric titrations 
The a c i d d i s s o c i a t i o n constants f o r the m a c r o c y c l i c l i g a n d s , 
[ 1 8 ] - N 4 S 2 ( 1 0 0 ) , [18]-N 4S 2Me 4 (101) and N,N'-bridged b i s [9]-NS 2 (102) 
38 
have been determined by pH-metric t i t r a t i o n . By a n a l y s i s of the 
pH-metric t i t r a t i o n curves of these l i g a n d s i n the presence of one 
e q u i v a l e n t of s i l v e r ion ( A g + ) , i t was p o s s i b l e t o determine the 
s t a b i l i t y c o n s t a n t s ( l o g K g, H 20) of the s i l v e r ( I ) complexes. 
T i t r a t i o n s were performed us i n g the apparatus i l l u s t r a t e d i n F i g . 
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F i g . 5.15. Apparatus f o r pH-metric t i t r a t i o n s . 
5.15. Stock s o l u t i o n s of the l i g a n d (0.002 mol dm ) i n m i l l i - Q water 
(25 ml), with n i t r i c a c i d (1 e q u i v a l e n t per amine nitrogen of the 
l i g a n d ) and t e t r a m e t h y l ammonium n i t r a t e ( to ensure constant i o n i c 
s t r e n g t h 1 = 0 . 1 mol dm ) were prepared. For each t i t r a t i o n , 3.5 ml of 
the st o c k s o l u t i o n was placed i n the t i t r a t i o n c e l l which was 
thermostatted a t 25°C and kept under an atmosphere of n i t r o g e n . 
T i t r a t i o n with tetramethylammonium hydroxide s o l u t i o n (0.109 mol dm" ) 
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was performed using a M e t t l e r DL20 automatic t i t r a t o r , c o n t r o l l e d by 
on 
B a s i c software on a BBC microprocessor. The pH was measured u s i n g a 
Corning 001854 combination m i c r o e l e c t r o d e . The d a t a was s t o r e d on the 
BBC microprocessor and t r a n s f e r r e d to the MTS mainframe ( u s i n g KERMIT) 
and subsequently analysed by two n o n - l i n e a r l e a s t squares programs 
SC0GS2 and SUPERQUAD. Two t i t r a t i o n s were performed on each l i g a n d i n 
the pH range 3-12. The r e s u l t s were anal y s e d by Dr. R. Kataky. 
The pK v a l u e s f o r the l i g a n d s (100) t o (102) a r e presented i n 
Table 5.5, where f o r ; 
LH N + J S a a * L H ( I 1 : 1 ) + + H + 
n n -1 
f o r example; 
LH + L + H + 
Then; 
K a l 
[L] [H +] 
[LH +] and p K a l = - l Q S K a l 
Table 5.5 
Acid d i s s o c i a t i o n c o n s t a n t s f o r l i g a n d s ( 1 0 0 ) , (101) and (102) 
Ligand P K a l P Ka2 P Ka3 P Ka4 $ a a a 
(100) 9.26 8.45 5.81 4.88 10.89 2.03 
9.41 8.47 6.06 4.94 11.69 1.58 
(101) 8.82 8.35 4.13 3.71 3.79 1.87 
8.76 8.32 4.10 3.71 5.71 1.37 





a) D e v i a t i o n s a < 3 and j> (superquad) < 12.6 f o r > 957. a c c u r a c y . 
^ There i s some doubt as to the accuracy of the r e s u l t s f o r l i g a n d (102) as the t i t r a t i o n s o l u t i o n s became cloudy a t pH > 7.15 due to the i n s o l u b i l i t y of the f u l l y deprotonated l i g a n d i n water. 
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The pK v a l u e s observed f o r the eighteen-membered r i n g s a r e 
a, 
comparable to those reported f o r the [ 1 8 ] - N ^ macrocycle ( p K a j 9.67, 
p K & 2 8.85, p K a 3 6.61 and p K & 4 3 . 2 1 ) . 4 0 At pH > 9.5 a l l f o u r of the 
amine groups of l i g a n d s (100) and (101) a r e protonated. The 
N-methylated l i g a n d i s l e s s b a s i c than i t s parent N 4 S 2 l i g a n d , i n accord 
with the f a c t t h a t t e r t i a r y amino groups a r e l e s s b a s i c than secondary 
amino groups i n aqueous s o l u t i o n . 4 * 
Determination of S t a b i l i t y Constants 
The s t a b i l i t y c o n s t a n t s ( l o g K g, H 20) f o r the 1:1 s i l v e r complexes 
of l i g a n d s (100)-(102) were determined by a n a l y s i s of the pH-metric 
t i t r a t i o n c u r v e s of the l i g a n d s , in the presence of one e q u i v a l e n t of 
s i l v e r ion. Stock s o l u t i o n s were prepared as f o r the a c i d d i s s o c i a t i o n 
measurements, with the a d d i t i o n of 1 e q u i v a l e n t of s i l v e r n i t r a t e and 
t i t r a t i o n s were performed as d e s c r i b e d p r e v i o u s l y . 
The method f o r determining metal binding c o n s t a n t s i s based upon 
the change i n pK of the amine groups of the l i g a n d , upon complexation. 
The a c i d i t y of the LHjj + s p e c i e s w i l l be i n c r e a s e d due to competition f o r 
the l i g a n d from the metal ion. The t i t r a t i o n c urves a r e thus s t r o n g l y 
dependent on the c a t i o n complexation and t h e i r a n a l y s i s may, i n 
p r i n c i p l e , y i e l d a l l the e q u i l i b r i u m c o n s t a n t s f o r pr o t o n a t i o n and 
complexation. 
The s i l v e r b i n ding constants and a c i d protonation c o n s t a n t s ( i n 
b r a c k e t s ) a r e presented i n Table 5.6. Spe c i e s d i s t r i b u t i o n p l o t s of the 
18-membered macrocycle complexes as a f u n c t i o n of pH a r e given i n F i g . 
5.16. These may be used to determine which s p e c i e s a r e p r e s e n t a t a 
given pH. Furthermore, at the point where two s p e c i e s alone (AgLH n and 
AgLH"n j ) a r e pr e s e n t i n equal c o n c e n t r a t i o n , then pH = pK a n-
The binding c o n s t a n t s f o r the s i l v e r ( I ) complexes i n H«0 a r e 
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Table 5.6 
Binding constants (and protonation c o n s t a n t s ) f o r the s i l v e r complexes of l i g a n d s (100), (101) and (102) 
Macrocycle l 0 S KAgL l 0 S KAgLH l 0 S KAgLH 2 
(100) 10.4 9.05 6.00 
(7.91) (5.40) (3.94) 
(101) 9.47 8.06 4.31 
(7.41) (4.60) 
(102) 7.03 4.97 -
(4.50) 
l 0 S KAgLH 3 
4.13 
e r r o r s i n log K v a l u e s a r e t y p i c a l l y ±0.1 mol . 
t y p i c a l l y 3 orders of magnitude lower than those measured i n methanol, 
due t o the g r e a t e r s o l v a t i o n of the s i l v e r ion i n the former s o l v e n t . 
Of i n t e r e s t , i s the binding constant f o r the [ l S j - N ^ M e ^ macrocycle 
( 1 0 1 ) , which i s lower than t h a t f o r the parent [18]-N^Sg macrocycle. 
Although t h i s i s a r e v e r s a l of the r e l a t i v e v a l u e s as determined i n 
methanol, i t i s c o n s i s t e n t with the idea t h a t an unfavourable 
conformational change i s a s s o c i a t e d with complexation f o r the 
N-methylated macrocycle. I n water, the negative entropy of complexation 
appears to be even more s i g n i f i c a n t than i n methanol, r e s u l t i n g i n a 
g r e a t e r r e d u c t i o n of the log K value. The metal binding c o n s t a n t s of 
the s i l v e r complexes of the monoprotonated 18-membered macrocycles a r e 
r e l a t i v e l y high, i n d i c a t i n g t h a t the l o s s of one metal b i n d i n g s i t e does 
not g r e a t l y impair s i l v e r complexation. T h i s i s i n c o n t r a s t t o the more 
s i g n i f i c a n t l o s s of binding observed with the polyaza cryptands r e p o r t e d 
38 
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t r i p r o t o n a t e d s i l v e r complex was s u f f i c i e n t l y stable t o be observed (3.2 
< pH < 5.0). 
The metal binding constant f o r the s i l v e r complex of (102) was 
di s a p p o i n t i n g l y low, although there i s some doubt as t o the accuracy of 
t h i s measurement, due t o the l i m i t e d s o l u b i l i t y of the f u l l y 
deprotonated species i n aqueous s o l u t i o n . A possible clue t o the o r i g i n 
of t h i s low value, i s i n the s o l i d s t a t e s t r u c t u r e (section 5.2.3.). 
This revealed t h a t the bridging ethylene group was rather too short t o 
allow the nine-membered rings t o adopt i d e a l binding p o s i t i o n s . The 
s i l v e r binding constant as determined i n methanol and the c a l o r i m e t r i c 
measurements f o r t h i s complex w i l l be of i n t e r e s t . 
5.4. Conclusions 
The metal binding constant f o r the s i l v e r complex of [18] -N^Me^ 
is the highest recorded f o r a monocyclic li g a n d . However, between pH 3 
and 7 the mono- and di-protonated complexes are the major species i n 
s o l u t i o n f o r both t h i s and the [ 1 8 ] - N ^ s i l v e r complex. Although the 
protonated s i l v e r complexes show s i g n i f i c a n t l y enhanced thermodynamic 
s t a b i l i t y over comparable polyaza cryptates, i t i s d o u b t f u l whether 
these complexes w i l l remain k i n e t i c a l l y stable over the f u l l 
p h y s i o l o g i c a l pH range (pH 2-9), as required f o r radiopharmaceutical 
a p p l i c a t i o n . However, i n vivo studies have yet t o be c a r r i e d out. 
A d d i t i o n a l studies which are necessary, include the i n v e s t i g a t i o n of the 
rate of complexation at low concentration (10-100 (M), under ambient 
conditions (e.g. pH 5, 20°C). 
I l l 
I f there were encouraging Ag i n v i v o b i o d i s t r i b u t i o n r e s u l t s , 
then the synthesis of f u n c t i o n a l i s e d [18]-membered macrocycles could be 
undertaken i n the f u t u r e , using e i t h e r s u b s t i t u t e d ethylenediamine (141) 
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NH 2 OTs 
NH 2 OTs 
( 1 4 1 ) ( 1 4 2 ) 
or ethyleneglycol d i t o s y l a t e (142). Macrocycle antibody conjugation 
would then be possible using s i m i l a r methods t o those described f o r the 
f u n c t i o n a l i s e d [ 9 ] - N o - t r i a c i d macrocycles (Chapter 3 ) . 
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The synthetic procedures f o r the compounds used i n t h i s work are 
described i n the proceeding section. Temperatures are reported i n °C 
unless otherwise stated. Rp values r e f e r t o s i l i c a gel TLC (Merck. A r t . 
5735, Kieselgel 60 F 2 5 4 ) or alumina TLC (Merck. A r t . 5550, Kieselgel 60 
^254^ w ^ t^ie e l u a n t system s p e c i f i e d . Column chromatography employed 
" g r a v i t y " s i l i c a (Merck. A r t . 7734, Kieselgel 60, 0.063-0.200 mm) or 
" f l a s h " s i l i c a (Merck. A r t . 9385, Kieselgel 60, 0.040-0.063 mm) or 
neu t r a l alumina (Merck. A r t . 1077, a c t i v i t y I , 0.063-0.200 mm). A l l 
HPLC analysis and p u r i f i c a t i o n was performed using a Varian Vista 
5500/polychrom 9060 instrument, f i t t e d w i t h e i t h e r a cation exchange 
("Synchropak" CM300), anion exchange ("Synchropak" AX100) or reverse 
phase ("Spherisorb" 50DS2) column. The flow rates employed were 1.4 
ml/min. f o r a n a l y t i c a l columns (4.0 mm x 25.0 cm) and 4.0 ml/min. f o r 
semi-preparative columns (10.0 mm x 25.0 cm) using the solvent systems 
s p e c i f i e d . Retention times 'R^ 1 are quoted i n minutes. I n f r a - r e d 
spectra were recorded on a Perkin-Elmer 577 spectrometer e i t h e r as a 
t h i n f i l m or n u j o l mull on NaCl plates or as a KBr disc. H and C nmr 
spectra were recorded on a Bruker AC250 spectrometer, wit h spectral 
frequency 250.134 MHz and 62.896 MHz re s p e c t i v e l y . Chemical s h i f t s are 
quoted i n ppm to higher frequency of TMS at 6 - 0 ppm and coupling 
constants (J) are given i n Hz. I n t e r n a l TMS reference was used f o r 
samples i n CDCl^, whereas samples i n were referenced e x t e r n a l l y t o 
TMS. *H nmr spectra recorded i n CD^ OD were referenced t o CD2HOD at 6 -
3.35 ppm. Mass spectra were recorded on a VG 7070E mass spectrometer 
operating i n the E I , CI, DCI or FAB mode. Optical r o t a t i o n s were 
recorded on an "OPTICAL ACTIVITY" AA-10 automatic polarimeter. 
Solvents were dried using the f o l l o w i n g reagents: Ethanol/Methanol 
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(Mg(0R) 2); Dichloromethane (CaH 2); Chloroform (P2O5)> Tetrahydrofuran 
(Na/benzophenone) and Toluene (Na). Anhydrous DMF (99+7«) was purchased 
from A l d r i c h and water was p r e - d i s t i l l e d . A l l other solvents were of 
reagent grade. 
6.2. Synthetic Procedures 
6.2.1. Hacrocycles to bind indium(III) and gallium(III) 
The ten and eleven-membered t r i a z a macrocycles were synthesised by 
1 
the tosylamide method using caesium carbonate. 
N,N* ,N"-tri(p-toluenesulphonyl)-1,4,7-triazacyclodeeane [30] 
Caesium carbonate (6.08 g, 18.5 mmol) was added t o a s o l u t i o n of 
N,N-bis((N-p-toluenesulphonyl)-2-aminoethyl)p-toluenesulphonamide (5.0 
g, 8.9 mmol) i n anhydrous DMF (200 ml). A s o l u t i o n of 
1,3-bis(p-toluenesulphonato)propane (3.4 g, 8.9 mmol) i n anhydrous DMF 
(60 ml) was added dropwise over a period of 3 hours, wit h vigorous 
s t i r r i n g . A f t e r s t i r r i n g at room temperature (20°C) f o r 12 hours the 
temperature was raised t o 60°C f o r 3 hours. Solvent was removed under 
reduced pressure and the residue taken up i n dichloromethane (150 ml) 
and washed w i t h d i s t i l l e d water (2 x 100 ml). The organic layer was 
dri e d over anhydrous magnesium sulphate, f i l t e r e d and solvent removed 
under reduced pressure. The 'glassy' s o l i d residue was r e c r y s t a l l i s e d 
from ethanol-dichloromethane t o give a white s o l i d (4.2 g, 807.); m.p. 
233-234°C; [ L i t : 2 234-236°C]; (Found: C, 54.8; H, 6.02; N, 6.34. 
C28 H35 N3 S3°6- 0 , 3 H2 0 r e ( l u i r e s C' 5 5 - ° ; H> 5- 8 3 <> N> 6 - 8 8 ) : m/ e ( D C I» 
NH3) 606 (M ++l) 605 (M +) 450, 296; 6^ (CDClg) 7.73 (2H, d, J 8.1 Hz, 
aromatic H) 7.69 (4H, d, J 8.2 Hz, aromatic H) 7.34 (2H, d, J 8.2 Hz, 
aromatic H) 7.32 (4H, d, J 8.2 Hz, aromatic H) 3.37 (8H, s, N-CH2CH2-N) 
3.20 (4H, t , N-CH2) 2.43 (12H, s, CH3) 2.20 (2H, m, C-Cfl 2). 
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1,4,7-triazacyclodecane [33] 
The d e t o s y l a t i o n was effected using concentrated sulphuric a c i d , as 
o 
reported by Zuberbiihler et a l . , with s l i g h t m o d i f i c a t i o n . 
Concentrated sulphuric acid (15 ml) was added t o the t r i t o s y l a m i d e 
[30] (4.0 g, 6.6 x 10" 3 moles) and the s o l u t i o n heated at 120°C f o r 48 
hours. The cooled reaction mixture (ice/water bath) was b a s i f i e d w i t h 
aqueous sodium hydroxide s o l u t i o n (407.), f i l t e r e d and extracted w i t h 
chloroform (4 x 50 ml). The combined organic e x t r a c t s were d r i e d over 
anhydrous magnesium sulphate, f i l t e r e d and solvent removed t o give a 
pale brown o i l (0.6 g, 607.); (Found: (M ++l) 144.1457. CyH^Ng 
requires 144.1500); m/e (DCI, NHg) 144 (M ++l) 143 (M +); 6^ (CDClg, 60 
MHz) 2.75 (12H, m, CH2N) 1.75 (3H, s, NH) 1.60 (2H, m, CHgC). 
1 t4^-triazacyclodecane-N,N], N"- triacetate [25]; was synthesised 
using the chloroacetic acid method of Takahashi and Takamoto; 
Chloroacetic acid (1.16 g, 12.2 mmol) was added t o a s o l u t i o n of 
1,4,7-triazacyclodecane (0.50 g, 3.5 mmol) i n d i s t i l l e d water (10 ml) 
and adjusted t o pH 10 with l i t h i u m hydroxide. The mixture was heated t o 
45°C and the s o l u t i o n maintained at pH 10 f o r 8 hours with p e r i o d i c 
addition of l i t h i u m hydroxide. The mixture was ref l u x e d f o r 3 hours and 
the cooled s o l u t i o n adjusted t o pH 2 with concentrated hydrochloric 
acid. The mixture was evaporated almost t o dryness, ethanol (5 ml) 
added and the mixture s t i r r e d vigorously t o give a white viscous 
m a t e r i a l . The remaining s o l u t i o n was decanted o f f and the white residue 
redissolved i n the minimum volume of water (0.5 ml). Ethanol (3.0 ml) 
was c a r e f u l l y p i p e t t e d on top of the aqueous layer and allowed t o 
d i f f u s e i n slowly. A f t e r 12 hours a c r y s t a l l i n e s o l i d was c o l l e c t e d by 
f i l t r a t i o n (0.55 g, 507.); [ L i t : 3 y i e l d 357.]; (Found: C, 48.9; H, 
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7.60; N, 13.1. C^H^NgOg requires C, 49.2; H, 7.25; N, 13.2); m/e 
(FAB, H 20/Glycerol) 318 ( M + + l ) ; 6^ ( D 2 0 ) 3.83 (4H, s, N-CH_2C02) 3.80 
(2H, s, N-CH2-C02) 3.49 (12H, br s, C f y i ) 2.23 (2H, br s, C-CH2-C). 
JV,A" ,If*-tri(p- toluenesulphonyl) -1,4,8-triazacycloundecane [31] 
Caesium carbonate (3.46 g, 10.6 mmol) was added t o a s o l u t i o n of 
N,N-bis((N-p-toluenesulphonyl)-3-aminopropyl)p-toluenesulphonamide (3.00 
g, 5.06 mmol) i n anhydrous DMF (200 ml). A s o l u t i o n of ethylene g l y c o l 
d i t o s y l a t e (1.87 g, 5.06 mmol) i n anhydrous DMF (60 ml) was added 
dropwise over a period of 3 hours w i t h s t i r r i n g continued f o r 12 hours. 
A f t e r heating the mixture t o 60°C f o r 3 hours the solvent was removed 
under reduced pressure and the residue taken up i n dichloromethane (150 
ml) and f i l t e r e d . Solvent was removed from the f i l t r a t e t o give a pale 
yellow residue. The t r i t o s y l a t e product was separated by 'g r a v i t y ' 
s i l i c a gel chromatography with gradient e l u t i o n , dichloromethane-
methanol [(99:1) t o (9 8 : 2 ) ] , t o give a white s o l i d (1.8 g, 577.); [ L i t : 2 
y i e l d 537.]; m.p. 215-217°C; [ L i t : 2 217°C ] ; Rp 0.3 [ s i l i c a g e l : 
CH2Cl2-MeOH (9 9 : 1 ) ] ; m/e (CI, NH3) 620 (M ++l) 464, 310; 6 H ( C D C I 3 ) 
7.69 (2H, d, J 8.0 Hz, aromatic H) 7.60 (4H, d, J 8.1 Hz, aromatic H) 
7.33 (4H, d, J 8.0 Hz, aromatic H) 7.30 (2H, d, J 8.1 Hz, aromatic H) 
3.43 (4H, t , J 6.7 Hz, CH2-N) 3.28 (4H, s, N-CH2CH2-N) 2.99 (4H, t , J 
5.3 Hz, CH 2N) 2.43 (12H, s, Me) 1.91 (4H, m, CH2-C). 
1,4,8-triazacycloundecane [34] 
The d e t o s y l a t i o n of the t r i t o s y l a t e [31](2.1 g, 3.4 mmol) was 
ef f e c t e d using the concentrated sulphuric acid method as described f o r 
the synthesis of 1,4,7-triazacyclodecane [33]; a pale yellow o i l was 
obtained (0.38 g, 737,); (Found: (M ++l) 158.2580. CgH^Ng requires 
- 187 -
158.2488); m/e (DCI, NHg) 158 (M ++l) 157 (M +); 6^ (CDClg, 60 MHz) 2.80 
(12H, m, CH2N) 2.50 (3H, s, NH) 1.55 (4H, m, CHg-C). 
1,4,8- triazacycloundecane-N , N \ N y - triacetate [26] was synthesised 
using the chloroacetic acid method as described f o r the synthesis of 
1.4.7- triazacyclodecane-N,N',N"-triacetate: reaction of the triamine 
(0.167 g, 1.06 mmol) with chloroacetic acid (0.349 g, 3.7 mmol) gave a 
colourless c r y s t a l l i n e s o l i d (132 mg, 39%); Decomp: 220-240°C; 
(Found: C, 49.1; H, 7.57; N, 12.1. C 1 4H 2 5N 30 6.0.5H. 20 requires C, 
49.4; H, 7.65; N, 12.3); m/e (FAB, Glycerol-water); m/e 332 ( M + + l ) ; 
<5H ( D 2 0 ) 3.89 (2H, s, N-CH2C02) 3.72 (4H, s, N-Cfl 2C0 2) 3.50-3.40 (12H, 
m, N-CH2) 2.21 (4H, br s, C-CH2). 
1,4,7-triazacyclononane-N,N',N"-triacetate was synthesised by two 
methods; the f i r s t gave the product as the dihydrochloride s a l t and the 
second gave the product, c h l o r i d e f r e e , as the f r e e amine. 
1,4,7- triazacyclonane-N' ,N* ,A"'- triacetate-dihydrochloride [24a] 
1,4,7-triazacyclononane (0.198 g, 1.53 mmol) was t r i a l k y l a t e d using 
the chloroacetic acid method as described f o r the synthesis of 
1.4.8- triazacyclodecane N,N 1,N"-triacetate. The dihydrochloride s a l t of 
the product was obtained (0.324 g, 707.); m.p. 230-232; (Found: C, 
38.3; H, 6.37; N, 10.9. C 1 2H 2 3N 30 6C1 2 requires C, 38.3; H, 6.12; N, 
11.2); m/e (FAB, g l y c e r o l - H 2 0 ) 304 ( M + + l ) ; <$H ( D 2 0 ) 3.96 (6H, s, 
CH 2-C0 2) 3.42 (12H, s, CH2N). 
l,4,7-triazacyclonane-N,N< ,fll"-triacetate (TCTA) [24b] 
Bromoacetic acid (0.776 g, 5.58 mmol) was added t o a s o l u t i o n of 
1,4,7-triazacyclonane [ A l d r i c h , 997.] (0.200 g, 1.55 mmol) i n d i s t i l l e d 
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water (10 ml) and the s o l u t i o n adjusted t o pH 10 with the a d d i t i o n of 
l i t h i u m hydroxide. The reaction mixture was heated to 45°C and the pH 
maintained at 10 over a period of 10 hours by regular a d d i t i o n of 
l i t h i u m hydroxide. The reaction mixture was s t i r r e d at 45°C f o r a 
f u r t h e r 24 hours a f t e r which the s o l u t i o n was adjusted to pH 2 with 
concentrated n i t r i c acid. The mixture was evaporated almost t o dryness 
a f t e r which ethanol (5 ml) was added w i t h vigorous shaking. The 
remaining s o l u t i o n was decanted from a white viscous residue which was 
redissolved i n a minimum volume of water (0.3 ml). Ethanol was added 
u n t i l a s l i g h t t u r b i d i t y remained and the s o l u t i o n allowed t o stand f o r 
12 hours. A colourless c r y s t a l l i n e s o l i d was c o l l e c t e d by f i l t r a t i o n . 
Second and t h i r d crops of product were obtained when the volume was 
reduced and the above procedure repeated (0.25 g, 537.); Decomp: 210°C 
(Found: C, 46.4; H, 6.90; N, 13.5. C 1 2H 2 1N 30 6.0.4H 20 requires C, 
46.4; H, 7.02; N, 13.5); *H nmr and FAB mass spec, as f o r [24a]. 
6.2.2. Indium(III) and Gallium(III) Complexes 
Indium (III) complex of 1,4,7- triazacyclononane N,N', J Y " - t r i a c e t a t e 
[24b], (In-L).4H 20 [36] 
A s o l u t i o n of indium n i t r a t e (0.175 g, 0.582 mmol) i n aqueous 
n i t r i c acid (0.04 mol dm ,1.0 ml) was added t o a s o l u t i o n of the 
_ o 
ligand (0.176 g, 0.582 mmol) i n aqueous n i t r i c acid (0.04 mol dm , 1.0 
ml) and the mixture allowed t o stand at room temperature f o r 12 hours. 
Acetone (4.0 ml) was added to the aqueous s o l u t i o n u n t i l a s l i g h t 
t u r b i d i t y remained. A f t e r several hours a f i n e white s o l i d was 
co l l e c t e d by f i l t r a t i o n . R e c r y s t a l l i s a t i o n from water-acetone (1:4) 
gave a f i n e white c r y s t a l l i n e s o l i d (0.164 g, 687.); (Found: C, 29.2; 
H, 4.61; N, 8.54. C 1 2H l gN 30 6In.4H 20 requires C, 29.6; H, 5.13; N, 
8.62); m/e (DCI, NHg) 416 ( M + + l ) ; <$H (D 20) 3.70 (6H, s, CH2-C02) 3.24 
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(6H, in, CH2N) 3.07 (6H, m, CH2N). 
The hydrated chloroindium complex (In-L).HC1.H2O [37] was also prepared 
A s o l u t i o n of indium t r i c h l o r i d e (18 mg, 80 mmol) i n aqueous 
hydrochloric acid (0.04M, 1.0 ml) was added t o a s o l u t i o n of the 
[ 9 ] - N g - t r i a c i d dihydrochloride [24b] (30 mg, 80 mmol) i n aqueous 
hydrochloric acid (0.04M, 1.0 ml). Slow evaporation of solvent over 
several days yielded colourless c r y s t a l s (16 mg, 507.). Crystals 
s u i t a b l e f o r X-ray d i f f r a c t i o n were obtained; (Found: C, 29.6; H, 
4.21; N, 8.49. C 1 2H 1 9N 30 6ClIn.2H 20 requires C, 29.5; H, 4.51; N, 
8.61): FAB mass spectrometry and nmr c h a r a c t e r i s a t i o n as f o r [36]. 
For X-ray c r y s t a l s t r u c t u r e c e l l data - see appendix. 
Indium {111) complex of 1,4,8-triazacyclodecane-N, An , ^-triacetate 
[ 2 5 ] , [In-L] 
Synthesis as f o r [36]. White c r y s t a l l i n e s o l i d (12 mg, 587.); 
(Found: C, 36.7; H, 4.93; N, 9.78. CjgH^HgOgln requires C, 36.4; 
H, 4.66; N, 9.79); m/e (DCI, NHg) 430 ( M + + l ) ; <$H ( D 2 0 ) 3.90-2.60 
(18H, br m's, CH 2C0 2, CH2N) 2.24 (1H, br m, C-CH2-C) 1.92 (1H, br m, 
C-CH2-C). 
Gallium(III) complex of 1,4, 7-triazacyclononane [ 2 4 ] , [Ga-L] 
Synthesis as f o r [ 3 6 ] , using g a l l i u m ( I I I ) n i t r a t e . Colourless 
c r y s t a l s (25 mg, 547.); (Found: C, 38.9; H, 4.99; N, 11.2. 
C 1 2H 1 8N 30 6Ga requires C, 38.9; H, 4.87; N, 11.4); m/e (FAB, p-NBA) 
371, 369 (M +) [ 7 1Ga-L and 6 9Ga-L]; ^ ( D 2 0 ) 3.87 (6H, s, CH 2C0 2) 3.50 
(6H, m, CH„N) 3.20 (6H, m, CH9N); X-ray c r y s t a l data - see appendix. 
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Gallium(III) complex of 1,4i8-triazacyclodecane-M,N',J\P'-triacetate 
[ 2 5 ] , [Ga-L] 
Synthesis as f o r [ 3 6 ] . White c r y s t a l l i n e s o l i d (16 mg, 45%); 
(Found: C, 40.4; H, 5.15; N, 10.8. C^H^NgOgGa requires C, 40.6; 
H, 5.21; N, 10.9); m/e (FAB, p-NBA) 385, 383 (M +) [ 7 1Ga-L and 6 9Ga-L] 
<5H (D 20) 3.81 (6H, m, CH2C02) 3.67-3.45 (8H, m, CH2N) 3.16 (4H, m, 
C-CH2-N) 2.34 (1H, br m, C-CHH-C) 1.87 (1H, br m, C-CHH-C). 
6.2.3. C-functionalised [9]-N^-triacid 
Route A 
The s t a r t i n g material f o r the synthesis of a f u n c t i o n a l i s e d 
I , 4,7-triazacyclononane N,N',N'"-triacetate system was (2S)-Lysine 
monohydrochloride (Fluka). 
(2S)-Lysine methyl ester [43] 
Acetyl c h l o r i d e (25.0 ml) was added c a r e f u l l y t o a s o l u t i o n of 
(2S)-Lysine monohydrochloride (15.0 g, 85.0 mmol) i n methanol (250 ml) 
and the s o l u t i o n was heated under r e f l u x f o r 14 hours. The volume of 
the s o l u t i o n was reduced (80 ml) under reduced pressure, and a white 
s o l i d was f i l t e r e d o f f , washed with cold methanol and dri e d i n vacuo 
(16.1 g, 817.); m.p. 212-213°C; ( L i t : 214-215°C); (Found: C, 35.2; 
H, 7.71; N, 11.5. C7H1602N2.2HC1.0.3H20 requires C, 35.2; H, 7.80; 
N, 11.7). 
2,6-diaminohexamide (Lysine amide) [44] 
Ammonia (250 ml) was condensed i n t o a reaction vessel containing 
(2S)-Lysine ester [43] (5.5 g, 0.024 moles) at -77°C ( s o l i d C0 2-acetone 
bath) and the mixture s t i r r e d f o r 3 hours. The ammonia was allowed t o 
evaporate t o give a cream coloured residue which was taken up i n 
methanol (15.0 ml). A white s o l i d was f i l t e r e d o f f and solvent removed 
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from the f i l t r a t e , under reduced pressure, t o give a cream coloured 
13 1 
s o l i d residue (estimated 907. pure from C and H nmr:- lactam 
i m p u r i t y ) . This product was used without f u r t h e r p u r i f i c a t i o n ; (Found: 
(M ++l)146.1427. C gH 1 6N 30 requires 146.1293); IR (Nujol mull) 3400 cm"1 
(br) (NH s t r ) 1650 cm"1 (Amide I ) 1440 cm"1; m/e (DCI, NHg) 146 ( M + + l ) , 
84; £ H (D 20) 3.93 (1H, t , J 6.5 Hz, CHN) 3.01 (2H, t , J 7.6 Hz, CH2-N) 
1.88 (2H, m, CH2-C) 1.72 (2H, m, CH2-C) 1.47 (2H. m, CHg-C); 6 (DgO) 
172.6 (C=0) 52.7, 39.0 (C-NH2) 30.5, 26.1, 21.2 (ChyC). 
1,2,6-triaminohexane [46] 
To the Lysine amide [44] (5.0 g, 0.0229 moles) was added dry THF 
(250 ml) and Borane.DMS (10.0 M, 35.0 ml) and the mixture heated under 
r e f l u x , under a nitrogen atmosphere, f o r 14 days. The re a c t i o n was 
quenched by adding methanol (100 ml). Solvent was removed under reduced 
pressure and methanol (2 x 100 ml) added and removed under reduced 
pressure. The o i l y residue was heated under r e f l u x i n hydrochloric acid 
(6 mol dm , 200 ml) f o r 4 hours. Solvent was removed under reduced 
pressure and the residue taken up i n methanol (2 x 75 ml) and solvent 
removed again t o give a clear o i l . The residue was taken up i n KOH 
so l u t i o n (100 ml, 6 mol dm ) and extracted with dichloromethane (4 x 
100 ml). The combined organic extracts were d r i e d over anhydrous 
potassium carbonate, f i l t e r e d and solvent removed under reduced pressure 
to give a clear o i l (3.0 g, 1007.). The product was used without f u r t h e r 
p u r i f i c a t i o n . (Found: (M ++l) 132.1490. CgH^Ng requires 132.1500); IR 
( t h i n f i l m ) 3400 cm"1 (br) (NH s t r ) 1570 cm"1, 1470 cm"1; m/e (DCI, 
NH3) 132 (M + + l ) ; <$H (CDClg) 3.53 (1H, m, CHN) 2.72-2.38 (4H, m, CH2N) 
1.72-1.21 (12H, m, CH2-C, NH's); <$c (CDClg) 56.2, 48.6, 42.1 (CH2N, 
CHN) 35.5, 33.8, 23.5 (CH2-C). 
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6-N-benzoyl-1,2,6-triaminohexane [47] 
Copper(II) carbonate [CuC0 3.Cu(0H) 2, A l d r i c h ] (2.95 g, 0.013 moles) 
was added t o a s o l u t i o n of the triamine [46] (3.0 g, 0.023 moles) i n 
d i s t i l l e d water and the s o l u t i o n s t i r r e d at room temperature f o r 30 
minutes. The temperature was raised t o 75°C f o r 90 minutes g i v i n g a 
very deep blue coloured s o l u t i o n . Benzoyl c h l o r i d e (4.88 g, 0.035 
moles) was added t o the cooled s o l u t i o n (-1°C, ice - s a l t - w a t e r bath) with 
vigorous s t i r r i n g over a period of 1 hour, wit h simultaneous a d d i t i o n of 
KOH (1.96 g, 0.035 moles) to maintain the pH > 9. A f t e r s t i r r i n g f o r a 
f u r t h e r 45 minutes the s o l u t i o n was decanted from a viscous o i l y residue 
and t r e a t e d w i t h hydrogen sulphide gas (10 min.). A brown p r e c i p i t a t e 
formed which turned black on standing at room temperature f o r 20 minutes 
and was f i l t e r e d , l e a v i n g a yellow/green s o l u t i o n . The volume of the 
aqueous layer was reduced (approx. 40 ml) under reduced pressure and the 
s o l u t i o n adjusted t o pH 13 with KOH. A f t e r exhaustive e x t r a c t i o n w i t h 
dichloromethane the combined organic extracts were d r i e d over anhydrous 
potassium carbonate, f i l t e r e d and solvent removed under reduced pressure 
t o give a clear o i l (2.98 g, 497.). This material was used without 
f u r t h e r p u r i f i c a t i o n ; (Found: (M ++l)236.2074. CjgHL^NgO requires 
236.1763); IR ( t h i n f i l m ) 3300 cm"1 (br) (NH s t r ) 1650 cm"1 (Amide I ) 
1540 cm"1 (Amide I I ) ; <$H (CDClg) 7.70 (2H, d, J 8.5 Hz, aromatic H) 
7.33 (3H, m, Aromatic H) 7.13 (1H, br s, NHCO) 3.32 (2H, m, Cfl2NHC0) 
2.64-2.30 (3H, m, CH2N and CHN) 1.77 (4H, br s, NH2) 1.60-1.10 (6H, br 
m, C-CH2). 
l,2-di(N-p-toluenesulphonyl)6-M-benzoyl-l,2,6-triaminohexane [48] 
A s o l u t i o n of the 5,6-diaminobenzamide [47] (2.3 g, 9.8 mmol) i n 
dichloromethane (40 ml) was added dropwise over a period of one hour t o 
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a so lu t ion of p-toluenesulphonyl chloride (4.48 g, 2.35 x 10 moles) 
and t r ie thylamine (2.37 g, 23.5 mmol) in dichloromethane (75 ml) wi th 
s t i r r i n g . A f t e r s t i r r i n g at room temperature f o r 18 hours the mixture 
was heated to 45°C f o r 20 minutes. The volume of the solvent was 
reduced (40 ml) under reduced pressure and a white p r ec ip i t a t e f i l t e r e d 
o f f . Solvent was removed under reduced pressure to give a brown o i l 
from which the d i tosy la ted product was separated by ' f l a s h ' s i l i c a gel 
chromatography; gradient e lu t i on dichloromethane-methanol (199:1 to 
99:1) to give a 'glassy' s o l i d (2.29 g, 437,); t . l . c . : R p 0.2 [ s i l i c a 
ge l : CH2Cl2-MeOH (95 :5 ) ] ; (Found: C, 60.2; H, 6.46; N, 7.23. 
C 2 7 H 3 3 N 3 ° 5 S 2 r e c l u i r e s C> 5 9 - 7 : H> 6 - 0 8 ! N> 7 - 7 3 ) ; m / e ( D C I > N H 3 ) 5 4 6 
(M++2) 545 (M + +l) 544 (M +) 390, 359; 6H (CDClg) 7.82 (2H, d, J 6.9 Hz, 
aromatic H) 7.66 (4H, m, aromatic H) 7.42 (3H, m, aromatic H) 7.22 (4H, 
m, aromatic H) 6.75 (1H, t , J 5.8 Hz, NHCO) 5.87 (2H, m, NH-S02) 3.29 
(3H, m, CH2N and CHN) 2.88 (2H, t , CH_2NHC0) 2.40 (3H, s, CHg) 2.37 (3H, 
s, CH3) 1.42 (4H, br m, CH2-C) 1.10 (2H, br m, CH 2-C); 8Q (CDClg) 167.9 
(NHCO) 143.4, 137.2, 136.7, 131.5, 129.6, 128.5, 127.1, 127.0, (aromatic 
C) 53.2, 46.6, 38.7 (CHg-N, CH-N) 31.3, 29.0, 21.8 (CH2-C) 21.5 (CH g ) . 
2-((N-benzoyl)-4-aminobutyl)-N,N' ,N"-tris(p-toluenesulphonyl)-1,4,7 
-triazacyclononane [49] 
A solut ion of N,N-bis[2-(p-toluenesulphonato)ethyl]p-toluene-
sulphonamide (1.67 g, 2.95 mmol) in dry DMF (40 ml) was added dropwise 
over a period of 4 hours to a suspension of caesium carbonate (2.02 g, 
6.20 mmol) in a so lu t ion of the ditosylamide [48] (1.60 g, 2.95 mmol) in 
dry DMF (200 ml) wi th vigorous s t i r r i n g under an atmosphere of n i t rogen. 
A f t e r s t i r r i n g at room temperature f o r 18 hours the mixture was heated 
t o 60°C f o r 3 hours. Cae sium carbonate (0.5 g, 1.5 mmol) was added to 
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the react ion mixture which was s t i r r e d at 60°C f o r a f u r t h e r 24 hours. 
Solvent was removed under reduced pressure and the residue dried i n 
vacuo (10~ 2 mm Hg, 50°C). The residue was taken up i n dichloromethane 
(150 ml) and washed wi th d i s t i l l e d water (3 x 150 ml ) . The organic 
layer was dried over anhydrous potassium carbonate, f i l t e r e d and solvent 
removed under reduced pressure to give a pale brown o i l . The cycl ised 
product was separated from the mixture by ' f l a s h 1 s i l i c a gel 
chromatography with gradient e l u t i o n , dichloromethane-methanol 399:1 to 
199:1 t o 99:1) (0.79 g, 357.); t . l . c . : R p 0.7 [ s i l i c a g e l : CH2Cl2-MeOH 
( 9 5 : 5 ) ] ; m.p. 105-108°C; (Found: C, 59.5; H, 6.25; N, 7.09. 
C 3 8 H 4 6 N 4 ° 7 S 3 r e ( l u i r e s C, 59.5; H, 6.00; N, 7.31); m/e (DCI, NHg) 769 
(M++3) 768 (M++2) 767 (M + +l) 611, 570, 457, 395, 373, 301; <5R (CDClg) 
7.85-7.62 (8H, m, aromatic H) 7.49-7.28 (9H, m, aromatic H) 6.46 (1H, 
brs , NHCO) 3.77-2.98 (13H, m, CH2N, CHN) 2.46 (3H, s, CH3) 2.44 (3H, s, 
CH3) 2.42 (3H, s, CH3) 1.64-1.20 (6H, br m, CH 2-C); SQ (CDC13) 167.5 
(NHCO) 144.1, 143.8, 136.9, 134.5, 134.3, 134.2, 131.3, 129.9, 128.5, 
127.6, 127.5, 127.3, 126.9 (aromatic C) 59.5, 53.7, 52.6, 50.8, 46.0, 
39.0 (CH2N, CHN) 29.3, 28.9, 23.8 (CH2-C) 21.5 (CH 3 ); [o]p° + 9.2 
(CH 2C1 2). 
2-((N-benzoyl)-4-aminobutyl)-1,4,7-triazacyclononane [50] 
The t r i t o s y l a t e [49] (0.91 g, 1.19 mmol) was treated wi th 
concentrated sulphuric acid (10 ml) at 115°C wi th s t i r r i n g f o r 36 hours. 
To the cooled so lu t ion (0°C, ice bath) was added NaOH solu t ion (30%, 5 
m l ) . The sodium sulphate p rec ip i t a te was f i l t e r e d o f f and washed with 
d i s t i l l e d water (3 ml ) . The combined f i l t r a t e and washings were 
extracted with dichloromethane (5 x 10 ml) and the organic layer dried 
over anhydrous potassium carbonate, f i l t e r e d and solvent removed under 
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reduced pressure to give a pale brown o i l (146 mg, 417.); HPLC: 13.7 
min. observed at ^ = 254 nm (CM 300 "Synchropak") gradient e lu t i on A = 
H20 B = 1.0 M NH40Ac pH 5.6, C = CHgCN from 707. A, 107. B, 207. C to 07. A, 
807. B, 207. C over 20 min; (Found: (M + +l) 305.2564. C 1 7 H 2 g N 4 0 requires 
305.2341); m/e (DCI, NHg) 306 (M++2) 305 (M + +l) 279, 262, 201, 188; <5R 
(CDClg) 7.82 (2H, m, aromatic H) 7.42 (3H, m, aromatic H) 7.00 (1H, br 
s, NHCO) 3.45 (2H, m, CHgNHCO) 3.07 (3H, br s, NH) 2.76 (11H, m, CH2N, 
CHN) 1.63 (2H, br m, CH2-C) 1.40 (4H, br m, CH 2-C); [o]p° + 4.1 
(CH 2C1 2). 
2-((N-benzoyl)-4-aminobutyl)-1,4,7-triazacyclononane-N,Nf , A m - t r i -
acetate [51] 
Bromoacetic acid (0.392 g, 2.82 mmol) was added to a so lu t ion of 
the t r iamine [50] (0.0855 g, 0.28 mmol) in water (5.0 ml) wi th s t i r r i n g 
at 60°C. Lithium hydroxide (0.118 g, 2.82 mmol) was added i n por t ions , 
to maintain a pH > 10. More bromoacetic acid (0.784 g, 5.64 mmol) was 
added ( i n two portions a f t e r 23 hours and 39 hours) and again l i t h i u m 
hydroxide (0.236 g, 5.64 mmol) added to the reaction mixture to maintain 
the pH > 10. A f t e r 46 hours the reaction mixture was allowed to cool 
and solvent was removed under reduced pressure to give a yellow brown 
residue which was taken up in HPLC grade water (500 ml ) . The t r i ace t a t e 
product was separated by ion exchange chromatography (sepharose DEAE) 
wi th gradient e lu t ion from aqueous NH^OAc (0.25 mMolar, pH 5.6) - CH^ CN 
(9:1) to aqueous NH40Ac (0.25 Molar, pH 5.6) - CH3CN (9 :1 ) . De-salt ing 
was achieved by reverse phase chromatography e lu t ing wi th water (0.17. 
t r i f l u o r o a c e t i c ac id , 50 ml) followed by a c e t o n i t r i l e (0.17. 
t r i f l u o r o a c e t i c ac id , 50 ml) . Solvent was removed from the eluates 
under reduced pressure to give a clear o i l (0.106 g, 797.); HPLC: R = 
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6.5 min. observed \ = 254 nra ("Synchropak" A101) e lu t i on A = H 2 0, B = 
1.0 M NH40Ac, pH 5.6, C = CHgCN from 707. A, 107. B, 207. C to 07. A, 807. B, 
207. C over 20 min; R = 12.0 min. observed A - 254 nm ("Spherisorb" 
S50DS) e lu t ion A = H20 (0.17. TFA), B = CH3CN (0.17. TFA) from 957. A, 57. B 
to 57. A, 957. B over 20 min; m/e (FAB, p-NBA) 479 (M+l): 6% (DgO) 7.81 
(2H, d, J 7.1 Hz, aromatic H) 7.62 (3H, m, aromatic H) 4.05-3.60 (6H, m, 
CH2C02) 3.55-2.90 (13H, m, CH2N) 1.71 (3H, m, CH2-C) 1.42 (3H, m, 
CH 2-C); [ f t ] J ° + 7.5 (H 2 0) . 
Route B 
2,6-diamino-N(2-aminoethyl)hexanamide [53] ; was synthesised by 
Dr. Ian Helps (Durham Unive r s i ty ) ; (2S)-Lysine methyl ester (9.0 g, 39 
mmol) was added in several portions to ethylenediamine (100 ml) wi th 
s t i r r i n g over a period of 2 hours. The reaction mixture was heated 
under r e f l u x f o r 16 hours a f t e r which the ethylenediamine was removed 
by d i s t i l l a t i o n under reduced pressure (10 mm Hg). The residue was 
dissolved in water (40 ml) and bas i f ied wi th NaOH and the volume reduced 
(~ 15 ml) under reduced pressure. Sodium chlor ide was removed by 
f i l t r a t i o n , washed wi th methanol and the combined f i l t r a t e and washings 
evaporated to dryness under reduced pressure. The residue was taken up 
in methanol (30 m l ) , f i l t e r e d and f i l t r a t e evaporated to dryness and 
then redissolved in dichloromethane (100 m l ) . A f t e r f i l t r a t i o n the 
organic layer was dried over anhydrous potassium carbonate and solvent 
removed to give a clear o i l (6.3 g, 877.); (Found: (M +) 188.1639. 
C gH 2N 40 requires 188.1637); IR ( th in f i l m ) 3350 (br) 3280 (br) [NH s t r ] 
1650 (Amide I ) 1550 (Amide I I ) ; m/e (DCI, NH3) 189 (M + +i) 188 (M +) 171, 
156, 129; 6H (CDC13) 7.56 (1H, br s, NHCO) 3.38 (1H, t , J 3.8 Hz, 
CHCONH) 3.33 (2H, t , J 5.7 Hz, CjyiHCO) 2.83 (2H, t , J 6.0 Hz, CH2N) 
2.71 (2H, t , J 6.5 Hz, CH2N) 1.87 (2H, m, CH2-C) 1.46 (11H, m, CH2-C, 
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NH 2 ) . 
1-N- (2-aminoethyl)-1,2,6-triaminohexane [54] 
Borane.Tetrahydrofuran complex (1.0 Molar i n THF, 300 ml) was added 
to a so lu t ion of the amide [53] (6.3 g, 40 mmol) and the mixture heated 
under r e f l u x f o r 21 hours. The cooled so lu t ion (ice-water bath) was 
quenched c a r e f u l l y with methanol (100 ml) and a f t e r s t i r r i n g f o r 1 hour 
solvent was removed under reduced pressure. The residue was treated 
wi th methanol (2 x 100 ml) and solvent removed under reduced pressure. 
The clear o i l was taken up in hydrochloric acid (6.0 mol dm , 150 ml) 
and heated under r e f l u x f o r 3 hours. Solvent was removed under reduced 
pressure and the residue treated wi th methanol as before. The white 
so l i d was taken up i n KOH solut ion (3 mol dm , 50 ml) and extracted 
exhaustively wi th dichloromethane. The combined organic extracts were 
dr ied over anhydrous potassium carbonate, f i l t e r e d and solvent removed 
under reduced pressure to give a pale yellow o i l (5.2 g, 757.); (Found: 
(M + +l) 175.1730. C g H 2 3 N 4 requires 175.1537); m/e (DCI, NHg) 175 
( M + + l ) , 133; <5H (HC1 s a l t , D 20) 2.96 (5H, m, CHN) 2.82 (3H, m, CHN) 
2.60 (1H, m, CHN) 1.68 (2H, br m, CH2-C) 1.47 (4H, m, CH 2-C); 6 (HC1 
s a l t , D 20) 53.0, 49.6, 48.0, (C-NH2) 39.2, 36.9 (C-NH) 32.6, 27 .1 , 21.8 
(CH 2-C). 
1-N- (2-aminomethyl)- 6-N-benzoyl-1,2,6-triaminohexane [55] 
Copper(II) carbonate [CuC0 3.Cu(0H) 2, Aldr ich] (1.47 g, 6.65 mmol) 
was added to a so lu t ion of the tetraamine [54] (2.1 g, 12.1 mmol) i n 
water (35 ml) and the mixture s t i r r e d at 50°C f o r 30 min. t o give an 
intense deep blue so lu t ion . Benzoyl chloride (1.04 g, 1.70 g) was added 
in small portions over 90 minutes, to the cooled solut ion (0°C, ice 
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bath) wi th simultaneous addi t ion of KOH to maintain a pH 9-10. The 
reaction mixture was s t i r r e d at room temperature f o r 1 hour fol lowed by 
f i l t r a t i o n , to remove a small amount of p r e c i p i t a t e . The f i l t r a t e was 
treated wi th h^S (10 min . ) , allowed to stand at room temperature f o r 20 
minutes and copper sulphide removed by f i l t r a t i o n . The yellow green 
f i l t r a t e was reduced in volume (~ 25 ml ) , adjusted to pH 14 with KOH and 
exhaustively extracted wi th dichloromethane. The combined organic 
extracts were dr ied over anhydrous potassium carbonate, f i l t e r e d and 
solvent removed under reduced pressure to give a pale yellow o i l (1.94 
g, 587.); (Found: (M + +l) 279.2027. C 1 5 H 2 7 N 4 0 requires 279.2010); IR 
( t h i n f i l m ) 1640 (NHCO) 1600 (aromatic H) 1580, 1540 (C-NH 2); m/e (DCI, 
NH3) 280 (M++2) 279 ( M + + l ) ; 6% (CDClg) 7.78 (2H, d, J 7.0 Hz, aromatic 
H) 7.40 (3H, m, aromatic H) 6.70 (1H, br s, NHCO) 3.43 (2H, m, CiyiHCO) 
2.76-2.30 (7H, m, CHN and CH2N) 1.65 (5H, br s, NH and NH2) 1.45-1.15 
(6H, m, CH 2-C); 6Q (CDClg) 167.2 (CONH) 135.0, 131.2, 128.5, 126.8, 
(aromatic C's) 56.5, 52.5, 50.9, 41.7, 39.8 (CH2N and CHN) 35.7, 29.7, 
23.4 (CH 2-C). 
l-N-((N-p-toluenesulphonyl)- 2-aminoethyl)-1,2-di(N-p-toluene -
sulphonyl)-6-N-benzoyl-1,2,6-triamine [56] 
A solut ion of the triamine [55] (1.82 g, 6.55 mmol) i n 
dichloromethane (35 ml) was added dropwise to a so lu t ion of 
p-toluenesulphonyl chloride (4.48 g, 23.6 mmol) and t r ie thylamine (2.38 
g, 23.6 mmol) in dichloromethane (50 ml) wi th s t i r r i n g over a period of 
1 hour. A f t e r s t i r r i n g at room temperature f o r 12 hours the react ion 
mixture was washed wi th d i s t i l l e d water (25 m l ) , dr ied over potassium 
carbonate, f i l t e r e d and solvent removed under reduced pressure. The 
brown residue was redissolved in dichloromethane (12 ml) and a f t e r 
199 -
several minutes a white p rec ip i ta te resul ted. The s o l i d was col lec ted 
by f i l t r a t i o n , washed wi th dichloromethane (15 ml) and dr ied in vacuo 
(10" 2 mm Hg) (3.3 g, 687.); R f 0.4 [ s i l i c a ge l ; CH.2Cl2-MeOH (95 :5 ) ] ; 
m.p. 149-151°C; (Found: C, 58 .1 ; H, 5.98; N, 7.25. CggH^N^Sg 
requires C, 58.4; H, 5.94; N, 7.56); m/e (DCI, NHg) 741 (M + +l) 740 
( M + ) , 373; <5H (CDClg) 7.83 (2H, d, J 7.1 Hz,aromatic H) 7.72 (4H, d, J 
7.9 Hz, part of AA'XX' system, aromatic H) 7.61 (2H, d, J 8.1 Hz, part 
of AA'XX' system aromatic H) 7.44 (3H, m, aromatic H) 7.31 (4H, d, J 8.0 
Hz, part of AA'XX' system, aromatic H) 7.18 (2H, d, J 8.1 Hz part of 
AA'XX' system, aromatic H) 6.49 (1H, br t , NHCO) 5.30 (2H, m, NH-Ts) 
3.40 (2H, br m, Cfl2NHC0) 3.30 (2H, br m, CH2N) 3.17 (5H, m, CH2N and 
CHN) 2.44 (6H, s, CHg) 2.32 (3H, s, CHg) 1.44 (2H, m, CH2-C) 1.25 (2H, 
m, CH2-C) 1.06 (2H, m, CH 2-C). 
2-((N-benzoyl)-4-aminobutyl)-N,Nr ,Am-tri(p-toluenesitlphonyl)-1,4, 7-
triazacyclononane [49] 
Caesium carbonate (3.26 g, 10 mmol) was added to a so lu t ion of the 
t r i tosy lamide [56] (3.70 g, 5.0 mmol) i n anhydrous DMF (200 ml) under 
dry n i t rogen. A so lu t ion of ethylene-glycol d i tosy la te (1.85 g, 5.0 
mmol) in anhydrous DMF (50 ml) was added slowly over a period of 4 
hours, wi th e f f i c i e n t s t i r r i n g . A f t e r s t i r r i n g f o r 12 hours (20°C) the 
temperature was raised to 65°C f o r 3 hours. Solvent was removed under 
reduced pressure and the residue dissolved in chloroform (200 ml) and 
washed wi th water (3 x 50 ml) . The organic layer was dr ied over 
anhydrous potassium carbonate, f i l t e r e d and solvent removed under 
reduced pressure. The pale brown residue was dissolved i n the minimum 
volume of dichloromethane (15 ml) and ethanol added u n t i l a t u r b i d i t y 
remained. A f t e r cooling to -20°C f o r 12 hours a colourless "glassy" 
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so l i d separated (2.7 g, 717.); m.p. 106-108°C; (Found: C, 59.8; H, 
5.88; N, 7.02. CggH^N^Sg requires C, 59.5, H, 6.00; N, 7.31) -
f u l l y characterised previously. 
6.2.4. C-funct ional ised DTPA 
l-N-(N,N-(bisaceto)-2-aminoethyl)-l-N-aceto-2-N,N-(bisaceto)6-N-
benzoyl-1,2,6-triaminohexane [59] 
A solut ion of potassium hydroxide (0.734 g, 13.1 mmol) in d i s t i l l e d 
water (3.0 ml) was added to a solut ion of bromoacetic acid (0.688 g, 
4.81 mmol) i n toluene (1.5 ml) at 0°C ( ice sa l t bath) . A so lu t ion of 
the t r iamine [55] (0.243 g, 0.874 mmol) i n d i s t i l l e d water (0.5 ml) was 
added and the heterogeneous system s t i r r e d vigorously. More bromoacetic 
acid (0.688 g, 4.81 mmol) in toluene (0.75 ml) and potassium hydroxide 
(0.734 g, 13.1 mmol) i n water (1.0 ml) were added a f t e r 24 hours and 
again a f t e r 48 hours. A f t e r 72 hours the aqueous solu t ion was adjusted 
to pH 1.5 wi th concentrated hydrobromic acid and washed with d i e t h y l 
ether (3 x 10 ml ) . The aqueous layer was evaporated to dryness, under 
reduced pressure to give a yellow so l id residue. The product was 
separated from sal ts and hydrolysis products by ion exchange 
chromatography (Dowex-50W, H + form, dry mesh 100-200, cation exchange). 
The residue was loaded onto the column as a dry so l id and eluted wi th 
d i s t i l l e d water (200 ml) followed by aqueous ammonia (0.2 M, 250 m l ) . 
The l a t t e r f r ac t i ons from the column were combined and solvent removed 
to give a colourless 'gummy' so l id (0.26 g, 527.). HPLC; R t 17.7 min. 
observed at \ = 254 nm ("Synchropak" A100 anion exchange column) wi th 
gradient e lu t ion A = H 2 0, B = 1.0 M NH40Ac, pH 5.6, C = CHgCN from 707. 
A, 107. B, 207. C to 07. A, 807. B, 207. C over 20 min. ; (Found: (M + +l) 
639.3752. C 2 5 H 3 7 N 4 0 u requires 639.3241); m/e (DCI, NH^, methyl 
es te r ) ; m/e 640 (M++2) 639 (M + +l) 626, 625, 611; 6% (D 20) 7.75 (2H, d, 
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J 7.1 Hz, aromatic H) 7.56 (3H, m, aromatic H) 3.90 (4H, s, CH_2C02) 
3.95-3.90 (6H, m, CH2C02) 3.50-2.84 (15H, m, CHgN) 1.87-1.48 (6H, m, 
CH 2-C); <5c (D 20) 177.3 (NHCO) 170.4, 170.0, 169.9, 169.8 (C0 2) 133.3, 
131.6, 128.4, 126.6 (aromatic C) 61 .1 , 59.4, 57 .1 , 56.7, 54.9, 53.3, 
53.0, 48.2 (C-0, C-N, C-CO) 27.8, 24.9, 22.5 (CH 2-C). 
6 .2.5. N- and N.N' - funct ional ised [ 9 ] - N ^ - t r i a c i d 
2-bromo-N-benzoyl-6-aminohexylethanoate [63] 
Synthesis was carr ied out by K. Jankowski and R. Matthews (Durham 
Univers i ty) i n two steps s t a r t i n g from N-benzoyl-6-aminohexanoic ac id . 
The bromination step was e f fec ted with red phosphorous and bromine 
according to the l i t e r a t u r e method.^ E s t e r i f i c a t i o n was achieved by 
standard methods using ethanol and acetyl chlor ide and the product 
p u r i f i e d by ' f l a s h ' s i l i c a chromatography e lu t i ng wi th 
ethylacetate-hexane (1 :1 ) . 
1-N- (2]-(N-benzoyl-4-aminobutyl)ethoxycarbonylmethyl)-1,4, 7-triaza-
cyclonane [65] 
Potassium carbonate (0.214 g, 1.54 mmol) was added to a so lu t ion of 
1,4,7-triazacyclononane (0.380 g, 2.95 mmol) i n anhydrous DMF (5 ml) 
under a nitrogen atmosphere and the mixture heated to 60°C. A so lu t ion 
of the a-bromo ester [63] (0.503 g, 1.48 mmol) in anhydrous DMF (5 ml) 
was added dropwise over a period of 5 hours and the mixture s t i r r e d f o r 
a f u r t h e r 15 hours at 60°C. The cooled reaction mixture was f i l t e r e d 
and solvent removed under reduced pressure to give a pale brown o i l . A 
small amount of product (50 mg) was separated by 'prep' HPLC 
("Synchropak" CM300 cation exchange), but the remaining product was used 
without f u r t h e r p u r i f i c a t i o n . 
P u r i f i e d mater ia l : HPLC: R. 7.8 min. observed at A = 282 nm 
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("Synchropak" CM300 cation exchange) wi th gradient e l u t i o n , 1.4 ml /min . ; 
A = H 2 0, B = 1.0 M NH40Ac, C = CHgCN from t = 0 min. ; 807. A, 07. B, 207. 
C; to t = 5 min. 607. A, 207. B, 207. C; to t = 10 min . , 07. A, 807. B, 207. 
C; IR ( t h i n f i l m ) 3500-3300 (NH) 1720 (C=0 ester) 1635 (NHCO); m/e 
(DCI, NHg) 392 (M++2) 391 (M + +l) 303, 264; 6% (CDClg) 8.63 (1H, br t , 
NHCO) 8.01 (2H, d, J 7.8 Hz) 7.41 (3H, m, aromatic H) 4.14 (2H, q, J 7.3 
Hz, 0-CH2) 3.63-3.29 (3H, m, CH2NC0 and CHN) 2.85-2.67 (10H, m, Chyi) 
2.45 (2H, m, CHgN) 1.76-1.45 (6H, m, CH2-C) 1.26 (3H, t , J 7.1 Hz, 
CH2CHg); SQ (CDClg) 173.4 (-COg-) 167.5 (NHCO) 134.7, 131.1, 128.2, 
127.1 (aromatic C's) 64.2, 60.2, 57.8 (CH20, CH2C0) 48.5, 46.9, 45.6, 
45.3, 39.8 (CH2N) 29.0, 23.5, 18.4 (CH2-C) 14.3 (CHg). 
A'- (2- (N-benzoyl-4-aminobutyl)ethoxycarbonylmethyl) -/V ,N"-bis-
(ethoxycarbonylmethyl)-1,4, 7-triazacyclononane [67] 
Caesium carbonate (1.20 g, 3.68 mmol) and ethylbromoacetate (0.615 
g, 3.68 mmol) were added to a solut ion of the crude monoalkylated 
triamine [65] [approx. 0.57 g, 1.5 mmol] in dry ethanol (6 ml) and the 
mixture s t i r r e d at 60°C f o r 20 hours. Solvent was removed under reduced 
pressure and the residue taken up i n dichloromethane (6 ml) and a f i n e 
white p rec ip i t a t e removed by cent r i fuge . The organic layer was 
evaporated to dryness and the residue chromatographed on neutra l 
alumina; gradient e lu t ion dichloromethane-methanol from (100:0) to 
(199:1) to (99:1) (0 .1 g, 127.). R f 0.4 [alumina: CHgClg-MeOH (98 :2 ) ] ; 
HPLC: R t 5.3 min. observed at A = 254 nm ("Synchropak" CM300 cat ion 
exchange) gradient e lu t ion - as f o r previous expt. (Found: (M + +l) 
563.3335. C 2 g H 4 7 N 4 0 7 requires 563.3227); IR ( t h i n f i l m ) 3400, 3240 
(br) (NH) 1725 (C=0 ester) 1645 (NHCO); 6% (CDClg) 7.81 (2H, d, J 6.8 
Hz, aromatic H) 7.43 (3H, m, aromatic H) 4.13 (6H, q, J 6.9 Hz, 0-CH9) 
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3.46 (7H, m, CH~2-C02, CH-C02 and CH2-NC0) 3.02-2.76 (12H, m, CH2N) 
1.50-1.28 (6H, m, CH2-C) 1.25 (9H, t , J 7.1 Hz, CHgCHg); 6 (CDClg) 
173.5, 171.7 (-C0 2 -) 167.4 (CONH) 134.4, 131.1, 128.3, 126.7 (aromatic 
C's) 66.3, 60.3, 60.2, 58.4, 55.4, 54.8, 52.9, (C-N, C-0 and C-CO) 39.7, 
29.6, 29.0, 23.7, 14.2 (C-CH 2, C-CHg). 
N,Nl -bis(2-(N- benzoyl-4~ aminobutyl) ethoxycarbonylmethyl)-1,4, 7-
triazacyclononane [66] 
Potassium carbonate (0.117 g, 0.85 mmol) was added to a so lu t ion of 
1,4,7-triazacyclononane (0.104 g, 0.81 mmol) in anhydrous DMF under a 
ni trogen atmosphere and the mixture heated to 55°C. A solu t ion of the 
a-bromo ester [63] (0.276 g, 8.1 mmol) in anhydrous DMF (4 ml) was added 
and the mixture s t i r r e d at 55°C f o r 48 hours. The cooled mixture was 
f i l t e r e d and solvent removed under reduced pressure to give a pale 
yellow o i l . The d i - a lky l a t ed product was separated by 'prep 1 HPLC 
("Synchropak" CM300 cation exchange 25 cm x 10 mm) gradient e l u t i o n , 4.0 
ml/min. A = H 2 0, B = 1.0 M NH40Ac pH 5.6, C = CHgCNjt = 0 min . , 807. A, 
07. B, 207. C; to t = 5 min. 607. A, 207. B, 207. C; to t = 10 min. 07. A, 
807. B, 207. C held f o r a f u r t h e r 5 min. The collected f r a c t i o n s were 
combined and solvent removed under reduced pressure, fol lowed by 
sublimation to remove the ammonium acetate, to give a pale brown o i l 
(0.11 g, 217.); HPLC: R t = 5.7 min. observed at A = 254 nm - conditions 
as above. IR ( t h i n f i l m ) 3500-3300 (NH) 1720 (C=0 ester) 1640 (NHCO); 
m/e (DCI, NHg) 653 (M++2) 652 (M + +l ) ; <5fl (CDClg) 8.00-7.74 (4H, m, 
aromatic H) 7.45-7.42 (6H, m, aromatic H) 4.15 (4H, m, 0-CH2) 3.47-2.55 
(18H, m, CH2N and CHN) 1.59 (12H, m, CH2-C) 1.24 (6H, m, CH2CHg); 6 
(CDClg) 172.4 (C=0 ester) 167.6 (CONH) 139.2, 131.1, 128.3, 127.3, 
126.4, (aromatic C's) 65.3, 64.6, 60.6 (CH20, CH2C0) 4 7 . 1 , 46.6, 44.6, 
43.2, 39.9 (CH2N) 30.2, 28.9, 24.5 (CH2-C) 14.4 (CHg). 
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N,N* -bis(2-(N-benzoyl-4-aminobutyl)ethoxycarbonylmethyl)- A"' -
ethoxycarbonylmethyl-1,4,7- triazacyclononane [69] 
Caesium carbonate (46.3 mg, 0.142 mmol) and ethylbromoacetate (24.0 
mg, 0.142 mmol) were added to a solut ion of the d i a lky la t ed t r iamine 
[66] (88.0 mg, 0.135 mmol) in anhydrous DMF. The mixture was s t i r r e d at 
60°C f o r 20 hours a f t e r which solvent was removed under reduced 
pressure. The residue was taken up i n dichloromethane and a f i n e white 
p rec ip i t a t e removed by cen t r i fuge . Solvent was removed under reduced 
pressure and the product p u r i f i e d by 'prep' HPLC ("Synchropak" CM300 
cation exchange 25 cm x 10 mm) - conditions same as previous experiment. 
The col lec ted f r ac t i ons were combined, solvent removed under reduced 
pressure and the residue sublimed to remove ammonium acetate leaving a 
pale brown 'gummy' so l i d (54 mg, 547.); R t = 6 min. observed at X = 254 
nm - conditions as above; IR ( th in f i l m ) 3500-3300 (NH) 1720 (C=0 
ester) 1640 (NHCO); m/e (DCI, NHg) 738 (M + +l) 621, 420; <5fl (CDClg) 
7.79 (4H, d, J 7.0 Hz, aromatic H) 7.42 (6H, m, aromatic H) 6.66 (2H, br 
s, NHCO) 4.11 (6H, m, 0CH2) 3.46-3.17 (8H, m, CH2C0, CHCO and CH2NC0) 
3.09-2.63 (12H, m, CH2N) 1.68 (12H, m, CH2-C) 1.24 (9H, t , J 7.1 Hz, 
CH 2CH 3); 6C (CDClg) 173.8, 172.4 (C0 2) 167.6 (NHCO) 134.8, 131.2, 
128.4, 127.6, 127.0 (aromatic C's) 66.8, 60.2, 6 0 . 1 , 56.0, 55.9, 53.4 
(C-0, C-CO, C-N) 39.9, 3 0 .1 , 29.3, 23.9, (C-CH2) 14.7 (CHg). 
6.2.6. Maleimide linkage 
N-(2-(N-(3-maleimidopropanoyl)-4-aminobutyl)carboxymethyl)-
N' ,N"-bis(carboxymethyl)-1,4,7-triazacyclononane [75] 
The t r i e s t e r [67] (25 mg, 0.044 mmol) was dissolved i n hydrochloric 
acid (6 mol dm , 2.0 ml) and heated under r e f l u x f o r 16 hours. Solvent 
was removed under reduced pressure and the residue dried i n vacuo (40°C, 
10 mm Hg). Hydrolysis of the ester and amide groups was seen to be 
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complete by *H nmr (D 20) and FAB (p-NBA matrix) mass spectrometry (m/e 
375 [ M + + l ] ) . The residue was dissolved in anhydrous DMF (200 and a 
so lu t ion of N-succinimidyl-3-maleimidopropionate [14.1 mg, 0.053 mmol] 
in anhydrous DMF (60 / / l ) was added. N-methyl morpholine (26.9 mg, 0.222 
mmol) was added to the mixture, r e su l t ing in an immediate p r e c i p i t a t i o n . 
M i l l i - Q p u r i f i e d water (25 / i l ) was added u n t i l the p r e c i p i t a t e 
redissolved and the mixture allowed to stand at room temperature f o r 24 
hours. The product was separated by 'prep' HPLC ("Spherisorb" S50DS2 
reverse phase). R^  = 8.5 min. observed at \ - 282 nm gradient e l u t i o n 
1.4 ml/min. A = H20 (0.17. TFA) B = CH^ CN (0.17. TFA) from 957. A, 57. B to 
57. A, 957. B in 20 min. ; m/e (FAB, p-NBA matrix) 526 ( M + + l ) , 453, 391, 
307; <5H (D 20) 6.85 (2H, s, CH=CH) 3.95 (5H, m, CH2C02) 3.79 (4H, m, 
CH2NHC0 and CH2NC0) 3.00-3.50 (12H, m, CH2N) 2.49 (2H, t , J 6.2 Hz, 
CH2C0NH) 1.69 (3H, m, CH2-C) 1.46 (3H, m, CH 2-C). 
N,N* -bis(2-(N- (3-maleimidopropanoyl)-4-aminobutyl)carboxymethyl)-
N"-carboxymethyl-1,4i7-triazacyclononane [76] 
The t r i e s t e r [69] (38 mg, 0.051 mmol) was dissolved in hydrochloric 
acid (6 mol dm , 3 . 0 ml) and heated under r e f l u x f o r 16 hours. Solvent 
was removed under reduced pressure and the residue dr ied in vacuo (40°C, 
-2 1 10 mm Hg). Hydrolysis was seen to be complete by H nmr (D 20) and FAB 
mass spectrometry (p-NBA matrix) [m/e 444 ( M + + l ) ] . 
The procedure of the previous experiment was fol lowed f o r the 
maleimide linkage step, (2.5 equivalents of N-succinimidyl-3-
maleimidopropionate and 7 eq. of N-methyl morpholine required i n t h i s 
case); Yie ld (10 mg, 267.); R t 10.4 min. ("Spherisorb" S50DS2 reverse 
phase) conditions as f o r previous experiment; m/e (FAB, p-NBA matr ix) 
748 (M + +l) 596; <$H (D 20) 6.85 (4H, s, CH=CH) 3.96 (4H, m, CH2C02) 3.79 
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(8H, m, CH2NC0 and CH^ NHCO) 3.10-3.25 (12H, m, CH2N) 2.49 (4H, t , J 6.3 
Hz, CH2C0NH) 1.82 (3H, m, CH2-C) 1.46 (3H, m, CHg-C). 
6.2.7. Macrocycles t o bind s i l v e r ( I ) 
3,13-dithia-6,9-diazatetradecyl-5,10-dione-1,14-diethanoaie [116] 
1,2-diaminoethane (6.14 g, 0.123 moles) i n dichloromethane (90 ml) 
was added dropwise to a solut ion of t h i o d i g l y c o l l i c anhydride (25.0 g, 
0.189 mmoles) in dichloromethane (250 ml) wi th vigorous s t i r r i n g to give 
a white resinous s o l i d . A f t e r heating under r e f l u x f o r two hours, the 
so l i d was collected by f i l t r a t i o n and dried in vacuo (10 mm Hg). The 
crude d i - ac id [115] was heated under r e f l u x i n a so lu t ion of ethanol 
(1.5 l i t r e s ) and concentrated sulphuric acid (15 ml) f o r 60 hours to 
give a clear so lu t ion . The volume of the react ion mixture was reduced 
to approximately 60 ml and a white so l i d removed by f i l t r a t i o n . The 
f i l t r a t e was evaporated to dryness under reduced pressure and the 
residue dissolved in d i s t i l l e d water (50 ml) and bas i f i ed wi th saturated 
sodium carbonate so lu t ion . The aqueous layer was extracted wi th 
chloroform (4 x 100 ml) dr ied over magnesium sulphate, f i l t e r e d and 
solvent evaporated under reduced pressure to give a brown s o l i d . 
Recrys ta l l i sa t ion from toluene gave a white c r y s t a l l i n e s o l i d (9.6 g, 
277.); m.p. 93-94°C; (Found; C, 41.7; H, 5.92; N, 6.39. 
C 1 4 H 2 4 N 2 ° 6 S 2 - H 2 ° r e ( l u i r e s C, 42.2; H, 6.53; N, 7.03); IR (Nujol) 3295 
cm"1 (NH) 1715 cm"1 (C=0 ester) 1640 cm"1 (Amide I ) 1535 cm" 1 (Amide 
I I ) ; m/e (CI-NHg) 381 (M + +l) 367, 363, 335; <5fl (CDClg) 7.36 (2H, brs , 
NHCO) 4.19 (4H, q, J 7.2 Hz, CH2-0) 3.46 (4H, m, CH2-N) 3.34 (8H, s, 
CH2-S) 1.29 (6H, t , J 9.3 Hz, CHg); 6Q (CDClg) 14.1 (CHg) 34.6, 36.4 
(CH2-S) 39.8 (CH2N) 62.0 (CH 2-0) 170.2 (C=0, Amide) 174.4 (C=0, e s te r ) . 
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4,13-dithia-1, 7,10,16-tetraaza-2,6,11,15-tetraonehexadecane [117] 
The diester [116] (8.92 g, 23.5 mmol) was dissolved i n ethanol (350 
ml) saturated with ammonia and allowed to stand at room temperature i n a 
t i g h t l y stoppered vessel f o r 60 hours. The so lu t ion was re-saturated 
with ammonia by bubbling ammonia gas through i t every 12 hours. The 
white so l i d was col lected by f i l t r a t i o n and dr ied i n vacuo (10 mm Hg) 
(5.67 g , 757.); m-P- 185-187°C; (Found: C, 36.0; H, 5.28; N, 16.6. 
c i o H i 8 N 4 0 2 s 2 - ° - 5 H 2 ° r e ( i u i r e s c ' 3 6 - 2 ; H> 5 - 7 4 ; N> 1 6 - 9 ) ; m / e ( C I > 
NH3) 279 (M+-C0NH 2); IR (Nujol) 3360, 3295, 3180 (NH s t r ) 1640 (Amide 
I ) 1540 (Amide I I ) ; <$H (D 20) 3.36 (8H, s, CH2S) 3.32 (4H, s, CH2N); 6Q 
(D 20) 34.8, 35.3 (CH2S) 38.7 (Chyi) 170.8 (C0NH) 174.3 (C0NH2). 
4,13-dithia-l,7,10,16- ietraazahexadecane [118] 
A solut ion of BHg.THF (250 ml, 0.250 moles) was added by syringe to 
the tetraamide [117] (4.73 g, 14.6 moles) under nitrogen and the mixture 
heated under r e f l u x f o r 60 hours. Af t e r cool ing, the reaction mixture 
was quenched cautiously wi th methanol (20 ml) and solvent evaporated 
under reduced pressure. 
The residue was dissolved in methanol (3 x 40 ml) and solvent 
removed under reduced pressure. Af te r r e f l u x in hydrochloric acid 
solut ion (6 mol dm , 100 ml) f o r 3 hours the solvent was evaporated 
under reduced pressure and the residue dissolved i n potassium hydroxide 
solut ion (50 ml, 6 mol dm ) . The aqueous layer was extracted with 
chloroform (4 x 50 ml) dried over magnesium sulphate, f i l t e r e d and 
solvent evaporated under reduced pressure to give a pale brown o i l (2.76 
g, 717.); (Found: ( M + + l ) , 267.1295; C 1 Q H 2 7 N 4 S 2 requires 267.1295); IR 
( t h i n f i l m ) 3350 cm"1 br (NH s t r ) 1575 cm"1 (NH bend) 1120 cm"1 (C-N 
s t r ) ; m/e (DCI, NHg) (M++2) 268 (M ++l) 267; 6^ (CDClg) 2.78 (16H, d of 
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pentets, J 6.4 Hz, N-CH2CH2-S) 2.74 (4H, s, N-CH2CH2-N) 1.80 (6H, s, 
NH); 6C (CDC13) 31.7, 35.6 (CH2S); 41.0, 48.5, 48.71 (CH 2N). 
4,13-diihia-N,N< ,A m ,A" ' 1 -tetrakis(p- toluenesulphonyl)-1,7,10,16-
tetraazahexadecane [120] 
A solu t ion of p-toluenesulphonyl chloride (9.31 g, 48.9 mmol) in 
pyridine (40 ml) was added to a solution of 4 ,13 -d i t h i a - l , 7 ,10 ,16 -
tetraazahexadecane in pyridine (100 ml) under ni t rogen over a period of 
30 minutes. A f t e r heating at 60°C f o r two hours the cooled react ion 
mixture was poured onto ice (200 g) wi th s t i r r i n g , using a glass rod, 
u n t i l the ice melted. Af t e r s t i r r i n g at room temperature f o r one hour 
the aqueous layer was extracted with dichloromethane (3 x 200 ml) and 
washed wi th hydrochloric acid (2 x 300 ml, 1.0 mol dm ) and then with 
d i s t i l l e d water (2 x 300 ml) . The organic layer was dr ied over 
magnesium sulphate, f i l t e r e d and solvent removed under reduced pressure 
to give a brown o i l . Two rec rys t a l l i s a t ions from chloroform/methanol 
(60 ml, 1:10) wi th cooling to -5°C gave a pale brown s o l i d (4.82 g, 
567.). R F 0.8 [ S i l i c a Gel; CH2Cl2-MeOH ( 9 : 1 ) ] ; m.p. 131-133°C; 
(Found; C, 51.0; H, 5.71; N, 6.03; CggH^NjOgSgO. 5H20 requires C, 
51.2; H, 5.72; N, 6.287.); m/e (DCI, NHg) 901 (M++17) 884 (M++2) 883 
(M ++l) 730;<$H (CDClg) 7.73 (4H, d, J 8.3 Hz, ha l f of AA'XX' system, 
aromatic H) 7.68 (4H, d, J 8.1 Hz, half of AA'XX' system, aromatic H) 
7.35 (4H, d, J 8.1 Hz, ha l f of AA'XX' system, aromatic H) 7.27 (4H, d, J 
8.1 Hz, ha l f of AA'XX' system, aromatic H) 5.24 (2H, t , J 6.0 Hz, NH) 
3.32 (4H, s, N-CH2CH2-N) 3.28 (4H, t , J 8.3 Hz, TsN-CH2) 3.18 (4H, m, 
CH2NHTs) 2.67 (8H, m, CH2S) 2.45 (6H, s, CHg) 2.40 (6H, s, CHg): SQ 
(CDClg) 21.3 (CHg), 30.5, 32.0 (CH2S), 42.4 (CH2N), 49.5, 50.2 
(CH2NTs), 126.7, 127.0, 129.5, 129.6, 134.9, 136.7, 143.7 ( tosy l 
aromatic). 
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N,N* ,N" , J V " 1 - tetrakis(p- toluenesulphonyl)-1,10-dithia-4,7,13,16-
tetraazacyclooctadecane [121] 
Caesium c a r b o n a t e (3.13 g, 9.62 mmol) and t h e t e t r a t o s y l a m i d e [120] 
(4.04 g, 4.58 mmol) were s t i r r e d v i g o r o u s l y i n d r y DMF (300 ml) under 
n i t r o g e n . A s o l u t i o n o f eth a n e 1 , 2 - d i o l d i t o s y l a t e (1.69 g, 4.58 mmol) 
i n DMF (120 ml) was added dr o p w i s e o v e r a p e r i o d of t h r e e h o u r s u s i n g a 
p r e s s u r e e q u a l i s e d a d d i t i o n f u n n e l . The m i x t u r e was s t i r r e d a t room 
t e m p e r a t u r e f o r 18 h o u r s t h e n h e a t e d t o 60°C f o r 4 h o u r s . S o l v e n t was 
removed under r e d u c e d p r e s s u r e and t h e brown r e s i d u e d r i e d i n vacuo 
-2 o 
(10 mm Hg, 60 C ) . D i c h l o r o m e t h a n e (50 ml) was added t o t h e r e s i d u e 
and t h e r e s u l t i n g s u s p e n s i o n was f i l t e r e d . A f t e r washing w i t h d i s t i l l e d 
w a t e r ( 3 x 20 ml) t h e c o l l e c t e d s o l i d was d r i e d i n vacuo (10 mm Hg, 
40°C). A f t e r t r e a t m e n t w i t h hot t o l u e n e (50 ml) t h e r e s u l t i n g 
s u s p e n s i o n was f i l t e r e d and t h e c o l l e c t e d p a l e brown s o l i d d r i e d i n 
vacuo ( 1 0 ~ 2 mm Hg) (2.59 g, 627.); Rp 0.7 [ s i l i c a g e l : CHjClgiMeOH 
( 9 7 : 3 ) ] ; m.p. 254-256°C; (Found: C, 52.0; H, 5.90; N, 6.21. 
C 4 0 H 5 2 N 4 O g S 6 . 0 . 5 H 2 0 , r e q u i r e s C, 52.3; H, 5.78; N, 6 . 1 1 ) ; m/e ( D C I , 
NH 3) 909 ( M + + l ) 753 ( M + - T s ) ; 6 R (CDClg) 7.68 (8H, d, J 8.1 Hz, p a r t o f 
AA'XX' system, a r o m a t i c H) 7.33 (8H, d, J 8.1 Hz, p a r t o f AA'XX' sys t e m , 
a r o m a t i c H) 3.34 (8H, s , N-CH 2CH 2-N) 3.29 (8H, t , J 11.4 Hz, CH 2N) 2.80 
(8H, t , J 7.4 Hz, CH 2S) 2.43 (12H, s , CHg). 
1,10-dithia-4,7,13,16-tetraazacyclooctadecane [100] 
The t e t r a t o s y l a m i d e [121] (1.80 g, 1.98 mmol) was d i s s o l v e d i n d r y 
THF (50.0 ml) and d r y e t h a n o l (5.0 ml) and s t i r r e d v i g o r o u s l y i n a 
r e a c t i o n v e s s e l f i t t e d w i t h an ammonia c o n d e n s e r w i t h an anhydrous 
c a l c i u m c a r b o n a t e guard tube. A f t e r c o o l i n g t o -77°C ( S o l i d C 0 2 / A c e t o n e 
b a t h ) ammonia (250 ml) was condensed i n t o t h e r e a c t i o n m i x t u r e and 
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l i t h i u m (0.75 g, 108 mmol) was added i n s e v e r a l p o r t i o n s w i t h v i g o r o u s 
s t i r r i n g . A deep b l u e c o l o u r e d s o l u t i o n r e s u l t e d , l a s t i n g 5-6 min u t e s 
b e f o r e c h a n g i n g t o a y e l l o w c o l o u r . A f t e r s t i r r i n g a t -77°C f o r 2 h o u r s 
t h e s o l u t i o n was a l l o w e d t o r e t u r n t o room t e m p e r a t u r e and t h e ammonia 
e v a p o r a t e d . D i s t i l l e d w a t er (20 ml) was added t o t h e r e m a i n i n g s o l u t i o n 
and s o l v e n t removed under r e d u c e d p r e s s u r e t o g i v e a w h i t e r e s i d u e which 
was d i s s o l v e d i n h y d r o c h l o r i c a c i d (40 ml, 6 mol dm ) and washed w i t h 
d i e t h y l e t h e r (2 x 40 m l ) . The aqueous l a y e r was e v a p o r a t e d t o d r y n e s s 
and t h e r e s i d u e d i s s o l v e d i n KOH s o l u t i o n (40 ml, 6 mol dm ) and 
e x t r a c t e d w i t h d i c h l o r o m e t h a n e (5 x 50 m l ) . The o r g a n i c l a y e r was d r i e d 
o v e r anhydrous magnesium s u l p h a t e , f i l t e r e d and s o l v e n t removed under 
reduce d p r e s s u r e t o g i v e a p a l e brown o i l which s o l i d i f i e d o v e r f i v e 
m i n u t e s . The c r u d e p r o d u c t was r e c r y s t a l l i s e d t w i c e from t o l u e n e (20 
ml) t o g i v e a w h i t e s o l i d (0.37 g, 647.); m.p. 88-89°C; (Found: C, 
49.5; H, 10.0; N, 18.8. C 1 2 H 2 g N 4 S 2 r e q u i r e s C, 49.3; H, 10.0; N, 
1 9 . 1 ) ; m/e (DC1, NHg) 293 ( M + + l ) 294 (M ++2) 295 (M ++3), 190, 116; <$H 
(CDC1 3) 2.85 (8H, m, CH 2N, CH 2S) 2.78 (8H, m, CH 2N, CH 2S) 2.76 (8H, s , 
N-CH 2CH 2-N) 2.05 (4H, b r s , NH); 6 Q (CDClg) 32.93 ( C H 2 S ) 48.0 (CH 2N) 
48.3 (CH 2N). 
4,7,13,16-tetrameihyl-l,10-dithia-4, 7,13,16-tetraazacyclooctadecane 
[101] 
l , 1 0 - d i t h i a - 4 , 7 , 1 3 , 1 6 - t e t r a a z a c y c l o o c t a d e c a n e (80.0 mg, 0.274 mmol) 
was h e a t e d a t 95°C w i t h formaldehyde (0.24 ml, 377. s o l u t i o n ) and f o r m i c 
a c i d (0.32 ml) f o r 20 h o u r s . To t h e c o o l e d s o l u t i o n was added 
h y d r o c h l o r i c a c i d (1.0 mol dm' , 5.0 ml) and t h e s o l u t i o n e v a p o r a t e d 
under r e d u c e d p r e s s u r e t o g i v e a p a l e brown r e s i d u e . A f t e r d i s s o l v i n g 
i n w a t e r (3.0 ml) t h e pH was a d j u s t e d t o 14 w i t h KOH s o l u t i o n and t h e 
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s o l u t i o n e x t r a c t e d w i t h d i c h l o r o m e t h a n e ( 5 x 5 m l ) , d r i e d o v e r anhydrous 
p o t a s s i u m c a r b o n a t e and s o l v e n t removed under r e d u c e d p r e s s u r e t o g i v e a 
c o l o u r l e s s r e s i d u e . R e c r y s t a l l i s a t i o n from hexane gave a w h i t e s o l i d 
(52.0 mg, 557.); m.p. 43-44°C; (Found: C, 54.8; H, 10.8; N, 15.5; 
C 1 6 H 3 6 N 4 S 2 ' ° - 2 H 2 ° r e < l u i r e s C, 54.6; H, 10.4; N, 1 5 . 9 ) ; m/e ( D C I , NH 3) 
350 (M ++2) 351 (M ++3) 335, 323, 262, 161; <5H (CDClg) 2.64 (16H, s , 
CH 2N, CH 2S) 2.51 (8H, s , CH 2N) 2.27 (12H, s , CHg); 6 C (CDClg) 29.2 
(CHg) 43.1 (CH 2S) 55.2, 57.7 (CHgN). 
N- (p-toluenesulphonyl)- 3-aza-1,5-bis(p-toluenesulphonato)pentane 
[123] 
To a s o l u t i o n of p - t o l u e n e s u l p h o n y l c h l o r i d e (107.8 g, 0.565 m o l e s ) 
i n p y r i d i n e (100 ml) was added a s o l u t i o n of d i e t h a n o l a m i n e (16.5 g, 
0.157 moles) i n p y r i d i n e (90 ml) dr o p w i s e o v e r a p e r i o d o f 30 m i n u t e s , 
under n i t r o g e n . The m i x t u r e was l e f t a t -18°C f o r 48 h o u r s . A f t e r 
p o u r i n g onto i c e (400 g ) , w i t h s t i r r i n g u n t i l t h e i c e m e l t e d , t h e 
m i x t u r e was l e f t a t room t e m p e r a t u r e f o r 2 h o u r s t o g i v e a ye l l o w / b r o w n 
s o l i d w h i c h was c o l l e c t e d by f i l t r a t i o n and t w i c e r e c r y s t a l l i s e d from 
e t h a n o l / t o l u e n e ( 5 : 1 ) t o g i v e a y e l l o w s o l i d ( 75.0 g, 847.); m.p. 
96-97°C; (Found: C, 52.5; H, 4.92; N, 1.81. C^H^NOgSg r e q u i r e s C, 
52.9; H, 5.11; N, 2 . 1 1 ) ; m/e (DCI, NHg) 585 (M ++18), 568 ( M + + l ) ; 6^ 
(CDClg) 7.75 (4H, d, J 8.1 H z , p a r t of AA'XX' s y s t e m , a r o m a t i c H) 7.35 
(4H, d, J 8.1 H z , p a r t of a r o m a t i c AA'XX' system, a r o m a t i c H) 7.60 (4H, 
d, J 8.1 Hz, p a r t of AA'XX1 system, a r o m a t i c H) 7.28 (4H, d, J 8.1 Hz, 
p a r t o f AA'XX' system, a r o m a t i c H) 4.11 (4H, t , J 5.9 Hz, CH 20) 3.37 
(4H, t , J 5.9 Hz, CH 2N) 2.43 (3H, s , CHg) 2.35 (6H, s , CHg). 
If- (p- toluensulphonyl)-3-azapentane-1,5-dithiol [124] 
T h i o u r e a (22.8 g, 0.299 moles) was added t o a s o l u t i o n o f t h e 
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1 , 5 - d i t o s y l a t e [123] (75.0 g, 0.136 moles) i n d r y e t h a n o l (500 ml) and 
t h e s o l u t i o n was h e a t e d under r e f l u x , under a n i t r o g e n atmosphere f o r 30 
ho u r s . S o l v e n t was e v a p o r a t e d under r e d u c e d p r e s s u r e and t h e r e s i d u e 
t a k e n up i n s a t u r a t e d sodium b i c a r b o n a t e s o l u t i o n (250 ml) and h e a t e d 
under r e f l u x f o r 3 h o u r s . The c o o l e d s o l u t i o n was a d j u s t e d t o pH 7 w i t h 
h y d r o c h l o r i c a c i d (6 mol dm ) . The aqueous l a y e r was e x t r a c t e d w i t h 
d i c h l o r o m e t h a n e ( 3 x 250 ml) d r i e d o v e r anhydrous magnesium s u l p h a t e , 
f i l t e r e d and s o l v e n t removed under r e d u c e d p r e s s u r e . The c o l o u r l e s s 
r e s i d u e was chromatographed on ' f l a s h ' s i l i c a g e l e l u t i n g w i t h 
d i c h l o r o m e t h a n e - m e t h a n o l [ 1 9 9 : 1 ] . E v a p o r a t i o n o f t h e e l u a t e s gave a 
c l e a r o i l which c r y s t a l l i s e d o v e r a p e r i o d o f 24 h o u r s (32.7 g, 837o); 
R p 0.5 [ s i l i c a gel:CH 2Cl 2-MeOH ( 9 9 : 1 ) ] ; (Found: ( M + + l ) 292.0460 
C 1 1 H 1 7 N 0 2 S 3 r e 9 - u i r e s 2 9 2 . 0 4 9 6 ) ; m/e (DC I , NHg) 292 ( M + + l ) ; <$H (CDClg) 
7.70 (2H, d, J 8.0 Hz, p a r t o f AA'XX' system, a r o m a t i c H) 7.33 (2H, d, J 
8.1 Hz, p a r t o f AA'XX' s y s t e m , a r o m a t i c H) 3.28 (4H, t , J 7.5 Hz, N-CH 2) 
2.74 (4H, m, S-CH 2) 2.43 (3H, s , CHg) 1.44 (2H, t , J 8.5 Hz, SH); 6 
(CDClg) 21.4 (CHg) 23.8 ( C H 2 S ) 52.6 (CH 2N) 126.7, 126.9, 129.7, 135.9, 
143.6 ( a r o m a t i c C ) . 
N-(p-toluenesulphonyl)-1,4-dithia-7-azacyclononane [125] (and J V , ^ V " -
(p-toluenesulphonyl)-1,4,10,13-tetratkia-7,16-diazacycloociadecane) 
[128] 
Caesium c a r b o n a t e (3.60 g, 11.0 mmol) was added t o d r y DMF (500 ml) 
under a n i t r o g e n atmosphere i n a r e a c t i o n v e s s e l f i t t e d w i t h two 
p r e s s u r e e q u a l i s e d a d d i t i o n f u n n e l s and t h e s u s p e n s i o n h e a t e d t o 55°C. 
A s o l u t i o n o f N - ( p - t o l u e n e s u l p h o n y l ) 4 - a z a p e n t a n e - l , 5 - d i t h i o l (2.91 g, 
10.0 mmol) i n DMF (200 ml) and a s o l u t i o n o f 1,2-dibromoethane (1.88 g, 
10.0 mmol) i n DMF (200 ml) were added s y n c h r o n o u s l y o v e r a p e r i o d of 12 
- 213 -
ho u r s w i t h v i g o r o u s s t i r r i n g . A f t e r s t i r r i n g f o r a f u r t h e r 6 hours a t 
55°C t h e s o l v e n t was removed under r e d u c e d p r e s s u r e and t h e r e s i d u e 
d r i e d i n vacuo ( 1 0 ~ ^ mm Hg, 50°C). The r e s i d u e was t a k e n up i n 
d i c h l o r o m e t h a n e (100 ml) and washed w i t h d i s t i l l e d w a t e r (2 x 100 m l ) . 
The o r g a n i c l a y e r was d r i e d o v e r anhydrous magnesium s u l p h a t e , f i l t e r e d 
and s o l v e n t removed under r e d u c e d p r e s s u r e t o g i v e a p a l e brown o i l . 
Two p r o d u c t s were i s o l a t e d a s w h i t e c r y s t a l l i n e s o l i d s by f r a c t i o n a l 
c r y s t a l l i s a t i o n from t o l u e n e - h e x a n e ; [ ( 4 : 1 ) , 25 ml] gave t h e 18-
membered r i n g p r o d u c t (0.31 g, 107c); [ ( 2 : 1 ) , 10 ml] gave t h e 9-membered 
r i n g p r o d u c t (1.38 g, 437,). 
[ 1 2 8 ] ; Rp = 0.4 [ s i l i c a g e l : M e t h a n o l - d i c h l o r o m e t h a n e ( 1 : 9 9 ) ] ; m.p. 
206°C; (Found: C, 49.2; H, 5.97; N, 4.20. C ^ H g g N ^ S g r e q u i r e s C, 
49.1; H, 5.83; N, 4 . 2 7 ) ; m/e (DCI, NH 3) 636 (M ++2) 576, 480; <$H 
( C D C l g ) 7.72 (4H, d, J 8.2 Hz, p a r t of AA'XX' system, a r o m a t i c H) 7.32 
(4H, d, J 8.2 Hz, p a r t of AA'XX' system, a r o m a t i c H) 3.32 (8H, t , J 7.2 
Hz, CH 2N) 2.86 (8H, t , J 7.2 H z , C H 2 S ) 2.79 (8H, s , S-CH 2CH 2-S) 2.42 
(6H, s , C H 3 ) . 
[ 1 2 5 ] ; R p = 0.5 [ s i l i c a g e l : MeOH-CH 2Cl 2 ( 1 : 9 9 ) ] ; m.p. 122-124°C; 
(Found: C, 49.2; H, 5.99; N, 4.42. C ^ H j g N f ^ S g r e q u i r e s C, 49.1; H, 
5.83; N, 4 . 2 7 ) ; m/e 318 ( M + + l ) 244 162; <5R (CDClg) 7.70 (2H, d, J 8.1 
H z f p a r t o f AA'XX' system, a r o m a t i c H) 7.34 (2H, d, J 8.1 H z , p a r t of 
AA'XX' s y s t e m , a r o m a t i c H) 3.40 (4H, m, CH 2N) 3.15 (4H, s , S-CH 2CH 2-S) 
3.14 (4H, m, CH 2S) 2.43 (3H, s , CHg); S Q (CDClg) 21.3 (CHg) 32.2, 34.0 
( C H 2 S ) 53.3, (CH 2N) 127.3, 129.6, 134.0, 143.6 ( A r o m a t i c C ) . 
1,4-dithia-7-azacyclononane [126] 
A s o l u t i o n o f hydrogen bromide i n a c e t i c a c i d (457c, 15.0 ml) and 
ph e n o l (1.40 g, 14.9 mmol) were added t o N - ( p - t o l u e n e s u l p h o n y l ) - l , 4 -
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d i t h i a - 7 - a z a c y c l o n o n a n e (1.17 g, 3.69 mmol) and t h e s o l u t i o n was s t i r r e d 
a t 80°C f o r 48 h o u r s . (A f u r t h e r a d d i t i o n of hydrogen bromide i n a c e t i c 
a c i d (457., 5.0 ml) was made a f t e r 12 h o u r s . ) T o l u e n e was added t o t h e 
c o o l e d r e a c t i o n m i x t u r e and s o l v e n t removed under r e d u c e d p r e s s u r e 
[ a z e o t r o p e : 72% t o l u e n e , 287c a c e t i c a c i d ] . The r e s i d u e was t a k e n up i n 
d i c h l o r o m e t h a n e (15 ml) and wa t e r (15 ml) and t h e aqueous l a y e r 
s e p a r a t e d and washed w i t h d i c h l o r o m e t h a n e ( 3 x 15 m l ) . The s o l u t i o n was 
a d j u s t e d t o pH 14 w i t h sodium h y d r o x i d e s o l u t i o n (5 mol dm ) and 
e x t r a c t e d w i t h c h l o r o f o r m (4 x 20 m l ) . The combined o r g a n i c e x t r a c t s 
were d r i e d o v e r anhydrous magnesium s u l p h a t e and s o l v e n t removed under 
r e d u c e d p r e s s u r e t o g i v e a p a l e brown s o l i d . R e c r y s t a l l i s a t i o n from 
t o l u e n e - h e x a n e gave a p a l e y e l l o w s o l i d (0.43 g, 737c); m.p. 7l-72°C; 
(Found: C, 43.2; H, 7.83; N, 7.61. C gH 1 3NS 2.0.2H 20 r e q u i r e s C, 43.2; 
H, 8.04; N, 8 . 4 0 ) ; m/e (DC I , MeOH) 164 (M + + l ) 116, 89; <5R (CDClg) 
3.00 (4H, s , S-CH 2CH 2-S) 2.95 (8H, d o f m, CH 2N, CH 2S) 2.36 (1H, b r s , 
NH); 6 C (CDClg) 33.1, 33.2 (CH 2 S ) 48.1 ( C f y j ) . 
1,2-Bis(l-aza-4,7-dithia-l-cyclononyl)ethane [102] 
A m i x t u r e o f 1 , 4 - d i t h i a - 7 - a z a c y c l o n o n a n e (0.200 g, 1.23 mmol), 
ethane 1,2 d i o l d i t o s y l a t e (0.227 g, 6.15 x 10'^ moles) and sodium 
c a r b o n a t e (0.130 g, 1.23 mmol) i n a c e t o n i t r i l e (30 ml) was h e a t e d under 
r e f l u x f o r 36 h o u r s . The c o o l e d r e a c t i o n m i x t u r e was f i l t e r e d and 
s o l v e n t e v a p o r a t e d under r e d u c e d p r e s s u r e . The brown c o l o u r e d r e s i d u e 
was d i s s o l v e d i n h y d r o c h l o r i c a c i d ( 0 . 3 mol dm , 15 ml) and washed w i t h 
d i c h l o r o m e t h a n e ( 3 x 15 m l ) . The aqueous l a y e r was a d j u s t e d t o pH 14 
w i t h KOH s o l u t i o n ( 6 . 0 mol dm ) and e x t r a c t e d w i t h d i c h l o r o m e t h a n e (4 x 
20 m l ) . The o r g a n i c l a y e r was d r i e d o v e r anhydrous magnesium s u l p h a t e , 
f i l t e r e d and s o l v e n t removed under r e d u c e d p r e s s u r e t o g i v e a p a l e brown 
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s o l i d . R e c r y s t a l l i s a t i o n from t o l u e n e gave a p a l e y e l l o w s o l i d (0.114 
g, 537.); R F 0.9 [ s i l i c a g e l : MeOH-CH 2Cl 2 ( 1 : 9 9 ) ] ; m.p. 104-106°C; 
(Found: C, 47.3; H, 7.75; N, 7.31. C 1 4 H 2 g N 2 S 4 . 0 . 3 H 2 0 r e q u i r e s C, 
47.2; H, 8.04; N, 7 . 8 7 ) ; m/e (DCI, NHg) 353 ( M + + l ) 259, 232, 176; 6] 
(CDC1 3) 3.09 (8H, s , S-CH 2CH 2-S) 2.87, 2.72 (4H, d of m, CH 2N, CH 2S) 
2.62 (4H, m, N-CH 2CH 2-N); S Q (CDClg) 58.7, 55.6 (CH 2N) 34.8, 33.1 
( C H 2 S ) . 
N,N' ,Afl "-tetrakis(p- ioluenesulphonyl)-1,10-dioxa-4, 7,13,16-tetra 
-azacyclooctadecane [ 1 2 9 ] ; and 
N,N' -bis(p-toluenesulphonyl)-l-oxa-4,7-diazacyclononane [130] 
Caesium c a r b o n a t e (8.26 g, 25.4 mmol) was added t o a s o l u t i o n o f 
3 - o x a - l , 5 - b i s ( p - t o l u e n e s u l p h o n a t o ) p e n t a n e (5.00 g, 12.1 mmol) i n 
anhydrous DMF (50 ml) under a n i t r o g e n atmosphere. A s o l u t i o n o f 
N , N ' - b i s ( p - t o l u e n e s u l p h o n y l ) - l , 2 - d i a m i n o e t h a n e (4.44 g, 12.1 mmol) i n 
anhydrous DMF (50 ml) was added d r o p w i s e o v e r a p e r i o d of 4 h o u r s w i t h 
v i g o r o u s s t i r r i n g . The r e a c t i o n m i x t u r e was s t i r r e d a t room t e m p e r a t u r e 
f o r 12 h o u r s and h e a t e d t o 60°C f o r 4 h o u r s . The s o l v e n t was removed 
under r e d u c e d p r e s s u r e and t h e r e s i d u e t a k e n up i n d i c h l o r o m e t h a n e (100 
ml) and washed w i t h d i s t i l l e d w a t e r (2 x 100 m l ) . The o r g a n i c l a y e r was 
d r i e d o v e r anhydrous magnesium s u l p h a t e , f i l t e r e d and s o l v e n t removed 
under r e d u c e d p r e s s u r e t o g i v e a p a l e y e l l o w s o l i d . The m i x t u r e was 
t a k e n up i n hot t o l u e n e (40 ml) and t h e 18 membered r i n g t e t r a t o s y l a m i d e 
was c o l l e c t e d a s a w h i t e s o l i d by f i l t r a t i o n (warmed f i l t r a t i o n 
a p p a r a t u s ) (1.06 g, 207.). The n i n e membered r i n g d i t o s y l a m i d e was 
o b t a i n e d from t h e c o o l e d f i l t r a t e a s a c r y s t a l l i n e s o l i d and c o l l e c t e d 
9 by f i l t r a t i o n and d r i e d i n vacuo (10 mm Hg) (2.17 g, 417.). 
Diiosylamide [ 1 3 0 ] ; m.p. 160-161°C [ L i t . : 5 160°C]; (Found: C, 
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54.8; H, 6.02; N, 6.34. C 2 ( ) H 2 6 N 2 0 5 S 2 r e q u i r e s C, 54.8; H, 5.94; N, 
6 . 3 9 ) ; m/e ( C I , NHg) 440 (M ++2) 439 ( M + + l ) 283; <$H (CDClg) 7.70 (4H, 
d, J 8.1 Hz, p a r t of AA'XX' system, a r o m a t i c H) 7.32 (4H, d, J 8.2 Hz, 
p a r t of AA'XX1 s y s t e m , a r o m a t i c H) 3.90 (4H, t , J 4.3 Hz, CH 20) 3.47 
(4H, s , N-CH 2CH 2-N) 3.26 (4H, t , J 4.3 Hz, CH 2N) 2.43 (6H, s , CHg). 
Tetratosylamide [ 1 2 9 ] ; m.p. 242-244°C [ L i t . : 6 245°C]; (Found: C, 
55.0; H, 6.13; N, 6.12. C 4 ( ) H 5 2 N 4 0 1 ( ) S 4 r e q u i r e s C, 54.8; H, 5.94; N, 
6. 3 9 ) ; m/e ( C I , NHg) 880 (M ++2) 879 ( M + + l ) 722, 440; <5H (CDClg) 7.71 
(8H, d, J 8.2 Hz, p a r t of AA'XX' system, a r o m a t i c H) 7.32 (8H, d, J 8.1 
Hz, p a r t of AA'XX' sys t e m , a r o m a t i c H) 3.54 (8H, t , J 4.9 Hz, CH 20) 3.32 
(8H, s , N-CH 2CH 2-N) 3.22 (8H, t , J 4.8 Hz, CH 2N) 2.44 (12H, s , CHg). 
1AO-dioxa-J,, 7 A S , 16-tetraazacyclooctadecane [131] 
A s o l u t i o n of hydrogen bromide i n a c e t i c a c i d (457., 100 ml) and 
phenol (5.0 g, 53 mmol) were added t o t h e t e t r a t o s y l a m i d e [129] (1.25 g, 
1.43 mmol) and t h e s o l u t i o n h e a t e d under r e f l u x f o r 6 d a y s . D i e t h y l 
e t h e r (40 ml) was added t o t h e c o o l e d r e a c t i o n m i x t u r e and a f i n e w h i t e 
p r e c i p i t a t e c o l l e c t e d by f i l t r a t i o n . T h i s was t a k e n up i n d i s t i l l e d 
w a t e r (40 ml) b a s i f i e d w i t h aqueous KOH (307.) and e x t r a c t e d w i t h 
d i c h l o r o m e t h a n e (4 x 40 m l ) . The o r g a n i c l a y e r was d r i e d o v e r anhydrous 
p o t a s s i u m c a r b o n a t e , f i l t e r e d and s o l v e n t removed under r e d u c e d 
p r e s s u r e . The r e s i d u e was r e c r y s t a l l i s e d from d i c h l o r o m e t h a n e - h e x a n e t o 
g i v e a c o l o u r l e s s c r y s t a l l i n e s o l i d (90 mg, 257.); m.p. 58-60°C [ L i t . : ^ 
58-60°C]; m/e ( D C I , NHg) 262 (M ++2) 261 ( M + + l ) 204, 131; <$H (CDClg) 
3.59 (8H, t , J 4.7 Hz, CH 20) 2.80 (8H, t , J 4.9 Hz, CH 2N) 2.78 (8H, s , 




1 , 1 0 - d i o x a - 4 , 7 , 1 3 , 1 6 - t e t r a a z a c y c l o o c t a d e c a n e (60 mg, 23 mmol) was 
h e a t e d a t 95°C w i t h f o r m a l d e h y d e (377., 0.20 ml) and f o r m i c a c i d (0.27 
ml) f o r 20 h o u r s . H y d r o c h l o r i c a c i d (1.0 mol dm , 5.0 ml) was added t o 
t h e c o o l e d s o l u t i o n and s o l v e n t removed under r e d u c e d p r e s s u r e . The 
r e s i d u e was r e d i s s o l v e d i n w a t e r (3.0 ml) and a d j u s t e d t o pH 14 w i t h 
p o t a s s i u m h y d r o x i d e . A f t e r e x t r a c t i o n w i t h d i c h l o r o m e t h a n e ( 5 x 5 ml) 
t h e o r g a n i c l a y e r was d r i e d o v e r anhydrous p o t a s s i u m c a r b o n a t e , f i l t e r e d 
and s o l v e n t removed under r e d u c e d p r e s s u r e . The r e s i d u e was t r e a t e d 
w i t h hexane ( 3 x 5 m l ) , t h e e x t r a c t s combined and s o l v e n t removed under 
r e d u c e d p r e s s u r e t o g i v e a c l e a r o i l which c r y s t a l l i s e d on c o o l i n g (5°C) 
(59 mg, 807.); m.p. = 23-25°C; 6% (CDClg) 3.55 (8H, t , J 5.5 Hz, CH 20) 
2.63 (8H, t , J 5.5 Hz, CH 2N) 2.59 (8H, s , NCHgCHgN) 2.28 (12H, s , CHg). 
6.2.8. S i l v e r ( I ) complexes 
Silver(I) complex of 1,10-dilhia-4 ,7,13,16-tetraazacyclooctadecane 
[ 1 0 0 ] , [AgL][PF6] ( 1 3 4 ) 
S i l v e r n i t r a t e ( 8.4 mg, 4.9 x 10 moles) i n d r y a c e t o n i t r i l e ( 1 . 0 
ml) was added t o l , 1 0 - d i t h i a - 4 , 7 , 1 3 , 1 6 - t e t r a a z a c y c l o o c t a d e c a n e (14.4 mg, 
4.9 x 10 moles) i n d r y d i c h l o r o m e t h a n e (1.0 m l ) . The s o l u t i o n was 
f i l t e r e d t o remove a s m a l l amount of dark c o l o u r e d p r e c i p i t a t e . S o l v e n t 
was removed from t h e f i l t r a t e under r e d u c e d p r e s s u r e and t h e r e s i d u e 
d i s s o l v e d i n d r y methanol (1 m l ) . To t h i s was added ammonium 
h e x a f l u o r o p h o s p h a t e (8.0 mg, 4.9 x 10 mol) i n methanol ( 1 . 0 m l ) . 
A f t e r r a p i d f i l t r a t i o n t h e s o l u t i o n was l e f t a t -20°C i n t h e d a r k f o r 3 
h o u r s . C o l o u r l e s s c r y s t a l s were c o l l e c t e d by f i l t r a t i o n , washed w i t h 
c o l d methanol (2 x 0.5 ml) and d r i e d i n vacuo (10 mm Hg) (19.5 mg, 
737.); (Found: C, 25.3; H, 4.96; N, 9.84. C 1 2 H 2 g N 4 S 2 P F 6 A g . H 2 0 
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r e q u i r e s C, 25.6; H, 5.33; N, 9 . 9 5 ) ; m/e (FAB, g l y c e r o l ) 401, 399 
(M +) [ 1 0 9 A g + - L and 1 0 7 A g + - L ] ; (CDgOD) 2.99 (16H, s , CH 2N, CH 2S) 2.79 
(8H, s , CH 2N). X - r a y c r y s t a l s t r u c t u r e d a t a - s e e a p p e n d i x . 
Silver(I) Complex of 4,7,13,16-tetramethyl-l ,10-dithia-4,7,13,16-
tetraazacyclooctadecane [ 1 0 1 ] , [Ag-L][PF^\ ( 1 3 5 ) 
S i l v e r n i t r a t e (13.2 mg, 7.76 x 10 moles) i n a c e t o n i t r i l e ( 1 . 0 
ml) was added t o t h e l i g a n d [101] (27.0 mg, 7.76 x 1 0 " 5 m o l e s ) i n 
d i c h l o r o m e t h a n e (1. 0 m l ) . A f t e r s t a n d i n g f o r 30 min. t h e s o l u t i o n was 
f i l t e r e d and t h e s o l v e n t e v a p o r a t e d from t h e f i l t r a t e under r e d u c e d 
p r e s s u r e . The brown r e s i d u e was d i s s o l v e d i n methanol ( 1 . 0 ml) and t o 
t h i s was added ammonium h e x a f l u o r o p h o s p h a t e (12.5 mg, 7.7 x 10 m o l e s ) . 
A f t e r f i l t r a t i o n t h e volume o f s o l v e n t was re d u c e d t o 0.75 ml and t h e 
s o l u t i o n l e f t i n t h e dark a t -20°C f o r 24 hour s . Brown c r y s t a l s were 
i s o l a t e d and r e d i s s o l v e d i n hot methanol (0.5 ml) and l e f t a t -20°C f o r 
12 h o u r s . C o l o u r l e s s c r y s t a l s were c o l l e c t e d by f i l t r a t i o n , washed w i t h 
3 -2 c o l d methanol (2 x 0.5 cm ) and d r i e d i n vacuo (10 mm Hg) (28.4 mg, 
617.); (Found: C, 31.4; H, 5.91; N, 8.89. C ^ H g g N ^ P F g A g r e q u i r e s 
C, 31.9; H, 5.99; N, 9 . 3 1 ) ; m/e (FAB, g l y c e r o l ) 457, 455 (M +) 
[ 1 0 9 A g + - L and 1 0 7 A g + - L ] ; ^ (CD3OD) 3.05 (8H, t , J 5.8 Hz, CH 2S) 2.72 
(8H, t , J 5.6 Hz, CH 2N) 2.60 (8H, b r s , N-CH 2CH 2-N) 2.41 (12H, s , CHg); 
S Q (CDgOD) 59.0 (CH 2N) 55.8 (CH 2N) 44.3 (CHg-N) 33.4 ( C H 2 - S ) . 
Silver(I) complex of 1,2-bis(l-aza-4,7-dithia-l-cyclononyl)ethane 
[ 1 0 2 ] , [Ag-L)[PF6] ( 1 3 6 ) 
S i l v e r n i t r a t e (9.4 mg, 5.5 x 10 moles) i n a c e t o n i t r i l e ( 1 . 0 ml) 
was added t o t h e l i g a n d [102] (19.4 mg, 5.5 x 10 m o l e s ) i n 
d i c h l o r o m e t h a n e (1.0 ml) and t h e m i x t u r e f i l t e r e d and s o l v e n t e v a p o r a t e d 
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from t h e f i l t r a t e under r e d u c e d p r e s s u r e . The c o l o u r l e s s r e s i d u e was 
d i s s o l v e d i n methanol (1.0 ml) and t o t h i s was added ammonium 
h e x a f l u o r o p h o s p h a t e (9.0 mg, 5.5 x 10 m o l e s ) i n methanol ( 1 . 0 ml) and 
t h e s o l u t i o n f i l t e r e d . The volume o f t h e f i l t r a t e was r e d u c e d t o 0.5 ml 
and t h e s o l u t i o n l e f t a t -20°C f o r 36 h o u r s . Needle shaped c o l o u r l e s s 
c r y s t a l s were c o l l e c t e d by f i l t r a t i o n and washed w i t h c o l d methanol (2 x 
0.5 ml) and d r i e d i n vacuo (10 mm Hg) (17 mg, 557.). C r y s t a l s s u i t a b l e 
f o r X - r a y d i f f r a c t i o n s t u d i e s were grown from a s o l u t i o n o f t h e complex 
i n MeOH:MeCN ( 1 0 : 1 ) ; (Found: C, 27.6; H, 4.61; N, 4.39. 
c i 4 H 2 8 N 2 s 4 P F 6 A g r e ( i u i r e s c' 2 7- 8; H > 4- 6 2; N > 4 - 6 2 ) ; m/ e ( F A B > 
g l y c e r o l ) 461, 459 (M +) [ 1 0 9 A g + - L and 1 0 7 A g + - L ] ; <$H ( D 2 0 ) 2.6-2.9 (28H, 
m). X - r a y c r y s t a l s t r u c t u r e d a t a - s e e a p p e n d i x . 
Silver(I) complex of 1,4-dithia-7-azacyclononane [ 1 2 6 ] , 
[Ag-(L)2] [PF6] 
S y n t h e s i s a s f o r [134] u s i n g a 2:1 r a t i o o f l i g a n d t o s i l v e r 
n i t r a t e . C o l o u r l e s s c r y s t a l s were o b t a i n e d a f t e r r e c r y s t a l l i s a t i o n from 
methanol (10 mg, 287.); m/e (FAB, G l y c e r o l ) 435, 433 [ 1 0 9 A g - ( L ) 2 and 
1 0 7 A g - ( L ) 2 ] ; (5 H ( D 2 0 ) 2.93 (8H, s , S-CH 2CH 2-S) 2.86 (8H, m, CH 2S) 2.78 
(8H, m, CH 2N). 
Silver(I) complex of 25,26-diaza-3,7,15,19-tetrathiairicyclo-
[19.3.1.1.1]hexacosa 1(25)9(26),10,12,21,23-hexane [ 1 3 7 ] , 
[Ag-i] [PF6] 
S y n t h e s i s a s f o r [ 1 3 4 ] ; Y i e l d ( 5 mg, 257.); m/e (FAB, 
Glycerol-MeOH) 531, 529 ( 1 0 9 A g + - L and 1 0 7 A g + - L ) ; 6^ ( D 2 0 ) 7.49 (2H, t , 
7.7 Hz, P y r H) 7.52 (4H, d, J 7.7 Hz, P y r H) 4.29 (8H, s , P y r - C H 2 - S ) 
2.74 (8H, t , 7.5 Hz, S-CH 2-C) 1.75 (4H, p, J 7.5 Hz, C-CH 2-C). 
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Silver(I) complex of 15-diaza-S,6,9-trithiabicyclo[9.3.l]penta-
decyl-l(15),11,13-triene-12-carboxylate ethyl ester [ 1 3 8 ] , 
W\ [PF6] 
S y n t h e s i s a s f o r [ 1 3 4 ] . R e c r y s t a l l i s a t i o n from a c e t o n i t r i l e gave 
y e l l o w c r y s t a l s (10 mg, 197.); m/e (FAB, G l y c e r o l - H 2 0 ) 438, 436 
( 1 0 9 A g + - L , 1 0 7 A g + - L ) ; <5H (CDgCN) 8.02 (1H, d, J 8.0, P y r H) 7.19 (1H, 
d, J 7.8 Hz, P y r H) 4.24 (2H, s , Pyr-CH 2-S) 4.14 (2H, q, J 7.1 Hz, 
CH 2CH 3) 3.91 (2H, s , Ar-CH 2-S) 2.55 (4H, m, CH 2S) 2.29 (4H, m, CH 2S) 
1.15 (3H, t , J 7.0 Hz, C H 3 ) . 
Silver(I) complex of 15-aza-3,9-dithia-6-oxabicyclo[9.3.l]penta-
decyl'l(15),ll,13-triene [ 1 3 9 ] , [Ag-L] [NOy] 
S i l v e r n i t r a t e (17.0 mg, 0.099 mmol) was added t o t h e l i g a n d (24 
mg, 0.099 mmol) i n CH 2C1 2-CH 3CN [ ( 1 : 1 ) , 1.0 m l ] . A f i n e w h i t e 
p r e c i p i t a t e was c o l l e c t e d by f i l t r a t i o n and r e c r y s t a l l i s e d from w a t e r 
(0.4 ml) (9 mg, 227.); m/e [FAB, g l y c e r o l - H 2 0 ] 350, 348 ( A g + - L , 
10V-L). 
Silver(I) complex of 21-aza-3,15-dithia-6,9,12-trioxabicyclo-
[15.3.1]Heneicosa-l(21),17,19-triene [ 1 4 0 ] , [Ag-L] 2 [ P F 6 ] 2 
S y n t h e s i s a s f o r ( 1 3 4 ) , c o l o u r l e s s c r y s t a l s (20 mg, 527.); m/e 
(FAB-Glycerol-MeOH) 438, 436 ( 1 0 9 A g + - L , 1 0 7 A g + - L ) ; 6 R ( ( C D 3 ) 2 C 0 ) 7.87 
(1H, t , J 7.6 Hz, P y r H) 7.47 (2H, d, J 7.6 Hz, P y r H) 4.19 (4H, s , 
P y r - C H 2 - S ) 3.79 (4H, t , J 5.2 Hz, S-CH 2CH 2-0) 3.75 (8H, s , 0-CH 2CH 2-0) 
3.10 (4H, t , J 5.2 Hz, S-CH 2CH 2-0). X - r a y c r y s t a l s t r u c t u r e c e l l d a t a -
s e e appendix. 
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6.3. pH-Metric T i t r a t i o n s 
6.3.1. Apparatus 
The t i t r a t i o n c e l l was a double w a l l e d g l a s s v e s s e l ( c a p a c i t y 5 ml) 
which was m a i n t a i n e d a t 25°C, u s i n g a Techne Tempette J u n i o r T E - 8 J . 
T i t r a t i o n s o l u t i o n s were s t i r r e d u s i n g a m a g n e t i c s t i r r e r and kept under 
an atmosphere o f n i t r o g e n . T i t r a t i o n s were performed u s i n g an a u t o m a t i c 
t i t r a t o r ( M e t t l e r DL20, 1 ml c a p a c i t y ) and b u r e t t e f u n c t i o n s (volume 
i n c r e m e n t s and e q u i l i b r a t i o n t i m e ) were c o n t r o l l e d by a BBC 
m i c r o p r o c e s s o r . The pH was measured u s i n g a C o r n i n g 001854 c o m b i n a t i o n 
m i c r o e l e c t r o d e which was c a l i b r a t e d u s i n g b u f f e r s o l u t i o n s a t pH 4.008 
( C 0 2 H . C 6 H 4 C 0 2 K , 0.05M) and pH 6.865 ( K H 2 P 0 4 , 0.025M/Na2HP04, 0.025M). 
D a t a was s t o r e d on t h e BBC m i c r o p r o c e s s o r and t r a n s f e r r e d t o t h e MTS 
mainframe u s i n g KERMTT and s u b s e q u e n t l y a n a l y s e d by two n o n - l i n e a r l e a s t 
s q u a r e s programs SC0G2 and SUPERQUAD. 
6.3.2. Acid dissociation constants 
S t o c k s o l u t i o n s o f t h e l i g a n d (0.002M) i n m i l l i - Q w a t e r (25.0 ml) 
w i t h n i t r i c a c i d (1 eq. p e r amine n i t r o g e n o f t h e l i g a n d ) and 
tetramethylammonium n i t r a t e ( I = 0.10 mol dm ) were p r e p a r e d . I n each 
t i t r a t i o n 3.5 ml o f t h e s t o c k l i g a n d s o l u t i o n was t i t r a t e d w i t h 
tetramethylammonium h y d r o x i d e (0.109M), t h e e x a c t m o l a r i t y o f which was 
de t e r m i n e d by t i t r a t i o n a g a i n s t h y d r o c h l o r i c a c i d , 0.100M. 
6.3.3. Metal binding constants 
S t o c k s o l u t i o n s were p r e p a r e d a s above w i t h t h e a d d i t i o n o f one 
e q u i v a l e n t of s i l v e r n i t r a t e . T i t r a t i o n s were performed a s b e f o r e . 
6.4. NMR Experiments 
13 
6.4.1. C nmr experiments 
C nmr s p e c t r a of t h e C - a c e t o c a r b o n y l e n r i c h e d (997.) 
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[ 9 ] - N g - t r i a c i d and i t s i n d i u m ( I I I ) complex were r e c o r d e d on a B r u k e r 
AC250 s p e c t r o m e t e r (62.896 MHz). S o l u t i o n s o f t h e complex (1.0xlO~ 2M) 
i n D.2O (2.0 ml) were a c i d i f i e d w i t h c o n c e n t r a t e d n i t r i c a c i d (15.6M). 
T y p i c a l l y 75-100 s c a n s were r e q u i r e d t o o b t a i n s p e c t r a w h i c h c o u l d be 
i n t e g r a t e d ( a l i n e b r o a d e n i n g f a c t o r of 6.0 Hz was e m p l o y e d ) . The 
s h i f t s were quoted r e l a t i v e t o an i n t e r n a l D i o xane r e f e r e n c e a t 66.296 
ppm. 
71 
6.4.2. Ga nmr experiments 
71 
Ga nmr were r e c o r d e d on a B r u k e r AC250 s p e c t r o m e t e r w i t h s p e c t r a l 
f r e q u e n c y 76.282 MHz. C h e m i c a l s h i f t s a r e quoted i n ppm, r e f e r e n c e d t o 
G a ( D 2 0 ) g + a t S = 0 ppm and Ga(OD)^ a t 222.6 ppm. S o l u t i o n s o f t h e 
9 
g a l l i u m [ 9 ] - N g - t r i a c i d complex (1.5x10 M) i n D 20 ( 0 . 6 ml) were 
a c i d i f i e d w i t h c o n c e n t r a t e d n i t r i c a c i d (15.6M). 
6.5. X-ray Crystal Structure Determinations 
The X-ray c r y s t a l s t r u c t u r e s of t h e [ A g - p y S r > 0 g ] 2 [ P F g ] 2 , 
[ A g - N , N ' - b i s [ 9 ] N S 2 ] [ P F 6 ] and [ I n - [ 9 ] N g - t r i a c i d ] H C l . H 2 0 c o m plexes were 
d e t e r m i n e d by P r o f e s s o r George Ferguson (Department o f C h e m i s t r y , 
U n i v e r s i t y of Guelph, O n t a r i o , Canada). The X - r a y c r y s t a l s t r u c t u r e s of 
t h e [ A g - [ 1 8 ] N 4 S 2 ] [ P F g ] , [ G a - [ 9 ] N g - t r i a c i d ] and [ I n - [ 9 ] N g - t r i a c i d ] H C l . H 2 0 
complexes were determined by Dr. Ha r r y Adams and Dr. N e i l B a i l e y 
( U n i v e r s i t y o f S h e f f i e l d , U.K.). C e l l d a t a , e x p e r i m e n t a l d e t a i l s , 
p o s i t i o n a l and t h e r m a l p a r a m e t e r s and m o l e c u l a r d i m e n s i o n s f o r e a c h 
s t r u c t u r e a r e g i v e n i n t h e Appendix. 
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APPENDIX - CRYSTAL DATA 
( 1 ) [ l n - ( 9 ) - N 3 - t r i a c i d ] . H C I . H 2 0 
C r y s t a l d a t a f o r [ ( L ) I n C l J . 0 . 4 6 ( H 2 0 ) , 0 . 1 8 ( B 2 0 ) ; 
C 1 2 H 1 9 C l I n N 3 0 6 . 0 . 6 4 ( H 2 0 ) , Mf = 463.1. C r y s t a l d i m e n s i o n 0.25 x 0.43 x 
0.55 ma, M o n o c l i n i c a. = 7 . 0 1 7 ( 3 ) , b, 1 7 . 7 0 1 ( 5 ) , £ = 1 4 . 0 8 3 ( 3 ) A, 3 = 
99.02(2)°. U = 1 7 2 8 ( 2 ) A 3 , = 1.78 gem' 3, 2 = 4. S p a c e group P ^ / n Mo-Ka 
r a d i a t i o n (X = 0.71073 A), / i(Mo-K t f) = 15.3 c i " 1 , E(000) = 929.6. 
T h r e e d i m e n s i o n a l d a t a were c o l l e c t e d u s i n g a CAD4 d i f f r a c t o m e t e r i n t h e 
r a n g e 4° < 28 < 40° by t h e u/20 s c a n method. C o l l e c t i o n o f d a t a i n t h e r a n g e 
40° < 28 < 5 4 ° was t e r m i n a t e d because o f r a p i d d e c a y o f t h e c r y s t a l soon a f t e r 
d a t a c o l l e c t i o n f o r t h i s s h e l l s t a r t e d ; t h e r e had been no s i g n i f i c a n t d e c a y 
d u r i n g t h e i n i t i a l d a t a c o l l e c t i o n ! S t r u c t u r e s o l u t i o n and r e f i n e m e n t 
p r o g r e s s e d w i t h t h e 4-40° d a t a s e t . The c e l l d a t a were d e t e r m i n e d by a 
l e a s t - s q u a r e s a n a l y s i s of t h e s e t t i n g a n g l e s o f 25 r e f l e c t i o n s w i t h 14 < 28 < 
40°. 3 259 r e f l e c t i o n s were c o l l e c t e d of w h i c h 2564 were u n i q u e ( g - f a c t o r on 
a v e r a g i n g 1.67.). The d a t a were c o r r e c t e d f o r a b s o r p t i o n (max. and min. 
t r a n s m i s s i o n c o e f f i c i e n t s 0.734, 0.664) and d u r i n g r e f i n e m e n t f o r s e c o n d a r y 
e x t i n c t i o n . The 1488 r e f l e c t i o n w i t h I > 3 * ( J J were l a b e l l e d o b s e r v e d and 
used i n s t r u c t u r e s o l u t i o n and r e f i n e m e n t . The s t r u c t u r e was s o l v e d v i a t h e 
h e a v y atom method and r e f i n e d by f u l l - m a t r i x l e a s t - s q u a r e s c a l c u l a t i o n s . Two 
s i t e s c o r r e s p o n d i n g t o p a r t i a l l y o c c u p i e d w a t e r m o l e c u l e s were a l s o l o c a t e d . 
No h y d r o g e n o f w a t e r m o l e c u l e s c o u l d be l o c a t e d form d i f f e r e n c e maps, bat a l l 
h y d r o g e n s o f t h e complex were c l e a r l y v i s i b l e . The c o m p l e x m o l e c u l e s a r e 
l i n k e d by an u n u s u a l l y s h o r t O-H-0 hydrogen bond ( 2 . 4 8 7 ( 6 ) A) and a d i f f e r e n c e 
map showed a c l e a r maximum midway between t h e two oxygen atoms. A l l o t h e r 
h y d r o g e n atoms were p o s i t i o n e d g e o m e t r i c a l l y (C-B 0.95 A) and i n c l u d e d but not 
r e f i n e d i n t h e r e f i n e m e n t p r o c e s s . R e f i n e m e n t c o n v e r g e d w i t h R. = 0.039, 
R w = 0.075 ( l a r g e s t s h i f t / e r r o r r a t i o 0 . 0 5 ) . S c a t t e r i n g f a c t o r and anomalous 
d i s p e r s i o n d a t a were t a k e n from I n t e r n a t i o n a l T a b l e s f o r C r y s t a l l o g r a p h y and 
a l l c a l c u l a t i o n s were done w i t h SDP-Plus. I n t h e r e f i n e m e n t c y c l e , w e i g h t s 
were d e r i v e d from t h e c o u n t i n g s t a t i s t i c s ; a f i n a l d i f f e r e n c e map had no 
c h e m i c a l l y s i g n i f i c a n t maxima. 
Table 
Positional and thermal parameters and their a.a.d. 'a 
Atom I V I B (A ) 
In 0. 00307(6) 0. 15377(2) 0. 18844(3) 1. 87(1) 
CL 0. 1644(3) 0. 15215(8) 0. 3518(1) 3. 39(5) 01 0. 1160(5) 0. 2749(2) 0. 1920(3) 2. 73(9) 02 0. 0896(6) 0. 3854(2) 0. 2636(3) 3. 5(1) 03 0. 1028(6) 0. 0225(2) 0. 1918(3) 2. 71(9) 
04 0. 0882(6) -0. 0811(2) 0. 2767(3) 3. 6(1) 
05 0. 1989(6) 0. 1441(2) 0. 0891(3) 2. 5(1) 
06 0. 2295(6) 0. 1133(3) -0. 0587(3) 3. 7(1) 
07 0. 200(3) 0. 336(1) 0. 017(1) 11. 0(6) 
08 0. 210(7) 0. 498(2) 0. 003(3) 10(1) 
Nl -0. 2499(6) 0. 2359(3) 0. 2043(3) 2. 3(1) 
N2 -0. 2407(7) 0. 0760(3) 0. 2281(3) 2. 2(1) 
N3 -0. 2012(8) 0. 1443(2) 0. 0454(4) 2. 4(1) 
CI -0. 4095(8) 0. 1984(3) 0. 2439(4) 2. 6(1) 
C2 -0. 3489(9) 0. 1236(4) 0. 2886(4) 2. 5(1) 
C3 -0. 1557(9) 0. 0109(4) 0. 2791(5) 2. 8(1) 
C4 0. 0228(9) -0. 0162(3) 0. 2446(4) 2. 6(1) 
C5 -0. 3638(9) 0. 0517(4) 0. 1373(5) 3. 2(2) 
C6 -0. 2748(9) 0. 0640(4) 0. 0485(5) 3. 0(1) 
C7 -0. 0795(10) 0. 1537(3) -0. 0300(5) 3. 2(2) 
C8 0. 1336(9) 0. 1346(4) 0. 0020(5) 2. 6(1) 
C9 -0. 3604(9) 0. 2001(4) 0. 0374(4) 2. 9(1) 
CIO -0. 3149(9) 0. 2652(4) 0. 1057(5) 2. 9(1) 
C l l -0. 1632(8) 0. 2986(3) 0. 2642(4) 2. 7(1) 
C12 0. 0287(9) 0. 3200(3) 0. 2378(3) 2. 5(1) 
Atoms 07 and 08 are from water molecules that have p a r t i a l 
occupancies (0.46 and O. 18 respectively). Atom 08 was 
refined isotropically. 
Anisotropically refined atoms are given in the form of the 
isotropic equivalent thermal parameter defined as: 
2 2 2 i»/3 [a B • b B 0 0 + c B • abcosYB, _ + a c c o a B B 1 0 + b c c o s « B 5 , ] 
Table Molecular dimensions 
(a) Bond lengths (A) 
(1) (2) 
In CL 2. 399<2) 2. 406(4) 
In 01 2. 284<4) 2. 281(6) 
In 03 2. 424(4) 2. 413(6) 
In 05 2. 116(5) 2. 106(5) 
In Nl 2. 332(5) 2. 338(6) 
In N2 2. 331 (5) 2. 335(6) 
In N3 2. 288(5) 2. 281 (6) 
01 C12 1. 246(8) 1.262(9) 
02 C12 1. 267(7) 1. 254(8) 
03 C4 1. 212(8) 1. 219(9) 
04 C4 1. 292(7) 1. 287(8) 
05 C8 1. 252(7) 1. 275(8) 
06 C8 1. 228(8) 1. 214(9) 
Nl CI 1. 483(8) I. 490(9) 
Nl CIO 1. 486(8) 1. 479(9) 
Nl C l l 1. 468(7) 1. 459(8) 
N2 C2 1. 489(8) 1. 490(9) 
N2 C3 1. 437(8) 1. 473(9) 
N2 C5 1. 489(8) 1. 485(9) 
N3 C6 1. 514(8) 1. 492(9) 
N3 C7 1. 473(10) 1. 468(10) 
N3 C9 1. 482(8) 1. 486(9) 
CI C2 1. 499(9) 1. 513( 10) 
C3 C4 1. 492(9) 1. 489(11 ) 
C5 C6 1. 499(10) 1.516(11) 
C7 C8 1. 531(10) 1.493(12) 
C9 CIO 1. 502(9) 1. 515( 10) 
C U C12 1. 501(9) 1.507(10) 
01 07 2. 84(2) 2. 84 
02 04(1) 2. 487(6) 2. 497 
07 08 2. 87(5) 2. 96 
08 08(11) 2. 94(7) 2. 79 
(6 ) Bond angles <°) 
(1) (2) 
CL In 01 83. 1(1) 83.4(2) 
CL In 03 83. 0( 1) 82. 8(2) 
CL In 05 112. 0(1) 112. 0(1) 
CL In Nl 99. 6(1) 99. 7(2) 
CL In N2 91. 0( 1) 91. 2(2) 
CL In N3 168. 3(2) 168. 6(3) 
• 1 In 03 143. 2(1) 143. 2(2) 
01 In 05 80. 3( 1) 80. 5(2) 
01 In Nl 71. 3(2) 71. 1(2) 
01 In N2 144. 5(2) 144. 9(2) 
01 In N3 104. 8(2) 104. 3(2) 
03 In 05 73. 8(1) 73. 6(2) 
03 In Nl 144. 8(2) 145. 0(2) 
03 In N2 69. 5(2) 69. 4(2) 
03 In N3 94. 9(1 ) 95. 3(2) 
OS In Nl 134. 2(2) 134. 3(2) 
05 In N2 133. 5(2) 132. 9(2) 
05 In N3 78. 1(2) 77. 9(2) 
Nl In N2 75. 3(2) 75. 7(2) 
Nl In N3 75. 4(2) 75. 5(2) 
N2 In N3 77. 6(2) 77. 7(2) 
In 01 C12 114. 6(4) 115. 0(4) 
In 03 C4 113. 3(4) 113. 5(5) 
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N2 C5 C6 114. 4<5) 112.7<5) 
N3 C6 C5 110. 4 ( 5 ) 112. 2 ( 6 ) 
N3 C7 C8 114. 4 ( 6 ) 115. 6 ( 6 ) 
05 C8 06 124. 6<6> 123. 7 ( 6 ) 
05 CB C7 116. 7 ( 6 ) 116. 6 ( 6 ) 
06 C8 C7 118. 7 ( 6 ) 119. 7 ( 6 ) 
N3 C9 CIO 112 4 ( 5 ) 1 1 1 . 7 ( 5 ) 
Nl C I O C9 1 0 9 . 5 ( 5 ) 110. 3 ( 5 ) 
Nl C l l C12 110. 8<5) 110.9 ( 6 ) 
01 C12 02 124. 2 ( 6 ) 124.3(7) 
01 C12 C l l 120. 0 ( 5 ) 1 1 8 . 9 ( 6 ) 






0 8 ( I I > 
1 1 7 . ( 1 ) 
90 ( 2 ) 
116 
86 
T h . roman n u m e r a l , r e f e r to t h e A l l o w i n g e o . u i v a l . n t p o s i t i o n s : 
I . O. 5 - x. O. 5 + Y- 0. 5 - x 
I I . -«. 1 - <J. " » 
D e p o s i t i o n data 
G e n e r a l T e m p e r a t u r e F a c t o r E x p r e s s i o n s - U's 
Nam* U ( l , 1 ) U(2. 2 ) U ( 3 . 3 ) U ( l . 2) U(l< 3) U ( 2 . 3 ) 
I n 0. 0 1 5 8 ( 3 ) 0. 0 2 7 2 ( 4 ) 0. 0 2 8 2 ( 4 ) -0. 0 0 1 0 ( 2 ) 0. 0 0 3 8 ( 3 ) -0. 0 0 3 0 ( 2 ) 
CL 0. 0 3 7 ( 1 ) 0. 0 5 7 ( 1 ) 0. 0 3 2 ( 1 ) 0. 0 0 1 3 ( 7 ) -0. 0 0 2 2 ( 9 ) -0. 0 O34(7 > 
• 1 0. 0 2 5 ( 2 ) 0. 0 2 9 ( 2 ) 0. 0 5 3 ( 2 ) -0. 0 0 7 ( 2 ) 0. 0 1 4 ( 2 ) -0. 0 1 1 ( 2 ) 
02 0. 0 3 7 ( 3 ) 0. 0 3 3 ( 3 ) 0. 0 6 5 ( 3 ) -0. 0 0 5 ( 2 ) 0. 0 0 9 ( 2 ) -0. 0 1 0 ( 2 ) 
0 3 0. 0 2 9 ( 2 ) 0. 0 2 9 ( 2 ) 0. 0 4 6 ( 2 ) 0. 0 0 9 ( 2 ) 0. 0 1 2 ( 2 ) 0. 0 1 2 ( 2 ) 
04 0. 0 3 9 ( 3 ) 0. 0 3 1 ( 3 ) 0. 0 6 7 ( 3 ) 0. 0 1 3 ( 2 ) 0. O i l ( 2 ) 0. 0 1 6 ( 2 ) 
0 5 0. 0 2 1 ( 2 ) 0. 0 4 4 ( 3 ) 0. 0 2 8 ( 2 ) -0. 0 0 5 ( 2 ) 0. 0 0 5 ( 2 ) -0. 0 0 5 ( 2 ) 
06 0. 0 4 1 ( 3 ) 0. 0 5 7 ( 3 ) 0. 0 4 9 ( 2 ) -0. 0 0 2 ( 2 ) 0. 0 2 3 ( 2 ) -0. 0 1 1 ( 2 ) 
07 0. 0 9 ( 1 ) 0. 2 6 ( 2 ) 0. 0 6 7 ( 9 ) -0. 0 3 ( 1 ) 0. 0 0 5 ( 9 ) 0. 0 6 0 ( 9 ) 
Nl 0. 0 1 3 ( 2 ) 0. 0 3 1 ( 3 ) 0. 0 4 3 ( 3 ) -0. 0 0 4 ( 2 ) 0. 0 0 7 ( 2 ) -0. 0 0 7 ( 2 ) 
N2 0. 0 1 7 ( 3 ) 0. 0 3 1 ( 3 ) 0. 0 3 3 ( 3 ) -0. 0 0 1 ( 2 ) -0. 0 0 1 ( 2 ) -0. 0 0 7 ( 2 ) 
N3 0. 0 2 4 ( 3 > 0. 0 3 5 ( 3 ) 0. 0 3 1 ( 3 ) -0. 0 0 0 ( 2 ) 0. 0 0 2 ( 2 ) -0. 0 1 3 ( 2 ) 
C I 0. 0 1 7 ( 3 ) 0. 0 4 1 ( 4 ) 0. 0 4 1 ( 3 ) 0. 0 0 8 ( 3 ) 0. 0 0 8 ( 3 ) -0. 0 0 3 ( 3 ) 
C2 0. 0 2 0 ( 3 ) 0. 0 4 7 ( 4 ) 0. 0 3 1 ( 3 ) -0. 0 0 0 ( 4 ) 0. 0 1 1 ( 3 ) 0. 0 0 3 ( 3 ) 
C3 0. 0 3 1 ( 4 ) 0. 0 3 0 ( 4 ) 0. 0 4 7 ( 4 ) 0. 0 0 5 ( 3 ) 0. 0 0 8 ( 3 ) 0. 0 1 1 ( 3 ) 
C4 0. 0 3 2 ( 4 ) 0. 0 3 7 ( 4 ) 0. 0 3 1 ( 3 ) -0. 0 0 7 ( 3 ) 0. 0 0 6 ( 3 ) -0. 0 1 0 ( 3 ) 
C5 0. 0 2 7 ( 3 ) 0. 0 2 5 ( 4 ) 0. 0 7 3 ( 4 ) -0. 0 0 6 ( 3 ) 0. 0 1 7 ( 3 ) -0. 0 0 2 ( 3 ) 
C6 0. 0 3 4 ( 4 ) 0. 0 2 8 ( 3 ) 0. 0 4 7 ( 4 ) -0. 0 0 9 ( 3 ) -0. 0 0 7 ( 3 ) -0. 0 1 4 ( 3 ) 
C7 0. 0 2 8 ( 4 ) 0. 0 6 2 ( 5 ) 0. 0 3 1 ( 4 ) -0. 0 0 3 ( 3 ) 0. 0 0 1 ( 3 ) 0. 0 0 2 ( 3 ) 
C8 0. 0 2 9 ( 4 ) 0. 0 3 3 ( 3 ) 0. 0 3 7 ( 4 ) -0. 0 0 6 ( 3 ) 0. 0 0 9 ( 3 ) -0. 0 0 4 ( 3 ) 
C9 0. 0 2 6 ( 3 ) 0. 0 4 6 ( 4 ) 0. 0 3 5 ( 3 ) 0. 0 0 3 ( 3 ) -0. 0 0 1 ( 3 ) 0. 0 0 6 ( 3 ) 
C10 0. 0 2 5 ( 3 ) 0 0 3 7 ( 4 ) 0. 0 5 0 ( 4 ) 0. 0 0 8 ( 3 ) 0. 0 0 5 ( 3 ) 0. 0 0 8 ( 3 ) 
C l l 0. 0 2 2 ( 3 ) 0. 0 3 3 ( 4 ) 0. 0 4 6 ( 4 ) -0. 0 0 5 ( 3 ) 0 0 0 3 ( 3 ) -0. 0 1 1 ( 3 ) 
C12 0. 0 3 8 ( 4 ) 0. 0 1 4 ( 3 ) 0. 0 4 4 ( 4 ) -0. 0 0 6 ( 3 ) 0. 0 0 6 ( 3 ) 0. 0 0 8 ( 3 ) 
The form of the a n i s o t r o p i c t h e r m a l p a r a m e t e r i s : 
• x p [ - 2 r 2 ( U t , h 2 « " 2 + U 2 2 k 2 b * 2 + U 3 3 l 2 c , 2 * 2 u 1 2 h ' < « * b " * 2 u 1 3 h l « * c * + 2 U 2 3 k l b , c * ) ) 
Deposition data 
Calculated hydrogen coordinates (C-H 0.93 A* Biso 3 A ) 
Atom i V z 
H<02-04) 0. 2506 0. 4021 0 2434 
Hla -0. 4494 0. 2302 0 2913 
Hlb -0. 5142 0. 1907 0. 1933 
H2a -0. 4612 0. 0969 0. 2990 
H2b -0. 2688 0. 1324 0. 3484 
H3a -0. 1241 0. 0235 0. 3452 
H3b -0. 2477 -0. 0288 0. 2715 
H5a -0. 3900 -0. 0006 0. 1422 
H5b -0. 4812 0 0793 0. 1307 
H6a -0. 3689 0. 0550 -0. 0065 
H6b -0. 1702 0 0299 0. 0485 
H7a -0. 1282 0. 1217 -0. 0823 
H7b -0. 0881 0. 2048 -0. 0506 
H9a -0. 3831 0. 2191 -0. 0264 
H9b -0. 4732 0. 1755 0. 0511 
HlOa -0. 4272 0. 2952 0. 1052 
HlOb -0. 2154 0. 2950 0. 0861 
HI la -0. 2470 0. 3410 0. 2550 
HI lb -0. 1458 0. 2837 0. 3298 
(2) Ga-[9]N 3-triacid 
C r y s t a l data for [< (CH 3) a-N.CH a.CO a>s6a]; CtaHt«6aN»0,.; M = 370.01. 
C r y s t a l l i s e s from solvent as colourless needles; c r y s t a l dimensions 0.68 
x 0.05 x 0.13 ma. Monoclinic, a = 8.927(10), b = 13.646(15), c = 
12.086(10) 8, beta = 105.36(7) °, U = 1419.6(25) &*; D« = 1.731 g cm"3, 
Z = 4. Space group P2 t/n (a non-standard s e t t i n g of P2»/c, Ca* a, No. 
14), Mo K„, p„. radiation ( A = 0.71069A), ji(Mo ««,„„.) = 19.62 cm"1, 
F(000) = 759.78. 
Three-dimensional, room temperature X-ray data were c o l l e c t e d in 
the range 3.5 < 28 < 50° on a Nicolet R3 4 - c i r c l e diffractometer by the 
omega scan method. The 1491 independent r e f l e c t i o n s for which SF!/o-(!F!) 
> 3.0 were corrected for Lorentz and p o l a r i s a t i o n e f f e c t s , and for 
absorption, by a n a l y s i s of 10 azimuthal scans. The s t r u c t u r e was solved 
by Patterson and Fourier techniques and refined by blocked cascade le a s t 
squares methods. Hydrogen atoms were included in c a l c u l a t e d positions 
with isotropic thermal parameters related to those of the supporting 
atom. Refinement converged at a f i n a l R 0.0627, with allowance for the 
thermal anisotropy of a l l non-hydrogen atoms. Complex s c a t t e r i n g factors 
were taken from reference Z, and from the program package SHELXTL V as 
implemented on the Data General Nova 3 computer. A weighting scheme w - 1 = 
Co- a(F)+g(F) a3, with g = 0.00025, was used in the f i n a l c y c l e s of 
refinement. Table 1 l i s t s atomic positional parameters with estimated 
standard deviations. 
Reference Z International Tables for X-ray Crystallography, Vol, 
Kynoch Press, Birmingham, 1974. 
4, 
Reference Y 6. h. Sheldrick, SHELXTL, An integrated system for 
solving, r e f i n i n g and displaying c r y s t a l s t r u c t u r e s from 
d i f f r a c t i o n data (Revision 4), University of Gottingen, 
F.R.Germany. 
Supplementary material 
anisotropic thermal v i b r a t i o n a l parameters with e.s.ds. 
hydrogen atom position parameters 
observed structure amplitudes and calculated s t r u c t u r e fa c t o r s . 
TABLE 2. (a) Bond lengths (A) 
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TABLE 2. (b) Bond an9les (deg.) 
0 ( l ) - G a ( l ) - 0 ( 3 ) 
0(3)-6a (1>-0(5) 
0 ( 3 ) - S a ( l ) - N ( l ) 
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C ( l ) - N ( l ) - C ( 1 0 ) 











































0 ( l ) - 6 a ( l ) - 0 ( 5 ) 
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TABLE 1. Atom coordinates (xlO*) and temperature factors (A 2xlO*> 
at oa X y z u. 
Gad) 1103(1) 2517(1) 3169(1) 27 (1 ) * 
0(1) 2924(6) 1670(4) 3532(4) 30 (2 ) * 
0(2) 5199(6) 1441(4) 3117(5) 47 (2)« 
0(3) 389(6) 2151(4) 4488(4) 34 (2)* 
0(4) -889(6) 977(4) 5164(5) 49 (2)# 
0(5) 2235(6) 3666(4) 3886(4) 32 (2)« 
0(6) 1879(6) 5172(4) 4510(5) 46 (2)» 
N(l) -658(6) 3541(4) 2475(5) 26 (2)# 
N(2> 1615(6) 2648(5) 1575(5) 30 (2 ) * 
N(3) -563(7) 1487(4) 2308(5) 30 (2 ) * 
C ( l ) -475(8) 3888(5) 1322(6) 30 (3)* 
C(2) 1131(9) 3661(6) 1176(7) 36 (3)# 
C(3) 3323(7) 2459(7) 1850(6) 38 (3)* 
C(4) 3902(9) 1791(6) 2909(6) 33 [3)# 
C(5) 689(9) 1890(6) 758(6) 36 (3)# 
C(6) 141(8) 1050(6) 1404(6) 35 13)* 
C(7) -671(10) 807(6) 3237(8) 42 14)* 
C(8) -405(9) 1336(6) 4393(7) 34 (3)« 
C(9) -2077(9) 2015(6) 1798(7) 36 t3)» 
C(10) -2145(9) 3013(6) 2357(7) 38 13)* 
C ( l l ) -361(9) 4354(6) 3345(7) 35 (3)* 
C(12) 1378(9) 4432(6) 3967(6) 31 3)» 
* Equivalent isotropic U de-fined as one t h i r d of the 
trace of the orthogonalised U t j tensor 
TABLE Anisotropic temperature f a c t o r s (A^xlO 3) 
a too U t i u» u » U i , u i a 
B a d ) 26(1) 29(1) 25(1) 1(1) 8(1) 1(1) 
0(1) 30(3) 40(3) 21 (3) 3(2) 8(2) 1(3) 
0(2) 28(3) 64(4) 48(4) -0(3) 9(3) 14(3) 
0(3) 41(3) 36(3) 27(3) -3(2) 13(3) -2(3) 
0(4) 64(4) 44(4) 53(4) 10(3) 38(3) 5(3) 
0(5) 30(3) 34(3) 32(3) -5(3) 9(2) -3(3) 
0(6) 51 (4) 37(3) 48(4) -12(3) 10(3) -15(3) 
N(l) 23(3) 27(4) 26(4) 3(3) 7(3) 0(3) 
N(2) 27(3) 31 (4) 31 (3) 3(3) 9(3) 6(3) 
N(3) 33(4) 33(4) 29(3) 6(3) 17(3) 5(3) 
C ( l ) 34(5) 20(4) 41(5) 6(4) 17(4) 12(4) 
C(2) 36(5) 42(5) 31 (5) 9(4) 9(4) 7(4) 
C(3) 32(4) 46(4) 41 (4) 3(6) 19(3) -0(6) 
C(4) 32(5> 35(5) 33(5) 1 (4) 14(4) -3(4) 
C(5) 43(5) 41(5) 28(5) -5(4) 16(4) -6(4) 
C(6) 24(4) 45(5) 33(5) -7(4) 4(4) 3(4) 
C(7) 44(6) 33(5) 53(6) 11(5) 18(5) -2(5) 
C(8) 33(5) 38(5) 35(5) 5(4) 14(4) 12(4) 
C(9) 22(5) 41(5) 41 (5) 5(5) 0(4) -5(4) 
C(10) 35(5) 41 (5) 39(5) -12(5) 9(4) 3(4) 
C ( l l ) 36(5) 38(5) 30(5) 2(4) 6(4) 7(4) 
C(12) 38(5) 34(5) 26(4) 1 (4) 13(4) -4(4) 
The ani s o t r o p i c temperature factor exponent takes the iorm: 
-2< a(h aa- aU»»+k ab- aU M+ ... +2hka-b*U4a> 
Hydrogen coordinates (xlO*) and temperature f a c t o r s ( f c x l O 3 ) 
a toot X y z U 
H(la) -616 4586 1284 37 
H(lb) -1249 3584 713 37 
H(2a) 1871 4119 1614 44 
H(2b> 1103 3717 379 44 
H(3a) 3555 2153 1199 49 
H(3b) 3858 3074 2002 49 
H(5a) 1336 1619 313 44 
H(5b) -200 2199 255 44 
H(6a) -622 664 872 40 
H(6b) 1010 643 1767 40 
H(7a) -1681 509 3051 55 
H(7b) 107 308 3305 55 
H(9a) -2205 2104 991 43 
H(9b) -2913 1621 1916 43 
H(10a) -2320 2930 3102 48 
H(10b) -2974 3394 1882 48 
H ( l l a ) -698 4961 2956 43 
H ( l l b ) -938 4233 3898 43 
(3) [Ag - (18 ) -N 4 S 2 ] [PF 6 j 
C r y s t a l data for CCS.(CH a) a.NH.(CH a) a.NH.(CH a) a} aAg3* (PF*)—, 
C» aHaoAgF AN*PS a; M = 545.34. C r y s t a l l i s e s from solvent as colourless, 
elongated blocks; c r y s t a l dimensions 0.45 x 0.25 x 0.225 mm. 
Orthorhombic, a = 10.859(22), b = 20.247(26), c = 9.742(10) 8, U = 
2142(6) A*3; D c = 1.691 g c u r 3 , = 4. Space group Pbcn ( Dan*", No. 
60), Mo K . i p h . radiation ( A" = 0.71069A), ^(Mo Kaip„ffl) = 12.46 cm"1, 
F(000) = 1103.84. 
Three-dimensional, room temperature X-ray data Mere c o l l e c t e d in 
the range 3.5 < 28 < 50° on a Nicolet R3 4 - c i r c l e diffractometer by the 
omega scan method. The 1205 independent r e f l e c t i o n s for which !F!/o~(!F!) 
> 3.0 H e r e corrected for Lorentz and polarisation e f f e c t s , and for 
absorption, by a n a l y s i s of 7 azimuthal scans. The struc t u r e was solved by 
Patterson and Fourier techniques and refined by blocked cascade le a s t 
squares methods. Hydrogen atoms were included in c a l c u l a t e d positions 
with isotropic thermal parameters related to those of the supporting 
atom. Refinement converged at a f i n a l R 0.0718, with allowance for the 
thermal anisotropy of a l l non-hydrogen atoms. Complex s c a t t e r i n g factors 
were taken from reference Z, and from the program package SHELXTLV' as 
implemented on the Data General Nova 3 computer. A weighting scheme w _ 1 = 
Co- 2 ( F ) + g ( F ) a ] , with g = 0.0009, was used in the f i n a l c y c l e s of 
refinement. Table 1 l i s t s atomic pos i t i o n a l parameters with estimated 
standard deviations. 
Reference Z International Tables for X-ray Crystallography, Vol. 4, 
Kynoch Press, Birmingham, 1974. 
Reference Y 6. M. Sheldrick, SHELXTL, An integrated system for 
solving, r e f i n i n g and displaying c r y s t a l s t r u c t u r e s from 
d i f f r a c t i o n data (Revision 4), University of Gottingen, 
F.R.Germany. 
Supplementary material 
anisotropic thermal vibra t i o n a l parameters with e.s.ds. 
hydrogen atom position parameters 
observed struc t u r e amplitudes and calculated s t r u c t u r e f a c t o r s . 
TABLE 2. (a) Bond lengths <A> 
A g d ) - S ( l ) 
Ag(l)-N(2) 




P ( l > - F ( l ) 










S ( l ) - C U ) 
Nd)-C(2) 
N(2)-C(4) 
C(l ) - C ( 2 ) 
C(5)-C(6) 








TABLE 2. (b> Bond angles (deg.) 
S ( D --Agd)-N(l) 75.9(3) S(l)-Ag(l)-N(2> 113.2(3) 
N(D- Agd)-N(2) 70.6(4) S d ) - A g d ) - S ( l a ) 124.5(2) 
S d ) - -Agd)-N(la) 144.7(3) Nd)-Agd)-N(la) 104.3(4) 
S ( l ) - Ag(l)-N(2a) 74.6(3) N(l)-Ag(l)-N(2a) 99.5(4) 
N(2)--Agd)-N(2a> 164.3(5) A g d ) - S ( l ) - C d ) 100.4(4) 
Ag(l> - S ( l ) - C ( 6 a ) 101.1(5) C ( l ) - S d ) - C ( 6 a ) 104.2(7) 
Ag(l) -Nd)-C(2) 113.4(8) Ag(l)-N(l)-C(3) 107.7(8) 
C(2>- N(l)-C(3) 115.4(10) Ag(l)-N(2)-C<4) 107.1(8) 
Ag(l) -N(2)-C(5) 111.5(8) C(4)-N(2)-C(5) 112.0(11) 
S ( l ) - C d ) - C ( 2 ) 117.2(9) Nd ) - C ( 2 ) - C ( l ) 113.0(11) 
N d ) -•C(3)-C(4) 112.6(11) N(2)-C(4)-C(3) 110.4(11) 
N(2)- C(5)-C(6) 112.9(12) C(5)-C(6)-S(la) 119.0(9) 
F ( l ) - •P(l)-F(2) 91.1(10) F d ) - P ( l ) - F ( 3 ) 166.6(8) 
F ( 2 ) - P d ) - F ( 3 ) 87.7(8) F d ) - P ( l ) - F d a ) 110.7(12) 
F d > - P ( l ) - F ( 2 a ) 91. 1(10) F ( 2 ) - P d ) - F ( 2 a ) 176.2(16) 
F d ) - P ( l ) - F ( 3 a ) 82.7(8) F ( 2 ) - P ( l ) - F ( 3 a ) 89.4(8) 
F ( 3 ) - P ( l ) - F ( 3 a ) 84.0(10) 
TABLE 1. Atom coordinates (xlO*) and temperature f a c t o r s (A 3xl0 : 
atom X y z 
Agd) 0 953(1) 2500 58(1)* 
S d ) -1502(3) 341(1) 760(4) 81d)« 
Nd) -107(12) 1738(4) 405(10) 81(4)* 
N(2) 2162(9) 1125(5) 1535(12) 88(4)* 
C d ) -1331(12) 859(6) -736(13) 88(5)* 
C(2) -1128(13) 1602(7) -492(14) 92(6)* 
C(3) 1119(15) 1739(7) -258(15) 100(6)* 
C(4) 2141(13) 1746(7) 749(15) 99(6)* 
C(5) 3087(13) 1136(8) 2624(15) 116(7)* 
C(6) 3000(11) 569(7) 3544(16) 103(6)* 
P d ) 5000 1395(2) 7500 86(2)* 
F d ) 6068(15) 989(7) 7225(21) 321(12)* 
F(2) 4687(11) 1420(10) 5988(13) 262(10)* 
F(3) 4058(12) 1969(6) 7717(12) 201(7)* 
* Equivalent isotropic U defined as one t h i r d of the 
trace of the orthogonalised U t 4 tensor 
TABLE Hydrogen coordinates (xlO*) and temperature f a c t o r s (A^xlO 3) 
atom X y z U 
H(N1) -232 2167 797 97 
H(N2) 2350 771 914 102 
H(la) -2066 812 -1276 100 
H(lb) -638 697 -1248 100 
H(2a) -1856 1781 -74 98 
H(2b) -992 1813 -1362 98 
H(3a) 1188 1349 -815 115 
H(3b) 1190 2124 -829 115 
H(4a) 2031 2107 1376 104 
H(4b) 2908 1799 270 104 
H(5a> 2983 1534 3146 126 
H<5b) 3890 1133 2212 126 
H(6a) 3309 192 3057 108 
H(6b) 3527 663 4311 108 
TABLE Anisotropic temperature factors ( A a x l 0 3 ) 
atom ut» U22 u 3 3 U,3 u t a 
Ag(l) 53(1) 63(1) 57(1) 0 -6(1) 0 
5(1) 86(2) 52(1) 105(2) -2(2) -42(2) -0(2) 
N(l) 136(9) 44(4) 64(6) -5(4) 19(8) 5(7) 
N(2) 73(7) 94(8) 99(8) -32(7) 11(6) -17(6) 
c m 103(10) 91(9) 70(8) -16(7) -20(8) 22(8) 
C(2) 133(12) 75(9) 68(8) 25(7) 5(9) 26(9) 
C(3) 157(14) 68(9) 76(10) 3(7) 44(11) -23(9) 
C(4) 113(11) 88(10) 96(11) -12(9) 53(10) -41(9) 
C(5) 71(8) 155(14) 124(13) -54(12) 19(10) -27(9) 
C(6) 65(8) 108(10) 134(13) -37(10) -35(8) 13(8) 
P ( l ) 65(2) 72(3) 120(4) 0 -25(4) 0 
F<1> 264(17) 267(16) 432(28) -188(17) -164(17) 204(13) 
F(2) 147(10) 507(27) 131(9) -149(15) -27(8) -37(13) 
F(3) 222(12) 213(12) 169(11) 29(9) 4(10) 103(10) 
The anisotropic temperature factor exponent takes the form: 
-2r*lti**maUtt+k*bm*\laa+ ••• +2hka-b-U,») 
(4) [Ag-N,N'-bis(9)NS 2 ][PF 6 ] 
T a b l e of E x p e r i m e n t a l D e t a i l s 
A. C r y s t a l D a t a 
C14 H28 Ag F6 N2 P S4 
F. W. 605.48 F ( 0 0 0 ) = 1224 
c r y s t a l d i m e n s i o n s : 0.07 x 0.18 x 0.20 mm 
peak w i d t h a t h a l f - h e i g h t = 0. 30° 
Mo K* r a d i a t i o n ( X = 0. 71073 A) 
t e m p e r a t u r e = 21 t 1° 
t e t r a g o n a l s p a c e group P41212 
a = 10. 128 ( 3 ) A c = 21. 711 ( 4) A 
V = 2227. 0 A 1 
Z = 4 L\ = 1. 81 g/cm' 
= 13. 8 cm-1 
T a b l e of E x p e r i m e n t a l D e t a i l s 
B. I n t e n s i t y Measurements 
I n s t r u m e n t : 
Monochromator: 
A t t e n u a t o r : 
T a k e - o f f a n g l e : 
D e t e c t o r a p e r t u r e . 
C r y s t a l - d e t e c t o r d i s t . 
S c a n type: 
S c a n r a t e : 
S c a n width, de g 
Max ifflum 2@: 
No. of r e f l measured. 
C o r r e c t i ons: 
E n r a f - N o n i u s CAD4 d i f f r a c t o m e t e r 
G r a p h i t e c r y s t a l , i n c i d e n t beam 
Zr f o i 1. f a c t o r 17. 6 
o 
2. 8 
2.0 to 2. 5 mm h o r i z o n t a l 
4. 0 mm v e r t i c a l 
21 cm 
"-20 
1 - 7 /min ( i n omega) 
0. 6 + 0. 350 t a n 6 
50 0 ° 
4341 t o t a l . 1946 unique 
L o r e n t z - p o l a r i z a t i o n 
R e f l e c t i o n a v e r a g i n g ( a g r e e m e n t on I = 4.3V.) 
N u m e r i c a l a b s o r p t i o n (from76 52 t o 9 1 . 9 6 on I ) 
C S t r u c t u r e S o l u t i o n and R e f i n e m e n t 
S o l u t i o n : 
M i n i m i z a t i o n f u n c t i o n : 
L e a s t - s q u a r e s w e i g h t s : 
Anomalous d i s p e r s i o n : 
R e f l e c t i o n s i n c l u d e d : 
P a r a m e t e r s r e f i n e d : 
U n weighted agreement f a c t o r : 
W eighted agreement f a c t o r : 
E s d of obs. of u n i t w e i g h t : 
C o n v e r g e n c e , l a r g e s t s h i f t : 
High peak i n f i n a l d i f f . map: 
Computer hardware: 
Computer s o f t w a r e : 
P a t t e r s o n method 
X w<:FO!-:FC:> 
4Fo Z " ) l ( F c l ) 
A l l non-hydrogen atoms 





<. 0 OOS 
0. 52 ( 9) e/A' 
PDP-11 
SDP-PLUS ( E n r a f - N o n i u s & 
B. A. F r e n z fc A s s o c i a t e s . I n c . ) 
Tab'le 
M o l e c u l a r d i m e n s i o n s 
( a ) Bond l e n g t h s ( A ) 
Ag S4 2. 9 0 2 ( 2 > 
Ag S7 2. 61 1 ( 2 ) 
Ag Nl 2 5 8 6 ( 5 ) 
S4 C3 1 . 8 0 4 ( 9 ) 
S4 C5 1 . 8 5 3 ( 9 ) 
S7 C6 1 . 7 8 3 ( 9 ) 
S7 C8 1. 8 0 5 ( 7 ) 
Nl CIO 1. 431 ( 8 ) 
Nl C2 1. 450( 10) 
Nl C9 1. 517 < 10) 
CIO C 1 0 ( I > 1 4 6 5 ( 9 ) 
C2 C3 1. 497 ( 1 1 ) 
C5 C6 1. 4 7 5 ( 1 3 ) 
C8 C9 1. 488( 1 1 ) 
P F l l . 5 2 5 ( 4 ) 
P F 2 1. 5 3 9 ( 4 ) 
P F 3 1. 5 7 2 ( 5 ) 
P F4 1. 5 7 4 ( 5 ) 
The d i s t a n c e s i n v o l v i n g the minor components of 
the d i s o r d e r e d atoms were c o n s t r a i n e d as f o l l o w s ; 
Nl C2* 1. 469 
Nl C9# 1. 469 
C3 C2» 1. 524 
C6 C5* 1. 524 
C8 C9* 1. 524 
S4 C5» 1.817 
< b ) Bond angles ( ) 
S4 Ag S 4 ( I ) 156 8 3 ( 7 ) C 1 0 N , c 9 106.5(6) 
S4 Ag S7 80.90(7) c 2 N , C 9 111 8 ( 5 ) 
S« Ag S 7 ( I ) 93 0 4 ( 6 ) N l C 1 0 C 1 0 ( I > 121.2(6) 
S4 Ag Nl 74 0 ( 1 ) N 1 C 2 C 3 1 1 5 3 ( 7 ) 
S4 Ag N1(I> 126.6(1) s 4 c 3 C 2 
Ag 57 CB 100.2(2) F 2 p F 4 
Ag Nl C9 100 8 ( 4 ) S 4 C 5 , C 6 
116 1(6) 
S7 Ag S 7 ( I ) 149 6 3 ( 6 ) S A c 5 C 6 115 7 ( 6 ) 
S7 Ag Nl 77 0 ( 1 ) S 7 C 6 C 5 1 ? 1 1 ( 6 ) 
S7 Ag N K I ) 130 1(1) S 7 C 8 C 9 117.2(5) 
Nl Ag N K I ) 73 7 ( 1 ) N 1 c < ? c 8 113.2(6) 
Ag 54 C3 95.6(3) F I p F 2 
Ag S4 C5 100.8(3) F , p F 3 
C3 S4 C5 99 5 ( 4 ) 
Ag S7 C6 101 3 ( 3 ) F 2 p F 3 90.0(2) 
180 0 
90. 0(2 ) 
F1 P F4 89 8 ( 2 ) 
90 2 ( 2 ) 
C6 57 C8 106 1(4) F 3 p F 4 68.1(3) 
Ag Nl CIO 105 7 ( 3 ) F 3 p F 4 ( I ) 91 9(3) 
Ag Nl C2 115 5(4) N 1 c ? t c 3 112 (3) 
116 (2) 
CIO Nl C2 115.3(6) N J c 9 » C B 1 M ( 3 ) 
The romal numeral ( I ) r e f e r s to e q u i v a l e n t p o s i t i o n g. «. - i 
T a b l e 1. 





















x y z 
0.09287(5) 0 . 0 9 2 8 7 ( 5 ) 0.0 
0.2831(2) - 0 . 0 1 8 8 ( 2 ) - 0 . 0 7 7 9 ( 1 ) 
0. 2 6 3 8 ( 2 ) 0. 0 1 7 4 ( 2 ) 
0. 0 5 6 4 ( 4 ) -0. 1 5 9 6 ( 5 ) 
-0. 0805 ( 7 ) -0.1797 (6 ) 
0. 1472(8) -O. 2 3 8 4 ( 8 ) 
O. 1979(9) -O. 1 7 3 6 ( 9 ) 
0. 4 0 9 3 ( 8 ) -O. 071 1 ( 8 ) 
0 . 0 0 2 3 ( 1 0 ) 0. 4 0 9 9 ( 9 ) 
0. 2 0 7 0 ( 7 ) -0. 1 4 8 8 ( 7 ) 
0. 0 7 3 3 ( 8 ) -0. 1841 ( 8 ) 
0. 5 1 0 3 ( 2 ) 
0 . 4 0 3 8 ( 6 ) 
O. 6 1 7 7 ( 5 ) 
0. 4 3 4 5 ( 5 ) 
0. 5 8 6 7 ( 6 ) 
O. 0 6 2 ( 4 ) 
0. 431 ( 4 ) 
0. 1 4 7 ( 4 ) 
0 . 5 1 0 3 ( 2 ) 
O . 4 0 3 8 ( 6 ) 
O. 6 1 7 7 ( 5 ) 
0. 5 8 6 2 ( 5 ) 
0. 4 3 2 9 ( 6 ) 
-0. 1 9 7 ( 4 ) 
-O. OOl ( 4 ) 
-0. 2 3 2 ( 4 ) 
0. 0828 ( 1 ) 
0. 0051 ( 3 ) 
-O. 0082 ( 5) 
- 0 . 0 3 1 2 ( 4 ) 
-0. 0 8 8 4 ( 3 ) 
-O. 0211 ( 5 ) 
0. 0 3 7 6 ( 4 ) 
0. 0 9 6 7 ( 3 ) 




0. 0 5 2 4 ( 2 ) 
0. 0 5 1 8 ( 2 ) 
- 0 . 0 6 1 ( 2 ) 
-0. 0 3 2 ( 2 ) 
O. 0 4 5 ( 2 ) 
D (A ) 
3. 56 ( 1 ) 
5. 0 3 ( 5 ) 
4. 4 7 ( 5 ) 
2. 8 ( 1 ) 
5. 1 ( 2 ) 
4. 1 ( 2 ) 
5. 1 ( 2 ) 
5. 2 ( 3 ) 
7 . 3 ( 3 ) 
4. 0 ( 2 ) 
3. 4 ( 2 ) 
4 . 1 4 ( 4 ) 
12. 5 ( 2 ) 
11. 6 ( 2 ) 
7 . 8 ( 1 ) 
9. 8 ( 2 ) 
3. 3 ( 9 ) 
2. 8 ( 9 ) 
2. 4 ( 8 ) 
C2/C2*. C5/C5*. and C9/C9* a r e d i s o r d e r e d atom s i t e s w i t h r e l a t i v e 
o c c u p a n c i e s 0. 84/0. 16. 
The x and y c o o r d i n a t e s of each of the atoms, Ag, P, F l , and F 2 
were c o n s t r a i n e d to be equal. 
A n i s o t r o p i c a l l y r e f i n e d atoms a r e g i v e n i n the form of t h e 
i s o t r o p i c e q u i v a l e n t t h e r m a l p a r a m e t e r d e f i n e d as: 
2 2 2 •l/3Ca B n • b B 2 2 + c • a b c o s Y B 1 2 + a c c o 3 8 B 1 3 • b c c o s « B 2 3 ] 
D e p o s i t i o n data 


















U( 1. 1 ) U(2,2) 
0 0307(2) U(1. 1) 




0. 056 ( 5) 




0. 035 < 5) 









E x p r e s s i o n s - U's 
U(3, 3) U ( l . 2) 
0 0738(4) -0 0007(4) 
0 069(1) -0 0 0 2 ( I ) 
0. 076 ( 1 ) -0. 007 ( 1 ) 
0 051(3) -0.000(2) 
0.121(6) -0 00 8 ( 3 ) 
0 066(6) -0.003(4) 
0 0555(9) U( 1, 1 ) 
0 176(4) U(1. 1 ) 
0 159(4) U(1, 1 ) 
0 094(4) 0. 128(4) 




0 048(4 ) 
0 052(5) 








-0 00 4 ( 4 ) 
-0 00 6 ( 4 ) 
0. 0 1 8 ( 1 ) 
-0 09 5 ( 6 ) 
-0 09 5 ( 5 ) 













-0. 009 ( 4 ) 
0. 006 ( 1 ) 
0 062(5) 
0.023(6) 
0. 022 ( 3) 
-O 008(3) 
U(2.3) 
-U (1, 3) 
0 023(1> 






0. 04 5 ( 6 ) 







The form of the a n i s o t r o p i c thermal parameter i s : 
exp(-2r 2(U 1 1h 2a* 2+U 2 2k 2b* z+U 33l 2c* 2*2U 1 2hka*b**2U 13hl«*c*+2U23klb*c*) 
D e p o s i t i o n d a t a 
Calculated hydrogen coordinates (C-H 0.95 A. Biso 5. O A ) 
Atom i y z 
H101 -0 0868 -0 1919 -0 0514 
H102 -0 1054 -0 2589 0 0122 
H21 0 1029 -0 3172 -0 0428 
H22 0 2208 -0 2596 -0 0059 
H31 0 1246 -0. 1580 -0. 1148 
H32 0. 2573 -0. 2332 -0 1077 
H51 0. 4937 -0. 0608 -0. 0396 
H52 0. 3947 -0 1616 -0. 0120 
H61 0. 4375 0. 0896 0 0281 
H62 0. 4740 -0. 0389 0. 0630 
HB1 0. 2072 -0. 1625 0. 1400 
H82 0. 2684 -0. 2072 0. 0779 
H91 0 0098 -0. 1327 0 0951 
H92 0 0582 -0. 2751 0. 0815 
c f i u i z z z i D c n c n t n t n c n w c n c n c n z z z 2 M U ) i n u ) ( n t n z z z 2 ( n t n 
> > > > > > > > > > > > > > > > > > > > > > > > > > > > > > > 
I O I Q I O I Q I O U 3 I D t O U 3 U 3 I O I O I D I f l l D I O I Q t O I Q I O I O I O t D I D I O t D t O I O l Q I D I O 
O 
-J 







Z Z Z Z Z Z Z Z Z zzwcncncntncocncncncncnincncncncncowcnco 
o n o n o n o n n n o o o n o o r j o n o o n o n o n n o o o o iu^^iu^>OM^^iu^CDO*ajo*CDO»a)(h(DChaicouicjuiuo)iJuicj o o o o 
i l i t I I 
0 D - t > O U CJ CD M I U » - O 0 ' a i - > » O l » - * ^ 0 C D I U v | N j * > ^ U C J 0 0 I U I > 0 
^ > 4 > - c D>o> j j o t D » ^ ^ N i * v i m>ow> - ' i u t h a ) o o i u i a 3 0 t n j»ooi-'-o 
o m w z z o o > o a > o o > o > o > o > n > t n t n z c n t n c n t n t n c o 
O O O ^-V *>N 
n n r ) n o z z z z z z z z z t n c n a ) t n c n ( n c n c n > > > > > > > > > 
^ C D U J l U ^ ' - * » - L ^ ^ * * * , - l » - * ^ » - ' N j v l v j v j . t » . f c . > . f c « i e i i f i t o u o u 3 t o i £ j i Q > o 
O O 
z r i n n n n o n n n o o n n n n n n n o o o z z z z z z z z z 
K« s 0 0 " t J > - ' - 0 - O > 0 I U I U I U^^H» a 3 C D t h t > O J U l C J t J » - * » - ' » - * » - * » - ' ^ > - ' » - ' > - ' 
~ o o o o ~ ~ ~ ~ ~ 
> z a ) t n z o o n o n o n r > r ) r ) r > o o r j r j o n r > r > n r > n o n o r > 
~ o o o o o o o o o 
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O OI * Nl 0* •* •* OI CJ O (> <0 O -t» OI «0 [0 4» N] >J CD >0 v l -t» (r 0* 4» sj 
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(5) lAg -PyS 2 0 3 ] 2 [PF6 ]2 
Table of Experimental D e t a i l s 
A. C r y s t a l Data 
CI5 H23 AC F6 N 03 P S2 
F. U 582 32 F(000) = 2336 
c r y s t a l dimensions: O. 18 x 0. 25 x O. 30 mm 
peak width at h a l f - h e i g h t = 0.256 
Mo KG r a d i a t i o n (§ = 0. 71073 A) 
temperature = 21 6 16 
monoclinic space group P21/N 
a = 23.678 ( 3) A b = 18 721 ( 4) A c = 9.690 < 3) A 
@ = 96. 31 ( 1 > e 
V = 4269.3 A6 
Z = 8 6 = 1 82 g/cmS 
6 = 12.7 cm-1 
T a b l e of E x p e r i m e n t a l D e t a i l s 
B. I n t e n s i t y Measurements 
Instrument: 
Monoc hromator: 
A t t e n u a t o r : 
T a k e - o f f angle: 
D e t e c t o r a p e r t u r e : 
C r y s t a l - d e t e c t o r d i s t . 
Scan type: 
Scan r a t e : 
Scan width, deg: 
Maiimum 28: 
No. of r e f l . measured: 
C o r r e c t i ons 
En r a f - N o n i u s CAD4 d > f f r a c t o m e t e r 
G r a p h i t e c r y s t a l , i n c i d e n t beam 
Zr f o i l , f a c t o r 17 O 
2 86 
2.0 to 2.4 mm h o r i z o n t a l 
2.0 mm v e r t i c a l 
21 cm 
w-e 
1 - 46/min <in omega) 
0 6 * 0 350 tan e 
4a. oe 
7496 t o t a l . 6651 unique 
L o r e n t z - p o l a r i zat i on 
R e f l e c t i o n a v e r a g i n g (agreement on I = 2. I X ) 
Numerical a b s o r p t i o n (from74. 58 to83.72 on I ) 
C. S t r u c t u r e S o l u t i o n and Refinement 
S o l u t i o n : 
Refinement: 
M i n i m i z a t i o n f u n c t i o n : 
L e a s t - s q u a r e s weights: 
Anomalous d i s p e r s i o n : 
R e f l e c t i o n s i n c l u d e d : 
P a r a m e t e r s r e f i n e d : 
Unweighted agreement f a c t o r : 
Weighted agreement f a c t o r : 
Esd of obs. of u n i t weight. 
Convergence, l a r g e s t s h i f t : 
High peak in f i n a l d i f f . map: 
Computer hardware: 
Computer s o f t w a r e : 
P a t t e r s o n method 
B l o c k - d i a g o n a l l e a s t - s q u a r e s 
9w( !Fo '. - !Fc ! )« 
4Fo«/ee(Foe) 
A l l non-hydrogen atoms 





0. 0 7 t 
0.88 ( 8) e/Ae 
PDP-11 
SDP-PLUS (Enra f - N o n i u s 
B. A. Frenz & A s s o c i a t e s . I n c . ) 
Table 
Molecular dimensions 
(a) Bond lengths (A) 













































2. 461 (5) 
2. 398(6) 
1. 335( 10) 
1. 331 ( 10) 
1. 374 ( 11 ) 
1. 516( 11 ) 
1. 375( 13) 
1 372(14) 
1. 375 (11) 




1. 426( 15) 
1. 234( 13) 
1. 443( 15) 
1. 414( 12) 
1. 409(12) 













































1. 408( 10) 












1. 318( 18) 
1 375(16) 
1. 381 (13) 
1. 493 ( 14) 
1. 823 ( 10) 
1. 790(9) 
1. 505 ( 14) 
1. 434( 12) 
1. 427( 12) 
(continued. 
CI2B C13B 1. 460(14) 
C13B 014B 1. 432(13) 
014B C15B 1. 398<12) 
C15B C16B 1. 445(17) 
C16B 017B 1. 370(15) 
• 17B C183 1. 320(18) 
C18B C19B 1. 158(27) 
C19B S20B 1. 814(14) 
S20B C21B 1. 783(14) 
PI F l i 1. 538(7) 
PI F12 1. 553(7) 
PI F13 1. 527(7) 
PI F14 1. 563(7) 
PI F15 1. 476(9) 
PI F16 1. 535(8) 
P2 F21 1. 566(9) 
P2 F22 1. 504(8) 
P2 F23 1 467<10) 
P2 F24 1. 557(8) 
P2 F25 1 552(10) 
P2 F26 1. 411(11) 
( b ) Bond a n g l e s ( ) 
N1A Agl S8A 81 3 ( 2 ) 
N1A Agl 011A 83 4 ( 3 ) 
N1A Agl 014A 129 7 ( 2 ) 
N1A Agi 017A 104 3 ( 2 ) 
S8A Agl 011A 77 4 ( 2 ) 
S8A Agl 014A 124 9 ( 2 ) 
S8A Agl 017A 158 5 ( 2 ) 
O U A Agl 014A 65 6 ( 2 ) 
011A Agl 017A 123 5 ( 3 ) 
•14A Agl 017A 67 6 ( 2 ) 
Agl N1A C2A 124 1 ( 5 ) 
Agl NlA C6A 116 0 ( 3 ) 
C2A N1A C6A 118 7 ( 6 ) 
Nl A C2A C3A 122 9 ( 7 ) 
N1A C2A C21A 116 8 ( 6 ) 
C3A C2A C21A 120 3 ( 7 ) 
C2A C3A C4A 118 0 ( 8 ) 
C3A C4A CSA 119 5 ( 8 ) 
C4A CSA C6A 119 3 ( 8 ) 
Nl A C6A CSA 121 7 ( 8 ) 
N1A C6A C7A 119 8 ( 7 ) 
C5A C6A C7A 118 4 ( 7 ) 
C6A C7A S8A 119 0 ( 6 ) 
Agl S8A C7A 97 3 ( 3 ) 







Q U A 
C12A 
Agl 



















0 1 I A 
011A 













































103 1 ( 3 ) 
115 2 ( 9 ) 
118 ( 1 ) 
107. 3 ( 6 ) 
110 9 ( 7 ) 
121 ( 1 ) 
119. ( 1 ) 
110 8 ( 8 ) 
1 1 6 . 8 ( 5 ) 
115 2 ( 5 ) 
114. 4 ( 7 ) 
109 5 ( 7 ) 
108 8 ( 8 ) 
1 1 1 . 9 ( 5 ) 
118 9 ( 5 ) 
1 16 4 ( 7 ) 
107 7 ( 7 ) 
I I S 0 ( 6 ) 
105. 1 ( 4 ) 
102 8 ( 3 ) 
105 1 ( 2 ) 
114 8 ( 5 ) 
123 3 ( 2 ) 
100 5 7 ( 8 > 
115 6 6 ( 8 1 














































































































F l l 
F l l 
Fl 1 
F l l 































































114. ( 1) 
116. ( 1) 
134. (2) 

































S8A -O. 1167(1> 
C9A -O. 1253(6) 
C10A -0.0760(7) 








C19A O. 0364(4) 











































B (A ) 
4 37(1) 












































x y z B (A ) 
0.0875(3) 0.2585(4) -0.1054(7) 3.8(2) 
0. 15862(3) 0. 15456(4) O. 15813(7) 5. 56(2) 
0 1692(3) 0.0394(4) 0.2951(8) 6.0(2) 
0.1487(4) 0 0424(6) 0.4162(10) 6.9(3) 
0 1780(5) 0.0114(6) 0.5343(11) 9.2(3) 
0.5284(11) 9.2(3) 
0.4022(11) 7.2(3) 
0.0077(5) 0.2881(9) 5.7(2) 
0.0062(5) 0.1480(11) 6.7(3) 


















O. 1507(6) -0. 1573(9) 
5. 4(2) 
6. 7(3) 
6. 2(2) O. 2095(3) -0. 1313(6) 
0.2777(6) -0.1236(10) 6.7(3) 
0.2902(6) 0.0091(11) 6.9(3) 
0.2931(3) 0.1195(6) 6.0(2) 
0.2963(6) 0.2492(11) 7.4(3) 
O. 2977(7) 0.3613(11) 8.9(3) 
O. 2372 (4 ) 0. 3720 (7 ) 9.7(2) 
O. 2321(13) 0.4835(14) 26.8(8) 
0.2113(9) 0.5031(11) 13.2(5) 


















0. 0999 ( 1 ) 
0. 0956(5) 




























0. 4491 (4) 
O. 3661 (6) 
< "2 
.1 B (A ) 
0. 3672(3) 8. 11(9) 
0. 4210( 11 ) 9. 5(4) 
0.6676(2) 5.00(6) 
0.5248(6) 11.8(2) 
O. 6285(8) 11. 1(2) 
0. 8068(6) 14. 1(3) 
0.7069(7) 11.6(2) 
0.7196(11) 17.2(3) 
0. 6111(11) 16. 1(3) 
0.6736(3) 6.72(7) 




0. 6185( 10) 16. 5(3) 
0.7301(12) 27. 1(4) 
A n i s o t r o p i c a l l y r e f i n e d atoms are given i n the form of the i s o t r o p i c e q u i v a l e n t 
thermal parameter defined as: 
H/3[a 2B 1 1 • ° 2 B 2 2 + + a o c o s - ^ 2 + accosBB^ + bccos-xB^] 
Deposition data 
Torsion Angles 
C6A N1A C2A C3A 1. 2 
C6A N1A C2A C21A -178 1 
C2A N1A C6A CSA 0. S 
C2A N1A C6A C7A -174. 5 
N1A C2A C3A C4A -1 . 5 
C21A C2A C3A C4A 177. 8 
N1A C2A C21A S20A -89. 8 
C3A C2A C21A S20A 90. 8 
C2A C3A C4A CSA 0. 1 
C3A C4A CSA C6A 1. 5 
C4A CSA C6A N1A -1 . 9 
C4A CSA C6A C7A 173. 2 
N1A C6A C7A S8A -31. 5 
C5A C6A C7A S8A 153. 3 
C6A C7A S8A C9A -80. 3 
C7A S8A C9A ClOA 67. 7 
S8A C9A ClOA 011A 54. 0 
C9A ClOA 011A C12A 88. 2 
ClOA QUA C12A C13A -169. 4 
01 1A C12A C13A 014A 48. 8 
C12A C13A 014A C1SA -166. 1 
C13A 014A C1SA C16A 169. 9 
014A C13A C16A 017A -SS. 7 
C15A C16A 017A C18A -164. 4 
C16A 017A C18A C19A 170. 0 
017A C18A C19A S20A -63. 4 
C18A C19A S20A C21A 84. 7 
C19A S20A C21A C2A 68 4 
C6B NIB C2B C3B -1 . 2 
C6B NIB C2B C21B 174 6 
C2B NIB C6B CSB 0. 2 
C2B NIB C6B C7B 179. 9 
NIB C2B C3B C4B 2. 7 
C21B C2B C3B C4B -172. 8 
NIB C2B C21B S20B -56. 8 
C3B C2B C21B S20B 118. 9 
C2B C3B C4B CSB -3. 2 
C3B C4B C5B C6B 2. 2 C4B C3B C6B NIB -0. 7 C4B C5B C6B C7B 179. 6 
NIB C6B C7B S8B 65. 1 
C3B C6B C7B S8B -115 2 
C6B C7B S8B C9B -157. 1 C7B S8B C9B C10B -169. S 
S8B C9B C10B 011B -63 3 C9B CI OB 011B C12B 149. S 
C10B OUB C12B C13B -78. 3 
0118 C12B C13B 014B -65. 1 
C12B C13B 014B CI SB 172. 8 
C13B 014B CI SB C16B -178. 8 
014B CI SB C16B 017B 64. 0 
CI SB C16B 017B C18B 171. 3 C16B 017B C18B C19B 140. 8 017B C18B C19B S20B -0 1 C18B C19B S20B C21B 1 14. 8 C19B S20B C21B CSB -66. 2 
